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Abstract
The main question developmental biologists pursue is the understanding of the pro-
cesses involved in transforming a single cell into a whole organism with distinct tissues.
In this thesis, I addressed this question, using the frog embryo and focusing on
tissue-specific regulation by transcription factors. As an approximation for dorsal and
ventral tissues, I used UV and LiCl treatments, that resulted in ventralised and dor-
salised embryos, respectively. In a first instance, I did a whole poly(A)-transcriptome
comparison of LiCl- and UV-treated embryos which validated the use of this approach
as a proxy for dorsal and ventral cell types. Furthermore, I characterised these cell
types, identified and characterise new genes, with a special focus in a dorsally expressed
gene activated by the canonical Wnt signalling.
To study cell-specific regulation at the chromatin level I compared the chromatin
landscape of dorsalised and ventralised embryos. I observed that both RNAPII and the
putative enhancer marker p300 bind the chromatin differently in a way that correlated
with gene expression. I also compared the binding of Brachyury, a zygotic transcription
factor expressed in both cell types. Although the majority of sites were bound similarly,
a small subset was differentially bound in the two condition. I showed evidence that
these differences could be due to absence/presence of co-factors that mediated the
binding to these sites.
Finally, I compared Brachyury morpholino(MO)-mediated KD (knockdown) and
KO (knockout) embryos and showed, that whilst phenotypically are similar, transcrip-
tionally there was a group of genes misregulated only in MO-injected embryos. I further
explored the nature of these genes and revealed new insights into the use of morpholinos
in loss of gene function experiments.
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Chapter 1
Introduction
1.1 Signalling pathways and the role in development
Embryonic development can be summarised as the process of transforming one cell, the
mature zygote, into a organism composed of many different cell types. It is a highly
complex process that relies on interaction and communication between different cells.
An early observation of this cell-cell communication (then called embryonic induction)
was by Hans Spemann in amphibians, firstly with optic cup and later with grafting
experiments of the dorsal lip, which I shall discuss later.
The identification of cell communication as an essential process in development
preceded, by several decades, the identification of the molecules responsible for these
interactions and the mechanisms involved. We now know that cell-cell communication
is achieved by the transduction of a signal from one cell to the other: a cell secretes a
ligand to the extracellular space, other cells with the proper receptor will then transduce
the signal through a series of intermediates, which will lead to changes in the receiving
cell. During development, the most common effect of signal transduction between
cells is on transcription, either activation or repression. From the 1980s onwards, as
different molecules have been identified by their role and molecular nature, they have
been grouped into families based on their similarities and capacities to activate certain
pathways. In metazoa, about 17 signalling pathways have been identified, but only
5 of these families seem to have an essential role in early development. These are:
(i) wingless related (Wnt), (ii) TGF-β, Hedgehog, (iv) signalling by receptor-tyrosine
kinase and (v) Notch signalling. In the next sections I will expand on Wnt and TGF-β
23
signalling and refer to their role in development because these are the pathways more
relevant to my thesis.
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1.2 Wnt Signalling
1.2.1 History
The Wnt signalling pathway provides a powerful example of the link between develop-
mental biology and cancer, and why studying the former will greatly inform the latter.
The Wnt ligand was discovered in the late 1980s and early 1990s both as a develop-
mentally relevant gene in Drosophila, wingless, (Baker, 1987; Cabrera et al., 1987) and
as an oncogene in mouse, int-1 (Nusse and Varmus, 1982). With the realisation that
the genes belonged to the same family of extracellular signalling molecules (Rijsewijk
et al., 1987) the names were merged into Wnt (wingless+int).
Through the 1990’s more components of the pathway were identified. These in-
cluded Frizzled(Fzd), Dishevelled (Dsh,Dvl) (Sussman et al., 1994; Sokol et al., 1995;
Noordermeer et al., 1994), β-catenin/Armadillo (Noordermeer et al., 1994; Peifer et
al., 1991), T cell factor (TCF )/Pangolin (Brunner et al., 1997) and Glycogen synthase
kinase 3b (GSK3-β) (Dominguez, Itoh, and Sokol, 1995). Many of these genes were
identified through forward genetic screens and found to be conserved between species.
Epistasis experiments allowed the assembly of a model for the mechanism of Wnt sig-
nalling by identifying where in the pathway each component acted (Siegfried, Wilder,
and Perrimon, 1994; Noordermeer et al., 1994).
In classifying the different Wnt proteins based on function, Wnt signalling was
divided into ’canonical’ and ’non-canonical’. Canonical Wnt was able to induce the
formation of a secondary anterio-posterior (AP) axis in Xenopus embryos (McMahon
and Moon, 1989) and trigger morphological changes in mouse mammary cells (Wong,
Gavin, and McMahon, 1994). The activity responsible for these phenotypes is the accu-
mulation of β-catenin in the nucleus and the activation of the β-catenin/TCF complex
(Shimizu et al., 1997). I shall focus on this canonical signalling in this Introduction.
1.2.2 Canonical Wnt signal transduction
The canonical signal transduction pathway comprises of different components that can
be separated into major groups: ligands (the Wnt proteins), the Frizzled transmem-
brane receptors, the LRP co-receptors, agonists and antagonists of the pathway, the
25
APC/Axin/GSK3-β destruction complex (determines β-catenin stability) and nuclear
effectors (such as TCFs). A summary of the Wnt signal transduction cascade is rep-
resented in Fig.1.1. Wnt ligand binds the primary receptor Frizzled leading to the
association of Axin2 to the phosphorylated co-receptor LRP. This results in the disas-
sembly of the destruction complex and the stabilisation and accumulation of β-catenin
which enters the nucleus, binding to TCF leading to changes in gene expression. In the
absence of a Wnt ligand, β-TrCP binds β-catenin, resulting in its phosphorylation and
ubiquitination and thus its degradation. In the nucleus, the transcriptional repressor
Groucho (Gro) regulates gene expression negatively. I will briefly refer to each of these
components in the following subsections.
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Figure 1.1: Diagram of active and inactive canonical Wnt/β-catenin signalling
The left panel is a representation of a cell in the absence of a Wnt ligand: the destruction complex
(composed of Dvl, Axin, CK1α, APC, GSK3-β) binds β-catenin which is marked for degradation
by β-TrCP via ubiquitination (Ub) and phosphorylation (p). The right panel is a representation of
cell upon binding of a Wnt ligand to the Frizzled receptor which leads to the association of Axin2
to the phosphorylated LRP. The destruction complex is disassembled resulting in the accumulation
and nuclear transport of β-catenin. In the nucleus β-catenin bind the effector TCF and activates
the expression of target genes. This figure was adapted from (Nusse and Clevers, 2017). APC -
adenomatous polyposis coli, CK1α - Casein kinase 1 alpha, Dvl - Dishevelled, GSK3-β - Glycogen
synthase kinase 3 beta.
1.2.3 The Wnt ligands
Wnt ligands belong to an evolutionary conserved family, only present in metazoans, of
which there are 19 known genes in vertebrates. The ligands are around 40kDa in size,
and act mostly as short-range intercellular signals. During synthesis, Wnt proteins
undergo major modifications: these include N-glycosylation that facilitates secretion
and lipidation/acylation (Doubravska et al., 2011; Komekado et al., 2007; Kurayoshi et
al., 2007; Tang et al., 2012) that confers the ability to bind Fzd receptors (Janda et al.,
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2012). In the endoplasmatic reticulum (ER), Wnts are lipid modified by a palmitoyl
transferase, Porcupine (Porc) (Hofmann, 2000; Zhai, Chaturvedi, and Cumberledge,
2004). Following the post-translation modifications in the ER, Wnts are trafficked
to the Golgi assisted by the p24 cargo adaptor family (Buechling et al., 2011; Port,
Hausmann, and Basler, 2011). Once in the Golgi, Wnts bind Wntless/Evi/Sprinter
(WLS), a seven-pass transmembrane protein, (Bartscherer et al., 2006; B nziger et al.,
2006; Goodman et al., 2006) via their palmitate modifications, and are then transferred
to the plasma membrane. Wls is a sorting receptor that facilitates trafficking of Wnts
to the membrane after which it is recycled back to the Golgi by the retromer complex
(Belenkaya et al., 2008; Franch-Marro et al., 2008; Port et al., 2008). This recycling step
is essential for the maintenance of active Wnt signalling as shown in both Drosophila
(Herr and Basler, 2012) and in mammalian cells (Belenkaya et al., 2008). Although
not yet fully understood, some evidence suggests that Wnts, together with Wls, are
incorporated into exosomes and subsequently secreted (Gross et al., 2012; Korkut et al.,
2009), reviewed by (McGough and Vincent, 2016). However, a cell-bound mechanism
has been proposed to occur in the intestinal stem cell niche, in which direct cell contact
promotes Wnt transfer mediated by Fzd and E3 ligases Rnf43/Znrf3 (Farin et al., 2016).
In these examples, the signal is propagated not by diffusion but through cell division
(Farin et al., 2016).
In summary, the synthesis and secretion of Wnt proteins is a complex process that
it still not fully understood, but one that is essential for the start of signal transduction.
Although this mechanism seems to be shared between most Wnt proteins, additional
factors including the cell/developmental context and rate of signal diffusion will also
impact upon signal transduction.
1.2.4 Wnt receptors and co-receptors
After secretion, Wnt ligands bind their corresponding receptor and initiate a signal
transduction cascade in the receiving cell. The main receptors are part of the Frizzled
(Fzd) family, but, other receptors and co-receptors include the lipoprotein receptor-
related protein (LRP) (Wehrli et al., 2000; Pinson et al., 2000; Tamai et al., 2000),
Ror/Ryk (Masiakowski and Carroll, 1992), the muscle-specific kinase (MuSK) (Baner-
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jee et al., 2011) and the protein tyrosinase kinase 7 (PTK7) (Hayes et al., 2013) family
members. Generally, canonical Wnt/β-catenin pathway ligands (i.e. Wnt1, Wnt3a
and Wnt8) bind to the Fzd/Lrp5/6 complex, while non-canonical Wnts (i.e. Wnt5a,
Wnt11) bind the co-receptors Ror2 and PTK7.
The seven-pass-transmembrane receptor Fzd was first identified in Drosophila as
a regulator of tissue polarity (Vinson and Adler, 1987). There are 10 Fzds encoded
in the mammalian genomes all of which resemble, structurally, the G-protein coupled
receptors. Fzds are composed of an extracellular cysteine rich domain (CRD) which
interacts with the Wnts (Bhanot et al., 1996), the transmembrane domain (TMD) and
4 intracellular domains (ICDs) that can interact with other components of the pathway
and regulate Wnt signalling.
A few years ago the structure of the Wnt-Fzd complex was resolved (Janda et al.,
2012). Besides other observations, the structural analysis revealed a two-domain Wnt
structure resembling a ’hand’ with ’thumb’ and ’index fingers’ extended to grasp Fzd8-
CRD at two sites (Janda et al., 2012). Furthermore, the CRD contains a hydrophobic
pocket that establishes the contact with the Wnt palmitoyl moiety. The same group
has shown more recently that upon Wnt binding, LRP5/6 and Fzd dimerise, leading
to conformational changes of the receptors (Janda et al., 2017).
The most common mechanism of signal transduction through Fzd is via Dishev-
elled’s (Dvl) interaction with the ICD (Tauriello et al., 2012). Upon phosphorylation,
the intracellular tail of LRP5/6, a long single-pass-transmembrane co-receptor, inter-
acts with the scaffold protein Axin (Liu et al., 2003; Mao et al., 2001; Tamai et al.,
2004; Tolwinski et al., 2003). The complex of LRP5/6 with Fzd and consequently DVL
and Axin has been characterised as a signalsome (Bilic et al., 2007).
The next step in the cascade is the transduction of the signal from the membrane,
through the cytoplasm and finally to the nucleus. The next section will focus on the
cytoplasm, specifically β-catenin and the destruction complex.
1.2.5 The destruction complex
At the core of the canonical Wnt pathway is β-catenin, which is synthesised in the
cytoplasm and degraded by the destruction complex (DC). It is the balance between
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these two processes that determines the stabilisation and accumulation of β-catenin and
consequently its nuclear entry and target gene activation. Proteins with different roles
make up the DC: the scaffold proteins Axin and adenomatous polyposis coli (APC)
and the kinases GSK3-β and CK1α.
β-catenin was discovered in Drosophila as the segment polarity gene Armadillo
(Nu¨sslein-Volhard and Wieschaus, 1980) and later in Xenopus as part of the adherens
junction (McCrea, Turck, and Gumbiner, 1991). The protein is composed of 42 amino-
acid armadillo repeats (Huber, Nelson, and Weis, 1997) that foster protein-protein
interaction (Graham et al., 2000; Huber, Nelson, and Weis, 1997; Xing et al., 2004;
Xing et al., 2003).
The main scaffold protein Axin, identified in mice, (Zeng et al., 1997) assembles
the components of the DC, interacting with all its proteins. It has also been proposed
that Axin acts as an anchor to keep β-catenin from moving to the nucleus (Peterson-
Nedry et al., 2008; Tolwinski and Wieschaus, 2001). Axin plays an important role in
regulating Wnt signalling; it is present at low concentration in cells, and therefore the
limiting factor for the DC (Lee et al., 2003). APC acts to promote Wnt transduction
by downregulating Axin (Takacs et al., 2008).
GSK3-β is a serine-threonine (Ser/Thr) kinase with roles in numerous cellular pro-
cesses. In the DC, GSK3-β phosphorylates β-catenin, APC, Axin and LRP (Rubinfeld
et al., 1996). Similarly, the Casein kinase 1 (CK1) family of Ser/Thr kinases has many
roles and targets in the cell (Knippschild et al., 2005). CK1 family members regulate
Wnt signalling both positively and negatively by phosphorylating different components
of the cascade: Dvl, LRP5, β-catenin, APC, Axin and TCF (Yanagawa et al., 2002;
Zeng et al., 2005; Zhang et al., 2006; Sakanaka et al., 1999; Ha¨mmerlein, Weiske, and
Huber, 2005; Rubinfeld, Tice, and Polakis, 2001; Lee, Salic, and Kirschner, 2001).
APC was first identified as a tumor suppressor in colon cancer cells (Kinzler et al.,
1991; Nishisho et al., 1991), and it too has many roles independent of Wnt signalling.
In the DC, APC phosphorylation by CK1, protein kinase 4 (PK4) and GSK3-β (Morin
et al., 1997; Rubinfeld et al., 1996), and ubiquitination and deubiquitination by Trabid,
USP15 or HECT D1 E3 ligase, control its capacity to regulate Wnt signalling. In the
absence of Wnt ligand, CK1 and GSK3β phosphorylate β-catenin, which is bound to
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Axin (Liu et al., 2002). The phosphorylated motif is recognised by the E3 ubiquitin
ligase β-TrCP resulting in β-catenin poly-ubiquitination and degradation (Aberle et
al., 1997; Kitagawa et al., 1999).
Upon Wnt ligand engagement with Fzd/LRP, Axin binds LRP and together with
the adaptor protein Disheveled (DVL) the DC is recruited to the membrane promoting
the disintegration of the complex. Under these circumstances, β-catenin is not degraded
and its subsequent accumulation leads to nuclear transport.
1.2.6 Nuclear effectors -TCFs
T-cell factors (TCFs) were first discovered in lymphocytes (Laudet, Stehelin, and
Clevers, 1993) and are the main family of transcription factors that associate with
β-catenin in the nucleus, bringing it to the chromatin. These proteins act on the
genome both to activate and repress gene expression, depending on the co-factor they
bind to. TCFs contain a high mobility group (HMG) domain that enables them to
bind DNA in a sequence-specific manner (Giese, Amsterdam, and Grosschedl, 1991;
Love, Huber, and Anders, 2014). The N-terminal portion of TCF binds to β-catenin
and is therefore essential for its positive activity on transcription (Wetering et al., 1997;
Molenaar et al., 1996).
In vertebrates, the number of TCF genes differs between species: frogs and mice
both have 4 genes: TCF1, LEF1, TCF3 and TCF4. The diversity of TCF genes pro-
vides a mechanism for either activating or repressing gene transcription. For example,
LEF1 acts only as an activator (Kratochwil et al., 2002; Reya et al., 2000; Genderen
et al., 1994), while TCF3 is a repressor (Kim et al., 2000; Liu et al., 2005; Merrill
et al., 2004). TCFs bind gene regulatory regions classified as Wnt responsive ele-
ments (WREs) which have been shown to respond both positively and negatively to
the binding of TCF (Brannon et al., 1997; Hikasa and Sokol, 2011).
In the absence of Wnt signalling, TCF3 binds co-repressors, inhibiting the activation
of Wnt targets. However, when β-catenin is stabilised and becomes present in the
nucleus, it induces the phosphorylation of TCF3 removing it from the DNA. In this
context, TCF1 binds β-catenin, replacing TCF3 resulting in the activation of Wnt the
target genes (Hikasa and Sokol, 2011; Hikasa et al., 2010). This process is also known as
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’TCF exchange’ and was shown to play a role during development in Xenopus (Hikasa
et al., 2010).
The most common mechanism for repressing Wnt target expression is by recruit-
ing co-repressors, such as Groucho (Gro), to the chromatin. Gro was first discovered
in Drosophila (Schrons, Knust, and Campos-Ortega, 1992) as part of a family of co-
repressors, the transducin-like Enhancer of split (TLE). Gro/TLE binds to a variety
of transcription factors (TFs), including TCFs, and represses expression by recruiting
histone deacetylases (HDACs) to the target chromatin (reviewed by (Zhang and Cadi-
gan, 2014). Gro/TLE (and other co-repressors, such as Corepressor of Pangolin (Coop)
in Drosophila (Song et al., 2010) and myeloid translocation gene (MTG) in mammals
(Barrett et al., 2012; Moore et al., 2008)) competes with β-catenin for the binding to
TCFs (Arce, Pate, and Waterman, 2009; Daniels and Weis, 2005; Moore et al., 2008;
Song et al., 2010). Another repressive mechanism of Wnt target genes is disruption of
the β-catenin/TCF interaction by proteins such as the inhibitor of ?-catenin and TCF-
4 (ICAT) (Hasegawa et al., 2007; Tago et al., 2000), the Sry-type HMG box containing
protein 9 (Sox9) (Akiyama et al., 2004; Topol et al., 2009), and Chibby (Cby) (Love
et al., 2010; Li et al., 2008; Takemaru et al., 2003).
Conversely, there are also factors that facilitate the activation of Wnt target genes,
the so-called co-activators. Some proteins strengthen the interaction between TCF and
β-catenin, such as transducin β-like protein 1 (TBL1), TBL1-related protein (TBLR1),
(Li and Wang, 2008) and the ring finger protein 14 (RFN14) (Wu et al., 2013). Other
proteins act as co-activators by specifically binding to the C-terminal transactivation
domain of β-catenin: histone acetyl transferases (HATs), Creb binding protein (CBP)
and p300 (Hecht et al., 2000; Takemaru and Moon, 2000; Li et al., 2011; Sun et
al., 2000), and the ATPase subunit of the Swi/Snf chromatin remodelling complex
(Brg-1) (Barker et al., 2001). In addition to HATs, β-catenin has also been shown
to interact with other components of epigenetic regulation, including proteins respon-
sible for depositing histone markers. There are reported interactions with MLL1/2
(responsible for H3K4me3) (Chen et al., 2010), protein arginine methyltransferase 2
(PMRT2) (H3R8me) (Blythe et al., 2010), SET8 (H3K20me) (Li et al., 2011), CARM1
(H3R17me2) (Ou et al., 2011) and DOTL1/DOT1 (H3K79m3) (Mahmoudi et al., 2010;
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Mohan et al., 2010; Sierra et al., 2006).
1.2.7 Wnt signalling in early Xenopus development
Wnts are involved in many cellular processes and are essential during development as
morphogens, impacting cell polarity, cell division and gene expression that ultimately
will lead to cell identity. In amphibians, Wnt plays a crucial role in early development
and in Xenopus, embryos have become ’test tubes’ to study Wnt signalling and its
components. In this section, I will refer to specific developmental processes where Wnt
is involved.
The dorso-ventral (DV) axis in Xenopus, determined by the sperm entry point, has
at its core the differential activation of Wnt signalling in the early embryo. The deter-
mination of the dorsal side of the embryo, where the blastopore is formed, gastrulation
starts and from where the most anterior structures originate is a hub of active Wnt
signalling (the organiser). Exogenous activation of Wnt signalling in the opposite side,
the ventral side, will cause the formation of a secondary axis (head and trunk), by
simulating the organiser activity. This characteristic has made Xenopus a model in
which to study Wnt signalling, and in particular to test the role of a gene in the cas-
cade based on its capacity to induce a secondary axis (Christian et al., 1991; Funayama
et al., 1995; Yost et al., 1996).
In summary, dorsal determination occurs upon fertilisation; as the embryo under-
goes cortical rotation ’dorsal determinants’ are transported to the prospective dorsal
side resulting in β-catenin enrichment. Throughout the 1990s this process was well
studied, but the nature of the ’dorsal determinants’ was still a mystery. The hypothe-
sis was that some Wnt component would be involved in the stabilisation of β-catenin
dorsally. Initial experiments looked at Wnts expressed maternally in the vegetal pole,
since cortical rotation would ’bring’ the determinants from this region to the prospec-
tive dorsal side. Wnt11 was the first candidate, given the desired expression, but when
it was tested, Wnt11 was not capable of inducing a secondary axis (Ku and Melton,
1993). It was only in 2005 that maternal Wnt11 was shown to be important for dorsal
determination as Wnt11 -depleted embryos lacked the capacity to make dorsal struc-
tures (Tao et al., 2005). Further studies have shown that Wnt11 forms a heterodimer
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with Wnt5a and only the region of co-expression has dorsalising capacity (Cha et al.,
2008). While Wnt5a is present throughout the whole embryo, Wnt11 is only vegetal,
but cortical rotation relocates it to the dorsal side where it forms the heterodimer.
Fzd7 and LRP6 are also maternally inherited and ubiquitously expressed; they are
activated by the Wnts resulting in the stability and accumulation of β-catenin in the
nucleus where it interacts with one of the three maternal effectors: TCF1, 3 and 4
(reviewed by (Sokol and Hoppler, 2014)). Recent studies have identified, by means of
chromatin immunoprecipitation followed by deep-sequencing (ChIP-Seq), where in the
genome β-catenin binds at this and later stages of development (Nakamura et al., 2016;
Nakamura and Hoppler, 2017). These well characterised and relevant targets include
the homeodomain TFs siamois1 (sia1 ) and twin, as well as the nodal related 3 (xnr3
or nodal3.1 ) (Brannon and Kimelman, 1996; Hikasa and Sokol, 2013; Ishibashi et al.,
2008; Laurent et al., 1997; Lemaire, Garrett, and Gurdon, 1995; Lustig et al., 1996).
The activation the of these genes is the starting point of induction of the Nieuwkoop
centre and later the organiser.
The other major roles of Wnt signalling during development occur after zygotic
activation of the genome and during gastrula stage. Wnt regulates two major processes:
patterning of the mesoderm in the DV axis and patterning of the neuroectoderm in
the antero-posterior (AP) axis. For both processes, Wnt is not the sole player, as there
is crosstalk with other signalling pathways. For example, BMP is essential for DV
patterning as discussed in the next section.
Wnt8 is the main player at this developmental stage, a zygotic activated gene
expressed in the prospective ventrolateral mesoderm and repressed dorsally by Wnt
antagonists Dickkopf-1 (Dkk1) and Frzb1. Its role in mesodermal patterning is to
induce MyoD (a paraxial/posterior mesoderm marker) and to repress axial mesoderm
(notochord) via the inhibition of goosecoid (gsc) (reviewed by (Hikasa and Sokol, 2013).
The dorsal centre continues to have active Wnt signalling, maternally activated, that
is simultaneously repressed ventrally by sizzled (szl) (Salic et al., 1997).
The role of Wnt in regulating the patterning of the neuroectoderm involves mostly
Wnt3a that posteriorises the neural tube (Ulloa and Mart´ı, 2010). Kiecker and Niehrs
have shown that Wnt signalling is necessary and sufficient to pattern the AP neural
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axis by a posterior to anterior gradient acting on the neural plate (Kiecker and Niehrs,
2001).
Although not referred to in this Introduction, non-canonical Wnt signalling also
plays an important role in early development regulating the process of convergent
extension during gastrulation.
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1.3 TGF-β Signalling
1.3.1 History
Transforming growth factors (TGFs) were discovered around a decade before Wnts in
the 1970s, whilst studying the C-type RNA tumor virus and its transforming activity
in cells (Larco and Todaro, 1978). In the 1970s, research started to focused on cancer
cells, and the initial concept was that some molecule was secreted and cause a ’normal’
cell to ’transform’ into a cancer cell. An example of such a transforming factor was
the RNA of type-C tumor viruses, that, when expressed in ’normal’ cells, caused the
transformation into a cancer cell (Todaro and Huebner, 1972).
Initially, the transforming growth factors (TGFs) were described as sarcoma growth
factors (sGFs), proteins secreted by murine sarcoma virus (MuSV) transformed cells
that would bind ectodermal growth factor (EGF) receptors (Larco and Todaro, 1978).
By the late 1970s, the sGFs were renamed TGFs because they were secreted factors that
lead to growth of cells and were thought, incorrectly, to be produced by transformed
cancer cells. Early on, two kinds of TGFs were described, TGF-α and TGF-β, the
distinction between them being that only TGF-α was capable of binding EGF receptors.
For the purpose of this work I will focus solely on the TGF-β family of dimeric growth
factors, as they have a critical role during development.
Other components of the TGF-β signalling pathway were subsequently discovered
and described in the 1980s. Competitive assays showed that TGF-β family members
bind with high affinity (Frolik et al., 1984; Tucker et al., 1984) to what were later
characterised as type I and type II receptors, and type III co-receptors (also known
as betagycan) (Massague and Like, 1985). Historically, the next major step was the
cloning of the TGF-β gene in 1985, a 2439bp precursor mRNA from human cDNA
(Derynck et al., 1985). The gene was called TGF-β1 and discovered to be produced
not only by cancer cells, as previously described, but also by normal cells, although at
higher levels in tumors (Derynck et al., 1985; Derynck and Rhee, 1987). Other TGF-β
homologs were identified in the 1980s: the homodimeric TGF-β2 and the heterodimeric
TFG-β1:TGF-β2 (Cheifetz et al., 1987). TGF-β2 was found to have different affini-
ties with the three types of receptors, specifically lower affinity to the type II receptor
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(Lo´pez-Casillas, Wrana, and Massague, 1993; Cheifetz et al., 1987). These three ho-
mologs are the only TGF-β genes found in the mammalian genome, but when reference
is made to TGF-β signalling it usually refers to a larger group of proteins, known as
the TGF-β superfamily. Members of this family share sequence homology, specifically
the ’cysteine knot’, the last six cysteines of the proteins (McDonald and Hendrick-
son, 1993). TGF-β genes were identified in other model organisms and were shown
to have a role during development: decapentaplegic (dpp) in Drosophila has a role in
patterning (Padgett, St Johnston, and Gelbart, 1987); Vg1 in Xenopus is important
for mesoderm induction (Padgett, St Johnston, and Gelbart, 1987; Birsoy et al., 2006).
Other members of the superfamily include the bone morphogenetic proteins (BMPs);
also identified in the 1980s and isolated from bone tissue, BMP2 and BMP3 (Wozney
et al., 1988).
The remaining components of the pathway, the effector proteins that act both in
the cytoplasm and in the nucleus, are the Smads. Smads were discovered in the early
1990s, initially in Drosophila when studying Dpp. There, mothers against dpp (mad)
was identified as a downstream component of the Dpp signalling pathway (Raftery
et al., 1995). Similarly, in C.elegans, 3 genes, Sma 2-4, were shown to be required for
the activation of the homolog of the BMP2/4 receptor (Savage et al., 1996). Smads
became Smads in 1996 by combining mad and sma (Derynck et al., 1996) and many
homologs have been found since then. In total we now know 33 genes that encode for
human proteins that belong to the TGF-β superfamily, having many distinct roles in
development and disease. In the next sections I will summarise what is understood
about the general mechanism of signal transduction and its components while giving
examples of the role of the pathway in early Xenopus development.
1.3.2 TGF- β signalling cascade - the commonly accepted model
37
TGF-β/ΒMP
TGF-β RI
TGF-β RII
R-Smad
R-Smad
R-Smad
R-Smad
Co-
factors
Smad 4
Smad 4
P
P
Figure 1.2: Diagram of TGF-β/Smad signalling
This figure represents a cell with active TGF-β signalling. TGF-β ligands bind as dimers to type I
and type II receptors leading to the phosphorylation of the R-Smad. Active R-Smad binds Smad4
forming an heteromeric complex that is translocated to the nucleus. In the nucleus, this complex binds
co-factors and regulates the activation of target genes. The figure was adapted from (Luo, 2017).
The TGF-β signalling cascade starts with the binding of the dimeric ligands to
type I and type II transmembrane receptors, which are assembled as a heterodimeric
complex. After binding, the cascade can take different paths; I will focus here on the
Smad-dependent pathway, which is the more relevant to this thesis. Upon binding,
the type II receptor activates the type I receptor which in turn phosphorylates the
receptor-regulated Smad (R-Smad) proteins via its intracellular kinase domain. Once
activated, R-Smads bind other R-Smads plus a common Smad (Co-Smad), Smad4,
forming a heteromeric complex. This complex is then translocated to the nucleus where
it binds co-factors and regulates transcription of target genes by interacting with the
chromatin (Fig. 1.2). The complexity of the TGF- β signalling pathway is conveyed
by the different types of components (ligands, receptors, smads) which in different
combinations can lead to different transcriptional outputs. In the next sections, I shall
refer to these different components and how they are regulated.
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1.3.3 TGF-β sub-families
The members of the TGF-β superfamily are generally subdivided into two large groups,
the TGF-β-like (includes TGF-β, activin, nodals and some growth differentiation fac-
tors (GDFs)) and the BMP-like (BMPs, most GDFs and the anti-Muellerian hormones
(AMH)). What distinguishes the two families is their differing affinities for the receptors
and the R-Smads that are in turn activated. TGF-β and activins have a higher affinity
for type II receptor and activate Smad2/3, while Smad1/5/8 are phosphorylated upon
BMP binding to type I receptor (reviewed by (Massague´, 2012; Heldin and Moustakas,
2016). The higher affinity binding of BMPs requires both types of receptors (Sebald
et al., 2004; Feng and Derynck, 2005; Kirsch, Sebald, and Dreyer, 2000). These rules
are commonly accepted, although many of the conclusions derived from overexpression
studies that may mask the endogenous activities of both ligands and receptors.
1.3.4 TGF-β ligands and its regulation in the extracellular space
There are more than 30 proteins in the TGF-β superfamily and 19 homologs in Xenopus
(summarised in table 1.1). Biochemically, these proteins are cytokines with 6 conserved
cysteine residues known as the ’cysteine knot’. The synthesis process includes the
conversion of a precursor protein by furins (and other convertases) into the dimeric
active protein (Constam, 2014; Taylor, Van De Ven, and Creemers, 2003). Dimerisation
is mediated by the 7th cysteine and while homodimers are the most common active
ligands, heterodimers have also been described to be active. Lefty is the exception as
it does not contain the 7th cysteine and is active as a monomer (Meno et al., 1996).
After synthesis and release into the extracellular space, different mechanisms can act
to regulate TGF-β signalling. For example, several antagonists have been identified,
including molecules capable of binding the ligands and sequestering them from the
receptors. The first to be identified was follistatin (FS), that binds activin (Bragdon
et al., 2011), and others include the BMP binding proteins Noggin, Chordin, Twisted
gastrulation, Cerberus1 and Gremlin 1/2 (reviewed by (Zakin and Robertis, 2010;
Umulis, O’Connor, and Blair, 2009; Bragdon et al., 2011)). The accessibility of ligands
to bind the receptors is controlled by the so-called ligand binding traps. These traps
occur as a result of the action of the antagonists. The ligand traps are a type of TGF-β
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TGF-β family
members in Xenopus
BMP2
BMP4
BMP7
Gdf6
Vg1, Derriere
Admp
Xnr1-4
Activin-β A
Activin-β B
Activin-β C
Activin-β D
TGF-β5
TGF-β2
Lefty-A
Lefty-B
Table 1.1: TGF-β family members present in Xenopus. The four Xnr1-4 proteins are
homologous to Nodal in humans and Vg1 and Derriere are the only proteins without
human homology
inhibition that functions to regulate excess of BMPs, and a well described example is
the BMP7-Noggin ligand trap (Groppe et al., 2002).
1.3.5 TGF-β receptors
In vertebrates there are 7 type I receptors ( Activin A receptor like type I (ACVRLI also
known as Activin like kinase 1 (ALK1)), Activin A receptor type I (ACVRI/ALK2),
BMP receptor type I A (BMPRIA/ALK3), Activin A receptor type I B (ACVRIB/ALK4),
TGF-β receptor I (TGFβRI/ALK5) , BMP receptor type I B (BMPRIB/ALK6), Ac-
tivin A receptor type I C (ACVRIC/ALK7)), and 5 type II receptors (TGF-β receptor
type II (TGFβRII), Activin receptor type II A (ACVRIIA), Activin receptor type II
B (ACVRIIB), BMP receptor type I (BMPRII) and anti-Muellerian homone receptor
type II (AMHRII). Both kinds of receptors have a small cysteine-rich extracellular do-
main, a single transmembrane portion, a juxtamembrane domain and a cytoplasmic
domain with kinase activity.
As referred to above, the commonly accepted model of signal transduction involves
the initial binding of ligand to type II receptors. Type II receptors are thought to be
constitutively active (Lin and Wang, 1992; Lin et al., 1992) with ligand binding leading
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to the formation of a type I and type II complex that in turn leads to the phosphory-
lation of the juxtamembrane domain of type I by type II. The juxtamembrane domain
is also known as the ’GS’ domain because of its rich composition of glycine and serine
residues (Wrana et al., 1994). The receptor complex formed upon ligand binding is
composed of two type I and two type II receptors, and since the ligands are dimeric, it
forms a 2:2:2 heterotetrameric complex (Wrana et al., 1992; Moustakas et al., 1993; He-
nis et al., 1994; Wells et al., 1999; Yamashita et al., 1994; Massague, 1998). Moreover,
the receptor-receptor interaction increases the stability of the receptor-ligand binding
(Radaev et al., 2010). When the receptors are inactive that is, not bound by TGF-
β ligands, they exist in the membrane as monomers, homodimers and heterodimers
(Chen and Derynck, 1994; Henis et al., 1994; Gilboa et al., 1998; Zhang et al., 2009;
Ehrlich et al., 2012).
Regulation of TGF-β signalling in the membrane
The receptors can be regulated by different mechanisms such as post-translational mod-
ification, co-receptors, microRNAs (miRNAs) and other interacting proteins. Phospho-
rylation is the most common form of modification since this is how the receptors are
activated. Besides the phosphorylation process already described, type II receptors,
specifically TGFβRII, are autophosphorylated, maintaining an active form (Luo and
Lodish, 1997). Dephosphorylation of the receptors also occurs in order to inhibit signal
transduction.
At this point, I should introduce a distinct type of Smad protein, known as I-
Smad, for its inhibitory role in TGF-β signalling. These I-Smads compete with R-
Smads by binding to the receptors and blocking access. Smad7, an I-Smad, can also
promote dephosphorylation of the TGFβRI by recruiting GADD34, a subunit of protein
phosphatase 1 (PP1), to the type I receptor (Shi et al., 2004). In a developmental
context, another protein phosphatase, Dullard, has been shown to dephosphorylate
BMPRIA, which in turn results in the degradation of the BMPRII, a process required
for neural induction (Satow et al., 2006).
The Smad ubiquitin regulatory factors (Smurfs) are a family of E3 ubiquitin lig-
ases that can bind to Smad7 and mark TGFβRI for degradation by polyubiquitination
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(Kavsak et al., 2000; Ebisawa et al., 2001). This regulatory mechanism is part of a
feedback loop, since Smurf2 and Smad7 are activated by TGF-β. SUMOylation is a
modification, analogous to ubiquitination that involves the addition of small ubiquitin-
like modifiers (SUMOs). Upon TGF-β stimulation, TGFβRI is modified by the ad-
dition of SUMOs, enhancing R-Smad phosphorylation (Kang et al., 2008). Another
kind of modification, Neddylation, is provided by the neural precursor cell-expressed
developmentally down-regulated 8 (NEDD8), a ubiquitin-like molecule that stabilises
TGFβRII (Zuo et al., 2013). Deubiquitination of the receptors also occurs, resulting
in a positive effect on signal transduction. Examples of proteins involved include the
ubiquitin carboxy-terminal hydrolase 37 (UCH37) (Wicks et al., 2005), the ubiquitin-
specific protease 4 (USP4) (Zhang et al., 2012a), USP11 (Al-Salihi et al., 2012) and
USP15 (Zhang et al., 2013).
Smad7 is the most studied example of an I-Smad that interacts with and regu-
lates type I receptors (Hayashi et al., 1997; Nakao et al., 1997) in ways other than
recruiting protein modifiers to the receptor. The mode of action of this protein also
includes blocking R-Smad recruitment and inhibition of the Smad-DNA interaction in
the nucleus (reviewed by (Yan and Chen, 2011)).
Other molecules can also interact with the receptor and regulate the pathway,
with one example being the BMP and Activin membrane-bound inhibitor (BAMBI),
a transmembrane protein that directly binds to either the ligands TGF-β/Activin or
the BMP receptors (Grotewold et al., 2001; Loveland et al., 2003; Onichtchouk et al.,
1999). Additionally, BAMBI binds Smad7 reinforcing its inhibitory role on the TGF-β
type I receptor (Yan et al., 2009). It is part of a negative feedback loop, as Bambi
is activated by TGF-β signalling (Xi et al., 2008; Sekiya et al., 2004). In Xenopus,
BAMBI has an important role in regulating anterio-posterior (AP) patterning, which
I will refer to below.
Finally, receptor control also occurs at the mRNA level, which can be targeted
by miRNAs, causing downregulation. The most pertinent example is the role of the
miR-15 family members (miR-15 and miR-16) in early Xenopus development, regulat-
ing Nodal signalling. The miRNAs act to restrict Nodal signalling to the organiser by
targeting the ACVRIIA; moreover, the miRNAs are inhibited by Wnt/β-catenin sig-
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nalling, resulting in its ventral expression (Martello et al., 2007). Many other miRNAs
have been shown to regulate TGF-β in other contexts: miR-302/miR-372 in induced
pluripotent stem cells (iPSc) (Subramanyam et al., 2011) and miR-520/miR-373 in
cancer cells (Keklikoglou et al., 2012), the cluster miR-17-92 (Mestdagh et al., 2010)
and miR-140-5p (Yang et al., 2013).
1.3.6 TGF-β effectors - the Smads
The basic structure of R-Smads and Co-Smads is of two globular domains: the mad
homology 1 (MH1) domain on the amino-terminus (N-terminus) and the mad homology
2 (MH2) domain at the carboxyl-terminus (C-terminus). The MH1 domains contain the
nuclear localisation signal (NLS) and the DNA-binding domain, a β-hairpin structure.
The MH2 domain contains an L3 loop, a series of hydrophobic surface patches, essential
for the interaction with the type I receptor (Lo et al., 1998). Upon ligand binding,
phosphorylation of the type I receptor by the type II receptor creates a binding site
for the basic surface patch of the MH2 domain of R-Smads (Wu et al., 2000). The
subsequent phosphorylation of the C-terminal end of R-Smads allows for the association
with Smad4, the Co-Smad; an acidic knob allows the binding of homologous MH2
domains (Abdollah et al., 1997; Kretzschmar, Doody, and Massague, 1997; Liu et al.,
1997; Souchelnytskyi et al., 1996). Smad4 is not able to interact with type I receptors
since its MH2 domain lacks the required C-terminal serine residues (SXS). Once in the
nucleus, the MH1 domain binds to DNA whilst MH2 interacts with other nuclear factors
to modulate transcription (reviewed by (Massague´, 2012; Moustakas and Heldin, 2009;
Weiss and Attisano, 2013)). MH1 and MH2 domains are coupled by a non-conserved
linker region. This linker region can be phosphorylated by a variety of kinases (such as
the cyclin C-cyclin dependent kinase 8 (CDK8) and CDK9) that, among other things,
control the maintenance of Smads in the nucleus and create docking sites for nuclear
proteins (Alarco´n et al., 2009). I-Smads do not contain an MH1 domain nor the SXS
motif. Rather they have only the MH2 domain which allows the binding to the type I
receptor .
The Smad-receptor interaction can be modulated by Smad-interacting proteins that
either promote or repress it. The best studied examples are the Smad anchor for
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receptor activation (SARA) and the hepatic growth factor-regulated tyrosine kinase
substrate (Hrs)(Hgs); FYVE-motif proteins that recruit Smad2 and 3 to the type I
receptor (Tsukazaki et al., 1998). Other proteins include the serine/threonine kinase
receptor associated protein (STRAP) and the destruction complex component Axin
(Datta and Moses, 2000; Furuhashi et al., 2001; Guo et al., 2008).
The nuclear transport of Smads can also be modulated in order to influence the
outcome of signal transduction. Although R-Smads and Co-Smads have a NLS in
their MH1 domain, nuclear transport is processed differently for each kind of Smad.
Smad3 interacts with importin-β, whereas Smad4 interacts with importin-α for nuclear
transport (Xiao, Latek, and Lodish, 2003; Xiao, Liu, and Lodish, 2000; Kurisaki et al.,
2001). However, Smads3, 4 and 2 can also interact with nucleoporin proteins for import,
such as the nucleoporin 153 (Nup153) and Nup214 (Xu et al., 2002; Xu et al., 2003). In
Drosophila it has been shown that importin 7 and 8 can also mediate nuclear import of
Smad1, 2 and 3 (Xu et al., 2007). In the presence or absence of a TGF-β signal, Smads
continuously shuttle between the cytoplasm and the nucleus via interaction with the
nuclear pore complex (Xu et al., 2002).
Although all R-Smads have a nuclear export signal in the linker region, only Smads1
and 4 use it for this purpose (Watanabe et al., 2000). Furthermore, Smad4 export can
also be mediated by exportin 1 (CRM1) (Xiao et al., 2003; Xiao et al., 2001; Pierreux,
Nicola´s, and Hill, 2000). Translocation of Smad3 from the nucleus to the cytoplasm
is mediated by exportin 4 and a Ras related nuclease (Ran) GTPase (Kurisaki et al.,
2006).
Smads in the nucleus
In the nucleus, the Smad complex binds with low affinity to DNA regions called Smad-
binding elements (SBE), present near TGF-β/Smad target genes, that are commonly
enriched for the AGAC or GTCT sequence (Zawel et al., 1998; Jonk et al., 1998;
Dennler et al., 1998). Smad1 has the particularlity of a hairpin structure in the MH2
domain that might be responsible for the affinity of the protein to the CG-rich se-
quences (Korchynskyi and Dijke, 2002). The low affinity of Smads to DNA sequences
is overcome by the presence of other TFs that act as co-factors to increase binding
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affinity. These co-factors include cell-type specific transcription factors or nuclear fac-
tors such as histone acetyltransferases (HATs) and histone deacetylases (HDACs). In
the nucleus there is also cross-talk between signalling pathways. One example is the co-
operation with Wnt via co-occupancy of Smad target enhancers by LEF1 and TCF7L2
(Labbe´ et al., 2007; Labbe´, Letamendia, and Attisano, 2000; Nakano et al., 2010).
The need for co-factors adds another layer of regulation to TGF-β signalling, as differ-
ent cell types will have different co-factors which in turn will influence the activation
of distinct target genes. This results in distinct roles for TGF-β/Smad signalling in
the cell, from differentiation to self-renewal. Once in the nucleus, several mechanisms
occur to maintain Smads and allow accumulation. Such mechanisms include the asso-
ciation with DNA and proteins like Fast1/Foxh1 (Xu et al., 2002) and TAZ (Varelas et
al., 2008). Association of phosphorylated-Smad3 (pSmad3) (active form) with Smad4
blocks its interaction with CRM1 and consequently its export from the nucleus (Chen
et al., 2005).
1.3.7 TGF-β in early Xenopus development
The main TGF-β superfamily members that play an important role in early frog de-
velopment are the Xenopus-related nodal (Xnr) 1-6, Derriere, Vg1 and Activin from
the Nodal family and BMP2, 4 and 7 from the BMP family. Nodals are involved in
regulating endoderm and mesoderm specification and patterning, gastrulation move-
ments and left-right asymmetry, while BMPs regulate ventral and lateral mesoderm
patterning and determine ectodermal cell fate. I will refer to some of these processes
here, but they will be described in more detail in the section related to early Xenopus
development.
The first zygotic genes to be expressed are the Nodal members xnr5 and xnr6. The
activation of these genes occurs by the blastula stage in the most dorsal cells of the
embryo, a region where both β-catenin and maternal VegT (T-box transcription factor
present in the vegetal pole of the embryo) are present and cooperate in the activation
(Takahashi et al., 2000) (Fig. 1.3). By itself, maternal VegT is capable of inducing
low levels of both genes in the prospective endoderm. Other members of the Nodal
family, xnr1, xnr2 and xnr4 are subsequently induced by xnr5 and xnr6 (Agius et
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al., 2000). Simultaneously, Derrie`re, another TGF-β member, starts to be expressed
in the marginal zone, a similar pattern to that of zygotic VegT, with slightly higher
levels dorsally (Sun et al., 1999; Stennard et al., 1999). Hence, a coarse gradient of
Activin-like TGF-β signalling is formed, higher in the dorsal side, which will pattern
the mesoderm and endoderm. Other molecules act to better define the gradient, for
example, Cerberus1 (Cer1) which is an antagonist of both TGF-β and Wnt signalling
(Piccolo et al., 1999).
Interestingly, BMPs have the opposite gradient in the early embryo, with higher
expression in ventral cells. BMP is also expressed in the prospective ectoderm where
lower levels determine neural tissue (Graff, 1997). BMP4 is the main player at this
point in development and its expression is restricted ventrally as the result of an-
tagonist signals and diffusion limitations (Fainsod, Steinbeisser, and Robertis, 1994;
Hemmati-Brivanlou and Thomsen, 1995). The other two BMPs, BMP2 and BMP7,
share expression domains in the ectoderm and mesoderm (Piccolo et al., 1996). Other
antagonists that constrain BMP expression are Chordin and Noggin, both expressed
dorsally, keeping these cells BMP-free (Zimmerman, De Jesu´s-Escobar, and Harland,
1996; Jones and Smith, 1998). Bambi, the pseudo-receptor described above (first iden-
tified in Xenopus) is activated by BMP4 and expressed in the same cells, associating
with TGF-β receptors and repressing the signal (Onichtchouk et al., 1999).
The anti-dorsalising morphogenetic protein (Admp), a TGF-β ligand, was first
identified in Xenopus in a screen for genes expressed in the Spemann organiser and
is related to human BMP3 (Moos, Wang, and Krinks, 1995). Admp expression is
activated by low levels of BMP and despite being expressed dorsally it has a ventralising
activity, conserved in chicken and fish (Moos, Wang, and Krinks, 1995; Joubin and
Stern, 1999; Dosch and Niehrs, 2000; Lele, Nowak, and Hammerschmidt, 2001; Willot
et al., 2002). ADMP signals through Alk-2 but it does not do so dorsally, as it is
repressed by Chordin (Reversade and Robertis, 2005).
In relation to the Smads, in Xenopus, xSmad1 and xSmad5 are activated by BMPs
(Graff, Bansal, and Melton, 1996; Suzuki et al., 1997) and, as observed in other ver-
tebrates, xSmad2 and xSmad3 are activated by Activin and Nodals (Howell, Mohun,
and Hill, 2001). SARA was also identified in Xenopus as the xSmad2 recruiter to the
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type I receptor (Tsukazaki et al., 1998). Interestingly, the co-Smad Smad4, is encoded
by two genes in the Xenopus genome: xSmad4α and xSmad4β (Smad10 ). The for-
mer is the human orthologue; it is expressed maternally and its expression decreases
with the onset of gastrulation when xSmad4α starts to be expressed (Masuyama et al.,
1999; LeSueur and Graff, 1999; Howell et al., 1999). Another distinction between the
two is that Smad10 does not contain a NES domain, making it constitutively nuclear
(Watanabe et al., 2000; Pierreux, Nicola´s, and Hill, 2000). I-Smads are also present
in Xenopus: xSmad6 (Nakayama et al., 1998) and xSmad7 (Nakao et al., 1997); their
expression mimics that of BMP4 and they act to inhibit some TGF-β signals.
Although the Smad proteins are ubiquitously and uniformely present in the embryo,
their active phosphorylated (p) forms are not. pSmad1 and pSmad2 have an assymetric
distribution, the former higher ventrally and lower dorsally (Faure et al., 2000; Kurata
et al., 2001), and the spatial and temporal localisation of pSmads follows that of the
corresponding activator ligands. By stage 9, pSmad1 is localised in dorsal and ventral
cells becoming enriched ventrally by stage 9.5 until stage 12.5 (early neurula) (Faure
et al., 2000; Kurata et al., 2001). pSmad2 is initially dorsally enriched and by stage
9.5 has spread through the marginal zone and the endoderm, moving from dorsal to
ventral, with higher levels vegetally and absence in animal cap cells (Lee, Heasman,
and Whitman, 2001).
Active forms of Smads in the nucleus interact with co-factors and bind DNA to
activate target genes. Early targets of TGF-β have been identified in Xenopus such
as the mix paired-like homeobox (mixl1 or mix.2 ) which contains a Activin responsive
element in its promoter and requires xFast1/Foxh1 as a co-factor (Chen, Rubock, and
Whitman, 1996; Chen et al., 1997). Other transcription factors, mostly homeodomain-
containing like Mixer, Milk and Bix3, have been shown to act as co-factors and recruit
Smad2/4 to the genome (Germain et al., 2000). At present, in the era of whole-
genomics, most genomic targets of TGF-β have been identified in different animal
models and at different stages by ChIP-Seq using antibodies against pSmad2/3 or
pSmad1 and cofactors like Foxh1 (Gupta et al., 2014; Kim et al., 2011; Yoon et al.,
2011; Wills and Baker, 2015; Chiu et al., 2014; Charney et al., 2017).
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1.4 Early amphibian development
Xenopus unfertilised eggs are polarised in the animal-vegetal axis, both in pigmentation
and in cytoplasmic yolk content: the animal pole is darker and has less yolk content,
the vegetal pole is rich in yolk and lighter. The polarity is broken at fertilisation as
a consequence of the rotation of the cortex in relation to the core of the egg, in the
direction of the animal pole. Given the differences in pigmentation, rotation leads to
the formation of the ’grey crescent’, a region with an intermediate pigmentation, on the
opposite side of the sperm entry point (SEP). As I will discuss below, this is the earliest,
and one of the most important processes in development, as it determines the dorsal-
ventral (DV) axis. Amphibian embryos cleave holoblastically: the first cleavage goes
through the SEP and the mid-line of the grey crescent, and the second is perpendicular
to this first. The first division takes longer to occur (timing depends on the species and
temperature) while the following divisions are roughly every 30 minutes. Initially, the
embryo is single layered, as all divisions are perpendicular to its surface, but becomes
multilayered as it cleaves. The cell divisions are synchronous up until cell cycle 13 when
the midblastula transition (MBT) occurs (Newport and Kirschner, 1982a; Newport and
Kirschner, 1982b).
1.4.1 Dorsal-Ventral Axis Determination
The dorsal-ventral (DV) axis of amphibians is established early in development, just
after fertilisation. The sperm entry point will determine the dorsal side of the em-
bryo as a result of cytoplasmic rearrangements, called cortical rotation (reviewed by
(Harland and Gerhart, 1997) (Fig. 1.3) . After fertilisation, the egg cortex rotates 30°
relative to the central core of the egg cytoplasm (Vincent, Oster, and Gerhart, 1986).
During cortical rotation, microtubules localised between the core and the cortex align
in parallel to the direction of rotation, towards the prospective dorsal side (Elinson
and Rowning, 1988), reviewed by (Gerhart et al., 1989). Elinson et al. further showed
that cortical rotation is a microtubule dependent event by using inhibitors of micro-
tubule polymerisation (UV irradiation and colchicine) that lead to the impairment of
rotation. This disruption of microtubule polymerisation leads to deficiencies in axis
determination, specifically the lack of dorsal determination and development of solely
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ventral structures (ventralised) (reviewed by (Gerhart et al., 1989)). Additional stud-
ies showed that microtubules are responsible not only for cortical rotation, but their
alignment allows for a rapid and efficient transport system for molecules to the plus end
(prospective dorsal side) (Rowning et al., 1997). Further experiments have shown that
the molecules transported by the microtubules to the dorsal side (herein called dorsal
determinants) come from the vegetal pole of the amphibian embryo (Sakai, 1996) (Fig.
1.3). Although it was understood that cortical rotation was essential for the determi-
nation of the dorsal side of the embryo, the molecular nature of the process was not
understood at the time. It was not until the mid-90s that it was shown that the main
consequence of cortical rotation is the asymmetrical activation of the Wnt/β-catenin
signalling pathway and the enrichment of β-catenin (ctnnb1) in the dorsal nuclei (Lara-
bell et al., 1997; Schneider et al., 1996). The molecular components began to emerge
and included Dishevelled and the GSK-3β binding protein GBP, all components of the
Wnt signalling pathway (Miller et al., 1999; Weaver, 2004). The nuclear translocation
of β-catenin in dorsal cells marks the earliest molecular event in DV asymmetry and
is also responsible for the formation of two signalling centres at blastula stage: the
Nieuwkoop center and the Spemann organiser.
Fertilisation
30o cortical 
rotation
Cleavage stage
Dorsal
Ventral
Figure 1.3: Diagram representing determination of the dorsal-ventral axis by
cortical rotation
The frog egg has maternally deposited dorsal determinants (red circles) enriched in the vegetal
pole. Fertilisation triggers reorganisation of the microtubule cytoskeleton and leads to microtubule
polymerisation in the vegetal cortex. The egg cortex rotates 30° in relation to the core displacing the
maternal determinants to the prospective dorsal side. Here, these determinants activate the canonical
Wnt signallings resulting in the accumulation of nuclear β-catenin (yellow circles). The figure was
adapted from (Wolpert and Tickle, 2011) and (De Domenico et al., 2015)).
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1.4.2 Spemann organiser and Nieuwkoop center
The Nieuwkoop center (NC) is formed on the dorsal vegetal region and it is charac-
terised by the expression of nodal related factors (xnr), activated by β-catenin, together
with chordin and noggin, BMP-signalling antagonists (Wessely et al., 2001) (Fig. 1.4,
1.5). This region is also known as the BCNE centre (blastula chordin and noggin ex-
pression center) (De Robertis and Kuroda, 2004) (Fig. 1.4) . Both centres are formed
at the blastula stage and both require β-catenin, however the NC further requires other
maternal mRNAs. The BCNE centre will give rise to neural tissue and regulates neu-
rulation, whilst the NC functions as a endoderm regulator (reviewed by (De Robertis
and Kuroda, 2004)). In addition to the expression of BMP antagonists, the BCNE
also expresses siamois (homeobox gene), foxa4a/pintallavis (winged-helix protein) and
xnr3 (nodal related-3) (Kuroda, Wessely, and Robertis, 2004; Wessely et al., 2004).
The NC is characterised by the expression of cerberus (a secreted antagonist) and nodal
related factors (xnr1,2,4,5, and 6 ), the latter being mesoderm inducers, specifically of
dorsal mesoderm (Agius et al., 2000; Takahashi et al., 2000). The equatorial cells over-
lying the NC are only induced to become dorsal during the gastrula stage (reviewed
by (Harland and Gerhart, 1997)).
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Figure 1.4: Diagram of the BCNE and Nieuwkoop center at blastula stage
that give rise to the Spemann organiser at gastrula stage
At blastula stage the BCNE centre is located in the dorsal-most part of the animal cap and it
is characterised by the expression of the BMP antagonists, chordin and noggin. In the dorsal vegetal
region the Nieuwkoop centre (NC) is formed and characterised by the expression of β-catenin and VegT
targets, the nodal related proteins. The BCNE gives rise to neural tissue while the NC is essential for
dorsal mesoderm induction, including the Spemann organiser at early gastrula. Also at the gastrula
stage the ventral signalling organiser is established. The figure was adapted from (De Robertis and
Kuroda, 2004).
The organiser is characterised by three properties: induction, morphogenesis and
self differentiation. It is responsible for organising embryonic development by signalling
to neighbouring cells to differentiate as different cell types, whilst organising the scale,
placement and orientation of the tissues (reviewed by Harland and Gerhart, 1997). The
amphibian organiser is also known as the Spemann organiser (SO), as a result of the
1924 experiments conducted by Hans Spemann and Hilde Mangold. They transplanted
a small fragment of the dorsal side of a newt gastrula into the ventral side resulting in
the formation of 2 conjoined embryos (Spemann and Mangold, 1924). The transplanted
cells were able to change the neighbouring cells of the host and make them differentiate
into central nervous system (CNS), somites and other axial components (dorsal tissues).
This indicated that the transplanted cells (Spemann graft) behave as an organiser and
inducer. We now know that these cells secrete paracrine factors that change the fate
of the surrounding cells.
Although the function of the SO has long been known, the molecular players were
only discovered many years later. The SO is characterised by the secretion of sev-
eral proteins, that regulate different molecular signalling pathways, including TGF-β,
Wnt and FGF signalling, such as chordin, noggin and xnr3. Xnr3, contrarily to the
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other nodal related proteins, is not a mesoderm inducer but acts as a BMP antagonist
(Haramoto et al., 2004). The organiser also secretes Wnt antagonists, such as Frizzled-
related proteins (frzb-1, crescent, sfrp-2 ) (Leyns et al., 1997), and dkk1 (Mao et al.,
2001). Cerberus is highly expressed in the dorsal mesoderm (the organiser), where it
acts as a Nodal, BMP and Wnt antagonist (Piccolo et al., 1996) and is required for
head induction (Kuroda, Wessely, and Robertis, 2004). Overall, the SO secretes mostly
BMP, Wnt and Nodal antagonists which promote head development whilst repressing
trunk-tail tissues (Niehrs, 2001; Piccolo et al., 1999). As referred to above, the cells
that form the Spemann organiser are in the equatorial region of the embryo and will
become the dorsal mesoderm. However, the inductive properties of the organiser influ-
ence all three germ layers. The organiser is able to anteriorise the endoderm, dorsalise
the mesoderm and induce neurulation in the ectoderm.
1.4.3 Germ layer determination
The use of fate maps, labelling cells early in development with a marker and observing
later in development which cells are marked has allowed for the identification of cells
which will give rise to the different germ layers and tissue types. In a simplified way, at
the pre-gastrula stage, the animal cap (AC) represents the presumptive ectoderm, the
vegetal pole will give rise to endoderm and the region in between, the marginal zone,
will form mesoderm.
For the purpose of this work, I will further discuss the process of mesoderm induc-
tion, but first I will refer to the developmental process responsible for the segregation
of the germ layers: gastrulation.
1.4.4 Gastrulation movements
Gastrulation starts on the dorsal side of the embryo and it is identifiable by Nieuwkoop
and Faber stage (NF) 10-10.5 (Nieuwkoop and Faber, 1994) with the formation of
a pigmented lip, called the dorsal lip of the blastopore. However, cell movements
involved in the process start before this structure is visible, with the formation of
bottle cells. Bottles cells gained the name from their shape and they are essential for
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gastrulation (Keller, 1991; Keller and Danilchik, 1988; Keller, 1984). These cells are
formed and, by invagination, are transported inside the embryo and by contracting
they pull the associated cells inwards. Cells from the marginal zone and the vegetal
pole will ingress through the blastopore whilst AC cells (prospective ectoderm) spread
vegetally replacing the involuting cells. The marginal zone cells can be categorised
into involuting marginal zone (IMZ) and non involuting marginal zone (NIMZ). The
IMZ has many layers that involute as sheets inside the gastrula and will form mostly
axial mesoderm: somites and notochord. The NIMZ and AC will give rise to neural
ectoderm, with the latter contributing to the brain and the former to the posterior
hindbrain and spinal cord. As the first cells ingress (the prospective neural tissue),
they extend and narrow toward the dorsal midline resulting in lengthening in an AP
orientation. This movement, essential for neural tube morphology, is called convergent
extension. Gastrulation starts on the dorsal side and then continues laterally and
ventrally, terminating with the blastopore closure.
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1.5 Mesoderm Development
1.5.1 Mesoderm Induction - the three-signal model
As described above, the organiser is able to dorsalise mesoderm, however mesoderm
induction happens earlier in development, at blastula stage. The equatorial cells of
the blastula are induced to become mesoderm, instead of ectoderm, by signals secreted
by the underlying cells, the endoderm (Fig. 1.5). This phenomenon was tested and
observed when cells of the animal pole (Animal cap), prospective ectoderm, were cul-
tured juxtaposed to vegetal pole cells and become mesoderm (Nieuwkoop and Ubbels,
1969). In the 1980s Jonathan Slack’s lab described mesoderm induction as the result
of a series of inducing signals, known as the 3-signal model. It postulated that two
signals arise from the vegetal pole cells, one that induces ventral-like mesoderm in the
marginal zone and a second signal restricted to the dorsal side (from the Nieuwkoop
center) that induces dorsal mesoderm (Spemann organiser). These signals differ quali-
tatively between dorsal and ventral vegetal cells (Dale, Smith, and Slack, 1985; Smith
and Slack, 1983), dividing the marginal zone into dorsal and ventral prospective meso-
derm (Fig. 1.5). The organiser then secretes the third signal that dorsalises some of
the mesoderm pre-specified as ventral. Due to diffusion limitations this signal does not
reach the ventral-most region of the marginal zone that will still form the ventral most
mesoderm (Dale, Smith, and Slack, 1985; Slack and Forman, 1980; Smith and Slack,
1983; Smith, Dale, and Slack, 1985).
This model is still accepted to this day as the principle behind mesoderm induction,
although some modifications and additions to the model have been made. Moon and
colleagues suggested that the two signals from the vegetal pole should be separately
characterised, one being a dorsal competent modifier (resultant from cortical rotation)
that modifies the interpretation of the second signal from the vegetal cells. The two
initial signals were then classified as two types; a generic meso-endoderm inducing
signal and a dorsal modifying signal that is superimposed (Christian and Moon, 1993;
Kimelman, Christian, and Moon, 1992).
A 4th signal was added as a result of work done in Edward de Robertis’ lab; BMPs
secreted by the ventral and lateral regions of the gastrula embryo that antagonise the
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organiser (reviewed by (De Robertis and Kuroda, 2004; Harland and Gerhart, 1997;
Heasman, 1997). This region was classified as the gastrula ventral centre that estab-
lishes a gradient of BMP activity across the marginal zone determining dorsal/ventral
mesodermal fates (Dosch et al., 1997). The secretion of BMPs leads to the expression
of ventral specific genes ventx (vent-homeobox1-3 ) and evx1 (even-skipped homeobox-
1 ) (Gawantka et al., 1995; Joly et al., 1993; Kawahara et al., 2000). The same lab
added another modification to the model, accounting for the dorsal-to-ventral gradient
of vegetally expressed nodal related proteins (Agius et al., 2000) (Fig. 1.5). The ma-
ternal vegt (a T-box transcription, below) and vg1 (a TGF-β member) together with
β-catenin are responsible for this gradient. High levels of β-catenin and nodals induce
dorsal mesoderm (organiser) whilst lower levels of nodals (which are induced by vegt
and vg-1 only) lead to the expression of bmp4 and wnt8a on the ventral side of the
embryo (Agius et al., 2000; De Robertis and Kuroda, 2004).
VegT, Vg1
β-catenin
nodal related proteins
mesoderm
endoderm
Nieuwkoop 
center
CNSectoderm
Spemann 
organiser
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Figure 1.5: Diagram representing mesoderm induction in early Xenopus de-
velopment
Mesoderm induction is initiated at stage NF8, maternal T-box VegT together with dorsal activated
β-catenin induce the expression of nodal related protein that establish a gradient in the vegetal pole
of the animal. Higher levels in the dorsal side induce dorsal mesoderm and lower levels lead to the
expression of ventral markers, such as bmp4 and wnt8a. This initial gradient will give rise to the
distinct types of mesoderm within the dorsal-ventral axis. The figure was adapted from (Wolpert and
Tickle, 2011). CNS - central nervous system.
The nature of the mesodermal inductive signals has mostly been identified using
techniques such as the animal cap assay. The animal cap assay is similar to the tech-
nique described above where animal cap cells are juxtaposed to vegetal cells, changing
their fate to mesoderm. By substituting the vegetal pole with a soluble molecule, or
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injecting the embryos with mRNA of the inducing agent, it was possible to discover
several molecules capable of inducing mesoderm (Jones and Smith, 1999). Different
mesoderm inducers were independently identified, many of which were members of
the TGF-β family, including nodals, Activin, Vg1 and BMPs (Asashima et al., 1991;
Kimelman and Kirschner, 1987; Smith, 1987; Smith et al., 1990; Weeks and Melton,
1987). FGF was also shown to have some mesoderm-inducing activity (Kimelman and
Kirschner, 1987; Slack et al., 1987). Induction of mesoderm is characterised by the
expression of specific genes that are required for the further development of this germ
layer. Brachyury is one of these genes. It encodes a T-box transcription factor and
it is a key protein for mesoderm formation and patterning. In the next section I will
discuss further this family of TFs.
1.6 T-box transcription factors during early development
Brachyury (also known as T) was the first member of the T-box gene family to be
discovered, in 1927 by Dobrovolska¨ıa-Zavadska¨ıa, when describing heterozygous mutant
mice with a short tail and embryonic defects (Dobrovolskaia-Zavadskaia, 1927). In the
1990s when the gene was cloned and sequenced, it was classified as a transcription
factor and its role in mesoderm regulation identified (Herrmann et al., 1990; Kispert
and Herrmann, 1993). It was also in the mid-1990s that the T-box gene family was
categorised, with the identification of novel genes in the mouse that shared a protein
motif, the T-box domain (Bollag et al., 1994).
The T-box is a 200 amino acid DNA-binding domain that binds in a sequence spe-
cific manner (reviewed by (Papaioannou, 2014; Smith, 1997; Smith, 1999; Gentsch,
Monteiro, and Smith, 2016)). The T-box domain binds a 20 nucleotide partially palin-
dromic sequence T[G/C] ACACCTAGGTGTGAAATT, made of two half-sites and
described to be bound by the protein as monomer (Kispert and Herrmann, 1993).
Other T-box proteins can bind the consensus half site AGGTGTGAA also known as
the TBE (T-box binding element) (reviewed by (Papaioannou, 2014)). The crystal
structure of the Xenopus Bachyury bound to a palindromic sequence derived from the
in vitro selected consensus sequences, was analysed and revealed that it binds as a
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dimer (Mu¨ller and Herrmann, 1997).
There are 5 T-box subfamilies, categorised in relation to their DNA-binding do-
main: T, Tbx1, Tbx2, Tbx6 and Tbr1. With the exception of tbx2 (Carreira et al.,
1998) T-box transcription factors have been shown to act as transcriptional activators,
although this is not yet completely understood. The members of this family of tran-
scription factors have a variety of roles during development: t, vegt and eomesodermin
(eomes) are essential during early development in regulation of mesoderm and endo-
derm (reviewed by (Showell et al., 2006)), tbx6 is important later in the presomitic
mesoderm, tbx4/5 exerts its role in limb development and tbx20 is important for car-
diogenesis. For the purpose of this project I will focus on the role in early amphibian
development, specifically mesoderm formation and regulation by t, Eomes and Vegt.
1.6.1 Eomes and Vegt
Eomes and Vegt are the earliest T-box genes to be expressed during Xenopus develop-
ment. Both act as transcription factors and are essential for mesoderm induction and
regulation.
The eomes gene was isolated in Xenopus and shown to be expressed in the prospec-
tive mesoderm (Fig. 1.6), before Brachyury induction, in a dorsal to ventral gradient
(Ryan et al., 1996). Later in development the gene is expressed in a subset of cells of
the central nervous system (Ryan et al., 1996) (Fig. 1.6). Expression of Eomes mRNA
in animal caps induces the expression of mesodermal markers like brachyury gsc and
wnt8a. These genes are induced in a dose-dependent manner, higher levels of Eomes
induce high level of gsc but less of brachyury and wnt8a. Furthermore, overexpression
of Eomes induces gsc and changes the fate of ventral to dorsal mesoderm (Ryan et al.,
1996). Overexpression of Eomes mRNA fused to the repressor domain Engrailed re-
sulted in gastrulation defects and reduction of mesodermal markers and muscle actin
(Ryan et al., 1996). Together, these experiments have shown that Eomes is essential
for mesoderm induction, regulation and patterning.
There are two VegT alternative splice isoforms in Xenopus, one that is maternally
deposited in the vegetal pole of the egg and the other is expressed upon zygotic genome
activation. I referred to maternal VegT and its role in inducing the SO and dorsal meso-
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derm. VegT was identified as a transcription factor capable of activating transcription
(Zhang and King, 1996). Similar to Eomes and Brachyury, zygotic VegT is expressed
in the prospective mesoderm but, by the end of gastrulation the gene is no longer ex-
pressed dorsally and it is later confined to a few cells of the neural tube (Zhang and
King, 1996; Lustig et al., 1996) (Fig. 1.6). VegT acts in a non cell autonomous manner
and is capable of inducing both mesoderm and endoderm (Clements et al., 1996; Horb
and Thomsen, 1997; Lustig et al., 1996; Stennard, Carnac, and Gurdon, 1996; Zhang
and King, 1996; Zhang et al., 1998a). VegT is a master regulator of endoderm, which
in turn is involved in the induction of mesoderm. Loss of maternal VegT results in
embryos with head defects as well as reduction of endodermal and mesodermal gene
markers (Zhang et al., 1998a). Zygotic VegT can be activated by /TGF-β factos,
FGFs, Brachyury and Eomes, although it is not known if the effect is direct (Horb and
Thomsen, 1997; Lustig et al., 1996; Stennard, Carnac, and Gurdon, 1996).
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Figure 1.6: Expression of Eomes, VegT and Brachyury in gastrula and tailbud
stage Xenopus embryos
Expression pattern of Eomes, VegT and Brachyury by whole mount in situ hybridasation in
gastrula and tailbud stages of the Xenopus tropicalis embryo. NF - Nieuwkoop and Faber stage.The
image was adapted from Figure 4 of (Gentsch et al., 2013).
1.6.2 The role of Brachyury in mesoderm formation and maintenance
T is necessary and sufficient for mesoderm formation. This was shown in animal
cap assays where overexpression of t is sufficient for the conversion of ectoderm to a
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mesodermal fate (Cunliffe and Smith, 1992). Furthermore t acts in a dose-dependent
manner with low concentrations inducing the formation of smooth muscle and higher
concentrations inducing skeletal muscle (O’Reilly, Smith, and Cunliffe, 1995; Tada,
O’Reilly, and Smith, 1997). In the experiments by O’Reilly et al they showed that
the notochord is only induced when t is coexpressed with pintallavis/foxa4a (dorsally
expressed gene), an example of how t can act synergistically with other TFs to specify
cell fates (O’Reilly, Smith, and Cunliffe, 1995).
1.6.3 Induction and regulation of t in the mesoderm
T is induced in mesodermal cells in the equatorial region of the embryo. Activation
occurs in response to mesoderm-inducing signals (discussed above) derived from the
vegetal hemisphere of the embryo (Slack, 1994). Mesoderm is formed only in the
equatorial cells of the embryo, which can be explained by the threshold response of t to
Activin, a strong Brachyury inducer. The activation of t occurs in a narrow window of
Activin levels, either high (vegetal pole) or low levels (animal pole) of Activin represses
t (Green, New, and Smith, 1992; Gurdon et al., 1994; Gurdon, Mitchell, and Mahony,
1995). The repression of t by high levels of Activin was shown to be indirect, through
goosecoid (gsc). Ectopic expression of gsc leads to down-regulation of t through a
direct interaction with the gene promoter (Artinger et al., 1997; Latinkic and Smith,
1999).
Another gene that is capable of inducing Brachyury expression and regulating meso-
derm formation is vegt. VegT is maternally expressed in the vegetal hemisphere of the
amphibian egg, a region that will form the endoderm (vegt also acts as an endodermal
regulator) (Horb and Thomsen, 1997; Lustig et al., 1996; Stennard et al., 1999; Zhang
and King, 1996). Zygotic vegt is expressed throughout the mesoderm in a broader
pattern compared to t, and its expression is later downregulated in the notochord
(Stennard, Carnac, and Gurdon, 1996) (Fig. 1.6). Depletion of maternal vegt impairs
endoderm formation and mesodermal cells differentiate as ectoderm while the animal
pole gives rise only to epidermis (no neural tissue) (Zhang et al., 1998b).
Expression of brachyury is also regulated by Wnt signalling. Overexpression of
canonical Wnt signalling inhibitors revealed that brachyury requires ligand-dependent
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activity of Wnt in order to be expressed (Vonica and Gumbiner, 2002). However, Wnt
by itself is not capable of inducing mesoderm, so it can only induce t in the presence of
TGF-β and FGF signalling. Analysis of the t promoter revealed elements that respond
to Activin and FGF signalling (Latinkic et al., 1997) as well as TCF-binding sites
(mediated by Wnt signalling) (Vonica and Gumbiner, 2002). Interestingly, FGF has
an additional role in maintaining Brachyury expression at later developmental stages
(Schulte-Merker and Smith, 1995) attained by an autoregulatory loop between these
two genes (Casey et al., 1998; Isaacs, Pownall, and Slack, 1994). This was shown using
the expression of Xbra-Enr (engrailed repressor domain) fusion construct that resulted
in a lack of expression of embryonic FGF (eFGF) in the notochord. Furthermore, FGF
is a direct target of t ; binds as a monomer to two Brachyury consensus sites in the
FGF promoter (Casey et al., 1998).
Besides eFGF, other genes have been identified as Brachyry targets, most of them
activated, which has led to the idea that Brachyury mostly acts as a transcriptional
activator (Conlon et al., 1996). The first Brachyury targets were identified by analysis
of cDNA libraries from embryos injected with a hormone-inducible version of Brachyury
(Tada, O’Reilly, and Smith, 1997; Tada et al., 1998). Among the genes induced, within
a short period of brachyury activation, there was a family of four genes encoding
proteins containing a paired-type homeodomain. These genes were related to the mix
family of homeobox-containing genes (Rosa, 1989) named bix1-4 (brachyury induced
homeobox containing genes). Bix are activated by both t and vegt and are expressed in
the prospective mesoderm and the vegetal hemisphere (Tada et al., 1998). Both bix1
and bix4 are responsive to mesoderm-inducing factors of the TGF-β family and they
direct ectoderm to mesodermal fates (Casey et al., 1999; Tada et al., 1998). As well as
being regulated by Wnt signalling, xwnt11 was also shown to be a Brachyury target
and mediates convergence during gastrulation (Tada and Smith, 2000).
In the era of whole genome analysis, the discovery of T-box targets has become
easier and more thorough. New techniques have allowed us to focus on defining the
gene regulatory networks (GRNs) initiated by these T-box transcription factors and
that regulate mesoderm development. In zebrafish, a chromatin immunoprecipitation-
microarray approach (ChIP- chip) allowed the identification of more than 200 potential
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targets of No-tail (Ntl, Brachyury homolog) (Morley et al., 2009). In Xenopus tropi-
calis, a detailed ChIP-Seq analysis of binding of Brachyury, Eomesodermin and VegT
at gastrula and tailbud stage led to significant insights into the role of these T-box
transcription factors in the regulation of neuromesodermal progenitors (Gentsch et al.,
2013). I shall discuss this work further in Chapter 4.
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1.7 Chromatin regulation in early embryonic development
1.7.1 Studying the chromatin; introduction to ChIP-Seq
Developmental fates are established during development as a result of complex gene
regulatory networks (GRNs) that lead to changes in gene expression. The main players
in these GRNs are proteins that are capable of binding chromatin, specifically regula-
tory regions (promoters and enhancers), leading to changes in the regulation of genes
by modulating transcription and ultimately gene expression. Proteins that are capable
of binding DNA, and that influence gene regulation are known as transcription fac-
tors (TFs). There is also an epigenetic layer, mainly involving histone modifications,
that contributes to regulation (establishment and maintenance) of the cell-specific gene
expression.
There are several techniques that allow the study of protein-DNA interactions,
such as the electrophoretic mobility shift assay (EMSA) (Garner and Revzin, 1981) and
DNA-pulldown (Roberts and Green, 1996). These are however, in vitro techniques and
require a priori knowledge of the DNA sequence. For the purpose of this Introduction,
I will focus on the most commonly used technique, Chromatin Immunoprecipitation
(ChIP), that allows the in vivo identification of DNA-protein interaction and their
genomic location. I will review how the technique has evolved throughout the years
and give examples of how it has contributed to the field of developmental biology,
specifically in the study of GRNs and the identification of regulatory regions.
In 1984 Gilmour and Lis made the first attempt to study protein-DNA intereac-
tions (Gilmour and Lis, 1984). They developed a method to covalently bind proteins to
DNA by irradiating E.coli with UV light. Using an antibody against RNA polymerase,
the authors pulled down DNA which was then purified and studied using hybridisa-
tion assays. This experiment showed that RNA polymerase is bound to genes which
are constitutively active. A year later, the same group applied the method to eukary-
otic DNA, in Drosophila melanogaster, where they showed that recruitment of RNA
polymerase II to heat shock genes increased as a response to increasing temperatures
(Gilmour and Lis, 1985). Three years later, Solomon et al. (Solomon, Larsen, and
Varshavsky, 1988) improved the technique by using formaldehyde to crosslink DNA
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to protein. This form of crosslinking is still the most widely used today. This work
was also done in D.melanogaster and they studied the positioning of histone H4 in the
heat shock gene hsp70. In 1993 the technique was first applied in developmental biol-
ogy, to study the homeotic bithorax complex (BX-C) in D.melanogaster. Orlando and
Paro (Orlando and Paro, 1993) used crosslinked chromatin and an antibody against
the Polycomb group (Pc-G) to map its binding sites. To identify the locations of the
binding sites they coupled ChIP with PCR to amplify chromatin fragments using linker
modifiers. This allowed them to identify Pc-binding sites with 1 kilobase (kb) resolu-
tion, and showed that Pc is a major component of a large repressive domain; regions
being actively transcribed were negative for Pc binding.
The next big development in the technique came seven years later, in 2000, in the era
of microarrays. The technique was pioneered in Richard Young’s lab which developed
a microarray method that revealed the genome-wide location of DNA-bound proteins.
They first used it to monitor binding of gene specific transcription factors in yeast
(Ren et al., 2000). The technique came to be known as ChIP-chip (or ChIP-on-chip).
Kim and colleagues then used this technique in human fibroblast cells and identified
more than 10,000 active promoters, including more than 1,000 that were previously un-
annotated (Kim et al., 2005), and predicted insulator regions by analysing the binding
of CCCTC binding factor (CTCF) (Kim et al., 2007).
With the increasing power of next generation sequencing such as Solexa/Illumina
and 454, the next step in ChIP evolution was possible. These sequencers were able to
obtain millions of short reads which would facilitate the direct measurement of the se-
quence content that was pulled down by ChIP. Combining ChIP with high-throughput
sequencing is better known as ChIP-Seq and it was first introduced in 2007. Several
groups published work introducing ChIP-Seq during this time, the first being on yeast,
Saccharomyces cerevisiae, where they studied nucleosomes containing the histone vari-
ant H2A.Z (Albert et al., 2007). A few months later, the first work using the technique
in human cells was published, using the term ChiP-Seq for the first time (Barski et
al., 2007). In this work they created maps for the genome-wide distribution of 20
histone modifications (lysine and arginine methylations), the histone variant H2A.Z,
RNA polymerase II and CTCF, a protein which binds insulator regions. They were
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able to show that H3K27me, H3K9me, H4K20me, H3K79me and H2BK5me modifica-
tions are associated with gene expression while repressed regions are characterised by
H3K27me3, H3K9me3, and H3K79me marks.
Similar analyses were undertaken in mouse embryonic stem cells, neural progenitors
and embryonic fibroblasts, where the histones modifications were mapped (Mikkelsen et
al., 2007) confirming the previous findings. Additionally, they identified H3K36me3 as
a mark of primary coding and non coding transcripts (gene annotation) and H4k9me3
and H4K20me3 as telomeric and satellite markers (active long-terminal repeats). In
the same period, two other papers where published describing the technique in human
cell lines (Johnson et al., 2007; Robertson et al., 2007).
1.7.2 Bioinformatic Tools
The rapid application of ChIP-Seq in different fields, but mostly in stem cell research
and developmental biology, led to advancements in computational tools to facilitate the
analysis of the genome-wide data being produced. From softwares of short-read map-
ping, such as Bowtie (Langmead, 2010) and Burrows-Wheeler Aligner (BWA) (Lang-
mead et al., 2009), to tools that identify regions with a high probability of binding,
called peaks (Model-based analysis for ChIP-Seq (MACS) (Zhang et al., 2008), SPP
(Kharchenko, Tolstorukov, and Park, 2008) and ultimately tools that allow visuali-
sation of the data like IGV (Robinson et al., 2011; Thorvaldsdottir, Robinson, and
Mesirov, 2013). The use of ChIP-Seq to compare the binding of transcription factors
in different cell types or conditions lead to the development of tools that allow this
kind of analysis, such as DiffBind (Ross-Innes et al., 2012) and MAnorm (Shao et al.,
2012).
1.7.3 Derivations of ChIP-Seq
In a manner analogous to the transition from ChIP-chip to ChIP-Seq, the ChIP-Seq
has had improvements and derivations. One example is ChIP-Exo (Rhee and Pugh,
2011; Rhee and Pugh, 2012) which was developed to improve the resolution of ChIP-
seq by combining ChIP with 5’ to 3’ exonuclease digestion. Another adaptation widely
used in developmental studies to investigate cell-type specific binding of TFs or his-
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tone modifications is the batch isolated tissue specific-ChIP (BiTS-ChIP) (Bonn et al.,
2012b; Bonn et al., 2012a) and the isolation of nuclei tagged in specific cell types (IN-
TACT) (Deal and Henikoff, 2010a; Deal and Henikoff, 2010b). More recently, Schmidl
and colleagues developed a technique that reduces the input requirements for library
preparation by combining ChIP with tn5 transposase (as used in ATAC-Seq), termed
chiPmentation (Schmidl et al., 2015).
1.7.4 Applications of the technique in developmental biology - mesendo-
derm GRNs
There is a wide range of studies focused on early germ layer specification in different
model animals, here I’ll provide examples of research that have contributed to the as-
sembly of the mesendoderm GRN in zebrafish and the frog (Xenopus tropicalis/laevis).
The main players in early mesendoderm development are effectors of the Nodal/TGF-
β signalling pathway (Smad2/3), Foxh1 and members of the T-box family of transcrip-
tion factors (Eomes, VegT and Brachyury). Researchers have studied the DNA binding
profile of these proteins in order to identify their targets and better understand the GRN
that governs mesendoderm development. An early study in X.laevis focused on ante-
rior endoderm, and they found that Foxh1 together with Smad2 binds to the promoter
of an early endoderm marker, hhex (Rankin et al., 2011). More recently, genome-wide
analysis of the binding of Foxh1 and Smad2/3, together with loss-of-function experi-
ments and RNA-Seq, has identified most of the early Nodal target genes regulated by
Foxh1 and Smad2/3 (Chiu et al., 2014). Integration of these analyses with ChIP-seq for
histone modifications that mark active enhancers (H3K4me1, H3K27ac), has led to the
hypothesis that Foxh1 acts as a pioneer factor in establishing Nodal enhancers and, as
a consequence, the start of the mesendoderm program (Gupta et al., 2014). These two
publications reinforce the importance of implementing different techniques, ChIP-seq
for TF and histone modifications, RNA-Seq and loss-of-function (morpholino or small
molecules treatments) in a genome-wide approach to allow a better understating of the
processes that regulate early development.
Similar experiments were performed in early zebrafish embryos to identify genomic
targets of Smad2 and Eomes. Nelson et al showed that these two proteins have common
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genomic targets, genes involved in both endoderm and mesoderm development and that
they both interact with Foxh1 (Nelson et al., 2014).
Regarding mesoderm formation and regulation, much effort has been put into iden-
tifying the genomic targets of the T-box TFs in zebrafish, frog and mouse (Garnett
et al., 2009; Gentsch et al., 2013; Lolas et al., 2014; Morley et al., 2009). Most of
the studies referred to above are focused on individual TFs and identification of their
targets, but it is the merging of these ChIP data that will allow the construction of the
GRN that governs development.
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Chapter 2
Materials and methods
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2.1 Materials
2.1.1 Buffers and solutions
Xenopus embryo culture media
Marc’s modified Ringer (MMR): 1M NaCl, 20mM KCl, 20mM CaCl2, 10mM
MgSO4, 50mM Hepes pH 7.8, 1mM EDTA.
Normal amphibian medium (NAM): 1.1M NaCl, 20mM KCl, 10mM Ca(NO3)2,
10mM MgSO4, 1mM EDTA.
Whole mount in situ hybridasation buffers
Phosphate buffered saline, PBS (10x) : 137mM NaCl, 2.7m KCl, 10mM
Na2HPO4, 1.8mM KH2PO4 pH7.4.
Phosphate buffered saline with tween-20, PBT (1x): 1x PBS, 0.1% (v/v)
tween-20.
MEM salts: 137 mM NaCl, 2.7mM KCl, 10mM Na2HPO4.
MEMFA fixative: 3.7% Formaldehyde pH 7.5, 10mM MEM salts (10x)
Saline sodium citrate (SSC) (20x): 17.5% NaCl, 8.8% Sodium citrate pH 7.
Hybridisation solution: 50% Formamide, 5x SSC (20x), 1mg/ml Torula yeast
RNA, 100ug/ml Heparin, 1x Denhart?s solution (50x), 0.1% Tween-20, 0.1% CHAPS,
10mM EDTA.
Maleic acid buffer (MAB) (2x): 200mM Maleic Acid, 300mM NaCl.
Staining Solution, Alkaline phosphatase buffer: 100µM Tris, 100µM NaCl,
0.1% Tween-20, 40mM MgCl2.
Protein immunoprecipitation and Western Blot
SDS loading buffer: 250mM Tris pH6.8, 10% (w/v) SDS powder, 50% glycerol,
25% β-mercaptoethanol, 0.02% bromophenol blue.
IP buffer: 50mM Tris, pH7.5, 150mM NaCl, 1mM EGTA, 1% (v/v) Igepal CA-
630, 0.25% (w/v) Sodium deoxycholate.
SDS running buffer (10x) : 25mM Tris Base, 192mM Glycine, 0.1% SDS.
Transfer Buffer: 25 mM Tris Base, 190mM Glycine, 2% MeOH.
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Chromatin immunoprecipitation buffers
E1: 50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA. 10% glycerol, 0.5%
Igepal CA-630, 0.25% Triton X-100).
E2: 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA.
E3: 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Igepal CA-630,
0.25% Na-Deoxycholate, 0.1% SDS.
RIPA buffer: 50 mM HEPES-KOH pH 7.5, 500 mM LiCl, 1 mM EDTA, 1%
Igepal CA-630, 0.7% Na-deoxycholate.
TEN buffer: 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 150 mM NaCl.
SDS elution buffer: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% SDS.
2.1.2 Other buffers
Tris-acetate EDTA buffer (TAE) : 40mM Tris base , 20mM Glacial acetic acid,
1mM EDTA pH 8.
Elution buffer (EB) : 10 mM Tris-Cl, pH 8.5.
2.1.3 Oligonucleotides
All oligonucleotides were designed using the Primer3 online software (http://primer3.ut.ee)
(Untergasser et al., 2012). Desalted nucleotides were synthesised by Sigma and a re-
ssuspended in distilled water to a final concentration of 100mM and stored at -20°.
Gene Forward primer (5’-3’) Reverse primer (5’-3’) Amplicon size, bp Source
gsc AGAGAACAGCTGGCAAGGAG TTTCTGCCTCCTCCACTTTG 90 (Gentsch et al., 2013)
noggin CGGAGGAGAGACTTGGAGTG TTTGATTTCTGCTGGCATTG 89 (Gentsch et al., 2013)
not ACAGCAGCCAATGAGGATG AGGGTTCATGGAACCATTTG 106 (Gentsch et al., 2013)
bmp4 ATGGAGTACCCGGAGAGACC TCCATTTTCTGCTGTGCTTG 99 (Gentsch et al., 2013)
wnt8a AAGATGCCAGAGCCCTAATG CCAGATATTCCATGGCACTTG 100 (Gentsch et al., 2013)
msgn1 TCACTTAGCCAGACCCCATC GAATGGCATCTCCTCCAGAC 105 (Gentsch et al., 2013)
mespa TCTCCAGACCAGGGATTTTG GGCTGAAATGATGTCCACAG 86 (Gentsch et al., 2013)
xcad3 ACTCACCCAGCGATCTTAGC CACCCGGTATTTTTCTTTGG 101 (Gentsch et al., 2013)
szl CACACAAGACAGTTTTGGAAGC GAACTCAACTGGGCCTTCTG 119 (Gentsch et al., 2013)
K00726 GGAGTCACCCCAACATCTCA ACCCGTCCGACTTCTTATCTC 79 this work
72022004 TGCACTTGTTACAGGATTCCT ACACAGCGGTAGGTCTCATT 117 this work
cpe GAGCCCGGTGAACCAGAAT TCCCTCTGGTACTCATTGCA 113 this work
odc GGGCAAAAGAGCTTAATGTGG CATCGTGCATCTGAGACAGC 103 (Gentsch et al., 2013)
c8orf4 CAGCCAACATCTTCCAAGGG GTCCTGGTCGATGCAGAAGA 113 this work
2.1.4 Chemicals
All chemicals used were of molecular biology grade and purchased from Sigma or Roche.
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2.1.5 DNA molecular size markers
The DNA molecular size markers used for DNA separation in gel electrophoresis was
either a 100bp DNA ladder or 1Kb DNA ladder from NEB.
2.1.6 Enzyme
Restriction endonucleases
All restriction enzymes used were obtained from Roche or NEB.
Other enzymes
Other enzymes used and its source are summarised in the table below:
Enzyme Company Catalogue number
Turbo DNase ThermoFisher Scientific, Life technologies AM2238
Proteinase K ThermoFisher Scientific, Life technologies AM2546
T7 RNA polymerase (Dig labeling) Roche 11175025910
SP6 RNA polymerase (Dig labeling) Roche 11175025910
T7 RNA polymerase (cap) ThermoFisher Scientific AM1344
SP6 RNA polymerase (cap) ThermoFisher Scientific AM1340
KAPA HiFi HotStart ReadyMix KAPA Biosystems KK2601
GoTaq HotStart Polymerase Promega M5132
T4 DNA ligase Promega A3600
KAPA2G Fast ReadyMix KAPA Biosystems KK5103
Pfx50 polymerase ThermoFisher Scientific, Invitrogen 12355-012
Table 2.1: Other enzymes used during this project
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2.2 Methods
2.2.1 Embryo culture and manipulation
Egg and testes collection
Animal procedures were performed under license, as required by Animals (Scientific
Procedures) Act 1986 (UK). Xenopus tropicalis and Xenopus laevis embryos were gen-
erated via in vitro fertilisation (IVF). Female Xenopus laevis frogs were primed for
ovulation a week prior to IVF by injection of 50 units of hCG (Human chorionic gon-
odatropin) subcutaneously in the dorsal lymph sac. Xenopus tropicalis females were
primed similarly but with a lower dose, 10 units, and around 20 hours prior to IVF.
To induce ovulation, Xenopus laevis were boosted by injecting 500-800 units of hCG
20 hours prior to IVF while Xenopus tropicalis were boosted 4 hours prior with 100
units of hCG. Egg collection differs between the two species; Xenopus laevis females
were kept in isolation for 8 hours in a 1x Marc’s modified Ringer (MMR) while col-
lection of Xenopus tropicalis eggs was done manually by gently squeezing the lower
abdomen of the female frogs. For IVF, testes isolation was processed similarly in both
species with the exception of the maintenance, X.laevis testes were kept up to 10 days
in Leibovitz’s L-15 Medium (Sigma L5520) + 10% fetal bovine serum (FBS, Sigma
12003C) at 4°C while X.tropicalis were used fresh. For testes isolation, male frogs
were sacrificed according to schedule 1 guidelines by immersion in fresh 0.2% Ethyl
3-aminobenzoate methanesulfonate (MS222, Sigma E10521), for 30 minutes to 1 hour
followed by decapitation. Frogs were placed belly up and with a pair of scissors a small
cut was done in the lower abdomen in order to expose the viscera. Blunt forceps were
used to push aside the liver, stomach and intestine in order to reach the testes, which
were connected to the fat body, on the back. Using forceps and scissors, the testes
were removed from the fat body and cleaned from the surrounding connective tissue
and place in the appropriate media.
in vitro fertilisation (IVF)
Eggs were collected in petri dish with 0.1x MMR and before IVF the majority of the
liquid was removed to facilitate fertilisation. Either the whole testes (X.tropicalis)
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or a piece (X.laevis) were put in a 1.5 ml Eppendorf tube containing L-15/FBS
(X.tropicalis) or 0.1x MMR (X.laevis) and were crushed with a pestle. Testes so-
lution was mixed with the eggs and allowed to fertilise for 5 minutes after which the
Xenopus tropicalis and Xenopus laevis eggs were flooded with either 0.05x MMR or
0.1x normal amphibian medium (NAM), respectively. Prior to all kinds of manipula-
tion referred to in this work, the thick protective jelly membrane that surrounds the
embryo was removed. This process was known as dejellying and can be done 10 min-
utes post-fertilisation by washing the embryos in 2.2% L-cysteine at pH 8.0, diluted in
the appropriate media for 5-8 minutes. Embryos were washed in the media without
cysteine and were ready for manipulation: microinjection, LiCl treatment or UV irra-
diation. Prior and post manipulation, the embryos were kept in agarose-coated Petri
dished in 0.05x MMR at 25-28°C in the case of Xenopus tropicalis and Xenopus laevis
embryos were incubated at 14-22°C in 0.1X NAM.
Microinjection
Embryos were manually injected with either mRNA, DNA (plasmid) or morpholinos
at either 1-cell, 2-cell or 4-cell stage embryos. Depending on the experiment, embryos
were also co-injected with a lineage tracer such as fluorescin dextran (10.000MW, An-
ionic; D1821, Thermo Scientific) at a concentration of 1-2% (250-500pg/nl). Xenopus
tropicalis embryos were injected at 1-cell stage with 2nl or with 1nl at the other two
stages, in each cell. The volume of injection was higher for Xenopus laevis: 1-cell stage
embryos were injected with 10nl while 2/4-cell stage embryos were injected with 5nl in
each cell. Needles used for microinjection were produced from glass capillaries (GC120-
15, Harvard Apparatus) that were pulled using a micropipette puller (Sutter p97). The
settings used for needle pulling were the following: pull 55, velocity 55, time 10 and
heat 580-590 (determined each time the procedure was done). Prior to microinjection
the tip of the needle was cut open using fine forceps and the needle mounted into a fixed
micromanipulator (Micro Instruments, LTD.) connected to a microinjector (Narishige
IM-300, Intracel). Injection volume was calibrated by injecting water into mineral oil
(Sigma 330779) and measuring the water bubble diameter at 5x magnification using
the eyepiece micrometer in a Leica MZ75 binocular stereomicroscope. Embryos were
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put into a ’injection dish’: a petri dish with a circle sheet of 800um mesh Nitex screen
’glued’ to the bottom using chloroform. During and a couple of hours after injection,
embryos were kept in 4% Ficoll (diluted in the appropriate media) which allows the
vitelline membrane to collapse, reducing pressure and therefore preventing leakage. Fi-
coll was replaced by 0.05x MMR or 0.1x NAM and embryos incubated at the desired
temperature. Death embryos were removed from the plate and the media was replaced
every 12 hours.
LiCl treatment
Xenopus tropicalis embryos, after being dejellied, were incubated at room temperature
for 2h30-3 hours until they reached 32/64-cell stage. At this stage, embryos were
transferred to a agarose-coated petri dish containing 0.3M LiCl (Sigma) in 0.05x MMR
and incubated for 4.30-5 minutes and swirled in the plate. The treatment was done
in batches of a maximum of 750-900 embryos. After the treatment, the embryos were
transferred using a plastic Pasteur pipette to another agarose-coated plate containing
fresh 0.05xMMR. Embryos were washed in the media by being swirled around in the
plate and this process was repeated 4-5 times (see Figure 3.2). Upon completion of
the washes, the embryos were transferred again to another agarose-coated plate and
incubated in 0.05x MMR at 25-28°C. Embryos were harvested at stagNF11.5 or NF12,
depending on the experiment, however around 10% were kept developing to assess
phenotype at tailbud stages. Only treatments that resulted in embryos with an average
DAI score of 9.4-10 were considered for further analyses.
UV treatment
In order to be an efficient treatment, UV irradiation into the vegetal pole of Xenopus
tropicalis embryos has to occur within the first 30 minutes post fertilisation. Upon
dejellying, embryos were transferred (no more than 200 embryos) into a 50 ml Falcon
conical centrifuge tube and the tube containing 0.05x MMR to the top. The tube
was closed by wrapping Saran wrap around the top using rubber bands and turned
upside down allowing the embryos to be placed on top of the Saran wrap (see Figure
1.1). Embryos were centred and allowed to be positioned with its vegetal pole down.
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The tube in positioned on top of a hole (same diameter as the falcon tube opening)
of a styrofoam platform (2cm high) which in positioned on top of the UV lamp (UVP,
LLC, UVGL-25). This allowed the embryos to be at the desired distance from the UV
source. The embryos were irradiated with an UV short-wave (254nm) for 2 minutes.
Upon irradiation, the tube was transferred in the same orientation to the incubator
as embryos must not be moved until the first cell division. After this, embryos were
transferred to an agarose-coated plate containing 0.05x MMR and incubated at 25-
28°C until the desired harvesting stage. Similarly to the LiCl treatment, around 10%
of the UV-treated embryos were kept after collection in order to assess the treatment
efficiency by tailbud stage. Only treatments that resulted in embryos with an average
DAI score of 0.5-0.8 were considered for further analyses.
Animal cap explants
mRNA was injected into the top of the animal pole of 1/2-cell stage Xenopus laevis
embryos and developed at 14°C in 4 %Ficoll in 0.1xNAM. By stage NF8-9 embryos
were placed in a agarose-coated petri dish containing 0.7xMMR where ’capping’ was
performed. Animal caps were cut using a micro wire tip cautery electrode (1mm
loop) (13-Y1, Protech International Inc.) connected to a micro cautery instrument
(Protech International Inc.) at medium voltage (setting 2). After dissection, caps were
transferred to a fresh agarose-coated plate containing 0.07x MMR and incubated at
18°C alongside with whole sibling embryos in order to track the stage. Animal caps
were collected at corresponding stage NF15 and processed for total RNA extraction.
2.2.2 Cloning
Throughout this work different cloning techniques were used depending on each project
objective. Here I will refer to the three kinds used: Gateway® cloning in order to
insert the gene of interest in an expression vector; to generate WMISH RNA probes
the pGEM-T-Easy vectors were used for easy cloning from PCR products; and for the
dual-luciferase assay, genomic regions of interest were cloned into pGl3-Basic vectors.
74
Cloning into expression vector using Gateway®
The first step of the Gateway cloning system was to produce an entry clone with
the gene of interest. For this I used directional TOPO® cloning that utilises the
attL sites in the pENTR™/TOPO® vector that allow for efficient recombination with
the destination vector that contains attR sites. The first step was to design primers
compatible with the pENTR directional TOPO cloning: forward primer must start
with CACC, complementary to the overhang of the cloning vector, GTCC, and the
reverse primer should end with or without a STOP codon depending on the position
(C- or N-terminus) of the tag on the destination vector. All genes were amplified
using Pfx50 polymerase (12355-012, Invitrogen, Thermo Fisher Scientific) and a final
concentration of 0.4µM of each of the following primers:
Cloning of K00726 from stage NF10-12 of Xenopus tropicalis cDNA (Chapter 3).
K00726 (1285bp)
Forward primer:
5’-CACCATGGAGAGTTCCTCCGGCCT-3’,
Reverser primer including STOP codon, for N-terminal tag:
5’-TTATCACAGGTATACTCTGCGTA-3’,
Reverser primer without a STOP codon, for C-terminal tag:
5’-TCACAGGTATACTCTGCGTA-3’.
Cloning of wild-type and mutant t and t2 for expression in embryos. t wt, t e1.2D
and t2 e3.7D were cloned from synthetic genes assembled from synthetic oligonucleotides
and manufactured by GeneArt® (Invitrogen, Thermo Fisher Scientific) and t2 wt from
IMAGE clone 5307982 (Gentsch et al., 2013) (Chapter 5).
t wt and t tm2.2 N-terminal:
5’-CACCATGAGTGTAAGTGCCACCGAGA-3’,
5’-TTAGATTGACGGCGGTGCAAC-3’;
t wt and t tm2.2 C-terminal:
5’-CACCATGAGTGTAAGTGCCACCGAGA-3’,
5’-GATTGACGGCGGTGCAACTG-3’;
75
t2 wt N-terminal:
5’- CACCATGAGTACAGGAACAGCTG-3’,
5’-CTATAATGATGGAGGTGTCACAGA-3’;
t2 wt C-terminal:
5’-CACCCAGAAGAGGCATCAGCAATAC-3’,
5’-TAATGATGGAGGTGTCACAGAAG-3’;
t2 tm1.2 N-terminal:
5’-CACCATGAGCACAGGCACAGCTGAGA-3’,
5’-CTATAATGATGGAGGTGTCACAGA-3’;
t2 tm1.2 C-terminal:
5’- CACCATGAGCACAGGCACAGCTGAGA -3’,
5’- TAATGATGGAGGTGTCACAGAAGC -3’.
Amplification parameters were the following: 2 minutes at 94°C, 35 cycles of 15
seconds at 94°C, 60°C for 30 seconds, 68°C for 1 minutes and 30 seconds; and 5 minutes
at 68°C and kept at 4°C. Part of the amplification reaction was used to verify the size of
the amplicon on a 1% agarose/TAE gel (containing 1:50,000 RedSafe, Ecogen, 21141)
gel. If the correct fragment was amplified I proceeded to the pENTR directional TOPO
cloning as follows: 1µl of fresh PCR product, 0.5µl of salt solution (1.2M NaCl, 0.06M
MgCl2, 1µl of H2O and 1µl of pENTR™/TOPO®vector. The reaction was gently mixed
and incubated at room temperature for 20 minutes to 1 hour. 1µl of this reaction was
used to transform 50µl of TOP10 competent cells (Life Technologies, C4040-06). The
cells and reaction were mixed and incubated on ice for 30 minutes followed by heat-
shock for 30 seconds at 42°C. Cells were transferred back to ice for a few minutes and
75µl of super optimal broth with catabolite repression (SOC) was added followed by
an incubation at 37°C for 1 hour, shaking. The whole volume of SOC, with competent
cells, was spread in a pre-warmed lysogeny broth (LB) agar plate containing 50µg/ml
of kanamycin. Plates were incubated overnight at 37°C and in the next day 3 colonies
from each transformation were picked and resuspended in 50µl of Tris-EDTA buffer
(TE) for a PCR colony reaction. The PCR reaction was as follows: 1µl of resuspended
colony, 0.4µl of 10µM of each primer (see above, or M13 forward or M13 reverse), 3.6µl
of H2O and 5µl of 2x KAPA2G Fast ReadyMix (KK5103, KAPA Biosystems). The
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reaction in run on a 1% agarose/TAE gel (containing 1:50,000 RedSafe, Ecogen, 21141)
gel. The resuspended colonies that have the insert were inoculated in 5ml of LB with
50µg/ml kanamycin and incubated overnight at 37°C shaking (1250rpm).
On the following day, the bacteria cultures were transferred to a 2ml Eppendorf
tube and centrifuged at RT for 2 minutes at 12,000xg to pellet bacteria. The media
was removed and the process was repeated until the whole culture was collected on
the bottom of the tube. The plasmid DNA was isolated using the Plasmid MiniPrep
kit (Qiagen, 27106) and eluted in 50µl of elution buffer (EB) (10 mM Tris-Cl, pH
8.5). The next step was the recombination with the destination vector containing the
attR sites. The destination vectors used were produced by Kevin Dingwell and besides
being compatible with the Gateway® Cloning system (contains att sites) they have
pCS2+ as backbone (contains a CMV minimal promoter and a SV40 polyA terminatior)
and contain 3x HA to tag the gene either C- or N-terminally (pCS2+-N-3xHA and
pCS2+-C-3xHA). The recombination was known as LR recombination since it uses a
LR clonase™that catalyses the reaction between the entry clone containing the attL-
flanked gene and the attR-containing destination vector, which results in an attB-
containing expression clone. The LR recombination reaction was as follows: 1µl of
pENTR/D-TOPO containing the insert (150ng), 1µl of destination vector (pCS2+-N-
3xHA or pCS2+-C-3xHA, 150ng), 2µl of TE (pH8.0) and 1µl of LR clonase™II enzyme
mix (Life Technologies, 11791-020). The reaction was gently mixed and incubated at
25°C for 1 hour. After this, 0.5µl of proteinase K (Life technologies, AM2546) was
added to the mix proceeded by an incubation at 37°C for 10 minutes. The reaction
was put one ice and 1µl used to transform TOP10 competent cells, as described above.
The destination vector has ampicillin resistance, so the SOC media was spread in
pre-warmed LB agar plates containing 100µg/ml ampicillin. On the following day,
three colonies from each transformation were picked and each inoculated in 5 ml of LB
with 50µg/ml ampicillin and grown at 37°C overnight. The following day, the plasmid
DNA was isolated as described above and eluted in 50µl of EB. In order to confirm
cloning of the gene of interest, right orientation and that no mutations occurred during
the PCR amplification, the DNA was Sanger sequenced (GENEWIZ) using primers
on each end of the insert, forward SP6 primer and reverse T3P primer. Results of
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the sequencing were analysed using the software SeqMan Pro™(DNASTAR®). The
plasmids containing the correct sequence were used for capped mRNA synthesis (see
below).
Cloning into pGEM®-T-Easy for WMISH probes
To clone genes to generate WMISH RNA probes I used the pGEM®-T-Easy plasmids
as they contain single 3’-T overhangs at the insertion site compatible with overhangs
produced by DNA polymerase (such as Taq) during PCR reaction, allowing for an
efficient and rapid ligation of PCR products. I have cloned full-length coding sequences
of the gene of interest from stage NF11-12 Xenopus tropicalis cDNA. Fragments were
amplified using GoTaq® Hot start polymerase (M5132, Promega) in a 25µl reaction:
1µl of 10µM forward and reverse primer, 2µl of cDNA and 8.5µl of H20. The following
primer pairs were used:
K00726 (1285bp):
forward: 5’- ATGGAGAGTTCCTCCGGCCT-3’,
reverse: 5’- TCACAGGTATACTCTGCGTA-3’;
72022004 (814bp):
forward: 5’- ATGGAAAACGCCATTCTCAGT-3’,
reverse: 5’- TTAGTGGGAAATATTAAGTAC-3’;
cpe (1392bp):
forward: 5’- ATGATGGCAGGAGTATGGGC-3’,
reverse: 5’- TCAAAAATTCAAGGTCTGTGACA-3’;
c8orf4 (291bp):
forward: 5’- ATGTCCGTCTCTCTGAGAGTCAG-3’,
reverse: 5’- TCAGGTCATGACCTTGAGAGGAATC-3’.
To verify that the correct fragment was amplified, 12µl of the reaction was run on
a 1% agarose/TAE gel (containing 1:50,000 RedSafe, Ecogen, 21141) gel. The PCR
product was purified from the remaining reaction using the QIAquick PCR Purification
kit (QIagen, 28194) and the concentration measure using NanoDrop™1000 (Thermo
Scientific). The ligation reaction was as follows: 5µl of 2x Rapid Ligation Buffer, T4
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DNA ligase, 1µl of pGEM-T Easy® vector (50ng) (A3600, Promega), 50ng of the
purified PCR product, 1µl of T4 DNA ligase (3 Weiss units/µl) (M1801, Promega)
and deionised water to a final volume of 10µl. The reaction was gently mixed and
incubated at RT for 1 hour. 2µl of the ligation reaction were used to transform 50µl
of JM109 competent cells (L2005, Promega). As described above, the competent cells
plus the ligation product were kept on ice for 20-40 minutes followed by a 30 seconds
heat-shock at 42°C, upon which, the cells were returned to ice for a few minutes. At
this point, 950µl of SOC was added and incubated for 1h30 minutes at 37°C while
shaking. 100µl of each transformation culture was plated in pre-warmed LB plated
containing Ampicilin (100µg/ml)/6-Chloro-3-indolyl-β-D-galactopyranoside (Salmon-
Gal) (80µg/ml/ isopropyl β-D-1-thiogalactopyranoside (IPTG) (0.5mM). The plates
were incubated at 37°C overnight and the following day white colonies (3-6) from each
plate were picked and re-suspended in 50µl of TE buffer. 1µl of each resuspension was
used for PCR colony as described above. The selected colonies were inoculated into 5
ml of LB with 50µg/ml ampicillin and grown at 37°C overnight. On the following day,
plasmid DNA was isolated from the cultures using the Plasmid MiniPrep kit (Qiagen,
27106) and eluted in 50µl of elution buffer (EB) (10 mM Tris-Cl, pH 8.5). In order to
confirm that no mutations occur during the amplification of the transcripts and verify
the orientation of the gene in the vector, the plasmid DNA was sequenced (Sanger
Sequencing, GENEWIZ) using the forward primer T7P and the reverse primer M13-
26. The plasmids were linearised and used to generate anti-sense RNA probes for
WMISH (see below).
Cloning into pGl3-Basic for Dual Luciferase Assay
In order to understand whether certain genomic regions were capable of driving ex-
pression and hence were potential regulatory regions for the nearest genes I used the
Dual-Luciferase® Reporter Assay System (Promega). The system uses the luciferase
activity of firefly (Photinus pytalis) and Renilla (Renilla reniformis) which were mea-
sured sequentially in the same sample. I used the pGL3 Luciferase reporter vector
(Promega, E1751) that contains the luc+ firefly luciferase expression and two multi-
cloning sites (MLS) that allow the insertion of up to two sequences, such as a pro-
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moter and an enhancer. In the context of this experiment I had 6 distinct versions
of the pGL3-Basic vectors: (1) pGL3-K00726 promoter, (2) pGL3-K00726 promoter-
e1, (3) pGL3-K00726 promoter-e2, (4) pGL3-K00726 promoter-e3, (5) pGL3-K00726
promoter-Neg.Reg. and (6) pGL3-Basic. Vector (1) contains only the gene promoter,
vectors (2)-(5) contain the same promoter plus the specific regulatory region to be
tested and vector (6) was also called empty vector as it does not contain any genomic
region.
The first step was to design primers that span the region of interest and include
the restriction site and a GATC region to ensure that restriction occurs efficiently.
Promoter was inserted into a HindII site and the ’enhancers’ into a BamHI site. The
sequences were amplified from genomic DNA (gDNA) of Xenopus tropicalis embryos
in the following reaction: 200ng of gDNA, 2µl of forward and reverse primer mix at
10µM, 25µl of KAPA HiFi HotStart ReadyMix (KAPA Biosystems, KK2601) and H2O
to final reaction volume of 50µl.
The following primer pairs were used to amplified the regions of interest:
K00726 promoter (133bp), containing a HindII restriction site
forward: 5’- GATCAAGCTTGACATTTTATCTGGTTTTACAG-3’,
reverse: 5’- GATCAAGCTTATTTTCCAACAGGTGGGTGA-3’;
K00726 e1 (306bp)
forward: 5’- GATCGGATCCCTGGTGATTGGTTGCTGTTG-3’,
reverse: 5’- GATCGGATCCGGGGTAGGTAAATGCCGAAA-3’;
K00726 e2 (583bp)
forward: 5’- GATCGGATCCAAATCAAGCGCCTCTCAGAC-3’,
reverse: 5’- GATCGGATCCAAGGTGGCCATACACCAATC-3’;
K00726 e3 (441bp)
forward: 5’- GATCGGATCCAACAACTGCATAAGGAATGTGC-3’,
reverse: 5’- GATCGGATCCCCCAGCCAGTGAATAGCATTA-3’;
K00726 Neg. Region (953bp)
forward: 5’- GATCGGATCCAAACCCCATCTGAAGCCTCT-3’,
reverse: 5’- GATCGGATCCGGGGGTTATTCTTCCCCTTT-3’.
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The reaction was added to a thermocycler (T100 Thermal Cycler, BioRad) and
amplified: pre-incubation for 45 seconds at 98°C, 35 cycles of; 10 seconds at 98°C, 10
seconds at 63°C and 30 seconds at 72°C; followed by a final extension at 72°C for 20
seconds. 5µl of the amplification reaction was used to verify the size of the amplicon on
a 1% agarose/TAE gel (containing 1:50,000 RedSafe, Ecogen, 21141). The remaining
45µl were used to purify the DNA fragment using the QIAquick PCR purification kit
(Qiagen, 28106) and following the manufacturer’s instructions. The PCR amplicons
were digested overnight in a 100µl reaction: 46µl of purified PCR amplicon, 10µl of 10x
restriction buffer, 10U of the appropriate restriction enzyme (HindIII or BamHI) and
and H2O. The vector (20µg) to which the sequence was going to be inserted (either
pGL3-Basic, if inserting the promoter ,or pGL3-K00726 promoter when inserting the
’enhancer’ sequence) was also also linearised overnight with the appropriate restriction
enzyme (30U) in a similar reaction. Both reactions were incubated overnight at 37°C
and the next day the digested PCR amplicon and linearised vector were purified using
the QIAquick PCR purification kit (Qiagen, 28106), as before, and the concentration
measured. Prior to ligation, the vector was dephosphorylated using the Rapid DNA
Dephosphorylation and Ligation kit (Roche, 04898117001) for 10 minutes at 37°C: 1µg
of linearised vector, 2µl of 10x phosphatase buffer, 1µl of 1U alkaline phosphatase and
H2O to a final volume of 20µl; followed by inactivation by incubating at 75°C for 2
minutes.
Both the vector and the insert were prepared for the ligation reaction. The liga-
tion was done with a vector:insert ratio of 1:3 and the amount insert used for 50ng
of vector was calculated accordingly (amount of insert (ng) = 50ng/4800bp*3 *[insert
size,bp]). The ligation used the reagents of the Rapid DNA Dephosphorylation and
Ligation kit (Roche, 04898117001) as follows: 50 ng of linearised-dephosphorylated
vector, insert (appropriate amount), 2µl of 5x DNA dilution buffer, H2O to a volume
of 8µl, 10µl of 2x DNA dilution buffer and 1µl of 5U T4 DNA ligase. The reaction
was incubated at room temperature for 20-40 minutes. Following ligation, TOP10
competent cells were transformed as described above and the cells were spread on
LB agar plates containing 100µg/ml ampicillin. Colonies were picked and inoculated
and DNA was purified from the cultures as described above. The plasmids were ver-
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ified for the right orientation and presence of mutation by Sanger sequencing (GE-
NEWIZ) using GLprimer2 (5’-CTTTATGTTTTTGGCGTCTTCCA-3’), RVprimer4
(5’-GACGATAGTCATGCCCCGCG-3’) and RVprimer3 (5’-CTAGCAAAATAGGCTG
TCCC-3’). Once the promoter was cloned into the pGL3-Basic vector, the processed
was repeated using this vector (pGL3-K00726 promoter) to insert the ’enhancer’ re-
gions. The plasmids were co-injected with Renilla mRNA into Xenopus tropicalis
embryos for the dual-luciferase reporter assay (see below).
2.2.3 Synthesis of capped mRNA for micro-injection
For the synthesis of capped mRNA for injections into Xenopus embryos, 10µg of plas-
mid containing the cloned cDNA of interest was linearised by the appropriate restric-
tion digest overnight at 37°C (Table 2.1). The linearised plasmid was purified using
the QIAquick PCR purification kit (QIAGEN, 28106) according to the manufacturer’s
guidelines and quantified using a NanoDrop™1000 (Thermo Scientific). 1µg of linearised
plasmid was used for in vitro transcription using the mMESSAGE mMACHINE®SP6
Transcription Kit (Life technologies AM1340) in the following reaction: 2µl of 10x re-
action buffer, 10µl of 2x NTP/CAP, 2µl of SP6 enzyme mix and H2O to final reaction
volume of 20µl. The reagents were carefully mixed and the samples were incubated at
37°C for 2 hours. 1µl of TurboDNase (Ambion, AM2238) was added and the sample
incubated for 15 minutes at 37°C to allow the digestion of the DNA template. RNA
was precipitated by adding 30µl of LiCl and 30µ H2O and an overnight incubation at
-20°C. On the following day the samples was centrifuged at full speed for 15 minutes at
4°C, the pellet was washed once with 80% EtOH and air-dried for 5 minutes at room
temperature. The RNA was re-suspended in RNase-free water, the concentration was
measured on the NanoDrop™1000 (Thermo Scientific). To assess the RNA integrity
and correct size, 200ng of pre-warmed (65°C) RNA was run on a 1.4% agarose/TAE
gel (containing 1:50,000 RedSafe, Ecogen, 21141). The sample was diluted to stock
solutions of 1ng/nl or 0.5ng/nl, aliquoted and stored at -80°C.
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mRNA Size Vector Restriction Enzyme Polymerase Origin
HA-t 1.8kb N-terminal 3xHA pCS2+ ApaI SP6 this work
t-HA 1.8kb C-terminal 3xHA pCS2+ ApaI SP6 this work
HA-t2 1.8kb N-terminal 3xHA pCS2+ ApaI SP6 this work
t2-HA 1.8kb C-terminal 3xHA pCS2+ ApaI SP6 this work
HA-te1.2D 1.8kb N-terminal 3xHA pCS2+ ApaI T7 this work
te1.2D-HA 1.8kb C-terminal 3xHA pCS2+ ApaI SP6 this work
HA-te3.7D 1.8kb N-terminal 3xHA pCS2+ ApaI SP6 this work
te3.7D-HA 1.8kb C-terminal 3xHA pCS2+ ApaI SP6 this work
HA-K00726 1.5kb N-terminal 3xHA pCS2+ ApaI SP6 this work
K00726-HA 1.5kb C-terminal 3xHA pCS2+ ApaI SP6 this work
fam83g-myc 3kb C-terminal MYC pCS2+ PvuII SP6 this work
β-catenin-GFP 2.3kb pCS2+ NotI SP6 Addgene (#16839)
Table 2.2: Constructs used to make capped mRNA to inject into embryos
2.2.4 Generation of anti-sense RNA probes
This protocol was very similar to the synthesis of capped mRNA for micro-injection,
so here the steps were summarised, for more detail refer to it. For the synthesis of
anti-sense RNA probes for WMISH, 10µg of plasmid containing the cloned cDNA of
interest was linearised by the appropriate restriction digest overnight at 37°C (Ta-
ble 2.2). The linearised plasmid was purified using the QIAquick PCR purification
kit (QIAGEN, 28106) according to the manufacturer’s guidelines and quantified us-
ing a NanoDrop™1000 (Thermo Scientific). 1µg of linearised plasmid was used for in
vitro transcription with the appropriate RNA polymerase (Table 2.2) to create the
Digoxigenin-labelled antisense (AS) RNA probe. For this purpose, the DIG-RNA La-
beling Mix (Roche 11277073910) was used following the manufacturer’s instructions.
The DNA template was removed by treating the reaction with TurboDNase (Ambion,
AM2238). The RNA probe was precipitated with LiCl overnight at -20°C and cleaned
with 80% EtOH. RNA was re-suspended in RNase-free water, the concentration was
measured on the NanoDrop™1000 (Thermo Scientific) and a 10x stock of the RNA
probe was made by diluting it with hybridisation buffer to 10 ng/ml and stored at
-20°C.
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Probe Size Vector Restriction Enzyme Polymerase Origin
t 2.2kb pSP73 BglII T7 (Smith et al., 1991)
cav1 1.4kb pExpress1 BglII T7 IMAGE clone: 7024946
actc1 0.4kb pSP21 EcoRI SP6 (Mohun et al., 1984)
not 1.1kb pCS2(+) XhoI T7 (Dassow, Schmidt, and Kimelman, 1993)
msgn1 1kb pCMV-Sport6.ccdB EcoRI T7 IMAGE clone: 699331
tal1 1.3kb pGEM-7Zf(+) XhoI SP6
European Xenopus
Resource Centre
myh6 0.4kb pGEM NcoI SP6 (Gentsch et al., 2013)
hoxd8 1kb pCR2.1-TOPO HindIII T7 (Gentsch et al., 2013)
noggin 0.7kb pGEM-5Zf(-) EcoRI T7 (Smith and Harland, 1992)
goosecoid 1.1kb pBS-SK(-) EcoRI T7 (Cho et al., 1991)
chordin 1kb pBS-SK(-) EcoRI T7 (Sasai, 1994)
wnt8a 1.42kb pGEM1 BamHI T7 (Christian et al., 1991)
bmp4 1.4kb pBS-SK(+) EcoRI T7 (Ko¨ster et al., 1991)
c8orf4 0.3kb PGEM®-T Easy NdeI T7 this work
72022004 0.8kb pGEM®-T Easy SacI T7 this work
K00726 1.3Kb pGEM®-T Easy SacI T7 this work
cpe 1.4kb pGEM®-T Easy ApaI SP6 this work
Table 2.3: List of WMISH probes and specific enzymes used to generated them.
2.2.5 WMISH
Embryos of the desired stage were fixed in MEMFA overnight at 4°C or for 2h at
room-temperature (RT) in glass vials. After fixation embryos were washed 2-3 times in
100% absolute Ethanol (EtOH) to keep them dehydrated and stored at -20°C at least
overnight (o/n). On the first day of the WMISH protocol, embryos were gradually
rehydrated by washing 5 minutes in 75% EtOH/25% PBT (PBS + 0.1% Tween-20),
50% EtOH/50% PBT followed by 25% EtOH/25% PBT and finally two washed in 100%
PBT. Embryos were permeabilised: embryos under NF22 were washed 5x in PBT for
5 to 10 minutes; embryos over NF22 were incubated in 10ug/ml proteinase K (Sigma)
in PBT, washed once for 5 minutes in PBT, re-fixed for 20 minutes in MEMFA and
washed again 5 times, for 10 minutes, in PBT. The protocol described here uses baskets
(2ml Eppendorf tube whose conical bottom was cut off and replaced by a fine mesh
that allows liquid to go in and embryos to be submerged in solution), although glass
vials were also permissible. Embryos were transferred to an agarose-coated plate and
under a stereomicroscope selected and distributed into the different baskets (each for a
different RNA probe) fitted into holes of a 1.5ml tube storage box containing PBT. All
subsequent washes were performed using the baskets submerged into the 1.5ml tube
storage box holes containing the different solutions. Following the last PBT wash,
baskets were transferred to pre-warmed hybridisation solution (pre-hyb solution) and
incubated at 60°C for 2-5 hours, in a hybridisation oven. After this, pre-hyb solution
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was saved and replaced by 500µl of DIG labelled antisense RNA probe was added at
1µg/ml and the embryos were incubated overnight at 60°C. The following day, the AS
probe was replaced by the previous day’s pre-hyb solution and the embryos washed for 5
minutes at 60°C. The AS probe was stored at -20°C and re-used up to 5 times. Embryos
were washed 3 times, for 20 minutes, in pre-warmed 2xSSC/Tween at 60°C followed
by two washes, 30 minutes each, in 0.2xSSC/Tween still at 60°C. Since SSC was the
main component of the hybridisation solution these washes were a gradual washing off
of the hybridisation solution. Embryos were transferred to RT and washed 2 times (5
minutes each) in MAB before blocking for 1 hour in MAB containing 2% BMB Blocking
Reagent (BR) (Roche 11096176001). Embryos were incubated for 4 hours at RT in
antibody solution: 1:2000 anti-DIG alkaline-phosphatase(AP)-conjugated antibody in
2% BMBBR/MAB containing 10% of lamb serum. Upon antibody incubation, embryos
were washed in MAB 4-6 times for 10 minutes at RT and kept overnight in MAB at
4°C with gentle shaking. The following day embryos were washed at RT 3 times in
MAB for 15 minutes, 2 times in freshly prepared AP buffer for 5 minutes. At this
point, embryos were removed from the baskets, returned to glass vials and to each was
added the staining solution (AP buffer + 3.4µl/ml NBT (100mg/ml) + 3.5µl/ml BCIP
(50mg/ml) + 4mM levamisole) and embryos were incubated at RT and protected from
light (using aluminium foil). The duration of incubation varies depending on the probe
(from 15 minutes to 24 hours) and staining was checked initially every 15 minutes
and every hour after that. For a slower staining reaction embryos were incubated at
4°C. The staining reaction was stopped by washing the embryos in MAB 2-3 times
at RT. Embryos were re-fixed in Bouin’s solution for 1 hour at room temperature or
overnight at 4°C. Upon fixation, embryos were washed 3-4 times in 70% EtOH/PBT
and rehydrated back to 100% PBT in 2 gradual steps. Embryos were bleached by
incubating them for 2-4 hours in bleaching solution on top of a light box while covered
with aluminium foil. Bleaching removes the pigmentation of the embryos allowing for
a better visualisation of the staining. Embryos were washed and stored in PBS at 4°C.
For image acquisition, embryos were placed in a petri dish coated with a thick agarose
layer and pictures taken under the stereomicroscope (Leica M165FC).
85
2.2.6 ChIP-grade polyclonal antibody production
In experiments described in Chapter 4, two distinct ChIP-grade antibodies against t
were used. One antibody was previously described (Gentsch et al., 2013) and a sec-
ond antibody was produced during the duration of this project. An anti-rabbit poly-
clonal antibody was produced by Cambridge Research Biochemicals using 1-1.75mg
of t (Xbra) full length protein previously derived from Baculovirus expression system
(Gentsch et al., 2013). The crude antisera of two rabbits was purified by affinity chro-
matography on thiopropyl sepharose 6B and NHS sepharose coupled with the antigen,
the native form of the protein. I were supplied with a glycine eluate (11ml) at 0.5mg/ml
protein in PBS and a TEA eluate (14ml) at 0.03mg/ml protein in PBS. Before purifi-
cation 4 bleeds from the rabbits were tested by Dotblot (see below) and once the
antibody was purified it was validated by Immunoprecipitation followed by Western
Blot (IP/WB) (see below) and by whole mount immunohistochemistry (WMIHC) (see
below).
2.2.7 Dotblot
A Polyvinylidene fluoride (PVDF) membrane was cut into rectangular shape and in
each, small circles (dots) were drawn with a pencil, about 2 cm apart. The PVDF
membrane was pre-wet in 100% Methanol (MeOH) and washed one time in H2O. The
membrane was placed on top of PBT-wet Whatman® filter paper inside an ’humid
chamber’. The ’humid chamber’ was composed, from bottom to top of: paper tissue,
one sheet of dried filter paper and the wet filter paper with the PVDF membrane
on top. To each circle, 1µl of different dilutions of the Brachyury purified protein
(3ng, 1.5ng and 500pg) was added, the ’chamber’ was closed and incubated for 1
hour at room temperature. The PVDF membranes were blocked with 5% (w/v) non-
fat milk powder (Cell Signalling Technology, 9999S) in PBT for 40 minutes at room
temperature. The bleeds/antibody were diluted 1:500 in 5% non-fat milk/PBT and
incubated with the membranes for 1 hour at room temperature. The membranes were
washed 3 times with PBT and the secondary antibody was added, goat α-rabbit, horse
radish peroxidase (HRP) conjugated (ThermFisher Scientific,) at 1:2000 (diluted in
5%(w/v) non-fat milk powder/PBT) and incubated for 1 hour at room temperature.
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The membranes were washed 3 times with PBT and once with PBS. The peroxidase
activity was detected by chemiluminescence reaction (BioFX® Chemiluminescent Ultra
Sensitive HRP membrane substract, Surmodics) and captured with ChemiDoc™XRS+
imager (BioRad).
2.2.8 Protein Immunoprecipitation followed by Western Blot (IP/WB)
X.laevis and X.tropicalis embryos were homogenised in 6µl/embryo of PhosphoSafe™
Extraction Buffer (Novagen) supplemented with cOmplete™ EDTA-free protease in-
hibitors (Roche Life Sciences, 11873580001). In order to remove yolk from the em-
bryonic extract the homogenate was mixed with the same volume of FREON and
centrifuged for 5 minutes at 4°C. This initial step was the same whether continuing
with protein IP or just for Western blot (see below). In the case of an IP, aliquots
of the supernatant were saved to use as input and the remaining used for IP. For the
IP, 0.5µg of Brachyury antibody ((Stennard et al., 1999), this work) was added to the
embryonic extract and incubated for 1 hour on a rotator (10 rpm) at 4°C. Dynabeads®
M-280 sheep anti-rabbit IgG (Thermo Scientific, 11203D ) were washed with IP buffer
(50mM Tris, pH7.5, 150mM NaCl, 1mM EGTA, 1% (v/v) Igepal CA-630, 0.25% (w/v)
Sodium deoxycholate), and 30µl were added to the embryonic extract and incubated
in a rotator (10 rpm) at 4°C overnight. The following day, the beads were washed 5
times, 5 minutes each, with IP buffer, using the rotator and a magnetic rack to bind
the beads. The immunoprecipitaed protein was eluted by re-suspending the beads in
SDS loading buffer (250mM Tris pH6.8, 10% (w/v) SDS powder, 50% glycerol, 25% β-
mercaptoethanol, 0.02% bromophenol blue) by warming up the sample to 65°C while
shaking (1000 rpm) for 5 minutes. Using the magnetic stand the supernatant was
removed and it was ready to be used for Western Blot.
Western Blot
The initial step of obtaining embryonic extract was described above. SDS loading buffer
was added to the embryonic extract in a 1:5 ratio and the samples were denatured by
incubating at 70°C for 5 minutes. The samples were loaded into mini-PROTEAN® pre-
cast polyacrylamide gels (Bio-Rad, 456102, 4569035) (7.5% and AnykD™) submerged
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in 1x SDS running buffer in a BioRad tank (BioRad, Mini-PROTEAN® Tetra Cell).
The samples were loaded alongside 5µl of Precison Plus Protein™WesternC™Blotting
standard (BioRad, 1610376) a pre-stained ladder. Gels were run at 100V for the first
5 minutes and the voltage was increased to 200V until the running front reached the
bottom of the gel. The gel cassette was taken from the tank and opened to removed
the gel which was trimmed off at the bottom and at the top. The Immobilon-P PVDF
membrane (Millipore, IPVH00010) was activated by submerging it in 100% MeOH for
2 minutes, washed one time in H2O and finally in transfer buffer (25mM Tris Base,
190 mM Glycine, 20% (v/v) MeOH). Before mounting the ’transfer sandwich’, the gel
was briefly rinsed in transfer buffer in order to remove SDS as well as four sponges
and 4 Whatman® filter papers. The ’transfer sandwich’ was set up, inside a holder,
with the following order from the positive pole (red): two sponges, two Whatman®
filters, the PVDF membrane, the polyacrylamide gel, two Whatman® filters and two
sponges. Bubbles were carefully removed by rolling a Western Blot roller on top of the
filter papers. The holder was placed inside a BioRad tank filled with transfer buffer,
with the correct orientation: gel to the negative pole (black) side and the membrane
towards the positive pole (red). An ice pack was added to the tank to keep the trans-
fer from overheating. The blot was transferred for 40 minutes at 200mA. After this,
the holder was removed and opened, and the membrane checked for complete transfer
by observing the ladder (pre-stained) transference. If the transfer was successful the
membrane was removed and placed in between two sheets of Saran Wrap to cut in half
if different antibodies were to be used. The membrane(s) was placed inside a 50 ml
Falcon conical centrifuge tube containing 5-10 ml of 5% (w/v) non-fat milk powder
(Cell Signalling Technology, 9999S) in PBT (MPBT) and incubated (while rolling) for
1 hour at room temperature or overnight at 4°C. The primary antibodies were added
at the appropriate dilution in MPBT and incubated for 1 hour at room temperature or
overnight at 4°C. The membranes were washed 3 times, 15 minutes each, with PBT, at
room temperature and the secondary antibody was added and incubation was similar
to the primary. Finally, the membrane was washed three times (15 minutes) with PBT
and one time with PBS. The secondary antibodies used were all HRP-conjugated, and
peroxidase activity was detected by chemiluminescence reaction (BioFX ® Chemilu-
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minescent Ultra Sensitive HRP membrane substract, Surmodics) and captured with
ChemiDoc™ XRS+ imager (BioRad). On the ChemiDoc™ XRS+ imager the images
were captured using the Chemiluminescence High Sensitivity detector, without filter
and with the aperture opened to the maximum (100). The membrane was exposed
from 1 second to 5 minutes in order to detect signal, depending on the experiment.
Primary antibodies: rabbit polyclonal anti-Xbra serum (Cunliffe and Smith, 1994)
at 1:5,000, rabbit polyclonal anti-t at 1:5000 (this work), mouse monoclonal anti-α-
tubulin(Sigma, T5168) at 1:5,000, mouse monoclonal anti-c-Myc (Sigma, M5546) at
1:5,000 and mouse monoclonal anti-HA (Sigma, H9658) at 1:10,000
Secondary antibodies: goat anti-rabbit IgG horse radish peroxidase (HPR) conju-
gate (TrueBlot®) 1:1000, goat anti-mouse IgG (H+L) HRP conjugate (Thermo Fisher
Scientific, 31430) and goat anti-rabbit IgG (H+L) HRP conjugate (Thermo Scientifc,
30954)
Semi-quantitative WB
Next to the embryonic extracts, a serial dilution of known concentrations of Brachyury
protein were load in the gel. This allowed to design a standard curve and quantified the
amount of Brachyury in embryonic extracts based on the luminescence. The analysis
was done using the Quantity One 1-D Analysis Software (BioRad) associated with the
ChemiDoc™ XRS+ imager (BioRad).
2.2.9 Whole mount immunohistochemistry in Xenopus embryos
Stage NF12 Xenopus embryos were fixed in MEMFA for 10 or 15 minutes at room tem-
perature. The embryos were washed in 100% EtOH and incubated overnight at -20°C.
On the following day, embryos were rehydrated in 3 steps to 100%PBT and washed
once in PBT. If needed, the embryos were bisected, through the blastopore, using a
disposable scalpel (Swann-Morton®, 0501) under a stereomicroscope. Upon dissection
embryos were transferred to a glass vial and fixed for 5 more minutes in MEMFA and
washed once with PBT (PBS + 0.1% Triton X-100). Bisected embryos were blocked by
washing 3 times, 10 minutes each, with PBT (PBS + 0.1% Triton X-100) with 2mg/ml
BSA (bovine serum albumin). The primary antibody was added (diluted in PBT/BSA)
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and incubated overnight at 4°C. On the following day, embryos were further incubated
for 1 hour at room temperature and washed five times (10 minutes each) in PBT. Em-
bryos were blocked again for one hour at room temperature and incubated overnight
at 4°C with the secondary alkaline phosphatase (AP)-conjugated antibody. On the
next day, the embryos were washed in PBT for 10 minutes, 3-4 times. Embryos were
washed one time in AP buffer (100mM NaCl, 100mM Tris, pH9.5, 50mM MgCl2 and
1% Tween-20) for 10 minutes. The AP buffer was replaced by AP buffer containing
3.4µl/ml of NBT (100mg/ml) and 3.5µl/ml BCIP (50mg/ml) and the glass vials were
kept in the dark and incubated at room temperature for 30-40 minutes. To stop the
reaction, the embryos were washed a couple of times with PBS, for 10 minutes each,
and fixed overnight in MEMFA at 4°C. Embryos were bleached and pictures taken as
described in the WMISH section.
Primary antibody: rabbit polyclonal anti-t at 1:500 (this work) Secondary anti-
body: Alkaline Phosphatase AffiniPure F(ab’)2 Fragment Goat Anti-Rabbit IgG (H+L)
(Jackson ImmunoResearch Laboratories, Inc, 111-056-045)
2.2.10 Extraction and purification of total RNA from Xenopus em-
bryos
Embryos (10-20 embryos) of the desired stage or animal caps (15-20) were collected
in 1.5ml Eppendorf tubes and the media removed using a pipette with a fine tip.
The appropriate volume (200µl for animal caps, 1-10 Xenopus tropicalis embryos or 5
Xenopus laevis and 400µl for 15-20 Xenopus tropicalis and 10 Xenopus laevis) of TRIzol
(Thermo Fisher Scientific, 15596018) was added and the embryos were homogenised by
vortexing for 10 minutes, at room temperature. The samples were snap-frozen in liquid
nitrogen and stored at -80°C or processed for total RNA extraction. The homogenate
was transferred to a 1.5 ml Phase-lock gel heavy tube (5 Prime) (prespun at 12,000x g
for 30 seconds) and 80/40µl of chloroform (1/5 of TRIzol volume) was added and shake
vigorously. Samples were incubated at room temperature for 2 minutes followed by 15
minutes of centrifugation at 4°C at full speed. After centrifugation, the upper phase was
transferred to a clean 1.5ml Eppendorf tube. RNA was precipitated using the RNA
Zymo Clean and concentrator™-5 (Zymo Research, R1016), as follows. To the tube
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containing the upper-phase it was added one volume of 100% EtOH and after mixing,
the mixture was transferred to the Zymo-Spin™ IC column in a collection tube which
was spinned for 1 minute at 12,000x g. The flow-through was discarded and 400µl of
RNA Wash Buffer added to the column and centrifuged for 30 seconds at 12,000x g and
the flow-through discarded. The samples were treated with DNAse in order to remove
any remaining DNA by adding 50µl of DNaseI cocktail (5µl of Turbo DNase, 5µl of 10x
Turbo Dnase Reaction Buffer and 40µl of RNA Wash Buffer) directly to the column’s
matrix. The samples were incubated at room temperature for 20-30 minutes. To each
column 400µl of RNA Prep Buffer was added, the column centrifuged for 30 seconds
at the same speed as before and the flow-through discarded. This step was repeated
with, first with 700µl and then with 400µl of RNA Wash Buffer. After discarding the
flow-through, the columns were spun at full speed for 2 minutes to remove all of the
remaining liquid, the collection tube was discarded and the column transferred to a
clean 1.5ml Eppendorf tube. To the centre of each column, 10µl of RNAse-free water
was added and incubated at room temperature for 5 minutes. Finally, the column was
centrifuged at 10,000x g for 30 seconds, the eluate RNA collected at the bottom of the
tube and kept on ice for a few minutes. The RNA concentration was determined in 1µl
of sample using a a NanoDrop™ 1000. Furthermore, the RNA integrity was assess
by running 200ng of RNA on a 1% agarose/TAE (containing 1:50,000 RedSafe) and,
in intact RNA, the 18S and 28S ribosomal RNA bands were clearly visible.
2.2.11 Extraction of RNA and DNA from single Xenopus tropicalis
embryos
For genotyping and RNA extraction of single embryos the initial steps of the protocol
were similar to the ones described in the section Extraction and purification of total
RNA from Xenopus embryos. The exception being that, instead of 1.5 ml Phase-lock
gel heavy tube (5 Prime) I have used 1.5 ml Eppendorf tubes that allowed us to use
the lower phase for DNA extraction.
The RNA extraction was processed as described above.
For DNA extraction from single embryos I have used the Back Extraction (BE)
protocol, as follows. After removing all of the aqueous phase overlying the interphase,
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250µl of BE buffer (4M of Guanidine Thiocyanate, 1M Tris Base and 50mM of Sodium
Citrate) was added and mixed well. The mixture was incubated at room temperature
for 10 minutes followed by a centrifugation at 12,000x g for 30 minutes at room tem-
perature. The aqueous phase, containing DNA, was transferred to a new tube and
one volume of wasopropanol (100%) was added and mixed. The sample was further
incubated for 30 minutes to 1 hour at room temperature and before spinning it for 15
minutes at 4°C at full speed, 0.5µg of GlycoBlue™ (Thermo Scientific, AM9516) was
added. The DNA pellet was washed 2 times with 500µl of 70% EtOH followed by a
spin at 4°C at 12,000x g for 15 minutes. The supernatant was removed and the pellet
air-dried for 10 minutes at room temperature. The pellet was dissolved in 20µl of H2O
and incubated for 5 minutes at 55°C to help dissolve DNA. The DNA yield from single
embryos ranges from 15-40ng/µl which was used for genotyping (see below).
2.2.12 Extraction of genomic DNA
This protocol for DNA extraction was distinct from the above, since the embryos
were pulled and used solely for DNA extraction. Whole embryos or clipped tails from
anaesthetised tadpoles were digested in 60µl of lysis buffer (50mM Tris pH8.5, 1mM
EDTA, 0.5% [v/v] Tween-20 and 100µl/ml of proteinase K) and incubated at 55°C for
2 hours. To inactivate proteinase K samples were incubated at 95°C for 5 minutes,
briefly centrifuged and the supernatant was used for genotyping.
2.2.13 Genotyping
For this work, embryos and tadpoles were genotyped for the t and t2 locus in order
to identify wild-types, homozygous and heterozygous mutants. The genomic DNA was
extracted as described above and 2µl of the lysate was mixed in the PCR reaction
containing 5µl of 2x KAPA HiFi HotStart ReadyMix (KAPA Biosystems, KK2600),
3.6µl of water and 0.4µl of each pair of primers:
t exon 1
forward: 5’- AATCAGAGGAAGAGCTGCTG-3’
reverse: 5’-CATTGGTGAGCTCCTTGAAC-3’
t2 exon 3
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forward:5’-TCACATCATTAAAATAGTGGCCTGCT-3’
reverse:5’-TCCATGAAATGTGAATTGTGGGCT-3’
The primers were designed to span the targeted site of mutagenesis and the region
was amplified with the following PCR conditions: 45 seconds at 98°C, 36 cycles of (10
seconds at 98°C, 10 seconds at 58°C (t) or 63°C((t2 ), 10 seconds 72°C) and 20 seconds
at 72°C. Following amplification, the fragments were digested with either SacI (t) or
EcoRI (t2 ) overnight and separated by gel electrophoresis. An example of fragment
distribution for each kind of genotype was shown in Figure 5.8.
2.2.14 Synthesis of complementary DNA (cDNA) from total RNA
For the reverse transcription (RT) reaction, 1µg of total RNA was used to synthesise
first-strand cDNA using the Superscript® III kit (Invitrogen, 18080-051). To the
total RNA, 10µM random hexamers, 500µM of each dNTP and RNAse-free water were
added to a final volume of 13µl. Samples were incubated in a thermocycler at 65°C for 5
minutes and chilled on ice. To each sample the following reagents were added: 4µl of 5x
First-strand buffer, 2µl of 0.1M DTT, 1µl of RiboLock RNase Inhibitor (Thermo Fisher
Scientific, E00381) and 1µl of Superscript® III reverse transcriptase. The contents were
gently mixed and incubated in a thermocycler: 5 minutes at 25°C, 50 minutes at 50°C
and 15 minutes at 70°C (to inactivate the polymerase). Samples were kept at 4°C
and diluted in RNAse-free water to a final volume of 100µl. To assess the synthesis
efficiency, 1µl of diluted cDNA was added to 3.6µl of H2O, 5µl of 2x KAPA2G Fast
ReadyMix (KK5103, KAPA Biosystems) and 0.4µl of 10µM odc primers and amplified:
pre-incubation at 94°C for 60 second, 35 cycles of; 15 seconds at 94°C, 15 seconds
at 60°C and 15 seconds at 72°C; followed by a final extension at 72°C for 5 minutes.
The product of this diagnostic PCR was loaded into a 2% agarose/TAE (containing
1:50,000 RedSafe, Ecogen, 21141) gel and fragment separated by electrophoresis.
2.2.15 Quantification of transcription
Expression levels were quantified in real-time (real time quantitative PCR, RT-qPCR)
relative to a gene or locus-specific standard curve using the LightCycler LC480 II
(Roche). For each primer pair a master mix was prepared: 5µl of SYBR Green I master
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mix (Roche, 04707516001), 0.4µl of 10µM reverse and forward primer mix and 3.6
H2O. The master mix was pipetted into a 384-well plate and 1µl of diluted cDNA was
added to each well. The LC480 II carried 55 cycles of amplification with the following
conditions: 10 seconds at 94°C, 60°C and 72°C with ramp rates of 4.8(°C/s), 2.5 (°C/s)
and 4.8(°C/s), respectively. Each sample was amplified in technical triplicates and the
standard curve for each primer set was calculated from 1:3 dilution series, of 8, of
wild-type cDNA. The LC480 II software calculated the concentration of each sample
based on the crossing point (CP) value and the standard curve calculated in each
experiment. Microsoft® Excel was used to normalise the concentrations to the control
gene (a house-keeping gene, odc), design plots and statistical analysis (Student’s T
test).
2.2.16 Dual Luciferase Assay
Xenopus laevis at 2-cell stage were injected with 50pg of firefly luciferase construct
(pGl3 constructs, see Cloning, Dual Luciferase Assay, pGl3-Basic) and 5pg of Renilla
reniformis luciferase mRNA into each blastomere. Embryos were incubated overnight
at 14°C and 3 times 8 embryos were harvested at stage NF10-11 in 1.5ml Eppendorf
tubes. Most of the media was removed from the tubes which were snap-frozen in liquid
nitrogen and stored at -80°C.
To detect luminesce from the luciferase construct I used the Dual-Luciferase® Re-
porter Assay System (Promega, E1910) kit. Embryos were homogenised in 100µl of
1x Passive Lysis Buffer (PLB) (made from 5x PLB, diluted in water) and the tubes
centrifuged for 3 minutes at 4°C at 16,000x g. 20µl of the supernatant was used for
luminescence detection, which was added to a well from a 96-well plate with solid white
bottom (Perkin Elmer, OpiPlate™-96). Each sample was read in triplicate (3x 20µl in
EnVision 2102 MultiLabel Reader (Perkin Elmer) using the EnVsion Manager 1.12
Software. The appropriate protocol was previously set up in the software (shaking, 0.2
seconds reading.). To each 20µl of samples 50µl of Luciferase Assay Reagent II (LARII)
(previously prepared by re-suspending lyophilised Luciferase Assay Substract in 10ml
of Luciferase Assay Buffer II) was added and the plate was immediately transferred to
the EnVision 2102 MultiLabel Reader and the first measurements made. Once finished,
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to each well I added 50µl of Stop & Glo® reagent (previously diluted in Stop & Glo®
1x buffer from 50x Stop & Glo® substract) and the plate was again transferred to the
plate reader that proceeded to make the second measurement. The first luminescence
signal was originated from the firefly luciferase while the second if from the Renilla
luciferase, which was co-injected and acts as an internal control. The measurement
data was exported as a .csv file and analysed on Microsoft® Excel: luminescence from
firefly (from the pGl3 constructs injected in Xenopus embryos) was normalised to the
Renilla luminescence measurements.
2.2.17 Chromatin immunoprecipitation
The protocol was carried out as described in (Gentsch et al., 2013; Gentsch and
Smith, 2014). I will refer to some alterations to the protocol and to the specific times
and amounts used. To create the ChIP-Seq library from Brachyury/RNA polymerase
II/p300 immunoprecipitated DNA, approximately 750-3000 X. tropicalis UV- and LiCl-
treated embryos were harvested at stage NF10.5-11.5. Embryos were cultured in 0.05x
MMR and prior to chromatin crosslinked transferred to a glass vial and washed 2 times
in 0.01x MMR. Embryos were fixed at room temperature by adding 225µl of 36.5-38.%
of formaldehyde (Sigma, F8775) to the glass vial containing 8ml of 0.01x MMR (final
concentration of 1% (v/v)) and incubating for 20 minutes. Fixation was stopped by
quickly and carefully washing the embryos with ice-cold 0.01X MMR 3-5 times. Batches
of 250 embryos were transferred to 2ml Eppendorf tubes, excess media was removed,
tubes were snap-frozen in liquid nitrogen and stored at 80°C for future use. Three dis-
tinct extraction buffers were used for chromatin extraction: E1 (50 mM HEPES-KOH
pH 7.5, 150 mM NaCl, 1 mM EDTA. 10% glycerol, 0.5% Igepal CA-630, 0.25% Triton
X-100), E2 (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA),
and E3 (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Igepal CA-630,
0.25% Na-Deoxycholate, 0.1% SDS). Prior to extraction, 1mM of DTT and protease
inhibitor, in the form of tablets (Roche,11836170001), were added to each buffer. The
buffers were used sequentially and 50 to 80 embryos per ml of extraction buffer. The
nuclear extraction was either done in 2 ml tubes or in 50 ml Falcon conical centrifuge
tubes. The embryos were first homogenised with E1 buffer by pipetting up and down
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followed by a 2-5 minutes centrifugation (depending on the volume) at 4°C at 1,000x
g. The nuclei were in the pellet together with dark insolubilise pigment granules. The
supernatant was aspirated and the homogenisation with E1 repeated, however, before
centrifugation, the samples were incubated on ice for 10 minutes. This process was re-
peated using the buffer E2 (homogenisation, centrifugation, aspiration of supernatant,
homogenisation, ice incubation, centrifugation and aspiration of supernatant). The pel-
let was re-suspended in E3 buffer and incubated on ice for at least 10 minutes, followed
by centrifugation and the supernatant discarded. At this point the pellet was smaller
as the anionic detergents in E3 removed most of the yolk platelets. After the last step
of nuclear extraction the pellet was resuspended in E3 buffer, and when using several
tubes for extraction, all the material was pulled together to a final volume of 2.5-3ml.
The next step was the solubilisation and fragmentation of cross-linked chromatin by
sonication.
The solution containing the cross-linked nuclei was transferred to polystyrene tube
previously clipped to fit the sonication probe. During sonication, the conical tube
in kept on icy water in a plastic beaker attached via a short thermometer clamp.
Sonication was done with a 1.6 mm microtip connected to a Misonix Sonicator 3000
Ultrasonic Liquid Processor. The microtip was inserted into the tube and immersed
in the sample to about two-thirds of the volume depth while keeping it centered and
away from the tube wall. Sonication consisted of 15-18 cycles of 30 seconds shock waves
with power of 1.5-2 until it reached 6-9W with interruptions of 60 seconds to allow the
sample to cool down. Upon sonication, the chromatin solution was returned into a
1.5ml Eppandorf tube and centrifuged for 10 minutes at 4°C at maximum speed; this
removed the debris. The supernatant contained the solubilised and sheared chromatin
and it was transferred to a new 1.5 ml low-retention microcentrifuge tube (Ambion,
AM12450).
Before proceeding to chromatin immunoprecipitation, the efficiency of the chro-
matin shearing was checked by collecting 50µl. While processing this aliquot to check
shearing efficiency, the remaining chromatin was kept at 4°C for one day or stored at
-80°C for a longer period. To the 50µl of sheared chromatin it was added 1 volume of
SDS elution buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% SDS), 4µl of 5M NaCl
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and 1µl of proteinase K (Ambion, AM3548) that, in combination with an overnight in-
cubation at 65°C results in the de-crosslinking of the chromatin. On the following day,
de-crosslinked chromatin was purified using the QIAquick PCR Purification kit (QI-
agen, 28194) and according to the manufacturer’s instructions. The DNA was eluted
twice in 11µl of EB buffer, treated with 0.4µl of RNase A (Invitrogen, 12091-039) by
incubating a few minutes at room temperature. To check the DNA fragment distribu-
tion, the sample was loaded into a 1.4% agarose/TAE gel (containing 1:50,000 RedSafe,
Ecogen, 21141) gel and ran by electrophoresis. The ideal distribution should be in the
range 0f 100-500 bp with a highest concentration at 200-300 bp. If this distribution
was not achieved by the first round of sonication the process would be repeated for
4-8 cycles. If the shearing was successful I proceed to the immunoprecipitation of the
sheared chromatin using a ChIP-grade antibody against Brachyury ((Stennard et al.,
1999; Gentsch et al., 2013) or this work, see ChIP-grade polyclonal antibody produc-
tion), p300 (Santa Cruz Biotechnologies, sc585) or RNA polymerase II (BioLegend,
MMS-126R).
Before the chromatin IP, an aliquot corresponding to 2-5% of the total volume was
kept at 4°C to be used as imput sample. For the IP, approximately 1µg/million cells
of T antibody was added to the chromatin and incubated overnight at 4°C on a rota-
tor (10rpm). DynaBeads® M-280 Sheep Anti-Rabbit IgG (Invitrogen, 11203D) were
washed with E3 buffer, using a magnetic rack and a rotator, and 30µl/µ of antibody
was added to the chromatin. The IP’ed chromatin was incubated with the beads for
at least 4 hours at 4°C in a rotator (10rpm). On the following day the beads were ex-
tensively washed, 10 times for 5 minutes, with cold RIPA buffer (50 mM HEPES-KOH
pH 7.5, 500 mM LiCl, 1 mM EDTA, 1% Igepal CA-630, 0.7% Na-deoxycholate) and
once with cold TEN buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 150 mM NaCl).
After the washed, the beads were resupsended in 50µl of TEN buffer and transferred to
a new 1.5 ml low-retention microcentrifuge tube (Ambion, AM12450). The beads were
collected at the bottom of the tube by using the magnetic rack and a short centrifuga-
tion at 1,000x g and most of the liquid was discarded. To strip the ChIP material from
the beads, 100µl of SDS elution buffer was added and mixed by continously vortexing
using a thermomixer at 1,000rpm for 15 minutes at 65°C. The sample was centrifuged
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at room temperature, for 5 minutes at maximum speed for 30 sec and the supernatant,
containing the ChIP eluate, was transferred to a new tube. The stripping process was
repeated to recover a total of 200µl of ChIP eluate.
The next step was to reverse crosslink the ChIP and the input chromatin (stored
at 4°C). SDS elution buffer was added to the input chromatin sample to a reach a total
volume of 200µl, same as the ChIP. To both the ChIP and input samples was added 10µl
of 5M NaCl (1/20 of the volume) and the samples were incubated overnight at 65°C.
On the following day, the samples were diluted with 200µl of TE (1 volume) and treated
with RNAse A at 200µl/ml and incubated at 37°C for 1 hour. This was followed by a
treatment with proteinase K (200µl/ml) for 2 to 4 hours at 55 °C. The DNA was purified
by phenol:chloroform:wasoamyl alcohol extraction followed by ethanol precipitation.
The DNA was transferred to a 1.5 ml Phase-lock gel heavy tube (5 Prime) (prespun
at 12,000x g for 30 seconds) and mixed with 1 volume of phenol:chloroform:wasoamyl
alcohol (24:24:1, pH7.9). The tubes were centrifuged at full speed for 5 minutes at room
temperature and the upper aqueous phase was transferred to a new microcentrifuge
tube. To this, 1/25 of the volume of 5M NACl, 2 volumes of 100% ethanol and 1µg of
GlycoBlue™ (Thermo Scientific, AM9516) were added. The samples were mixed by
inverting the tube a few times and incubated at -20°C for, at least, 16 hours. Samples
were centrifuged at full speed for 1 hour at 4°C. The supernatant was discarded without
disrupting the blue DNA pellet which was washed with 500µl of 80% EtOH followed
by a 3 minute full-speed spin at 4°C. The supernatant was carefully removed and air-
dried for 5-10 minutes at room temperature. Finally, 32µl of H2O was added to the
pellet and samples were left in ice for at least 2 hours to allow the pellet to completely
dissolve. The concentration of the co-immunoprecipitated DNA was measured with
Qubit™dsDNA HS Assay.
2.2.18 Preparation of Solid Phase Reverse Immobilisation (SPRI)
beads
Throughout this project SPRI beads were used to clean DNA, specifically to select cer-
tain fragment ranges, e.g. in preparation of DNA libraries for highthroughput sequenc-
ing these were used to remove smaller fragments, usually to remove adapter dimers, or
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longer fragments that impair cluster formation prior to sequencing. For some exper-
iments, I have used the Agencourt® AMPure® XP (Beckman Coulter, A63880) but
for others I have used ’homemade’ SPRI beads and here I will refer to its preparation
and validation.
TE buffer was prepared in a 50 ml Falcon conical centrifuge tube by adding 500µl
of 1M Tris pH8.0, 100µl of 0.5M EDTA and filling up with distilled water to the
50ml mark. The Sera-Mag SpeedBeads™ Carboxylate-Modified Magnetuc Particles
(GE Healthcare Life sciences, 65152105050250) were mixed and 1ml was transferred
to a 1.5ml Eppendorf tube. The tube containing the beads was placed in a magnetic
rack (ABI Applied Biosystems DYNAL MPC-S) and supernatant was removed using a
pipette. The beads were washed twice with 1ml of TE and re-suspended in 1ml of TE.
To a new 50 ml Falcon conical tube it was added: 9g of Polythylene glycol (PEG) 8000
(Amresco, 0777), 10ml of 5M NaCl, 500µl of 1M of Tris-HCl, 100µl of 0.5M EDTA
and distilled water(dH2O) to around 49ml. The tube was placed in a tube roller for 5
minutes to allow the PEG to go into solution, until tube was clear. To this solution
it was added 27.5µl of Tween-20 and mixed gently. The Sera-Mag beads re-suspended
in TE were transferred (1ml) to the tube containing PEG and the tube was filled with
dH2O to a final volume of 50ml.
The beads were tested against the AMPure XP beads® using aliquots of GeneRuler
50bp DNA ladder (Thermo Fisher Scientific, SM0371). The DNA ladder was diluted
by adding 2µl to 18µl of dH2O and different volumes of SPRI ’homemade’ beads were
added depending on the fragment range to include or exclude, e.g. a ratio of 0.9x
(20µl of DNA to 18µl of beads), should remove most fragments shorter than 300bp
and a 1.2x ratio (20µl of DNA to 24µl of beads) removes fragments shorter 200bp.
Beads were incubated with the DNA in a well of a 96-well microplate with V-bottom
(Greiner Bio-One International, 651101) for 5 minutes at room temperature. The plate
was placed on a magnetic stand-96 (Ambion, AM10027) for a few seconds to allow the
beads to separate from the supernatant which was removed and the beads washed
twice with 500µl of 70% EtOH. Following the last wash, the supernatant was removed
and the beads air-dried for 5 minutes at room temperature and re-suspended in 20µl
of dH2O by mixing up and down. The plate was returned to the magnetic stand
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and the supernatant was transferred to a new 1.5ml Eppendorf tube. The DNA was
mixed with 5x loading buffer (0.01g Orange G Dye (Sigma, O3756), 3ml 50% Glycerol,
0.6ml of 0.5M EDTA pH8.0 and 1.2ml of H2O) and loaded in a 1.5% agarose/TAE gel
(containing 1:50,000 RedSafe) and the fragments separated by electrophoresis.
2.2.19 Preparation of Paired-End indexed library for Illumina se-
quencing - RNA-Seq
This protocol refers to the library RNA-Seq libraries in Chapter 3.
Poly(A)+ RNA-Seq libraries, for sequencing, were made from 2µg of total RNA (see
section Extraction and purification of total RNA from Xenopus embryos) using
the version 2 of the TruSeq RNA low sample kit (Illumina, RS-122-2001) following the
manufacturer’s instructions. In summary, the RNA was first purified using oligo-dT
attached to magnetic beads and fragmented by enzymatic reaction. This step was
followed by the first stand cDNA synthesis and the second strand cDNA synthesis
after which the DNA was washed with AMPure® XP beads. The following step was
to perform end repair which converts the overhangs into blunt ends and subsequently
the 3’ ends were adenylated (addition of an ’A’ nucleotide to prevent fragments to
bind each other and, in addition, adaptors contain a ’T’ on the 3’ end for adapter-
fragment ligation). The next step was the ligation of indexed adapters to the end of
the double strand DNA which will be used for hybridisation to the flow cell. The
final step was an amplification, of 15 cycles, to enrich the DNA fragments followed by
purification with AMPure XP beads®. The final cDNA library was quantified using
the Qubit fluorometer and Qubit dsDNA high sensitivity reagents (Thermo Fisher
Scientific, Q3285) and fragment distribution checked on the Agilent 2100 Bioanalyzer.
Libraries were sequenced on an Illumina HiSeq 4000 to produce paired end reads of 50
bases
2.2.20 Preparation of Paired-End indexed library for Illumina se-
quencing - ChIP-Seq
A library was generated from 2-15ng of each ChIP and input using the KAPA Hyper
Prep kit (KAPA Biosystems, KK8502) for Illumina® platforms. Some modifications
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were done to the protocol. The amount of adaptors used and the number of ampli-
fication steps varied based on the starting amount of ChIP (see Table ,below). For
adapter ligation, the TruSeq DNA adapters (15µM) were diluted to the appropriate
concentration and used for the reaction.
Starting DNA TruSeq DNA adaptors PCR cycles
1ng 300nM 5+8
5ng 1.5µM 5+7
15ng 4.5µM 5+6
Table 2.4: Conditions for paired-ended ChIP-Seq library preparation.
To the protocol a pre-amplification step (5 cycles of amplification of denature for
15” at 98°C, annealing at 60°C for 30” and elongation 30” for 72°C) using Illumina
primers was added after adapter ligation was added. This step was used to convert
the Y-shaped Illumina adapters to dsDNA. This allowed for a proper size-selection of
fragments of the desired length (when running the samples on agarose gel) and also
reduces adapter dimer contamination (Ford et al., 2014). After the pre-amplification,
the DNA fragments were cleaned using the SPRI beads (Agencourt® AMPure® XP
beads, or ’homemade’ SPRI beads (see above)).
The DNA clean-up using SPRI beads was also altered from the protocol from KAPA
Hyper Prep kit. The appropriate amount of SPRI beads (the protocol includes 0.8x
and 1.0x bead cleaning steps) were added to each V-bottom well from a 96-well plate
(Greiner Bio-One International, 651101) containing the DNA sample and mixed by
pipetting up and down. The mixture was incubated at room temperature for 2 minutes.
The plate was transferred to a magnetic stand (Ambion, AM10027) and incubated for
3 minutes or until the beads were completely separated from the supernatant. The
supernatant was removed by pipetting with a fine tip and the beads washed twice
with 80% EtOH. Finally, the supernatant was removed and the plate sealed with an
adhesive PCR film (4titude, 4ti-0500) and centrifuged for 1 minutes at 200x g. The
plate was returned to the magnetic stand, the film removed, the remaining supernatant
was removed and the beads allowed to dry at room temperature for 5 minutes or until
pellets showed cracks. The dried beads, were eluted in 20µl of Elution buffer (EB)
(10mM Tris-HCl, pH8.5) by removing the plate from the magnetic stand and pipetting
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the beads up and down several times. The beads were incubated at room temperature
for 2 minutes, re-suspended again and the plate placed in the magnetic stand. When the
beads were completely separated, the supernatant containing the DNA was transferred
to a new tube to be used in the next step of the protocol.
Size-selection of the library fragments was done using an electrophoresis-based
method, using the E-gel® iBase™ Power System dock with the E-gel® EX agarose
gel, 2% and selected bands from 250-450bp. I proceeded to do DNA purification us-
ing the MinElute Gel Extraction Kit Protocol (Qiagen) following the manufacturer’s
instructions. The recovery DNA was amplified for the appropriate number of cycles in
a thermocycler followed by a post-amplification cleanup, as described in KAPA Hyper
Prep kit guide. The concentration of the library was assessed with Qubit™dsDNA HS
Assay (Thermo Fisher Scientific, Q32851) (ranged from 4µg/ml to 48µg/ml) and the
integrity of the library was checked on the Agilent 2100 Bioanalyzer. Libraries were
read single-end along 50-100 bases on the HiSeq 2000 machine (Illumina®).
2.2.21 Bioinformatic analysis
Sequenced libraries were provided by the Advance Sequencing Facility (The National
Institute for Medical Research (NIMR) and the The Francis Institute, core facilities)
in fastq file format and were analysed for sequencing quality control using the software
FastQC. The software provides information on the number of sequenced reads, the
read quality score and the percentage of duplication. This information is essential to
evaluate the quality of the sequenced library and decide whether to proceed or not with
the analysis.
RNA-Seq
The sequenced reads were aligned to the Xenopus tropicalis transcriptome assem-
bly JGI7.1 using Tophat2 (Kim et al., 2013) with the following parameters: -p 12
--transcriptome-index= xenTro7 --no-novel-juncs --no-coverage-search. The transcriptome
index was previously generated using version 2 of gene models of assembly JGI7.1 using
the following command: tophat2 -G JGI7.1 genes7.2 updated.gtf --transcriptome-index=xenTro7
indexes/xentrov7. The average alignment percentage was around 80%. The resulting
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aligned reads were in sequence alignment/map (SAM) format which where converted
to binary alignment/map (BAM) and sorted by reads name using SAMtools (Li et al.,
2009). The library was paired-end sequenced to obtain the correct fragment size, which
meant reads were mapped in pairs and, after sorting the BAM file, unpaired reads were
removed. The goal of the RNA-Seq experiment was to identify differentially expressed
genes between the different conditions which implicated quantification of transcripts.
To this end, I used HTSeq (Anders, Pyl, and Huber, 2015), a tool to count reads in
features, in this case in genes using the following command : htseq-count -s no -m
intersection-nonempty -t gene -i Name -f bam .bam genes.gff3. The result was a text file
with raw counts for each gene in each condition. The file was used to identify differen-
tially expressed genes using the R package (R Core Team, 2013; Maechler et al., 2013)
DESeq2 which performs a test based on a negative binomial distribution resulting a
data frame with adjusted p values (Benjamin-Hochberg correction) or false discovery
rate (FDR) and log2 fold changes for each genes. From here I selected genes based
a adjusted p-value smaller or equal to 0.01 (1% change of a false positive) and a fold
change equal or bigger than 2. The PCA plot was produced using DESeq2, the MA-plot
was designed using the R package ’ggpubr’ and the produce the other graphs I used
Ipython (Fernando Pe´rez, 2007), using the libraries ’pandas’ (“pandas: a Foundational
Python Library for Data Analysis and Statistics”) and ’seaborn’ (Waskom et al., 2014);
Microsoft® Excel for Mac OS X and GraphPad Prism 7 for Mac OS X.
ChIP-Seq
ChIP-Seq single-end sequenced libraries were aligned to Xenopus tropicalis genome as-
sembly JGI7.1 using Bowtie with the following parameters: --best -m 1 -p 12 --chunkmbs
512. The resulting SAM file was converted to BAM file, sorted and duplicated were
marked using ’MarkDuplicates’ from Picard Tools (http://broadinstitute.github.io/picard).
To identify regions of high probability of chromatin binding, peaks I used MACS2
(Feng et al., 2012) with the following command: macs2 callpeak -t <sorted.bam> -c
<inputs sorted.bam> -n <> -g 1.16e+09 -B --SPMR -q5e-4. The peak files, table of genomic
intervals were in the BED format are were manipulated and compared using Linux com-
mands (’grep’, ’awk’) and BEDTools (Quinlan and Hall, 2010). For example, peaks
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summits were filtered based on fold enrichment and extended 150bp on each direction
with this command: awk ’print $1"\t"$2+$10"\t"$2+$10+1"\t"$7’ .narrowPeak | awk ’if
($4 >= 5) print’ | bedtools slop -i - -g genome.txt -b 150 > 5fe 300bp.bed. Peaksets were
compared using the tool ’intersect’ from BEDtools (bedtools intersect -wa -wb -a <.bed>
-b <.bed> (-v)) and annotated with the nearest using using Homer (Heinz et al., 2010)
(annotatePeaks.pl xenTro7 -gtf <.gtf> <.bed> > <annotated.txt>.
Heatmaps were created using deepTools (Ramı´rez et al., 2016); correlation heatmap:
multiBamSummary BED-file --BED <.bed> --bamfiles <sorted.bam> <> -out <results.npz>
--ignoreDuplicates -p max and plotCorrelation -in <results.npz> --whatToPlot heatmap -o
<correlation.pdf> --skipZeros --plotNumbers --corMethod pearson. The reads coverage heatmaps
were produced with the following commands: bamCoverage -b <sorted.bam> <> -o <.bw>
--normalizeTo1x 1160000000 --ignoreDuplicates, computeMatrix reference-point -S <.bw> <>
-R <.bed> -a 2000 -b 2000 -out <matrix.ma.gz> --skipZeros -p max and plotHeatmap
-m <matrix.ma.gz> -out <heatmap.pdf> --colorMap YlGnBu --heatmapHeight 25 --missingDataColor
’#FEFED7’.
Representations of genomic regions as a dense plot of the ChIP-Seq reads were de-
signed using fluff (Georgiou and Heeringen, 2016): fluff profile -i <genomic interval>
-d <.bam> <> -o <profile.pdf> -n -S <#> -c <hex code>.
The RNA polymerase II ChIP-Seq was not processed for peak calling, instead, reads
mapped to gene bodies were counted with Homer annotatePeaks.pl genebody.gtf xenTro7
-size given -norm 1e7 -normLength 175 -hist 11 -ghist -noann -nogene -fragLength 175 -cpu
8 -d TagDirectories. ’TagDirectories’ are directories that summarise SAM files and used
instead of these by the software Homer; such directories are created with the com-
mand: makeTagDirectory TagDir/ .sam -unique -single. Identification of differentially ac-
tive genes following the requisites defined in Chapter 3, was done using R code provided
by George Gentsch.
Identification of differentially bound sites by comparing the Brachyury ChIP-Seq
of the different conditions was done using the R package ’DiffBind’ (Ross-Innes et al.,
2012). For such anlaysis, the input was a table containing the names and paths to the
each of the replicates mapped read files (sorted BAM files with marked duplicates) and
to the peak files containing peaks called in all conditions. ’DiffBind’ first counts and
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normalised the reads (total mapped reads) and then uses DESeq2 algorithm to identify
differentially bound sizes, as explained above. The output was a table with adjusted
p-values and fold changes for each peak, which was filtered to select only peaks with a
FDR equal or less than 0.05 (5% change of a false positive). The PCA plot on Figure
4.13A was designed using DiffBind.
De novo motif discovery and motif enrichment in peaks was done using Homer with
the commands: (findMotifsGenome.pl <.bed> xenTro7 <outputfile> -size 400 -len 8/12) and
annotatePeaks.pl <.bed> xenTro7 -m <.motif> <> -size 600 -noann -nogene, respectively.
Image design was processing was done using Ipython (’seaborn’), Microsoft® Excel
for Mac OS X, GraphPad Prism 7 for Mac OS X, Adobe Photoshop CC and Adobe
Illustrator CC.
105
Chapter 3
Transcriptome comparison of dorsalised and
ventralised Xenopus tropicalis embryos
In Chapter 1, I refered to the process of the dorso-ventral (DV) axis determination, the
first break in symmetry of the amphibian egg. DV determination occurs as early as
fertilisation; the sperm entry point (SEP) acts as a reference to the prospective dorsal
side of the embryo. This process is accompained by the formation of the grey crescent.
Historically, the grey crescent was first described as the initial break in the sym-
metry of the amphibian egg and was later associated with the DV axis determination.
During the decades of the 1970s and 1980s many researchers were interested in under-
standing how the grey crescent was formed. There were two theories: the contraction
and the rotation hypothesis. The first stated that upon fertilisation the egg cortex
would contract radially towards the SEP (Rzehak, 1972; Palecek, Ubbels, and Rze-
hak, 1978; Ubbels et al., 1983) leading to the formation of the grey crescent on the
opposite side. The rotation hypothesis, developed from observations in Rana pipiens,
stated that the cortical layer of the egg shifted 30° relative to the cytoplasmic core in a
direction related to the SEP (Elinson, 1975; Elinson and Manes, 1978; Elinson, 1980).
The latter theory is the one accepted today and much owed to the 1986’s experiments
from Vincent et al.. In that work, the authors used Xenopus laevis eggs in which they
injected two distinct fluorescent dyes, one in the subcortical cytoplasm and another
in the egg surface. They observed two movements of the subcortical cytoplasm: an
initial convergence of the animal subcortical hemisphere towards the entry point and
a second overall rotation of the subcortical cytoplasm that superimposes to the first.
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They confirmed that it was the 30° rotation or displacement of the cortical cytoplasm
that marks the prospective dorsal midline of the embryo (Vincent, Oster, and Ger-
hart, 1986). Two years later, in 1988, Elinson and Rowning observed for the first time
in eggs undergoing cortical rotation an array of parallel microtubules forming in the
vegetal hemisphere. These microtubules were parallel to the direction of the rotation
and disappeared at the end of cortex displacement. The authors suggested that the
microtubules would serve as tracks for the cytoplasmic rotation that ultimately would
be involved in the DV determination (Elinson and Rowning, 1988). Furthermore, the
authors showed that UV irradiation of the vegetal pole of the eggs, shortly after fer-
tilisation, lead to the disruption of the microtubule array which in turn resulted in an
embryo without dorsal structures.
The role of UV irradiation in early development had been tested and described many
years before. In 1972 it had been shown in Rana pipens that UV treatment affected
neural induction (Grant and Wacaster, 1972), in 1980 Scharf and Gerhart described
that embryos treated with UV irradiation developed without any dorsal structures
(Scharf and Gerhart, 1980) and Manes and Elinson showed that UV disrupted cortical
rotation and the formation of the grey crescent (Manes and Elinson, 1980; Vincent and
Gerhart, 1987). It was only in 1988, the work described above, that the authors made
the connection between the disruption of microtubule and consequently the absence
of a dorsal structures in these embryos. We now know, as described in Chapter 1,
that the microtubules are essential for dorsal determination, they transport Wnt/β-
catenin components to the prospective dorsal side resulting in an asymmetrical nuclear
enrichment of β-catenin that triggers the formation of the dorsal centre.
For many years, researchers have tested the effects of drugs or other perturbations,
such as UV irradiation, during early development in order to better understand the
process. An example is the treatment of amphibian eggs and embryos with lithium,
specifically lithium chloride (LiCl). During the decades of 1940s and 1950s researchers
have described different effects of LiCl treatment in amphibian embryos treated with
different doses and at different developmental stages (Pasteels, 1945; Hall, 1942; Back-
strom, 1954). By the late 1980s Kao et al. showed that by exposing 32-cell+ Xenopus
leavis embryos to 0.3M LiCl for 6 minutes, these embryos would develop exaggerated
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dorso-anterior structures, like the head and cement gland (Kao, Masui, and Elinson,
1986). The authors described this phenotype to be similar to the one obtained by
exposing the embryos to deuterium oxide (D2O), a drug that when used prior to corti-
cal rotation caused the development of hyper-dorsalised embryos (Scharf et al., 1989).
Furthermore, the authors used UV irradiation, a known ventralising treatment, to effi-
ciently rescue the embryos treated with LiCl (Kao, Masui, and Elinson, 1986). In the
same work, LiCl was introduced as an efficient drug to dorsalise embryos and as a tool
to study DV patterning. Two years later, Kao and Elinson further described the ’LiCl
phenotype’ as an over commitment of cells to a dorsal and anterior fate as the whole
marginal zone becomes dorsalised (Kao and Elinson, 1988). Furthermore, the authors
introduce a scale of dorsalisation development, the dorsoanterior index (DAI) (Figure
3.1). This index was constructed by adding the phenotypes of LiCl-treated embryos to
the index of axis deficiency (IAD) that described phenotypes of ventralised embryos.
The IAD in turn was adapted from the ’UV syndrome’ (Malacinski, Allis, and Chung,
1974) or ’Dorsal reduction’ (Scharf and Gerhart, 1980) in which 0 described a normal
embryo and 5 described an ’aneural’ embryo, without neural or dorsal tissue. The
IAD had a similar scale where 0 was normal and 5 was an embryo without somites or
any tail mesenchyme. Finally, the DAI introduced in 1988, inverted the scale and 5
represented a normal embryo, absence of dorsal structures was classified with a DAI
of 0 (5-0 would be a gradual loss of dorsal structures) and DAI of 10 represented the
hyperdorsalised embryo (DAI 6-10 are increasingly LiCl treatment effects) (Figure 3.1).
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Figure 3.1: Tailbud Xenopus laevis embryos drawing and pictures represent-
ing the different degrees of the dorsaoanterior index (DAI)
Drawings and pictures of Xenopus laevis embryos, either irradiated with UV for an increasing
time (DAI 0-4) or an increasing concentration of LiCl (DAI 6-10). DAI of 5 is an untreated embryo
that represents the wild-type phenotype. Increasing the exposure time to UV leads to embryos with
increasingly less dorso-anterior structures, to the extreme phenotype representing a ’belly’-like
structure (DAI of 0). Increasing the concentration of LiCl leads to embryos with increasingly
exaggerated dorso-anterior structures, like the eyes and the cement gland. At the highest
dorsalisation phenotype the embryo resembles a cylinder of radially formed dorso-anterior structures
or the formation of a proboscis-like structure of chordo-mesoderm (DAI of 10). Figure adapted from
(Danilchik, 2011) and (Kao and Elinson, 1988).
While the effect of UV was understood in the 1980s, it was only in 1996 that LiCl
was described to act specifically as a GSK-3β inhibitor (Klein and Melton, 1996; Stam-
bolic, Ruel, and Woodgett, 1996). This inhibition explains the dorsalisation phenotype,
since that at 32-cell stage, GSK-3β is highly enriched on the ventral side of the em-
bryo, maintaining β-catenin only on the dorsal side. Inhibition of GSK-3β, leads to the
ventral expansion of active (nuclear) β-catenin inducing these cells to become dorsal.
Since the end of the 1980s these two treatments, LiCl and UV have been used by
scientists as tools to study the determination of the dorso-ventral axis. In the late 1980s
the laboratory of Jonathan Cooke focused on analysing and describing the phenotypic
effects of these treatments during development, specifically the effect on mesoderm.
They showed that UV treatments has no effect on the midblastula transition, embryos
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have no developmental retardation, and have the same number of cells as untreated
embryos. In UV-treated embryos the mesoderm developed radially symmetrically and
as a tubular monolayer of the trunk lateral plate type. Moreover they showed that
embryos formed no prechordal mesoderm, formed 25% less of somite muscle and its
blood forming capacity was enhanced (Cooke and Smith, 1987). On the other hand,
LiCl-treated embryos, although also radially symmetric, develop a massive notochord
(prechordal mesoderm), smaller somites and blood tissue. Overall, these embryos gas-
trulate normally but only dorsal mesoderm ingresses, the kind that would in a normal
embryo only ingress through the blastopore (Cooke and Smith, 1988). Given the dor-
salising effect of lithium, and since mesoderm is first induced dorsally, researchers were
interested in testing the effect of LiCl in inducing this germ layer. While LiCl was not
capable of inducing mesoderm by itself, it enhanced the response to the mesoderm-
inducing factor, Activin (Cooke, Symes, and Smith, 1989; Kinoshita and Asashima,
1995; Smith, 1987).
These treatments have been widely described and scientists have confidently used
them as tools to generate dorsalised and ventralised embryos for decades. Given the new
’omics’ tools that allow us to study the whole proteome, transcriptome or epigenome,
we can now better understand the effects of these treatments. In this project, I set
out to analyse and compare the whole poly(A) transcriptome of LiCl- and UV-treated
embryos. The goal was to create a dataset of genes differentially expressed in each con-
dition that would allow to better understand the effect of the treatments. In addition,
by comparing to dissected dorsal and ventral sections of a developing embryo I was
able to assess the similarity of a whole dorsalised/ventralised embryo to its ’real’ cell
type in the untreated embryo. And finally, identify and characterise genes which have
not been described before. Throughout the duration of this project, some publications
have referred to the analyses of the whole poly-(A) transcriptome of LiCl-treated Xeno-
pus laevis embryos (Ding et al., 2016; Ding et al., 2017). My work differentiates from
these as I described the treatments in Xenopus tropicalis for the first time, focusing
the comparison on LiCl- and UV-treated embryos and the genes differentially expressed
between each condition.
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3.1 UV and LiCl treatments efficiently ventralise and dor-
salise Xenopus tropicalis embryos
3.1.1 Phenotypic analysis
Although LiCl and UV manipulations have been well described and widely used for
many years in Xenopus laevis, I could not find an example applied to Xenopus tropicalis
in the literature. Given this, I first tested the conditions that led to the most extreme
phenotypes (DAI of 0 for UV and of 10 for LiCl) in the highest number of embryos.
Figure 3.2 shows a scheme representing the treatments and conditions that led to these
results: LiCl; 32-64-cell embryos submerged in 0.3M LiCl/MMR for 5 minutes followed
by three washes in 0.05x MMR; UV, 20-40min post fertilisation embryos were irradiated
with a UV short wave (254nm) at a distance of 2 cm from the source for 2’-2’10”; WT,
untreated embryos (siblings) used as a control for staging and transcriptome analysis
(Fig. 3.2). For more details see Chapter 2.
0.05x MMR
WT
0.3M LiCl/MMR
0.05x MMR
Wash 3x 
5’ in
32-cell 
LiCl
30’ pf
UV  
254nm  
2’
2cm
UV
Figure 3.2: Diagram showing procedures to generate dorsalised (LiCl) and
vetralised (UV) embryos and the control (WT)
The three conditions studied in this work. Wild-type embryos were untreated Xenopus tropicalis
embryos cultured in 0.05X MMR until harvested at stage Nieuwkoop and Faber (NF) stage 11.5.
UV-treated embryos were placed in a 50 ml falcon conical tube closed with saran wrap and inverted,
allowing the embryos to be placed in the centre of the tube opening. Embryos were placed at 2 cm from
the UV source and irradiated for 2 minutes with a short-wave (254nm), within the first 30 minutes
after fertilisation. To dorsalise, 32-cell stage embryos were exposed to 0.3M LiCl for 5 minutes and then
gently washed in 0.05x MMR. Please refer to Methods (Chapter 2) for more details on the treatments
and embryo handling.’ - minutes
Both UV and LiCl treatments resulted in previously described abnormal formations
of the blastopore lip; in UV-treated embryos the appearance of the blastopore lip was
delayed, and it formed circumferentially rather than on the dorsal side while in LiCl
treatment caused blastopore lip formation to be initiated on time but circumferentially
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(Fig. 3.3). Given the differences in developmental speed between embryos, the forma-
tion of the blastopore lip could not be used to assess the efficiency of the treatments.
Hence, embryos were kept until tailbud stages and scored for its DAI at this stage (Fig.
3.3). Only treatments that resulted in embryos with an average DAI score of 0.5-0.8, in
the case of UV; and 9.4-10 in the case of LiCl were considered for further analyses. UV
irradiation was less penetrant than LiCl treatment given the lack of absolute control
of the irradiated area.
Early gastrula Tailbud
Un
tre
at
ed
LiC
l
UV
61/67
DAI=0-1
DAI=5
DAI=10
49/50
Figure 3.3: LiCl and UV treatments efficiently dorsalised and ventralised
Xenopus tropicalis embryos
Control/untreated embryos (WT) at early gastrula (Nieuwkoop and Faber (NF) stage 10.5) and tailbud
stages (NF26). UV-treated embryos show little phenotypic differences at early gastrula stage, compar-
ing to WT embryos. Tailbud UV-treated embryos show a clear ventralisation with complete loss of
dorso-anterior structures, representing an embryo with DAI=0. Dorsalisation is visible in LiCl-treated
early gastrula embryos, as the blastopore lip forms synchronously around the embryo. By stage 26 the
shows a clear dorsalised phenotype, DAI of 10, with exaggeration of anterior structures like a circular
cement gland. Number in picture: number of embryos with respective phenotype/total number of
treated embryos.
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3.1.2 Expression of known ventral and dorsal markers
The next step was to verify if the LiCl- and UV-treated embryos, which by stage 11
were phenotypically similar, had changed its cell fate and become enriched for dorsal
and ventral cells, respectively. I analysed the expression pattern by whole mount in
situ hybridisation (WMISH) and transcript level by q-RT-PCR (quantitative real-time
PCR, qPCR) of known ventral and dorsal gene markers (Fig. 3.4A). The expression
pattern of goosecoid and noggin by gastrula stage, as seen in WT (Fig. 3.4), was very
similar and marked the dorsal area of the embryo, the Spemann organizer (SO) which
will give rise to the dorsal- and anterior-most tissues of the embryo. The LiCl treatment
efficiently dorsalised the embryo, as seen by the expansion of these markers to the
ventral side and around the blastopore (Fig. 3.4A), suggesting a change in fate of these
cells. Although with less penetrance, for reasons explained above, the UV treatment
had the opposite effect, as it led to the loss (or reduction) of the expression domain
of dorsal markers. These results were further verified by quantitative comparison of
transcripts by qPCR between treated and untreated embryos (Fig. 3.4C). The graph
shows, by absolute quantification, that noggin and gsc were more expressed in LiCl-
treated and less in UV-treated embryos compared to WT (Fig. 3.4C). Since treated
and untreated embryos had the same number of cells, the qPCR analysis indicated that
more cells are expressing dorsal markers in LiCl-treated embryos.
The ventral markers bmp4 and wnt8a were expressed in the same cells of the gas-
trula in a broader area of the embryo, compared to the dorsal cells on the opposite
side (Fig. 3.4A). Dorsalised embryos had reduced or lost expression of these markers in
accordance with the expansion of Wnt and BMP antagonists such as noggin. Although
not very clear by WMISH, the expression pattern, of both ventral marker expanded
dorsally in UV-treated embryos (Fig. 3.4A). Similarly, the quantitative analysis of the
transcripts indicated a significant increase in UV-treated compared to WT and decrease
in dorsalised embryos (Fig. 3.4C). Another ventral marker sizzled (szl) also showed a
significant increase in expression levels in UV-treated embryos (Fig. 3.4C). In addition
to ventral and dorsal marker genes I analysed the expression of markers of posterior
and axial/dorsal mesoderm. The notochord is the dorsal-most mesodermal structure of
the embryo and it has been described to be ’overdeveloped’ in dorsalised embryos. In
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dorsalised gastrula embryos the expression pattern of notochord marker not expanded
ventrally (Fig. 3.4B) and the transcript levels were significantly higher when compared
to untreated embryos (Fig. 3.4C). The caudal homeobox gene xcad3 was expressed
ventrally in cells that will form posterior mesoderm and, upon UV-treatment its ex-
pression pattern expanded dorsally (Fig. 3.4B) and overall transcript levels increased
(Fig. 3.4C). The levels of posterior mesoderm markers, msgn1, mespA and tbx6 were
down in dorsalised embryos compare to untreated (Fig. 3.4C).
Together, these results indicated that the treatments were effectively altering the
cell fate during development; LiCl-treatment resulted in embryos enriched for dorsal
cells while UV irradiation led to embryos enriched for ventral cells.
114
WT
go
os
ec
oid
Do
rs
al 
m
ar
ke
rs
wn
t8
a
bm
p4V
en
tra
l m
ar
ke
rs
no
gg
in
LiCl UV
9/10 8/12
6/7 8/9
6/9
7/9 9/9
8/9
Ax
ial
 m
es
od
er
m
 
m
ar
ke
r
no
t
Po
ste
rio
r m
es
od
er
m
 
m
ar
ke
r
m
es
og
en
in1
WT LiCl
WT UV
10/10
A
B
C
10/10
-2
gsc
noggin
bmp4
wnt8a
LiCl UV2.5
2
1.5
1
0.5
0
-1.5
-1
-0.5
tra
ns
cr
ipt
 le
ve
l in
 re
lat
ion
 to
 u
nt
re
at
ed
 
co
nd
itio
n 
(lo
g 2
) ***
**
***
4/12
Figure 3.4: Expression of ventral and dorsal markers quantified by qPCR
and analysed by WMISH
A) Expression pattern of the dorsal markers, noggin and goosecoid and the ventral markers wnt8a
and bmp4 in untreated (WT), LiCl- and UV-treated gastrula stage (NF11.5) embryos. The expression
domain of dorsal markers expanded ventrally in LiCl-treated embryos and was lost or reduced in UV-
treated embryos. The expression domain of ventral markers expanded dorsally in UV-treated embryos
and the expression was loss in LiCl-treated embryos. B) Expression pattern of the axial mesoderm
marker not in WT and LiCl-treated embryos and the posterior mesoderm marker mesogenin 1 in WT
and UV-treated embryos. The expression of not expanded ventrally in LiCl-treated embryos and the
expression of mesogenin 1 expanded dorsally in UV-treated embryos, while it was only ventral in WT
embryos. C)Transcript fold changes (log2 scale) of dorsal (gsc and noggin) and ventral (bmp4 and
wnt8a) markers following LiCl or UV treatment as measured by RT-qPCR in mid-gastrula embryos
(n=3). Student’s two-tailed t test: *, p-value ¡0.1; **, p-value ¡0.05; ***, p-value ¡0.01. Error bars
represent the standard error of the mean (s.e.m.) of biological triplicates. Student’s-two-tailed t test:
** p-value<0.05; ***p-value<0.01. Error bars represent the standard error of the mean (s.e.m) of
biological triplicates.
3.2 Whole poly(A) comparison
To further characterise these embryos and have a better understanding of the transcrip-
tomic changes occurring in both treatments, I studied the whole poly(A) transcriptome
of gastrula stage (NF11-11.5) treated and untreated embryos. For this purpose, I col-
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lected 5 biological replicates of five to ten treated embryos for each condition, extracted
total RNA and prepared poly(A) libraries of the coding transcriptome (Fig. 3.5) fol-
lowed by paired-end sequencing. The resulting reads were aligned to the transcriptome
of the Xenopus tropicalis (assembly 7.1) and all further analysis is described in Methods
and Materials.
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Figure 3.5: Diagram of procedure for embryo collection for preparation of
poly(A) library followed by deep-sequencing
Embryos from 5 different crosses (biological replicates) were treated as shown in Figure 3.2, incu-
bated at 25-28°C and harvested at late gastrula stage (NF11.5 or NF11+). Total RNA was extracted
from 5-8 pooled embryos and poly(A) paired-end libraries were generated and sequenced (see Chapter
2 for details).
In order to understand the similarities between the treatments I compared the dis-
tribution of the transcripts for the three conditions. The principal component analysis
(PCA) (Fig. 3.6A) revealed that most variance was explained by PC1 (48%) which
clearly separated the two treatment conditions, LiCl and UV. This was quite striking
given that by this stage the embryos were phenotypically undistinguishable, however
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their transcriptome was very different. Biological variance (embryos from different
crosses) also played a role in separating the samples (PC2, 22%), a characteristic which
has been described in studies of absolute quantification of RNA in frog embryos (Owens
et al., 2016). The PCA analysis also indicated that, while WT embryos were located in
between the two other conditions, they were much more similar to UV-treated embryos.
The higher similarity between ventralised and untreated embryos was not unexpected,
as by this stage the ventral side represents most of the embryo (see Figure 3.4A, the
expression of ventral markers (bmp4, wnt8a, msgn1, xcad3 ) in untreated embryos).
The similarities between UV and WT replicates may also be explained by the lower
penetrance of the UV irradiation, as mentioned above.
These trends were confirmed when identifying differentially expressed (DE) genes
by pairwise comparison using DESeq2. I used 5 biological replicates, which were more
than what is generally used in similar experiments, which made the comparison more
robust and provided higher confidence in the identification of differentially expressed
(DE) genes. I identified genes DE in LiCl- or UV-treated embryos when compared to
untreated embryos (the upregulated genes are represented in red and the downregulated
in blue) (Fig. 3.6B-D). The criteria to identify these genes was based on a false discovery
rate (FDR) smaller than 0.01 and a fold change equal or bigger than 2. The analysis
revealed that only 0.6% of the active transcriptome is different between UV and WT
while it is around 10 times more different (6.57%) when comparing LiCl to untreated
(Fig. 3.6B-D). The DE genes in UV were mostly downregulated (79%, 93 genes) in
relation to WT (Fig. 3.6B,C) while the opposite occurs in dorsalised embryos, 74%
(914 genes) of the DE genes were upregulated (Fig. 3.6B,D).
These analyses revealed that at the transcript level ventralised embryos were very
similar to whole untreated embryos while dorsalised embryos had undergone more
transcriptomic changes and thus were more different from the control. As referred
above, these results were not unexpected as ventral markers are overepresented in the
embryo at this stage compared to the small domain of dorsal markers. The expansion
of the small dorsal domain to the whole embryo has a higher impact than the expansion
of an already dominating ventral domain.
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Figure 3.6: Ventralised embryos are transcriptionally more similar to whole
embryos than dorsalised embryos
A) Principal component analysis (PCA) of untreated, LiCl- and UV-treated embryos represented
by five biological replicates for each condition. B-D. Identification of affected genes upon UV or LiCl
treatment. C and D. MA plots showing the transcript fold change against read coverage between the
indicated conditions using the log2 scale for both fold change and mean of normalised read counts
among samples. Differentially expressed genes were classified (B) and highlighted (C,D) as such if fold
change ¿2 and FDR ?1%.
3.2.1 Identification of differentially expressed genes between dorsalised
and ventralised embryos
The main goal of this project was to understand the transcriptional effect of LiCl and
UV treatments, techniques that have historically been used to dorsalise and ventralise
frog embryos, respectively. With this in mind, I focused on comparing the transcrip-
tomes of both conditions to first confirm the effect of the treatments and second to
identify genes with unknown roles in early development. I compared the 5 replicates
of each condition and identified the differentially expressed genes (Appendix II and
III). The comparison was made in relation to dorsalised embryos, meaning that posi-
tive values correspond to genes that are upregulated in dorsalised and downregulated
118
in ventralised embryos, and vice-versa. As the PCA plot in Fig. 3.6 indicates, LiCl-
and UV-treated embryos are transcriptionally very different, 8.6% of the genes were
differentially expressed. Similar to the comparison to untreated embryos, most of the
differences were due to increase in expression, as 70% of the 8.6% are upregulated in
LiCl-treated embryos (fold change >2) (Fig. 3.7).
The Figure 3.7 denotes some of the most differentially expressed genes and with the
highest fold change. Among the upregulated genes in dorsalised embryos there were
known dorsal markers such as sia1, gsc, noggin chordin and admp. Other genes involved
in dorsal development, specifically in Wnt signalling included fzd8 (Itoh, Jacob, and S,
1998) and loc388630 (Tiki1 )(Zhang et al., 2012b; Reis et al., 2014; Zhang et al., 2016).
Within the group of upregulated genes I also found pkdcc.1, which has been recently
identified in RNA-Seq experiments done in dissected gastrula stage embryos, as a gene
dorsally enriched (Popov et al., 2016; Ding et al., 2016; Vitorino et al., 2015). The
neural marker zic2 known to be expressed in dorsal ectoderm and involved in anterior-
posterior (AP) patterning of the neural tube has a 2 fold increase in expression while
sarcalumenin (srl), a somite marker, has a 13 fold increase, compared to ventralised
embryos. Another example of a gene expressed in the chordo-mesoderm is foxa4, which
was also upregulated in LiCl-treated embryos. The examples given here are of genes
already identified as dorsal markers and others that are involved in the regulation of
anterior and dorsal/axial tissues.
I refer to the 485 genes downregulated in LiCl as the genes upregulated in UV.
In this group I found the ventral markers tested before (Fig. 3.4), bmp4, wnt8a and
the posterior mesoderm marker msgn1. The list of genes upregulated in ventralised
included genes involved in posterior development such as evx1, msx1 and mespb and
members of the ventx family of transcription factors (TFs), ventx1.1 and ventx1.2,
regulators of ventral fate. Furthermore there were genes involved in ectoderm develop-
ment, such as tfap2a and olfm4. The former is expressed in the neural crest and head
and the latter is secreted by non-neural head ectoderm (Tsuda et al., 2002; Luo et al.,
2003; Luo et al., 2002).
For both lists (upregulated in LiCl and in UV) it was reassuring to have identi-
fied dorsal and ventral markers together with genes expressed in tissues that derive
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from these cell types: neural tube and axial mesoderm in the case of dorsal cells and
epidermis, neural crest and posterior mesoderm in the case of ventral cells.
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Figure 3.7: Transcriptome of LiCl- and UV-treated embryos is highly distinct
at gastrula stage
MA plot showing the transcriptome differences between LiCl- and UV-treated embryos using trans-
formed (log2) fold change and the transformed (log2) mean average of each transcript. Differentially
expressed genes are represented as red and blue dots if upregulated or downregulated in LiCl, respec-
tively. Genes downregulated in LiCl are upregulated in the UV condition. The pie-chart on the top
right indicates the universe of active transcripts and the percentage of upregulated genes (red, 5.95%),
downregulated genes (blue, 2.59%) and unchanged genes (grey, NS, 91.46%) in LiCl-treated embryos.
This chart shows that 8.54% of the whole active poly(A) transcriptome is different between dorsalised
and ventralised embryos. The pie-chart on the lower right indicates that of these 8.54%, 70% of the
genes (1125 genes) are upregulated in LiCl-treated embryos while 30% (489 genes) are downregulated
(or upregulated in UV). srl-sarcalumenin; sia1 -siamois 1 ; nog-noggin; gsc-goosecoid ; chrd-chordin;
fzd8 -frizzled 8 ; pkdcc.1 -protein kinase domain containing, cytoplasmic homolog, gene 1 ; admp-anti-
dorsalising morphogen protein; foxa4 -forkhead box A4 ; ventx -vent homeobox ; bambi-bmp and activin
membrane-bound inhibitor ; msgn1 -mesogenin 1 ; msx1 -msh homeobox 1 ; mespb-mesoderm posterior
homolog B ; evx1 -even-skipped homeobox 1 ; olfm4 -olfactomedin 4 ; tfap2a-tto transcription factor AP-2
alpha.
120
Given the extent of the list of DE genes and that many genes were not classified
with a common name due to lack of annotation, to better understand the nature of
the transcriptome of each condition I proceeded to do a gene ontology (GO) analysis.
I focused on comparing the enrichment of terms associated with biological processes
(BP) using a previously generated list of gene-specific BP term associations (Owens
et al., 2016; Gentsch, Patrushev, and Smith, 2015). The most relevant GO terms and
the corresponding enrichment (represented by -log10(p-value) and number of genes in
each category) for each condition are represented in Figure 3.8.
Genes associated with both gastrulation (GO:0007369) and primitive streak for-
mation (GO:0090009) GO terms were enriched in LiCl compared to UV: although
both embryos go through gastrulation, the process starts on the dorsal side of the
embryo and this category was populated by genes expressed in this region, thus the
higher enrichment in LiCl-treated embryos. The genes found in this category, that
were overexpressed in dorsalised embryos, included gsc and cer1. Even though am-
phibian embryos do not form a primitive streak they have an analagous structure, the
blastopore,where the same genes are expressed, resulting in the enrichment of this GO
term in dorsalised embryos (Fig. 3.8A). The 9 genes in this category overexpressed in
LiCl-treated embryos included nodal, otx2 and otx1, lhx1 and hhex.
Transcripts associated with somitogenesis (GO:0001756) were overrepresented in
ventralised embryos, this was related to the overall enrichment for posterior tissues;
e.g genes involved in paraxial mesoderm, such as msgn1, mesp2, mespA, cdx4 and t.
As expected, the enrichment of genes associated with dorsal/ventral specification was
similar between the two conditions (Fig. 3.8A).
When analysing signalling pathways, ventralised embryos were enriched for genes in-
volved in the positive regulation of BMP signalling (GO:00030509) which substantiates
what is known of the ’ventral center’ as a source of active BMP signalling (Fig.3.8B).
Such genes included bmp4, msx1, foxj1 and members of the helix-loop-helix family of
transcription factors hes (hes3.3, hes5.1, hes6.1, hes8 ). Genes associated with overall
BMP signalling pathway (GO:0030509) were found in similar numbers in both condi-
tions, however, with higher significance in ventralised embryos (Fig. 3.8B). Among the
23 genes of this category overexpressed in UV, there was ventx1.1, ventx1.2, ventx3.2
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and bmp7.1 while genes of the same category enriched in dorsalised embryos, included
admp and bmp5.
When comparing genes associated with Wnt Signalling, the enrichment was not
so straight forward: genes associated with overall Wnt signalling (GO:0016055) were
represented in both conditions, while genes associated with positive regulation of the
pathway (GO:0030177) were enriched in dorsalised embryos (admp, zic1-4, hhex ), while
genes associated with canonical Wnt signalling (GO:0060070) were enriched in UV-
treated embryos (t, myc, xarp) (Fig. 3.8B). These discrepancies could be explained
by poor annotation of GO terms in relation to amphibian development as there are
two waves of Wnt signalling, maternal and zygotic. Maternal Wnt signalling is mostly
associated with dorsal enrichment of β-catenin on the dorsal side of the embryo that
triggers the cascade in these cells. After the midblastula transition (MBT), zygotic
Wnt signalling, mostly via Wnt8a, is high on the ventral cells of the embryo leading to
the formation of posteriorised tissues.
The comparison of genes associated with distinct tissue types is represented in
Figure 3.8C. Genes associated with mesoderm development (GO:0007498) were equally
represented in both conditions, however lateral (GO:0048368) (and its derivative blood
vessel (GO:0001568)) and paraxial mesoderm (GO:0048339) were more associated with
ventralised embryos. Transcripts associated with the GO term for heart development
(GO:0007507) was equally enriched in both conditions, probably due to the distinct
ancestries of its cells. LiCl-treated embryos were enriched for genes associated with
endoderm (GO:0007492) which affirmed the enrichment for dorso-anterior cells, that
will give rise to mesoderm and endoderm (mesendoderm). Genes associated with this
GO term that were overexpressed in LiCl-treated embryos included nodal, hhex, otx1-2,
foxa2 and nkx2-1. These results were in conformity with the morphology description
of LiCl- and UV-treated embryos and the quantification of the distinct mesodermal
derivatives (Cooke and Smith, 1987; Cooke, Symes, and Smith, 1989).
Regarding the ectoderm, there was a clear distinction between the different kinds
of derivatives of this germ layer: epidermis and neural tissue. Genes associated with
neurogenesis (GO:0022008), head development (GO:0060322) and central nervous sys-
tem development (GO:0007417) were enriched in LiCl-treated embryos, as its ancestry
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are the cells that first ingress during gastrulation, the dorsal-most cells in the em-
bryo. The genes that caused this enrichment included zic1-4, sia1, chd6, lama5 the
blimp-associated transcription factor prdm12 and the homeodomain transcription fac-
tor prdm16. On the contrary, terms associated with epidermis (GO:0008544) were
highly enriched in UV-treated embryo, these are the cells of the animal cap that do
not ingress and are formed in response to high levels of BMP and Wnt signalling. The
enriched genes in ventralised embryo that populate this GO-term category included
krt12, krt5.7 and grhl3.
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Figure 3.8: GO term enrichment comparison between dorsalised and ven-
tralised embryos
Bar plots show the -log10 of the p-value of a statistical hypergeometric test between selected
genes of each condition (upregulated) and the whole universe of transcribed genes in relation to Gene
ontolgy (GO) terms associated with biological function (BP). This analysis allows the understanding
of the nature of each condition’s transcriptome by comparing the enrichment of genes for each GO
term. The GO terms shown were selected based on the relevance to this study. The numbers in
each bar represent the number of upregulated genes in each condition associated with the specific GO
term. A) Comparison of the enrichment of genes associated with early developmental processes in
both conditions. Genes associated with gastrulation and the primitive streak formation are enriched
in dorsalised compared to ventralised embryos. Genes upregulated in UV-treated embryos are more
associated with somitogenesis than in dorsalised embryos, while there is no significant difference in
genes associated with dorsal/ventral axis specification. B) Analysis of enrichment of genes associated
with Wnt and Bmp signalling pathways. C) GO terms associated with the regulation and development
of different embryonic tissues are differentially enriched in the two conditions. LiCl-treated embryos
overexpress genes associated with head and neural tube development while UV-treated embryos are
enriched for genes associated with posterior and epidermis development.
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Although the use of GO terms allowed for the better understanding of the nature
of each condition’s transcriptome, it also revealed some limitations of such analysis in
the context of early Xenopus development. An example of such limitation was referred
above, when analysing genes involved in different waves of Wnt signalling that occur
in the embryo at gastrula stages.
Overall, these results reaffirmed that the treatments were correctly transforming
the whole embryo into a representation of either dorsal or ventral cells. Furthermore,
the transcriptome analysis not only captured the DV positioning of the cells but also
its downstream derivatives; e.g anterior mesoderm and head/neural tube in the case of
LiCl-treated and posterior mesoderm and epidermis in the case of UV-treated embryos.
3.3 Comparison with published transcriptomic data of
dissected embryos
This study has so far indicated that LiCl and UV treatments resulted in embryos that
represented dorsal and ventral cells (and its derivatives), however, to further confirm
these results I compared the transcriptomic data from this work to published data of
untreated dissected embryos. In recent years, the use of highthroughput sequencing has
become more widespread in the field of developmental biology and with it, the number
of whole-genome/transcriptome data available has increased. Many publications have
analysed and compared the transcriptome of dissected frog embryos using both Xenopus
laevis (Popov et al., 2016; Ding et al., 2016; Ding et al., 2017) and Xenopus tropicalis
(Blitz et al., 2017). For ease of comparison, in terms of annotation, I compared the
LiCl/UV data to the data of Blitz et al. in which they dissected Xenopus tropicalis
stage NF10.5 embryos into 5 pieces: animal cap (AC), ventral marginal zone (VMZ, or
VM in this study), lateral marginal zone (LMZ), dorsal marginal zone (DMZ or DM in
this study) and the vegetal mass (VEG) (Fig.3.9A) (Blitz et al., 2017). For the purpose
of this work I only compared the DM and VM datasets with each other, and with the
LiCl/UV datasets. It is important to point out that this was not the ideal way of
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comparing treatments with dissected halves, first these were independent experiments
executed by different researchers using different lines of frogs; second, the stage at which
the transcriptome was studied was not the same (their study was stage NF10.5 this
study was stage NF11-11.5) and third, for statistical significance purposes, their study
used only two biological replicates while I used 5. In that study the researchers focused
their analysis in identifying different transcription factors represented in each dissected
half, and I was interested in the whole poly-A transcriptome and so, I analysed their
raw data.
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Figure 3.9: Comparison and correlation of DE genes in dorsalised vs ven-
tralised with DE genes in DM VM halves
A) On left is a diagram representing dissections done in early gastrula embryo from Blitz et.
al., 2017, of which I used the data derived from the DMZ (DM) and VMZ(VM) (Blitz et al., 2017).
The Venn diagram represents the overlap between differentially expressed (DE) genes identified when
comparing DM with VM (DMvsVM) and LiCl with UV (LiClvsUV). B) Heatmap representing the
log2 of the fold change between UV and LiCl conditions of the 121 DE genes between DM and VM
halves. Positive fold changes are associated with genes upregulated in dorsalised and represented in
red, and in blue are negative fold changes, which are genes upregulated in ventralised embryos. For
each gene there is white or black box on the left-hand side of the heatmap representing whether the
gene is upregulated in DM or VM, respectively. Genes underlines in red (22) are not DE (p-value<0.01,
fold change>2) between LiCl- and UV-treated embryos. C) Regression plot of the fold changes in the
four conditions (LiCl, UV, DM and VM) of the genes identified in VM and DM. The plot is green
if the correlation between the two conditions is positive (pearsonr>0) and red is the correlation is
negative (pearsonr<0). D) Heatmap of the log2 of the fold change between LiCl and UV (LiCl vs UV)
and between DM and VM (DM vs VM) of the DE genes identified between dorsalised and ventralised
embryos. In red are positive fold changes and in blue negative fold changes (pairwise comparisons were
made in relation to UV and VM, which means that positive fold changes are associated with genes
upregulated in LiCl and DM). The regression plot on the right-hand side shows a positive correlation
(pearsonr>0) between the fold changes represented on the heatmap. DE - differentially expressed;
DMZ - dorsal marginal zone; VMZ - ventral marginal zone; AC - animal cap; LMZ - lateral marginal
zone; VEG - vegetal mass; fc -fold change; padj - p-value adjusted; pearsonr - Pearson correlation
coefficient; p - p-value; vs - versus; padj - adjusted p-value.
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The RNA-Seq reads from DM and VM were downloaded from the publicly available
databases and analysed the same way as the LiCl and UV data: aligned to the Xenopus
tropicalis transcriptome, reads on exons counted and I used DESeq2 to identify DE
genes between the two conditions. This analysis resulted in the identification of 121
genes DE when comparing DM vs VM (86 upregulated in DM and 35 in VM), a
much lower number than the LiCl/UV comparison but with the same proportion of
upregulated genes (71% up in DM, 29% down in VM (Fig. 3.9), similar to LiCl vs UV,
70% up and 30% down (Fig. 3.7)). The heatmap in Figure 3.9B shows the fold change
(log2) (positive values are in red and represent genes upregulated in LiCl and negative
values in blue, upregulated in UV) between LiCl- and UV-treated embryos of these 121
genes; black or white bar next to each genes represents whether it was overexpressed
in VM or DM, respectively. The majority of the genes clustered as expected, LiCl with
DM (red and white) and UV with VM (blue and black). The graphs in the Figure
3.9C reflect this observation as they show the correlation between the fold changes
of the genes upregulated in each condition. There was a positive correlation between
DM/LiCl (Fig. 3.9C,i) and VM/UV (Fig.3.9C,ii) and negative correlation between
DM/UV (Fig. 3.9C,iii) and VM/LiCl (Fig. 3.9C,iv). From the 121 DE genes of
the Blitz et al. experiment, there were 4 which did not follow the correlation stated
above: myf5, prdm1, pcdh8.2 and foxj1. Of these, myf5, prdm1, pcdh8.2 were not
differentially expressed between LiCl- and UV-treated embryos based on an adjusted
p-value smaller than 0.01 or a fold change higher than 2. On the other hand, foxj1 was
overexpressed in dorsal cells of the early gastrula embryo (in DM and in expression
profile in Xenbase) but the gene was upregulated in UV-treated embryos. Foxj1 is a
known marker of multiciliated cells and later in development is expressed throughout
the epidermis a multiciliated tissue. This characteristic justified the overexpression of
the gene in ventralised embryos, as these embryos were enriched for an epidermal cell
fate.
While the majority of the DE genes between DM and VM were represented in the
LiCl/UV comparison, there were 1286 that were only differentially expressed in the
latter group. Despite the fact that these genes were not differentially expressed in the
dissection experiments, the fold change of the transcripts still correlated positively with
128
LiCl/UV (Fig.3.9D).
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Figure 3.10: Comparison and correlation of unchanged genes in both exper-
iments
A Venn diagram representing the overlap between genes not differentially expressed (unchanged
genes) in both comparisons: LiClvsUV and DMvsVM. B) Regression plot of the fold changes of
LiClvsUV and of DMvsVM of the genes identified in VM and DM. As expected, the plot indicates low,
but positive correlation between the fold changes of unchanged genes. DE - differentially expressed; vs
-versus; padj - adjusted p-value.
In addition, when comparing the whole transcriptome, the majority of the tran-
scripts were not differentially expressed in both experiments (Fig.3.10A) and the fold
changes in both experiments correlated positively (Fig.3.10B).
So far, I showed that LiCl and UV treatments successfully dorsalised and ventralised
Xenopus tropicalis embryos, respectively, and that these embryos represented enriched
forms of each cell type and its derivatives. LiCl-treated embryos were a result of
an expansion of the early maternal Wnt Signalling into the whole embryo, resulting
in an enrichment for dorso-anterior structures such as head and neural tube. On
the other hand, UV-treated embryos were not exposed to this early maternal Wnt
signalling, resulting in the absence of Wnt and BMP antagonists and the expansion of
the BMP and zygotic Wnt domain into the whole embryo. This led to an embryo with
posteriorised mesoderm and neural tissue, together with an enrichment for epidermal
fate cells. I also showed that a LiCl-treated an UV-treated embryo was transcriptionally
comparable to a dorsal (DMZ) and ventral (VMZ) cells of the embryo.
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Gene Name Condition Expression Function/Information
cpe CarboxypeptidaseE LiCl
Small peak of expression
just before
stage 12 and increases
at later stages.
Function: Zinc carboxypeptidase: Catalysis the release
of C-terminal arginine or lysine from polypeptides.
Part of the dorsal signature identified in (Ding et al., 2016).
It has no expression data.
c8orf4
Chromosome 8 open
reading frame 4
UV
Starts at MBT increasing
during gastrulation and
peaks at stage 14,
increasing again at stage 32.
Also known as TC-1, a transposable element associated
with neural tissue (Faunes et al., 2011).
72022004 N/A UV
Expression starts at stage 10
and peaks just after stage 12,
decreasing during tailbud
stages.
N/A
K00726 N/A LiCl
Starts to be expressed at the start of
gastrulation, peaks around stage 15
and decreases from then on.
There is no data published data about the gene.
Contains an E3 ubiquitin-ligase RNF220 domain,
giving it high homology to the protein rnf220, a postive
regulator of Wnt signalling.
Table 3.1: Differentially expressed genes selected for spatial expression analysis
The four genes selected based on the successful generation of WMISH probes. The table includes
information derived from Xenbase (http://www.xenbase.org) (Karpinka et al., 2015) and the tem-
poral expression details were derived from Searchable Database of Xenopus tropicalis Gene
Expression Profiles (http://genomics.crick.ac.uk/apps/profiles/) (Collart et al., 2014; Owens et al.,
2016).
3.4 Identification and validation of novel genes
The comparison of dorsalised and ventralised embryos yielded a high number of dif-
ferentially expressed genes, and although a lot of them were known genes, others were
only classified based on the homology to other genes, but its expression pattern or
function had not been studied. A third group included genes which, using the most
recent annotation for gene models, had not been named yet. By inquiring the top genes
(lowest adjusted p-value and highest fold change) I selected genes that could have a
new or unknown role in early development.
First, I used BLAST to search for the sequences in the frog genome to ensure the
gene was not wrongly annotated, second I used published data of temporal expression
of early Xenopus tropicalis embryo (Owens et al., 2016; Collart et al., 2014) to select
genes expressed during gastrula stages. Once the genes were selected, the ones with
annotated names were searched on Xenbase (Karpinka et al., 2015) for expression and
publication data. For genes without annotation, the sequence was used to BLAST in
other genomes to find homologies. Of the full list of selected genes (Appendix I), Table
3.1 shows the ones chosen for further investigation.
My goal was to study the expression profile of these genes, in wild-type embryos, and
further explore any gene with a potential relevant role in early development. The genes
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were cloned from Xenopus tropicalis cDNA and sense and anti-sense mRNA probes
were made to study the spatial expression pattern by WMISH. I successfully generated
probes for 4 genes which gave conclusive expression patterns as shown in Figure 3.11.
From the four genes, two were detected as upregulated in UV-treated embryos, c8orf4,
and 72022004 and the other two in LiCl, K00726 and cpe. As summarised in Table
3.1, c8orf4 also known as tc1 and it has been identified as a transposable element
that acts on the neural tissue. By gastrula stage, the expression of the gene was barely
detectable in wild-type embryos although it seemed to be downregulated in LiCl-treated
embryos and upregulated in the prospective epidermis of UV-treated embryos (Fig.
3.11B). At tailbud stage, the gene was expressed in the head, but not the neural tube
(Fig. 3.11B). Interestingly, 72022004 had a similar expression pattern: low levels at
gastrula stage although higher in UV-treated embryos and by tailbud stage the gene
was expressed in the head, showing higher expression in the branchial arches, which are
populated by neural crest cells (Fig.3.11B). The other two genes, cpe and K00726, were
upregulated in LiCl-treated genes, as seen by qPCR analysis (Fig.3.11A), although it
was not clear by WMISH (Fig. 3.11B). cpe had been identified as enriched in the dorsal
half of dissected Xenopus laevis gastrula stage embryos (Ding et al., 2016), although its
expression pattern had not been described. I showed that the gene was faintly expressed
in the blastopore region of wild-type stage 10.5 embryos and by tailbud stage it was
expressed dorsally and in the anterior most area of the neural tube (Fig1.10B). Lastly,
K00726, showed a characteristic dorsal expression on the blastopore at gastrula stage
and by tailbud the gene was only present in the neural tube, similarly to cpe (Fig.
3.11B). At gastrula stage it was noticeable the expansion of the expression of K00726
in dorsalised embryos and the loss in UV-treated embryos (Fig. 3.11B).
As a result of the transcriptomic analysis I was able to identify and characterise
the expression pattern of genes with potential roles in dorsal/ventral tissues and its
derivatives, for the first time. From the spatial expression data it seemed clear that
genes enriched ventrally, as a result of high BMP and Wnt signals, were involved in the
regulation of tissues such as epidermis and neural crest cells, while genes discovered in
LiCl-treated embryos were expressed in the dorsal most structures, specifically of the
neural tube.
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Figure 3.11: Expression pattern analysis by WMISH and quantified by qPCR
of uncharacterised genes identified by RNA-Seq analysis
A) Transcript fold changes (log2 scale; RT-qPCR) inflicted on c8orf4, Xetrov72022004, K00726 and
cpe upon LiCl or UV treatment as measured by RT-qPCR in mid-gastrula embryos (n=3). B) Spatial
expression patterns of c8orf4, Xetrov72022004, K00726 and cpe as visualised by WMISH on untreated,
LiCl- and UV-treated embryos of gastrula (vegetal and lateral view except for cpe with vegetal view
only) and mid-tailbud stage (unperturbed condition only, lateral view). textitcpe-carboxipeptidase E ;
c8orf4 -chromosome 8 open reading frame 4 ; odc-ornithine decarboxylase.
3.5 Characterisation of K00726, a rnf220-like ubiquitin
ligase
Of the four genes described above, K00726 seemed to be an interesting gene to study
further: first, the gene had an expression pattern similar to a typical dorsal marker
and second contained a partial E3 ubiquitin-protein ligase RNF220 middle domain
(Fig1.12B). The domain is specific to the members of the Ring finger protein 220
(Rnf220) family of genes, of which there are two genes in Xenopus, rnf220.1 and
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renf220.2. To guarantee that K00726 was an unique gene and not a product of poor
annotation I aligned the two protein sequences found in Xenopus tropicalis and Xenopus
laevis (Fig1.12A), which showed that Rnf220.1 was more closely related to K00726 than
was with Rnf220.2, a much smaller protein. For the purpose of this study I did not
include Rnf220.2 in the analysis and I referred to Rnf220.1 simply as Rnf220.
Rnf220 is a RING domain E3 ubiquitin ligase that had been shown to positively
regulate Wnt signalling (Ma et al., 2014). While small quantities of β-catenin (5pg)
injected into the ventral blastomere of a 4-cell stage embryo did not induce a secondary
axis, when co-injected with mouse Rnf220 a proportion of the embryos developed a
partial or secondary axis (Ma et al., 2014). Despite its ubiquitin domain, Rnf220
stabilised β-catenin via its C-terminal RING domain in an interaction mediated by
the ubiquitin-specific protease 7 (USP7) (Ma et al., 2014). Furthermore, a construct
lacking the N-terminus (∆N) portion, including part of the E3 ubiquitin domain, was
still capable of stimulating Wnt reporter expression in the presence of β-catenin, while
removing both the N-terminus and the RING domain (∆N∆R) had the opposite effect,
inhibiting Wnt signalling (Ma et al., 2014). All of the experiments referred to in Ma
et al. were performed using the mouse Rnf220, however the Xenopus laevis Rnf220
had a similar Wnt enhancement activity in luciferase reporter assays in HEK293 cells
(personal communication).
I compared the protein sequences of the frog K00726 and Rnf220 (Fig.1.12B). As
referred above, K00726 contains the Rnf220 E3 ubiquitin specific domain (179-271aa)
and, similarly, the RING domain on the C-terminus of the protein. Although K00726 is
bigger than Rnf220, 419 amino acids (aa) and 301aa, respectively, its ubiquitin domain
was smaller. However, no other domains were identified in the K00726 protein sequence.
Given the importance of the RING domain and, potentially, of the E3 ubiquitin-protein
ligase domain I compared the domains of Rnf220 and K00726 (Fig1.12C, D). The RING
domain was very similar between the two protein, both with 40aa and only two of
the aminoacides were not conserved, overall they were 75% identical (using Clustal
2.1) (Fig.1.12C). On the other hand, the E3 ubiquitin protein ligase domain was very
distinct, only 35% identity (Clustal2.1) between the two proteins (Fig. 1.12D).
I was interested in understanding the role of K00726, specifically in enhancing Wnt
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Figure 3.12: K00726 and Rnf220 protein sequence analysis
A) Phylogenetic tree based on the protein sequence similarity of Xenopus laevis Rnf220.1.L
, Rnf220.1.S, Rnf220.2.S, Rnf220.2.L, K00726 and the Xenopus tropicalis Rnf220.1, Rnf220.2
and K00726. The .L and .S versions of each Xenopus laevis protein refers to the chromosome
from which it derived, the ’long’ (L), or the ’short’ (S), since Xenopus laevis is an allotetraploid
species. The tree was constructed by the MegaAlign Pro™software using Clustal Omega align-
ment with the default parameters. B) Representation of the proteins Rnf220 and K00726 and
the position of the E3 ubiquitin-protein ligase and the RING domains. The domains were
identified using the InterPro tool from EMBL-EBI (https://www.ebi.ac.uk/interpro/) (Jones
et al., 2014). C) Comparison of the Zinc-finger, RING-type domain sequences of Rnf220 and
K00726 by alignment. (*) - fully conserved aminoacid; (:) - conservative mutation; (.) - semi-
conservative mutation; ( ) - non-conservative mutation. D) Comparison of the E3 ubiquitin
ligase domain sequences of Rnf220 and K00726 by alignment. In both C) and D) the alignment
was done using the Clustal Omega in MegaAlign Pro™software with the default parameters.
rnf220-ring finger protein 220, RING-really interesting new gene.
signalling similarly to Rnf220. As reported by Ma et al. (Ma et al., 2014), the RING
domain is essential for promoting Wnt signalling, and since the domain was highly
conserved with K00726 (Fig. 3.12C) it was a plausible hypothesis. To test this I
used Xenopus laevis embryos and injected one of the ventral blastomeres at the 4-
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cell stage with K00726 mRNA or co-injected with 5pg of β-catenin and assessed the
formation of a secondary axis. This experiment was analogous to the one described in
Ma et. al and aimed to show whether K00726 was involved in stabilising β-catenin and
therefore would induce a partial or full secondary axis. As a control for the induction
of a double axis, embryos were injected with 250pg β-catenin (Fig. 3.13). Similarly
to Rnf220, K00726 by itself was not capable of inducing a secondary axis but, it
did not contribute to β-catenin stabilisation as co-injection of 5/10/20pg of β-catenin
and 1000pg of K00726 did not lead to the induction of a secondary axis (Fig. 3.13).
However, when an amount of β-catenin capable of inducing a secondary axis was co-
injected with K00726 there was a reduction in the number of full double axis formed
and an increase in embryos without a secondary axis (Fig. 3.13).
In summary, K00726, a newly identified dorsally expressed gene in early Xeno-
pus embryos, shares a partial E3 ubiquitin-ligase protein domain and a almost fully
conserved C-terminus RING domain with Rnf220. While Rnf220 has been shown to
enhance Wnt signalling by stabilising β-catenin, K00726 did not show the same ef-
fect, despite the conservation of the RING domain. Given that Rnf220 mediated the
stabilisation via USP7 it can be the case that K00726 was not capable of this interac-
tion. The main differences between the two proteins resided on the less conserved E3
ubiquitin-ligase domain, which, although not necessary for interaction with β-catenin,
when removed with the RING domain led to a repression of Wnt signalling. Further
experiments will be necessary to conclude on the role of K00726 in early development.
3.5.1 K00726 is a Wnt/β-catenin target gene
In addition to studying the protein sequences I investigated the genomic region of
K00726 and whether the gene was bound by relevant TFs. Since k00726 was ex-
pressed dorsally and at the start of gastrulation, I searched for binding of β-catenin in
the promoter and cis-regulatory regions. For this purposed I used publicly available
ChIP-Seq data on the binding profile of β-catenin at NF10.5 (Nakamura et al., 2016).
Although β-catenin did not bind to the promoter of the gene, it did bind to three other
regions within intron 1 (e1, e2 and e3) (Fig. 3.14A), which given the proximity were
potential regulatory regions of the gene. To test whether these regions were capable
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Figure 3.13: K00726 acts distinctly from Rnf220 in stabilising β-catenin
On the left-hand side is a diagram representing the injection strategy for the double axis assay:
inject one of the ventral cells (larger and darker) of the 4-cell stage Xenopus laevis embryo with
K00726 mRNA and/or β-cateninmRNA. On the right-hand side is a plot showing the quantification,
in percentage (%) of the embryos that formed a secondary axis. Normal embryos did not form any
secondary axis, partial refers to embryos that formed a secondary axis wihtout a cement gland (the
most anterior structure) and full refers to embryos that formed a secondary axis containing a cement
gland.
of driving expression I cloned them into a vector containing firefly luciferase, together
with the gene promoter sequence, to assess its transcription driver capacity. The plas-
mids were co-injected, into the 2 cells of the 2-cell stage embryo, with Renilla mRNA as
a control for a dual-luciferase assay (see Methods). A plasmid containing the Xenopus
cytoskeleton actin promoter (CSKA) was used as positive control (data not shown) and
the pGl3-Basic vector without any promoter or enhancer (empty vector) as the nega-
tive control (Fig. 3.14C). Embryos were collected at gastrula stage and processed for
luminescence readings. The luciferase assay indicated that the promoter by itself was
capable of driving expression; 6 fold increased compared to empty vector. When com-
bined with regulatory region e2 and e3 the transcription levels increased substantially,
specifically with e2 (Fig. 3.14C), which had the highest β-catenin binding (Fig. 3.14A).
Interestingly, the data indicated that e1 could represent an inhibitory regulatory region
given that its luciferase activity was reduced to levels similar to the negative control,
empty vector (Fig. 3.14C). In addition to the luciferase assay, I investigated whether
β-catenin induced expression of K00726. I injected β-catenin into the animal pole of
2-cell stage embryo and analysed the induction of K00726 in animal caps cultured
until the start of gastrulation. The levels of K00726 were measured by qPCR and
normalised to the house-keeping gene odc, and indicated that β-catenin induced the
expression of K00726 (Fig. 3.14D). Although I did not show directly that the binding
of β-catenin to the regulatory regions e2 and e3 led to the expression of K00726, I did
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show that β-catenin binds these regions prior to activation of the gene (Fig. 3.14A),
these regions were capable of driving transcription via the K00726 promoter and that
expression of β-catenin in na¨ıve cells led to the overexpression of K00726 (Fig. 3.14C).
Overall, I was confident that K00726 was a target gene of Wnt/β-catenin signalling.
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Figure 3.14: K00726 is activated by β-catenin
A) Genomic snapshot of DNA occupancy of ?-catenin near the K00726 locus in early gastrula
embryos (Nakamura and Hoppler, 2017). B) Promoter, putative cis-regulatory modules (e) 1 to 3 and
negative control region (N.R) of K00726 were explored for their regulatory capacity in a dual luciferase
assay. Reporter activity was normalised to basal activity of the endogenous promoter. Student’s two-
tailed t test: ***, p-value ¡0.01; n.s, not significant. Error bars represent the standard error of the
mean (s.e.m.) of biological duplicates. C) Transcript levels (normalised to odc) of K00726 in animal
caps derived from embryos injected with and without 500pg of ?-catenin as measured by RT-qPCR
(n=3). Student’s two-tailed t test: **, p-value ¡0.05. Error bars represent the standard error of the
mean (s.e.m.) of biological triplicates. odc-ornithine decarboxylase.
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3.6 Summary
• I described the conditions to successfully dorsalise and ventralise Xenopus tropi-
calis embryos with UV and LiCl treatments, respectively.
• I compared the whole poly-(A) transcriptome of the dorsalised and ventralised
embryos that revealed that the latter were transcriptionally more similar to whole-
embryos while the former had a substantially higher number of up-regulated
genes.
• The analysis of genes overrepresented in each condition indicated that dorsalised
embryos were enriched for genes associated with anterior mesoderm and head/neural
tube, while ventralised embryos were enriched for genes that regulate posterior
mesoderm and epidermis.
• The comparison of LiCl/UV datasets with published transcriptome of dissected
dorsal and ventral halves of gastrula stage embryos indicated that LiCl and UV
treatments accurately represented dorsal and ventral regions, respectively.
• By WMISH I uncovered the spatial expression pattern of uncharacterised genes
that were differentially expressed in dorsalised and ventralised embryos.
• I further characterised K00726, a dorsally expressed gene, similar to the Wnt-
enhancing Rnf220. Although I did not identify a similar role for K00726 in im-
proving Wnt signalling I was able to show that β-catenin binds active regulatory
regions near K00726 and induces its expression.
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Chapter 4
Differential binding of Brachyury in dorsalised
and ventralised Xenopus tropicalis embryos
In the previous chapter I showed how the perturbation of the dorsal-ventral axis de-
termination can alter the embryonic transcriptome. Xenopus has been used as animal
model for early development for its ease of manipulation and as a good provider of
biological material: one fertilisation can yield thousands of embryos. Together with
zebrafish and Drosophila, Xenopus has also become a good model to study early chro-
matin regulation. Such studies rely on chromatin immunoprecipitation to identify ge-
nomic regions to which modified histones, components of the transcriptional machinery
and transcription factors bind. In Chapter 1, I referred to examples of studies that
allowed the construction of gene regulatory networks of early vertebrate development
using ChIP-Seq. However, most of these studies use whole embryos, and although
they have provided detailed information of dynamics based on time-series experiments,
there is a lack of information on spatial regulation. To this end, one of the goals of this
project was to understand spatial regulation during early development.
As described in Chapter 3, dorsalised and ventralised embryos can be used as a
proxy for dorsal and ventral cells and its derivatives. With this in mind, I used the
same embryos to study regulation at the chromatin level. In this Chapter, I will describe
my attempts to understand the differences in the chromatin landscape between distinct
cell types in the early embryo.
The initial analyses focused on active transcription and regulatory regions by com-
paring the DNA binding of RNA polymerase II (RNAPII) and the co-activator protein
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p300. However, my main focus was to compare the binding of Brachyury, a develop-
mentally relevant transcription factor (TF), that is zygotically activated and expressed
in dorsal and ventral cells. Such comparison would allowed me to understand whether
early developmental events, such as dorsal-ventral determination, affect chromatin and
the binding of transcription factors.
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4.1 Identification of actively transcribed genes in dor-
salised and ventralised embryos by profiling RNAPII
As a proof-of-principle experiment to test ChIP-Seq on LiCl and UV-treated embryos,
I decided to do a ChIP-Seq experiment using a DNA-binding protein whose binding
associates with active transcription: RNA polymerase II (RNAPII). Such experiment
allowed me to test the ChIP-Seq protocol using treated embryos and I could access
its efficiency by comparing to transcriptome data generated in the previous Chapter.
The whole-genome profile of RNAPII binding has already been described for several
developmental stages in untreated Xenopus tropicalis embryos (Hontelez et al., 2015;
Charney et al., 2017). Although these data provide temporal information on gene
activation during development it fails to provide spatial information. Given this, by
profiling RNAPII occupancy in dorsalised and ventralised embryos I was able to identify
differentially active genes in the two conditions and validate the use of the technique
in these embryos.
Profiling of RNAPII was done by chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-Seq) using a ChIP-grade antibody previously used in
frog embryos (Hontelez et al., 2015). I analysed the binding of RNAPII in gastrula
stage embryos, the same stage used in RNA-Seq, described in the previous chapter,
Nieuwkoop-Faber stage 11 (NF11). Embryos were treated with UV irradiation or
LiCl as described in Chapters 2 and 3, harvested at stage NF11 and crosslinked with
formaldehyde for 20 minutes at room temperature. These conditions for crosslinking
were determined a priori by ChIP-qPCR (data not shown) and used for all ChIP-Seq
experiments described in this chapter. The number of harvested embryos depended on
the abundance of the protein to be precipitated. More details of the ChIP-Seq protocol
are described in Chapter 2. For each ChIP experiment prior to immunoprecipitation,
2-5% of sonicated chromatin was collected and used as an input control. DNA from
both the input and ChIP were used to create paired-end libraries containing adapter
sequences compatible with the Illumina® sequencing platform. Sequenced data were
assessed for quality of the ChIP, and if satisfactory were used for subsequent bioin-
formatic analyses. All of the sequencing reads were mapped to the Xenopus tropicalis
genome assembly JGI 7.1 using Bowtie1 (Langmead, 2010) allowing only 1 reported
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alignment per read and duplicate reads were suppressed from subsequent analysis.
For each condition, dorsalised (LiCl) and ventralised (UV) embryos, two biological
replicates were merged, as well as all the input samples, and all were normalised per 1
million mapped reads. To identify active transcription of genes I counted the reads that
mapped to gene bodies (Fig.4.1A). Annotated gene bodies were binned into 10 regions
and uniquely mapped reads were counted in each bin. Active transcription is associated
with transcript elongation and binning the gene body allowed to distinguish between
a localised enrichment of RNAPII or a continuous enrichment along the gene body.
Genes with less than 40% mappability were removed (based on the high complexity
input sample) before determining RNAPII enrichment over input (RNAPII/Input).
For each condition, genes were considered to be actively transcribed if at least 80%
of the gene body had an enrichment of 2.6 fold over the input sample. This allowed me
to identify 1468 genes actively transcribed in LiCl-treated and 1011 genes in UV-treated
embryos. Genes were specified as differentially active between LiCl- and UV-treated
embryos if there was >1.5 fold difference of continuous enrichment along the gene
body between these conditions. I identified 679 preferentially active genes in dorsalised
embryos and only 105 in UV. Figure 4.1B and C shows the average binding (coverage)
of RNAPII over gene bodies of each identified category of differentially active genes.
This approach allowed to confidently identify genes whose transcription levels were
higher in one condition compared to the other.
142
LiC
l C
ov
era
ge
UV
 C
ov
era
ge








R
N
A
PI
I C
ov
er
ag
e 
in
 g
en
es
 p
re
fe
re
nt
ia
lly
 
ac
tiv
e 
in
 L
iC
l
7DJ&RYHUDJHLQJHQHERGLHV
LiC
l C
ov
era
ge
UV
 C
ov
era
ge












7DJ&RYHUDJHLQJHQHERGLHV5
1
$
3
,,
&
RY
HU
DJ
H
LQ
J
HQ
HV
S
UH
IH
UH
QW
LD
OO\

DF
WLY
H
LQ
8
9














G
en
e 
bo
di
es
7DJVSHUESSHUJHQHERGLHV
5
1
$
3
,,
&
RY
HU
DJ
H
LQ
J
HQ
HV
S
UH
IH
UH
QW
LD
OO\
D
FW
LY
H
LQ
/
L&
O
/L
&
O&
RY
HU
DJ
H
8
9
&
RY
HU
DJ
H


















G
en
e 
B
od
ie
s
7DJVSHUESSHUJHQHERGLHV
5
1
$
3
,,
&
RY
HU
DJ
H
LQ
J
HQ
HV
S
UH
IH
UH
QW
LD
OO\
D
FW
LY
H
LQ
8
9
/L
&
O&
RY
HU
DJ
H
8
9
&
RY
HU
DJ
H
A
B
C
67
9 
ge
ne
s
10
5 
ge
ne
s
Genes differen-
tially acitve in 
UV (105)
Di
sta
nc
e 
to
 T
SS
 (K
b)
UV
Li
Cl
1030
TS
S
-2
TS
S
6
-2
6
TS
S
-2
TS
S
6
-2
6
Genes differentially acitve in LiCl (679)
Di
sta
nc
e 
to
 T
SS
 (K
b)
Li
Cl
UV
103050
Average coverage
TS
S
-2
TS
S
6
-2
6
TS
S
-2
TS
S
6
-2
6
0
20
40
80
60
7.
5 
kb
ot
x2
he
s3
.3
ve
nt
x 
3.
2
ve
nt
x 
1.
2
ve
nt
x 
2.
2
ve
nt
x 
1.
1
ve
nt
x 
2.
1
ad
m
p
2 
kb
gs
c
NF
11
Li
Cl UV In
pu
t
In
pu
t
In
pu
t
UVUVLi
Cl
Li
Cl
2 
kb
2 
kb 20
 k
b
m
sg
n1
2 
kb
F
ig
u
re
4
.1
:
R
N
A
P
II
p
ro
fi
li
n
g
in
d
o
rs
a
li
se
d
a
n
d
v
e
n
tr
a
li
se
d
e
m
b
ry
o
s
A
)
A
v
er
a
g
e
D
N
A
o
cc
u
p
a
n
cy
o
f
R
N
A
P
II
in
g
en
es
id
en
ti
fi
ed
a
s
p
re
fe
re
n
ti
a
ll
y
a
ct
iv
e
in
L
iC
l-
a
n
d
U
V
-t
re
a
te
d
em
b
ry
o
s.
B
)
H
ea
tm
a
p
o
f
R
N
A
P
II
b
in
d
in
g
in
g
en
es
d
iff
er
en
ti
a
ll
y
a
ct
iv
e
in
d
o
rs
a
li
se
d
(L
iC
l)
a
n
d
v
en
tr
a
li
se
d
(U
V
)
em
b
ry
o
s.
P
lo
t
o
n
to
p
o
f
th
e
h
ea
tm
a
p
re
p
re
se
n
ts
th
e
av
er
a
g
e
D
N
A
o
cc
u
p
a
n
cy
a
ro
u
n
d
th
e
tr
a
n
sc
ri
p
ti
o
n
st
a
rt
si
te
(T
S
S
).
C
)
G
en
o
m
ic
sn
a
p
sh
o
t
o
f
R
N
A
P
II
b
in
d
in
g
in
g
en
es
d
iff
er
en
ti
a
ll
y
a
ct
iv
a
te
d
:
o
tx
2
,
a
d
m
p
a
n
d
gs
c
in
d
o
rs
a
li
se
d
em
b
ry
o
s
a
n
d
h
es
3
.3
,
ve
n
tx
fa
m
il
y
m
em
b
er
s
a
n
d
m
sg
n
1
in
v
en
tr
a
li
se
d
em
b
ry
o
s.
L
iC
l
-
L
it
h
iu
m
ch
lo
ri
d
e;
U
V
-
U
lt
ra
-v
io
le
t;
T
S
S
-
tr
a
n
sc
ri
p
ti
o
n
st
a
rt
si
te
;
m
sg
n
-
m
es
o
g
en
in
;
o
tx
-
o
rt
h
o
d
en
ti
cl
e
h
o
m
eo
b
ox
;
a
d
m
p
-
a
n
ti
d
o
rs
a
li
si
n
g
m
o
rp
h
o
g
en
ic
p
ro
te
in
;
v
en
tx
-
v
en
t
h
o
m
eo
b
ox
;
g
sc
-
g
o
o
se
co
id
;
h
es
-
h
a
ir
y
a
n
d
en
h
a
n
ce
r
o
f
sp
li
t.
143
4.1.1 Preferentially active transcription positively correlates with tran-
scriptome output
Reassuringly, the preferentially active genes in dorsalised embryos included dorsal
markers such as otx2, admp, gsc, nog and not while ventral markers were preferen-
tially transcribed in ventralised embryos, such as msgn1, ventx1.1, ventx1.2, evx1,
bambi (Fig.4.1C). In addition to the known markers, other genes identified in the tran-
scriptome comparison also showed increased RNAPII enrichment, such as pkdcc.1 and
loc388630 in LiCl-treated embryos and hes3.3, foxj1 and 72022004 (Xetro.A01563 ) in
UV-treated embryos.
A more general comparison between RNAPII binding and the transcript level, re-
vealed that genes with higher transcript levels in LiCl (Chapter 3) had, on average, an
higher binding of RNAPII to its gene body in dorsalised than in ventralised embryos
(Fig.4.2A,B). Similarly, the coverage of RNAPII on genes with higher transcript levels
in ventralised embryos was higher compared to dorsalised embryos. Another common
feature to the RNAPII and transcriptome analyses was that higher numbers of dif-
ferentially active and upregulated genes were found in dorsalised embryos compared
to ventralised embryos. Moreover, Figure 4.2B indicates that even in genes downreg-
ulated in LiCl-treated embryos, there was some binding of RNAPII to the TSS, but
less elongation, while the binding of RNAPII to genes downregulated in UV-treated
embryos was generally lower.
In summary, RNAPII binding differed between dorsalised and ventralised embryos,
which allowed the identification of differentially transcribed genes. Furthermore, active
transcription correlated positively with the transcriptome data. The data also indicated
that dorsal cells were transcriptionally more active than ventral cells, as detected at
the chromatin and transcriptome levels.
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4.2 Binding of the enhancer protein p300 correlates pos-
itively with active transcription
Following the identification of transcriptional differences at the chromatin levels I was
interested in investigating regulation at the enhancer level. For this I opted to perform
ChIP-seq of the transcription co-activator protein p300, commonly used as a marker
for active enhancers (Heintzman et al., 2007; Visel et al., 2009). Like the RNAPII
ChIP, gastrula stage LiCl- and UV-treated embryos (NF11) were used to detect p300
binding. For this experiment I only had one sample per condition and because of this
I adopted a distinct approach to study active enhancers in dorsalised and ventralised
embryos. Instead of comparing the two samples I characterised the binding for each
cell type separately. p300 ChIP-Seq profile is similar to that of a transcription factor,
and so, unlike RNAPII, genomic profiling of p300 binding resulted in the identification
of peaks. These are regions with high focal enrichment compared to the input sample.
These peaks or genomic intervals represent putative regulatory regions. Like RNAPII,
the binding of p300 has also been described in early development of Xenopus tropicalis
across different developmental stages (Hontelez et al., 2015).
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Figure 4.3: p300 coverage in dorsalised and ventralised embryos
A) DNA occupancy of p300 near different genes, grouped by expression levels or RNAPII binding,
in dorsalised embryos. Genes upregulated and downregulated refer to the RNA-Seq comparison between
LiCl- and UV-treated embryos. Genes preferentially transcribed refer to genes with higher RNAPII
binding when compared to the other condition. Genes not preferentially transcribed are genes with an
RNAPII enrichment >2.6 over the input but <1.5 over the other condition. For each condition, the
plots on the left and right-hand side represent the same data, box-plot of the read distribution and an
average profile of the binding around the peak summit, respectively. B) Same as A) , but related to
p300 binding in ventralised embryos.
I used published data of p300 binding at gastrula stages (NF10.5 and NF12.5)
(Hontelez et al., 2015) to identify p300 binding sites (putative enhancers), in the whole
untreated embryo, by peak calling. Since there was no data to represent the exact
developmental stage at which I analysed the binding of p300 (NF11) I merged the
peaksets of the the time points immediately before and after, which should cover all
of the active enhancers during gastrulation. My approach was to count the number of
reads (normalised to 1 million mapped reads) from my p300 ChIP-Seq on dorsalised
and ventralised embryos, that covered distinct sets of these enhancers. Since there
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was no genome-wide data on chromosome conformation in early frog development that
would allow enhancers to be mapped to their genes, I used the closest gene approach.
For each condition I identified the p300 binding sites closest to genes with differential
transcript and RNAPII binding levels between UV- and LiCl-treated embryos. Figure
4.3 shows that, in both conditions, p300 DNA occupancy was higher near genes that
were upregulated and were preferentially transcribed compared to the other p300 peaks.
Figure 4.4, shows an example of the binding of RNAPII and p300 near the msgn1
and gsc loci. It showed that gsc was highly transcribed in LiCl, seen by RNAPII
track, which was accompanied by DNA occupancy levels of p300 (peak height) when
compared to msgn1, a gene downregulated in dorsalised embryos. Vice-versa when
analysing the same genes in ventralised embryos, msgn1 was highly transcribed and
had robust binding of p300 while gsc showed almost no binding of RNAPII and p300.
The positive correlation between RNAPII and p300 was expected since both pro-
teins mark positive transcription, and my analysis reinforced the cell-type specific be-
haviour of both. Unfortunately, I did not manage to generate genome-wide tracks of
chromatin accessibility, either by assaying for transposase accessible chromatin with
high-throughput sequencing (ATAC-Seq) or by mapping DNAse I hypersensitive sites
across the genome (DNase-Seq). This was due to technical complications of applying
either protocol in gastrula stage embryos derived from the high yolk content. However,
p300 binding has been associated with DNaseI hypersensitive sites (Heintzman et al.,
2007), indicating that the binding of this protein could be used as a proxy for open
chromatin. Given this, the data suggested that regions near active genes in dorsal and
ventral cells were more accessible than regions that are not active (Fig. 4.3).
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Figure 4.4: Binding profile of RNAPII and p300 in genomic regions near gsc
and msgn1 in dorsalised and ventralised embryos
Genomic snapshot around goosecoid (gsc) and mesogenin 1 (msgn1 ) loci in dorsalised and ven-
tralised embryos with the tracks for RNAPII and p300 ChIP-Seq. (msgn1 ) is upregulated and differ-
entially transcribed in ventralised embryos and gsc in dorsalised embryos. Higher RNAPII binding to
gene bodies correlates with higher p300 binding in the proximal regulatory regions.
4.3 Brachyury binding in dorsalised and ventralised em-
bryos
Since I detect cell type specific differences in active chromatin I was interested in
understanding if this would influence the behaviour of other transcription factors. For
the rest of this Chapter, I tackle this question by studying the binding of a zygotic
transcription factor present in dorsal and ventral cells. I hoped to explore whether and
how cell type specific recruitment behaviour of a transcription factor (TF) occurs in
vivo. I chose to study Brachyury (or t) binding because it is a well studied TF, whose
binding profile has been thoroughly analysed in early frog development (Gentsch et
al., 2013) and, furthermore, it has been described to bind different genomic targets
in distinct mesodermal derivatives from human embryonic stem cells (hESCs) (Faial
et al., 2015).
4.3.1 Validation of ChIP-grade antibody
To perform ChIP-Seq, I used two different antibodies against Xenopus Brachyury, one,
previously used and validated for the same purpose (Gentsch et al., 2013) and a sec-
ond antibody generated during this project (see Materials and Methods for details).
The second antibody, referred here as the new antibody (nAb) was generated as a
result of reduced stock of the original one. For validation of the new antibody I fol-
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lowed the ENCODE ChIP-Seq guidelines for antibody validation (Landt et al., 2012),
that includes primary and secondary characterisation. Before antibody purification,
the rabbits’ bleeds were tested in a dotblot assay (data not shown), using purified
Brachyury protein, and upon purification the antibody was tested by Western Blot
(WB), immunoprecipitation (IP) and whole-mount immunohistochemistry (WMIHC)
in gastrula stage embryos (Fig. 4.5). The antibody was used to immunoprecipitate en-
dogenous and exogenous Brachyury protein by WB using anti-Brachyury serum (Cun-
liffe and Smith, 1994) or an anti-HA antibody, which were detected as bands of the
correct size (50 kDA) (Fig. 4.5A). However, the antibody did not recognise the dena-
tured form of the protein in a WB (Fig. 4.5B). I reasoned that this happened because
the antibody was purified using the native full length protein. Furthermore, the an-
tibody was also validated for spatial expression of the protein as seen by WMIHC,
marking the mesodermal involuting sheet of cells of the late gastrula stage embryo
(Fig. 4.5C).Furthermore the antibody was successfully used for ChIP. This means that
this antibody was of ChIP-grade quality that preferentially recognised the native form
of Brachyury.
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Figure 4.5: Validation of anti-Brachyury antibody for ChIP-Seq
Three assays were used to validate the new antibody against Brachyury; immunoprecipitation (IP),
Western Blot (WB) and whole embryo immunohistochemistry. A) Embryonic extract of uninjected
and embryos injected with t-HA mRNA were immunoprecipitated with the new antibody and loaded
into a polyacrylamide gel for WB. For blotting I used anti-Brachyury serum and anti-HA antibody
to detect endogenous Brachyury and HA-t, respectively. B) Western Blot of whole embryos extract
and the new anti-Brachyury antibody was used to blot. No signal was detected, indicating that this
antibody does recognise the denatured form of the protein. B) WMIHC on bissected stage NF12
Xenopus tropicalis embryo using the new Brachyury antibody.
4.3.2 Comparison of the binding of Brachyury in dorsalised and ven-
tralised embryos
I performed several ChIP-Seq on stage NF11 Xenopus tropicalis LiCl- and UV-treated
embryos using different antibodies against Brachyury. For each condition I performed
the experiment three times, representing three biological replicates, replicate 1 (rep.1)
and 2 were performed using the antibody described before (Gentsch et al., 2013) while
replicate 3 corresponds to the ChIP experiment using the antibody generated during
this project. Figure 4.6 shows the correlation between the different replicates based
on normalised read coverage on peaks identified in any ChIP sample. The input pro-
file was the result of merging all the inputs libraries sequenced during the project in
order to obtain a high complexity control. The replicates of each condition clustered
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Figure 4.6: Correlation between Brachyury ChIP replicates in dorsalised and
ventralised embryos
The correlation was calculated based on the number of reads in peaks and the values represent the
Pearson correlation coefficient.
together, but UV replicates were more similar amongst each other than were LiCl
replicates; the average Pearson correlation factor was 0.9 and 0.8, respectively. This
clustering indicated that the Brachyury binding was distinct in ventralised and dor-
salised embryos, but most of the binding was probably similar, specially as seen by the
correlation between conditions.
The genomic targets of Brachyury have previously been identified for stage NF12
embryos, so in order to accuretely compare to my dataset I also performed ChIP-Seq
on untreated stage NF11 embryos (WT). The Brachyury genomic targets identified
in this sample are represented in the heatmap on Figure 4.7A, together with the read
coverage from Brachyury ChIP-Seq on LiCl- and UV-treated embryos. There were four
distinct clusters characterised by the Brachyury coverage which was seemingly higher
in UV compared to LiCl in the top two clusters (Fig. 4.7, dark blue and light blue),
but similar on the other two clusters (Fig. 4.7, lime green and orange).
To explore the differences between the two conditions I did peak calling on each
152
replicate separately using the same high complexity input and a more stringent q-value
cutoff (5e-4), using the software MACS2 (Feng, Liu, and Zhang, 2002; Zhang et al.,
2008). Each peakset was further filtered based on the fold enrichment of each peak
(minimum of 5 fold). The exact fold change threshold was set based on the visual
inspection of called peaks. MACS2 is an excellent tool to identify binding events based
on sequencing reads. However, peak calling success is largely dependant on the signal-
to-noise ratio of the binding profile and complexity of the ChIP-Seq library. For this
reason, it was necessary to evaluate the quality of the peak calling individually and
set different thresholds for each replicate. Each peakset, a list of genomic coordinates,
was extended by 150 basepairs (bp) up- and downstream from the peak summit. Ev-
ery ChIP-Seq experiment has regions with high artificial signal known as ’blacklisted’
regions, which I identified by performing peak calling on the input sample using no
control. These regions were then subtracted from the LiCl and UV peaksets. Next,
I defined a set of genomic regions that represented Brachyury binding events in dor-
salised and ventralised embryos. This list was constructed by finding peaks that were
shared by at least two of three biological replicates. Using this strategy I identified 627
peaks in dorsalised embryos and 1108 peaks in ventralised embryos (Fig. 4.7B).
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The first observation was that the number of peaks called in ventralised embryos was
almost twice the number of binding events that were detected in dorsalised embryos.
Secondly, when comparing the peaksets, the majority of the LiCl peaks were shared
with UV (433, 69%) (Fig. 4.7B). Comparison to the genomic targets identified in WT
NF11 embryos indicated that there was no extraordinary new binding events occurring
in any of the conditions (1185 of the total 1302 peaks, 91% are shared).
The genomic localisation of these peaks revealed little difference between the unique
(not shared) and shared peaks (Fig. 4.7C). The majority of the binding events was
found in intergenic and intronic regions, peaks unique to ventralised embryos were
detected more frequently in the promoter (transcription start site (TSS)) and exon
regions at the expense of intergenic regions (Fig. 4.7C).
The comparison of the read distribution between LiCl and UV conditions for these
peaksets revealed that DNA occupancy of Brachyury is higher in UV-treated embryos
(Fig. 4.7D, darker blue cluster); except for one cluster of peaks found in the LiCl
condition (Fig. 4.7D, orange cluster).
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Figure 4.8: Condition-dependent DNA occupancy of Brachyury at called
peaks
The peakset comparison revealed sites that are bound in both conditions (shared) or only in one
of the conditions (unique). The figures shows examples of genomic regions where the three kinds of
peaks are found; near the locus of msgn1,admp, not and hes3.3.
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Despite the fact that the overall enrichment of Brachyury in dorsalised embryos
was lower than in ventralised embryos, there was still a set of peaks called only in one
condition (unique). The classification of unique peaks was based on the peak calling
done for each condition as described above. In some cases, the unique peaks might have
Brachyury binding in the other condition, however, given the criteria defined for peak
calling, it was not considered a peak in that condition. Figure 4.8 shows four genomic
locations near four developmentally relevant genes, the binding profile of Brachyury and
the peaks called for each condition. The top two examples show binding near msgn1
and not, two known Brachyury targets, and a set of shared and unique peaks (Fig. 4.8).
The two bottom genomic snapshots are regions near the genes admp and hes3.3 and
show peaks unique to LiCl and UV, respectively. Interestingly, both admp and hes3.3
are differentially transcribed in dorsalised and ventralised embryos, respectively, which
could indicate that Brachyury occupancy is higher near genes transcriptionally active.
However, I did not find any correlation between sites uniquely bound in each condition
and gene transcription.
In summary, the data indicated that DNA occupancy by Brachyury was higher
in ventralised embryos compared to dorsalised embryos. These differences resulted in
the identification of more binding sites in UV- than in LiCl-treated embryos. The
comparison of the binding sites revealed that most of the identified sites in dorsalised
embryos were shared with the other condition, and only a small subset of sites were
uniquely bound. Furthermore, I did not find any correlation between unique sites and
tissue-specific active transcription or enhancers. Moreover, visual inspection of the
DNA occupancy of Brachyury in the sites identified as uniquely bound in one condition,
indicated that peak calling was not reliable in identifying differential binding.
4.3.3 Comparison of the binding of Brachyury in dorsalised and ven-
tralised embryos
Similarly to the analyses done for RNAPII, I calculated the ratio of normalised read
counts in peaks, between LiCl and UV (LiCl/UV, positive is high in LiCl). As ex-
pected the ratio was positive for the sites identified as unique in LiCl and negative
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in UV unique sites and the fold change of shared peaks is close to 1, with a similar
distribution of positive and negative ratios (Fig. 4.9). This indicated that most of the
peakset comparison reflected some of the quantitative differences of Brachyury binding
in between conditions.
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Figure 4.9: Peak calling reflected quantitative differences in Brachyury bind-
ing
Reads from dorsalised and ventralised Brachyury ChIP-Seq were counted in the three peaksets;
unique to LiCl or UV and shared peaks. For each condition the LiCl/UV ratio was calculated and log2
transformed. The boxplot shows the distribution of these ratios and the heatmap shows the ratio of
each peak. Red means that the binding is higher in dorsalised and blue in ventralised embryos.
4.4 Quantification of Brachyury in dorsalised and ven-
tralised embryos during gastrula stages
The main observation from the Brachyury ChIP-Seq experiment on dorsalised and
ventralised stage NF11 embryos was that the former had less binding events with less
DNA occupancy. This led me to question whether there were differences in Brachyury
157
protein levels between the two conditions: less protein in LiCl-treated embryos. The
transcriptome comparison by RNA-Seq (Chapter 3) revealed that Brachyury had higher
transcript levels in ventralised embryos with a fold change of around 2. In whole
embryos the expression of Brachyury is seemingly constant around the blastopore,
similar in ventral and dorsal cells, at gastrula stage. However, it has been described
that dorsally, the expression is lower due to the presence of goosecoid, a Brachyury
repressor (Boucher et al., 2000). Given that dorsalised embryos have an expanded
expression domain of goosecoid, it is expected that dorsalised embryos have lower levels
of Brachyury.
A
B
Figure 4.10: Semi-quantitative IP/WB of Brachyury in three gastrula stage
untreated (WT), LiCl- and UV-treated embryos
A) For each stage 10 Xenopus tropicalis embryos were collected and embryonic extract was im-
munoprecipitated using the same antibody used for ChIP-Seq. The IP samples were loaded into a
polyacrylamide gel, together with Brachyury purified protein of known concentration. The experiment
was done three times which are represented as replicate 1-3. B) Using the chemiluminescence from
the protein dilution series, a standard curve was designed and a concentration was assigned to each
experimental band. The tables show the ratio, averaged from the three experiments, between the
conditions at each stage. The second table shows that the ratio between LiCl NF12 and LiCl NF11 is
around 1.
To investigate this, I designed a short time-series experiment to quantify Brachyury
levels in LiCl-, UV-treated and WT embryos. The time series included the stage I used
for ChIP (NF11) plus the stage before (NF10.5) and after (NF12). This way, I was able
to detect the dynamics of Brachyury during gastrula stages, compare the conditions
and identify stages where the amount of protein was similar. Embryos were cultured at
25°C and embryos of the three stages were collected around 60-75min apart. For each
stage, 15 embryos were harvested and the embryonic extract was used to precipitate
Brachyury, using the old ChIP-grade antibody. The IP was visualised by Western
Blot and quantified by running a known amount of purified Brachyury protein on the
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same polyacrylamide gel (Fig. 4.10). The experiment was done three times and the
average ratio of protein quantification between the conditions is shown in Figure 4.10.
The expected dynamic of Brachyury expression was observed in untreated embryos;
increased during gastrulation reaching high levels at stage 12. Interestingly, on the one
hand UV-treated embryos reached similar levels of Brachyury, earlier, at stage NF11.5,
which were maintained during stage NF12. On the other hand, LiCl-treated embryos
had lower levels of Brachyury throughout the first two stages analysed, but by stage
NF12 the levels were similar to those in stage NF11 UV-treated embryos (Fig. 4.10,
ratio LiCl NF12/UV NF11.5 of 0.98). Neither dorsalised nor ventralised embryos had
differences in developing speed, as described before (Cooke and Smith, 1987; Cooke
and Smith, 1988) and observed in this work, which indicated that the differences in
Brachyury levels were specific to its regulation. I did not explore what led to these
differences, however I hypothesise, that in dorsalised embryos Brachyury expression is
reduced due to the high levels of goosecoid and otx2 (Latinkic et al., 1997; Latinkic
and Smith, 1999; Lerchner et al., 2000) while in ventralised embryos high zygotic Wnt
signalling, via xWnt8, maintains high levels of Brachyury (Vonica and Gumbiner, 2002;
Sokol, 1993).
The time-series experiment confirmed the hypothesis that the levels of Brachyury
are lower in dorsalised embryos which could explain the differences seen in the binding
of the transcription factor. This indicated that, in addition to the cell type specific
conditions that Brachyury encounters in the nucleus, the amount of available protein
may also influence its binding to the DNA. Given this, I decided to study the bind-
ing profile of Brachyury in stage NF12 dorsalised embryos in which the levels of the
TF were similar to those of the ventralised embryos. This comparison allowed me to
first understand whether the increase in protein concentration leads to more binding
of Brachyury and, secondly, I could more accurately compare it to ventralised em-
bryos. However, this comparison was not ideal since I was comparing two different
developmental stages, but given the circumstances of working with an in vivo model
this was the most reasonable strategy. Furthermore, the binding profile of Brachyury
had been shown to be reasonbly constant between developmental stages even further
apart, gastrula and tailbud (Gentsch et al., 2013), and so I assumed that one hour of
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development would not cause drastic changes.
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Figure 4.11: Brachyury ChIP-Seq on Stage NF12 dorsalised embryos and
comparison to the other two conditions
A) Pearson correlation between all replicates based on reads in peaks called in all conditions.
Replicates of each condition cluster together. B) Venn diagram of the comparison of peaksets identified
in each condition. Percentages are related to peaks called in all conditions, 2063. C) Average DNA
occupancy in all peaks, of the merged reads of the three replicates, of each condition. D) Heatmap
showing hierarchical distribution of Brachyury DNA occupancy of each replicate, within 2kb of the
Brachyury peaks summits.
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4.5 Higher levels of Brachyury lead to more binding events
in dorsalised embryos
Similarly to the experiments described above on stage NF11 embryos, I performed
ChIP-Seq on LiCl-treated embryos harvested at stage NF12 in biological triplicates,
using two different Brachyury antibodies; replicate 1 with the previously published
antibody (Gentsch et al., 2013) and replicates 2 and 3 with the antibody produced
during this project. The sequencing data was processed for quality control as previously
described and the for each replicate, peaks were called and subsequently filtered as
described above. A Brachyury peakset for LiCl NF12 was made from the comparison
of the three replicates; only peaks found in at least two of the replicates were considered.
This peakset contained 1639 peaks, which were almost three times the number of peaks
called in stage NF11 dorsalised embryos (Fig. 4.11B). This observation indicated that
the increase in the amount of Brachyury led to more binding events and even more
than the number observed in ventralised embryos with similar Brachyury expression
levels (Fig. 4.10).
The comparison of the peaksets of all conditions resulted in the identification of
2063 binding sites: 36.7% were unique to stage NF12 dorsalised embryos, while a similar
number of peaks were shared between LiCl NF12 and the other two conditions (395,
19.1%) or shared only with UV NF11 (373, 18%) (Fig. 4.11B). Ventralised embryos
yielded 305 uniquely called Brachyury binding sites, while dorsalised embryos of stage
NF11 shared most of their peaks with the other two conditions (Fig. 4.11B).
Interestingly, when comparing the overall DNA occupancy across all peaks, the
average in LiCl NF12 was marginally lower than the other two conditions which had
comparable DNA occupancies (Fig. 4.11C). The profiles shown in Figure 4.11 were
based on merging the reads from the three replicates of each condition. However, when
plotting the profile of each replicate a considerable variation among them was clear.
The most striking difference from other replicates was seen in replicate 3 of LiCl-
treated NF11 embryos which could be explained by the use of a different antibody.
However, I do not observe this trend in the other conditions e.g, UV NF11 rep.3
was done using the same antibody, and this was the replicate with the lowest overall
occupancy. Nevertheless, the comparison of DNA occupancy across all peaks revealed
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that the replicates of each condition clustered together, the Pearson correlation between
replicates for each condition ranged from 0.8 - 0.9 (Fig. 4.11A). However, LiCl NF11
replicate 3 had a correlation of 0.84 and 0.79 with LiCl NF12 replicate 2 and LiCl
NF12 replicate 3, respectively. These differences reinforced the importance of biological
replicates in ChIP-Seq experiments, specially when comparing different conditions and
dissecting quantitative differences.
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Figure 4.12: Venn diagram of peaks called based on tag/read count
Reads of each condition were counted in the 2063 peaks and regions with more than 20 tags
(normalised mapped reads) were considered a peak of that condition. The threshold was set on 20 tags
based in the maximum number of tags counted in the input sample. The percentages are related to
total number of peaks with more than 20 tags, 1719.
The analysis of stage NF11 LiCl- and UV-treated embryos revealed that peak calling
was not the most reliable tool to identify small differences in the binding profile of a
transcription factor. While peak calling algorithms are good at identifying higher DNA
occupancy peaks, the identification of smaller peaks is less reliable. A way of dissecting
the quantitative aspect of the binding was by counting the reads of each condition in
all 2063 peaks called previously. Thus, peaks were re-called if the condition yielded
more than twice the maximum of input tags (mapped reads) recorded within genomic
regions of the peakset. Figure 4.12 shows a Venn diagram that resulted from such an
approach and based on a threshold of 20 tags per peak. With this approach, around
300 peaks were discarded from all the conditions for the low number of reads, and the
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majority of peaks were shared between the conditions (853, 49.6%) (Fig. 4.12). This
led to an increase of 30% in the number of the shared peaks (Fig. 4.11B, 19.1%),
mostly at the expense of LiCl NF12 peaks. This approach also indicated that the
majority of the binding sites are shared between all the conditions; e.g, majority of
sites have more than 20 reads in the three conditions. This indicated that if there
were differences in the binding of Brachyury, these would be quantitative. In order
to identify these differences I would have to use a bioinformatic tool that allowed to
me identify which sites are consistently, within replicates, and significant, between
conditions, differentially bound.
So far, I have shown that the detection of Brachyury binding was affected by the
expression level. Stage NF11 dorsalised embryos yielded a low number of detectable
binding events which increased substantially by stage NF12, when protein levels were
similar to those observed in ventralised NF11 embryos. In dorsalised stage NF12 em-
bryos more Brachyury binding events were identified by peak calling. As a result of
analysing the data by counting mapped reads in peaks, I decided to dismiss the peak
calling as a tool to identify the differences between dorsalised and ventralised embryos,
since these were mostly quantitative.
4.6 Qualitative comparison of Brachyury binding in dor-
salised and ventralised embryos
The previous analysis that identified peaks by setting a threshold for the number of
reads allowed me to compare the conditions, however, it did not take into account
the variation among replicates, since the tags used were the average of the triplicates.
Furthermore, the analysis did not discriminate between peaks with more than 20 tags.
My goal was to identify genomic sites that were, consistently and significantly, differ-
entially bound in each condition. To identify these sites I used an approach similar to
that used for RNA-Seq analysis, in which a quantitative readout (reads in peaks) was
used to calculate the probability of a site being differentially bound in one condition
compared to another. For such analysis I used the R package ’DiffBind’ to calculate
differentially bound peaks. I counted the aligned reads of the three replicates of each
condition on peaks identified in all conditions, 2063. Similarly to RNA-Seq analysis,
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the software permits an unbiased comparison of the samples, by principal component
analysis (PCA) (Fig. 4.13A), before the identification of differentially bound (DB)
sites. The PCA plot showed that most of the variance was explained by principal
component (PC) 1 (65%) separates stage NF12 dorsalised embryos from ventralised
embryos, while one of the ventralised samples was more similar to stage NF11 dor-
salised embryos. The second component, PC2, represented only 14% of the variance
and separated dorsalised from ventralised embryos.
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Figure 4.13: Identification of differentially bound sites in dorsalised and ven-
tralised embryos
A) Principal component analysis (PCA) using normalised reads in peaks from three replicates
of each condition (LiCl NF11, LiCl NF12, UV NF11). The principal component 1 (PC1) explains
most of the variance between samples and separates LiCl NF12 from UV NF11. PC2 explains only
14% of the variance and separates dorsal from ventral conditions.B) Clustered heatmap of Brachyury
ChIP-Seq signal centred in sites identified as differentially bound (DB). The plot on top represents the
average coverage of each cluster. identifiable by the coloured bar next to the heatmap. Coverage if
Brachyury in dorsalised stage NF12 does not vary in the two clusters while in ventralised embryos it
is higher in the smaller cluster (cluster 1). C) Following previous representations of peaksets, here,
the Venn diagram shows the positively DB sites of each condition. Comparison between LiCl NF11
and UV NF11 or LiCl NF11 and LiCl NF12 did not yield any significant DB sites. Of the 2063
peaks,1595 peaks that are similarly bound in the two conditions while 95 have significantly more
binding in ventralised embryos and 373 in dorsalised embryos. The sites preferentially bound in each
condition are represented in hierarchical heatmaps of Brachyury binding. The heatmap and plot of
DNA occupancy are in accordance with the identification of the DB sites.
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Differentially bound (DB) sites were identified based on a false discovery rate
smaller than 0.05. Of the 2063 peaks, 468 sites were found to be DB between stage
NF11 ventralised embryos and NF12 dorsalised embryos (Fig. 4.13C). None of the
peaks was found to be differentially bound between stage NF11 dorsalised embryos
and any of the other two conditions (Fig. 4.13C). For this reason, for all the sub-
sequent analyses LiCl NF11 data was not included. The majority of the sites were
bound similarly in all the conditions, indicating that Brachyury binding was mostly
unchanged in dorsal and ventral cells (1595 peaks not differentially bound).
Read coverage in the 468 DB sites revealed two clusters, one where the binding
of Brachyury is higher in ventralised embryos (Fig. 4.13B, cluster 1) and the larger
cluster in which the binding was higher in dorsalised embryos (Fig. 4.13B, cluster
2). Interestingly, the DNA occupancy in dorsalised embryos did not change in both
clusters (cluster 1 and cluster 2 have a similar enrichment), while cluster 1 showed a
higher DNA occupancy in ventralised when compared to cluster 2.
Each of the identified DB sites had a fold change associated with it, which allowed
me to identify which peaks were preferentially bound in which condition: 378 sites in
LiCl NF12 and only 95 sites DB in UV NF11 (Fig. 4.13C,D). Figure 4.13C reveals
that while LiCl NF12 preferentially bound sites have higher occupancy in dorsalised
embryos than in ventralised embryos, the difference between the two conditions is more
predominant in UV NF11 preferentially bound sites (Fig. 4.13C).
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Figure 4.14: Differential Brachyury binding in dorsalised and ventralised em-
bryos
The figure shows four genomic regions around the mmp21, nog, ventx and hes3.3 loci. LiCl NF12
DB refers to peaks identified as preferentially bound in dorsalised embryos and UV NF11 DB refers
to peaks identified as preferentially bound in ventralised The first two show sites with higher binding
in dorsalised embryos and the last two in ventralised embryos. mmp - matrix metallopeptidase; nog -
noggin.
Sites with higher DNA occupancy of Brachyury in dorsalised embryo include the
promoter region of the matrix metallopeptidase 21 (mmp21 ) and a regulatory region
upstream of noggin (nog) (Fig. 4.14). The genomic regions around the ventx genes
include a few DB sites with higher occupancy in ventralised embryo as well as the
region of the promoter of hes3.3. Despite the examples given in Figure 4.14, I did not
find any correlation between Brachyury binding and active transcription or transcript
levels.
4.6.1 Differential binding near Brachyury gene targets
The list of true Brachyury direct gene targets is short and difficult to dissect due to
gene cross regulation (Gentsch et al., 2013), indicating that most of Brachyury binding
is opportunistic. When comparing Brachyury binding in ventralised and dorsalised
embryos, true gene targets were bound similarly in both conditions, e.g; msgn1, mespb,
mespa, myf5, sox2 with the exception of four genes: hes7.2, foxb1, pax3 and t2. These
genes had near their locus one or more DB sites in either or both conditions (Fig.
4.15). Of the four, two are repressed by Brachyury and expressed in neural tissue,
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foxb1 and pax3 while hes7.2 and t2 are expressed in posterior mesoderm and acti-
vated by Brachyury (Gentsch et al., 2013). Foxb1 was the only of these genes that
was differentially transcribed in dorsalised embryos, the same condition where DNA
occupancy of Brachyury is higher. Furthermore, hes7.2 a gene involved in posterior
mesoderm, more precisely in somitogenesis, had three sites with higher Brachyury bind-
ing in ventralised embryos, including one near the promoter region (Fig. 4.14). The
neural development regulator pax3 is repressed by Brachyury (Gentsch et al., 2013) and
had one site preferentially bound in dorsalised NF12 embryos and two in ventralised
NF11 embryos, that could represent cell type specific regulatory regions. Finally, the
other Brachyury gene, t2 was bound similarly in the promoter region, however there
were two regulatory regions upstream that were predominantly bound in dorsalised or
in ventralised embryos (Fig. 4.15). Similarly to the pax3 gene, this could represent
cell-type specific regulatory regions.
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Figure 4.15: Brachyury binding near true gene targets in dorsalised and
ventralised embryos
Six genomic snapshots of Brachyury binding in LiCl- and UV-treated embryos. LiCl NF12 DB
refers to peaks identified as preferentially bound in dorsalised embryos and UV NF11 DB refers to
peaks identified as preferentially bound in ventralised. The first two panels on the left-hand side show
the occupancy pattern near hes7.2 and foxb1 ; the former only has Brachyury preferential binding in
ventralised embryos and the latter in dorsalised embryos. The next two panels, show binding near tt2
and pax3, in both cases there are peaks preferentially bound in LiCl- and UV-treated embryos. Finally,
the last two panels show ChIP-Seq profile of Brachyury near msgn1, mespa and mespb, and in all cases
DNA occupancy is similar in both conditions.
The data indicated that most sites were bound similarly by Brachyury in both cell
types with a small subset of sites with higher occupancy in one condition than in the
other. As most of Brachyury binding is opportunistic and only 4 of its true targets were
differentially bound, the preferentially bound sites could be explained by differences in
chromatin accessibility in each dorsal and ventral cells. Unfortunately, I was unable to
generate data of chromatin accessibility in dorsalised and ventralised embryos, which
stopped me from exploring this hypothesis. In addition to chromatin accessibility, the
binding to DNA can be regulated by the presence of other TFs, co-factors. In the next
section I refer to my attempt to identify cell type specific co-factors that may influence
the binding of Brachyury to differentially bound sites.
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4.6.2 de novo motif analysis and enrichment comparison
Transcription factors are recruited to the DNA based on the presence of short sequences
recognisable by the DNA-binding domain of a protein, known as transcription factor
motifs. Different families of transcription factors, with homology within its DNA-
binding domain, will recognise variants of the same motif and bind the same genomic
sites. Data from a ChIP-Seq experiment can be used to identify the motifs bound
by the immunoprecipitated transcription factor, and, potentially identify co-factors
if other motifs are found enriched in the vicinity of the peak. For the purpose of
identifying potential co-factors I did de novo motif discovery on the peaksets identified
before. Such analysis resulted in the identification of short sequences enriched in the
peaks, which when compared to known motifs can suggest which family of factors could
bind these genomic regions.
Brachyury contains a T-box domain within its DNA-binding domain which recog-
nises a specific motif sequence, shared among T-box transcription factors. Furthermore,
Brachyury can bind as a dimer and there are variants of the motif that accommodate
for this, palindromic sequences. With this in mind, the de novo motif analysis for each
dataset was done twice, one searching for 8bp and the other for 12bp motifs. The
analysis was done in different peaksets; all the peaks, peaks not differentially bound
and peaks preferentially bound in each condition. This allowed me to investigate if the
nature of the bound regions influenced the binding of Brachyury.
The results of the analysis are in Figure 4.16 that shows the most enriched motifs
in both analysis, the predicted domain, the how many peaks had the motif (% targets)
and the motif frequency in random sequences (% background). In the peaks called in
all conditions, the T-box domain, the monomeric and partial palindromic motif were
the most commonly found, in 60% of the peaks. The other more commonly found
motifs included the Homeodomain and the Forkhead motifs (Fig. 4.16). The same
motifs were found enriched in peaks that were not differentially bound, in addition to
the high mobility group (HMG) domain, which is recognised by Sox proteins. Another
distinction between the two datasets was that the Homeodomain identified in the latter
was associated with the POU proteins. Given that the motifs were found at similar
percentages to that of Brachyury, indicated that transcription factors containing a
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Homeodomain, Forkhead or HMG domains could bind the same sites. These peaks
were not differentially bound which means that this data did not inform on what
leads to the differences in binding between dorsalised and ventralised embryos. For
that, I did a similar de novo motif analysis on peaks preferentially bound in dorsalised
or ventralised embryos. Interestingly, in both cases, the most enriched motif was no
longer the T-box, but the Forkhead or the Homeodomain in LiCl- and UV-treated
embryos, respectively. The T-box motif was found in around 48% of the peaks in both
peaksets, while two distinct versions of the Forkhead motif was found in 64% of the
sites preferentially bound in LiCl-treated embryos and the Homeodomain was found in
52% of the sites preferentially bound in UV-treated embryos (Fig. 4.16). This indicated
that sites where Brachyury binds distinctly in the two cell types are inherently different
in sequence and consequently in terms of the distinct transcription factors could bind.
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Figure 4.16: de novo motif discovery in differentially or similarly bound sites
The image shows the top motif sequences (based on p-value and percentage of occurrences) in
distinct peaksets: peaks called in all conditions, peaks not differentially bound and peaks preferentially
bound in dorsalised or in ventralised embryos. The de novo motif discovery was done within 300bp
of the peak summit and with instructions to find 8bp and 12bp sequence motifs. The % in targets
represents the percentage of peaks that contains the motif and the % of background is the proportion
found in randomly selected genomic regions.
4.6.3 Identification of cell type specific co-factors based on transcrip-
tome data
In dorsalised embryos, the sites with higher Brachyury binding are enriched for the
Forkhead domain and many proteins containing this DNA binding domain were up-
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regulated in these embryos: Fox genes involved in axial mesoderm regulation, such as
foxa1, foxa2 and foxa4. Other Fox proteins expressed in dorsalised embryos at this
stage included foxd4l1.1 and foxd4l1.2, involved in gastrulation and foxd3 and foxb1
which were associated with neural development. The basic helix-loop-helix (bHLH)
motif was also found in 11% of these sites and bHLH transcription factors upregulated
in this condition included neurogenin 3, myf6 and mycn. On the other hand, genomic
sites with higher DNA occupancy of Brachyury in ventralised embryos were enriched
for the Homeodomain and HMG/TCF domains (Fig. 4.16). There are very distinct
Homeodomain-containing TFs expressed in distinct tissues of the embryo and unfortu-
nately it was not possible to identify which specific family of proteins the domain
was related to. However, ventralised embryos upregulate homeodomain-containing
genes including: 7 members of the Hox family (hoxb1, hoxb5,hoxa1, hoxd1, hoxb1,
hoxb4, phox2a), all three members of the Cdx family (cdx1, cdx2, cdx4 ), members of
the Dlx family involved in epidermis and neurogenesis development (dlx2, dlx3, dlx5,
dlx6 ), gbx2.1 /gbx2.2 which repress anterior structures and the ventral factors of the
Ventx family (ventx1.1, ventx1.2, ventx3.2 ). Ventralised embryos have high levels of
Wnt zygotic activity, as seen in Chapter 3, which could explain the enrichment of the
HMG/TCF domain, indicating that these sites could be bound by both Brachyury and
the Wnt effectors, TCFs. Furthermore, the data indicated that in 8% of the sites there
was a motif that resembled the one that is recognised by the Brinker DNA-binding
domain. Brinker is gene discovered in Drosophila, a target of Bmp4 and acts as a
repressor downstream of BMP signalling. However, there is no ortholog described in
Xenopus to which I could infer the TF that binds this motif. It could indicate that
if these sequence motifs are conserved, the sites preferentially bound in ventralised
embryos were enriched for targets of BMP signalling, that similar to Wnt signalling is
highly activated in these embryos.
To confirm that these motifs were enriched in the peaksets where they were found,
I analysed the distribution of all these motifs in sites preferentially bound in LiCl- or in
UV-treated embryos. The analysis indicated that, the motifs found at high percentages
in each condition were enriched on those peaks and not on the others (Fig.4.17). The
UV motifs were enriched in peaks preferentially bound in ventralised embryos and not
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in the peaks preferentially bound in the LiCl condition, and vice-versa for LiCl motifs
(Fig. 4.17).
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Figure 4.17: Enrichment of motifs found in sites preferentially bound in LiCl-
and UV-treated embryos
Heatmaps show motif enrichment within 500bp of the DB peak summit. Enrichment is calculated
as the number of motifs found per bp per peaks calculated in bins of 25bp. The figure confirms that the
motifs more commonly found in cell-type specific peaks (DB sites) are more enriched in that condition.
The de novo motif discovery indicated that for genomic regions bound similarly in
dorsal and ventral cells the most enriched motif was the T-box and similar occurrences
of Forkhead and Homeodoamain motifs. However, when analysing cell type specific
preferential binding events, the T-box domain was no longer the predominant motif,
instead the Forkhead and the Homeodomain occupied most of these sites in dorsalised
and ventralised embryos, respectively. This indicated that these sites could rely on
other co-factors of these families for effective binding of Brachyury. This hypothesis
was supported by the transcriptome data, that revealed that TFs containing Forkhead
and Homeodomain binding domains were upregulated in dorsalised and ventralised
embryos, respectively.
4.7 Summary
• I described the cell type specific recruitment of RNAPII and transcription, with
more genes actively transcribed in dorsalised embryos.
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• Genes upregulated in each condition showed higher RNAPII binding to its gene
body, indicating that upregulated genes were actively transcribed in each cell
type.
• There is a positive correlation between RNAPII occupancy and p300 binding
in regulatory regions near active genes, revealing tissue specific regulation of
transcription.
• I described the validation of a new antibody against Xenopus Brachyury for
ChIP-Seq experiments.
• I studied Brachyury binding in stage NF11 dorsalised and ventralised embryos.
The experiment revealed differences in the DNA occupancy pattern of Brachyury
between LiCl- and UV-treated embryos. Peak calling and read quantification
revealed that dorsalised embryos have substantially less binding events and lower
overall DNA occupancy by Brachyury in these sites.
• The investigation of the levels of Brachyury protein during gastrulation in dor-
salised and ventralised embryos revealed that dorsalised embryos have lower levels
at the stage I performed the ChIP, however by stage NF12 the levels are similar
to those of stage NF11 ventralised embryos.
• I analysed the binding profile of Brachyury on stage NF12 dorsalised embryos
which allowed to accurately compare the DNA occupancy pattern in dorsal and
ventral cells. The increase in protein level led to the identification of more binding
events in LiCl-treated embryo, although the overall occupancy did not increase.
• I showed that the use of peak calling is not a good tool to identify differences
in DNA occupancy between two conditions. By counting reads in peaks and
comparing them, I identified genomic regions that are differentially bound by
Brachyury in dorsal and ventral cells: 468 sites, most of them with higher binding
in dorsalised embryos. However, the majority of the sites are bound similarly in
the two conditions (1595 peaks).
• Data mining on peak sequences revealed that different motifs are enriched in sites
predominantly bound in one condition; Forkhead motif in dorsalised and Home-
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odomain in ventralised embryos. These sites might be differentially bound due to
the presence or absence of specific co-factors, since Forkhead- and Homeodomain-
containing TFs are differentially expressed in dorsalised and ventralised embryos,
respectively.
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Chapter 5
Implications of knockout versus knockdown in
Xenopus embryos
In the previous chapter, I reported on the differential binding of Brachyury in dorsal and
ventral mesodermal cells. Brachyury is an essential gene for mesodermal development,
which was shown in different animal models (Stott, Kispert, and Herrmann, 1993;
Gentsch et al., 2013; Beddington, Rashbass, and Wilson, 1992; Schulte-Merker et al.,
1994). Downregulation or abrogation of its expression leads to a striking phenotype of
axial truncation, characterised by the loss of most axial mesoderm. In frog embryos, the
phenotype has been generated by morpholino oligomers (MOs) mediated knockdown
(KD) and thoroughly characterised (Gentsch et al., 2013).
Since the mid-1990s, a few years after their discovery, MOs have been an essential
tool for developmental biologists working with zebrafish and Xenopus to study gene
function. This KD approach is based on the use of antisense oligos complementary
to either translation or splicing sites of transcripts (mRNA) leading to perturbations
and ultimately downregulation of the gene. The advantage of MOs compared to other
antisense techniques is the use of a backbone of morpholine instead of ribose, as a nucleic
acid analogue. This transformation grants morpholinos, among another things, a higher
resistance to nucleases, making it an easy-to-use tool for gene function (Summerton,
2017; Summerton and Weller, 1997).
More recently, genome editing tools such as TALEN and type II CRISPR system
made it possible to knock out (KO), rather than only transiently knocking down genes.
Recent studies in zebrafish showed low concordance between mutant (KO) and mor-
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phant phenotypes, either because mutants are not null or the MO generated off-target
defects (Kok et al., 2015). Given this disagreement, in this chapter I report on the
implications of knocking out versus knocking down Brachyury in Xenopus tropicalis.
This work is part of a collaborative project where we compared the previously de-
scribed Brachyury morphant (Gentsch et al., 2013) with a newly TALEN-generated
Brachyury KO embryo both morphologically and transcriptionally and explore further
the unknown effects of MOs.
The experiments described in this Chapter were done in collaboration with George
Gentsch, Thomas Spruce and Nick Owens.
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5.1 Generation of TALEN-mediated KO of Brachyury Par-
alogues
The TALEN-mediated mutagenesis that led to the generation of mutant frog lines was
done by Thomas Spruce which I will described here. In order to generate the Brachyury
KO (knock-out) mutant the coding regions of the two Xenopus paralogues,Xbra(t) and
Xbra3 (t2 ) were targeted using TALENs (Fig. 5.1). Targeting the two genes was essen-
tial for the functional study of Brachyury, as they are expressed synergistically and have
redundant roles (Gentsch et al., 2013; Hayata et al., 1999). Furthermore, the mutant
embryos were compared with previously generated double morphants, embryos gener-
ated with MOs against both genes, t and t2, which reproduced the classical Brachyury
null mouse phenotype (Chesley, 1935; Gentsch et al., 2013). The two genes are present
in tandem in the Xenopus genome and, given the short distance between them (within
30kb) were likely to co-segregate during meiosis. Two rounds of TALEN-mediated
mutagenesis were carried-out to generate the double mutants (Fig. 5.1). In the first
round, wild-type (WT) 1-cell stage embryos were injected with a TALEN pair targeting
a SacI restriction site in exon 1 of t. This proved to be successful, with both vegetal
and animal injections, in ˜90% of the injections. This approach resulted in a series of
indels (insertions and deletions) ranging from 1-6bp in exon 1, identified in PCR clones
by Sanger sequencing.
The mutations were present in the germ line of 80% of F0 females raised to sexual
maturity, which were crossed with WT frogs to generate the F1 line of t with a 2bp
deletion (te1.2D) (Fig. 5.1). This deletion was expected to produce a truncated protein
lacking the critical T-box domain (Fig. 5.2). Furthermore, the short-tail phenotype was
observed, as previously described in t morphants (Gentsch et al., 2013), in homozygous
offspring of a F0 t (tTAL) mutant intracross (data not shown). Offspring of the F1 t
mutants (te1.2D/+) crossed with WT was used for the second round of mutagenesis
targeting t2 (Fig. 5.1). Heterozygous embryos of this F2 line (te1.2D/+) were injected
with a TALEN pair targeting a EcoRI restriction site in exon 3 of t2. The second
round was less efficient. Only 30% (6/21) of the embryos carried a mutation in the
t2 locus. Tadpoles identified by genotyping as carrying the t2 mutations were raised
to sexual maturity and 3 out of 15 frogs were found to have the mutation present in
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the germline. Embryos from one of these frogs carried a 7bp deletion in the exon 3
of t2 (t2 e3.7D) and on the same chromosome as the 2bp deletion of t (te1.2D) (Fig.
5.1). Similarly, the 7bp deletion in t2 locus affected the T-box domain by shifting stop
codons into the reading frame prematurely (Fig. 5.2). This strategy allowed us to
establish a heterozygous t/t2 frog line containing mutations (te1.2D and t2 e3.7D) on the
same allele which were used for all the subsequent experiments (Fig. 5.1).
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Figure 5.1: Diagram showing procedure to generate the heterozygous frogs
te1.2D/+/t2 e3.7D/+
te1.2D/+/t2 e3.7D/+ frogs were generated from two rounds of TALEN-mediated mutagenesis. In
the first round a TALEN targeting exon 1 of t was injected into wild-type (WT) Xenopus tropicalis
1-cell stage embryos. Frogs containing the mutation in the germline were crossed with WT and the
resulting embryos were injected with the second TALEN targeting exon 3 of t2. te1.2D/+ frogs with this
mutation were crossed with WT to generate the heterozygous frogs with mutations in both embryos
(te1.2D/+/t2 e3.7D/+, or t+/-/t2+/- ), used in the subsequent experiments. wt-wild-type, e-exon, D-
deletion.
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Figure 5.2: Localisation of TALEN-mediated mutations and predicted mu-
tated protein product
The diagrams represent the two mutations generated by TALENs: 2bp deletion in exon 1 of t and
7bp deletion in exon 3 of t2. These are frameshift mutations that result in premature a STOP codons
in frame which leads to the prediction of synthesis of truncated proteins: a 59aa t protein and 170aa
t2 protein.
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5.2 Deletions nullify Brachyury Function
In order to confirm that the genomic mutations were actually nullifying both loci, I
cloned te1.2D, t2 e3.7D and the corresponding WT mRNAs into N- and C-terminally
HA-tagged expression vectors. The strategy was to express the constructs in Xenopus
laevis and confirm the presence of a premature stop codon and production of shorter
proteins. The 8 constructs were individually injected into 1-cell stage Xenopus laevis
together with mRNA encoding for fam83g-myc to be used as control for translation
efficiency. Embryos were collected for protein extraction at mid-gastrula stage and
processed for Western Blot analysis (Fig. 5.3).
This experiment revealed the expected protein size for the endogenous expressed
mRNAs: WT t and t2 were fully transcribed as both N- and C-terminally HA-tagged
versions were present at the correct size, about 50 kDa (Fig. 5.3). The detection
of a single product for all translation products indicated that neither one of them
contains internal translational start sites. The absence of any C-terminally tagged
mutant protein suggests the premature end of translation. Analysis of the HA-te1.2D
clearly showed the production of a shorter protein of around 20 kDa, however I was
unable to detect the predicted 6kA product of HA-t2 e3.7D, possibly due to its poor
stability or technical issues in plotting such short proteins.
183
t or t2 HA-tagged mRNA + 
fam83g-myc mRNA
HA tag
TALEN generated mutation
t-HA
HA-t
t e1.2D -HA
HA- t e1.2D 
t2-HA
HA-t2
t2 e3.7D -HA
HA- t2 e3.7D 
A
kD
a
100
50
25
50
anti-myc
anti-HA 
anti-α-tubulin
t-H
A
H
A-
t
t e
1.
2D
 -H
A
H
A-
t e
1.
2D
 
t2
-H
A
H
A-
t2
t2
 e
3.
7D
 -H
A
H
A-
t2
 e
3.
7D
 
U
ni
nj
ec
te
d
B
t exons
t2 exons
Figure 5.3: Truncated mutant product confirmed by Western Blot
A) Diagram showing the mRNA constructs t/t2 wild-type and mutant tagged with HA either C-
or N-terminally. Xenopus laevis were co-injected at 1-cell stage with fam83g-myc mRNA as a control
for translation efficiency. B) Western Blot of embryonic extract of X.laevis embryos injected with
t and t2 wild-type and mutant HA-tagged constructs. Detection of myc shows the protein fam83g
as a translation efficiency control and endogenous α-tubulin was used as a gel electrophoresis loading
control. Blot using anti-HA antibody shows the t and t2 proteins. Both N- and C-terminal tagged wild-
type proteins (t-HA, t2-HA, HA-t and HA-t2) are present and at the right size, 50 kDa. As expected,
the C-terminally tagged mutant sequences ( te1.2D-HA and t2 e3.7D-HA ) do not show any product
using the HA antibody, indicating the production of a truncated protein. Of the N-terminally tagged
mutant proteins (te1.2D-HA and t2e3.7D-HA) only the 20 kDa from the mutant sequence is detected.
The absence of a band for HA-te1.7D is probably due to the size of the protein and its stability making
it difficult to blot.
Furthermore, the injection of the mutant mRNAs did not result in the typical
phenotype of overexpression of Brachyury. The phenotype is characterised by morpho-
genetic movements defects during gastrulation, which was absent in embryos injected
with te1.2D and t2 e3.7D mRNAs (Fig. 5.4). Both experiments led to conclude that the
TALEN-meditated mutations resulted in a null Brachyury. From here in I’ll refer to
the e1.2D as t - and t2 e3.7D as t2 -.
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Figure 5.4: Embryos injected with mutant Brachyury mRNA do not show
gastrulation defects
Phenotypes of embryos injected with constructs containing the mutant sequences for t and t2
(upper row) and embryos injected with wild-type sequences (lower row). As expected, overexpression
of Brachyury leads to developmental defects associated with gastrulation movements. Embryos in-
jected with the mutant sequences do not show any developmental defects, similar to control embryos
(uninjected), indicating that the mutation leads to a null allele.
The expression levels of t and t2 in t/t2 heterozygous and homozygous mutants
neurula stage embryos were analysed by quantitative real-time PCR (RT-qPCR). t
transcripts increased 1.5-2-fold in mutants compared to WT, suggesting an increased
stability of the transcript or transcription compensation for reduced Brachyury levels
(Fig5.5). This means that the generated mutations did not lead to non-sense mediated
decay, which is similar to what it has been reported for vegfaa mutants in zebrafish
(Rossi et al., 2015). Since t2 induction is directly dependant on t, its expression was
reduced by about 5-fold in mutants compared to WT. Heterozygous embryos did not
show the same reduction in t2, suggesting that half the amount of t was sufficient to
maintain expression of t2. This was in accordance with the lack of axial truncation
phenotype in heterozygous embryos. However, an increase in t levels could still be
detected in heterozygous embryos, similar to homozygous mutants.
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Figure 5.5: Quantification of t and t2 transcripts in wild-type, heterozygous
and mutant embryos
Transcript levels of t and t2 measured by RT-qPCR in heterozygous and homozygous early neurula
stage embryos. The expression is represented in percentage in relation to control levels (t+/+/t2+/+).
Each bar represents the average measure from biological triplicates and the error bar are the standard
error of the mean (SEM). Two-tailed t-test: *, p<0.05.
5.3 Brachyury KO and KD are phenotypically undistin-
guishable
After confirming that the mutations resulted in the nullification of Brachyury function I
proceeded to compare the mutants with the morphants. Natural mating of Brachyury
heterozygous ( t+/-/t2+/-) frogs resulted in the expected three types of genotypes:
wild-type (t+/+/t2+/+) (WT), heterozygous (t+/-/t2+/-) (t/t2 het) and homozygous
(t -/-/t2 -/- (t/t2 KO). For the analyses I used the three kinds of embryos and compared
them with the three conditions from the morpholino experiments: uninjected embryos
and embryos injected with either a control MO (cMO) or MO against t and t2 (a
total of 4 MOs were injected, for each gene a combination of translation start site- and
a splice-blocking MOs). These 4 morpholinos and the resulting phenotype had been
previously tested and validated (Gentsch et al., 2013).
The initial comparison was phenotypical, as the Brachyury lack of function phe-
notype is well described. The expectation was to observe a shortened antero-posterior
(AP) axis from tailbud-stage onwards. Figure 5.6 shows the comparison at tailbud
stages NF26 and NF30 for all the 6 different conditions. The control conditions (Unin-
jected, cMO, WT) and the heterozygous embryos showed no deviant phenotype while
t/t2 MO and t/t2 KO show a similar axis truncation with no distinguishable feature
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between both. I did not proceed to further investigate each phenotype; i.e., measure
AP axis length or other organs; so I did not exclude the existence of other morpho-
logical differences. Additionally, the previously described morphology and timing of
developmental defects in t/t2 MO (Gentsch et al., 2013) were confirmed. Together, I
concluded that the knockdown of Brachyury phenocopied the loss of function of the
same genes to the point that the embryos were undistinguishable. Moreover, half the
amount of Brachyury (t/t2 het) was sufficient for proper axial extension and resulted
in a wild-type-like phenotype.
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Figure 5.6: Mutant and morphants embryos are indistinguishable at tailbud
stages
Phenotypical comparison of between the different genotypes and conditions generated for the exper-
iment, at two tailbud stages, NF26 and NF38. The control embryos for both experiments, uninjected,
wild-type (wt), t/t2 heterozygous (t/t2 het) and embryos injected with control morpholino (cMO)
share the same phenotypic characteristics of a normal developing embryo. The KO and MO embryos
are undistinguishable, as both present the Brachyury null phenotype of axial truncation. *Numbers
refer to genotyping results. Scale bar, 0.25 mm.
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5.3.1 Posterior mesoderm the notochord are consistently affected in
Brachyury KO and KD
The genes t and t2 are master regulators of mesoderm development and known to par-
ticularly regulate dorsal and posterior mesoderm. To investigate whether KO and MOs
similarly affected mesoderm development, I analysed the expression of several meso-
dermal and mesodermal derivative markers by multi-probe WMISH (Fig.5.7). I used a
multi-probe approach, since the expression pattern of these genes is well characterised
and do not overlap spatially. Embryos injected with cMO had unaffected mesoderm
as seen by the expression pattern of markers of paraxial mesoderm (tbx6, T-box 6 ) its
derivatives , the somites (actc1, cardiac actin 1 ), notochord (cav1, caveolin 1 ), inter-
mediate and ventral mesoderm subtypes such as heart (myh6, myosin heavy chain 6 ),
pronepheros (hoxd8 ) and blood (tal1,T-cell acute lymphocytic leukemia 1 ). However,
both mutants (t/t2 KO) and morphants (t/t2 MO) had defects in paraxial and dorsal
mesoderm as seen by the loss of tbx6 expression in the paraxial mesoderm which re-
sults in the loss of posterior somites and malformation of more anterior ones, seen by
expression of actc1 (Fig. 5.6). The notochord, a derivative of the dorsal mesoderm,
was completely absent in embryos lacking Brachyury, shown by the (lack of) expression
of cav. However, despite a delay in the formation of some of these tissues, derivatives
of intermediate and ventral mesoderm were not affected in t/t2 KO nor MO.
TALEN-mediated mutagenesis of t and t2 led to the loss of function of both alleles
resulting in a phenotype of axial truncation and disruption of posterior mesoderm
undistinguishable from the MO-mediated knockdown of the same genes.
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Figure 5.7: Posterior mesoderm is affected in both KD and KO embryos
Combinatorial whole-mount in situ hybridisations at mid-tailbud stage showed that only posterior
mesoderm (paraxial mesoderm: tbx6, T-box 6 ) including its derivatives notochord (cav1, caveolin 1 )
and somites ( actc1, actin, alpha, cardiac muscle 1 ) are consistently absent or malformed in Brachyury
KO and KD embryos. In contrast, anterior (cardiac: myh6, myosin heavy chain 6, actc1, actin, alpha,
cardiac muscle 1 ), intermediate (pronephros: hoxd8 ) and ventral (blood: tal1, T-cell acute lymphocytic
leukemia 1 ) mesoderm were largely intact. Scale bar, 0.5 mm.
5.4 Transcriptome-wide comparison of Brachyury KO and
KD embryos
I was able to confirm that the TALEN-mediated mutation led to a null phenotype that
was morphologically undistinguishable from the MO-generated knockdown embryos.
Given this, we further investigated whether these two kinds of embryos, KO and KD,
were also transcriptionally similar, by comparing the whole poly-A transcriptome.
In order to do such analysis I collected embryos from a natural mating cross between
two t/t2 heterozygous frogs and processed them individually for DNA extraction and
genotyping. Single embryos were genotyped for both t and t2 (Fig. 5.8). Embryos
were collected at two developmental stages, stage NF26 and NF34, both tailbud stages
in which the effects of the absence of Brachyury take place. The RNA (see Chapter
3 for details) from 5 to 10 sibling embryos with the same genotype was combined and
processed together in order to obtain 3 biological replicates of each genotype: wild-
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type (t+/+/t2+/+), heteroxygous (t+/-/t2+/-) and mutant or KO (t -/-/t2 -/-). Embryos
from three different crosses were injected with t and t2 splice- and translation-blocking
morpholinos (total of 4 morpholinos, 4.5ng each) and standard control morpholino
(cMO) from GeneTools (18ng) plus uninjected embryos were collected at the same
stages and processed for RNA extraction, similarly.
200bp
t +/+ t -/-t +/-
t2 +/+ t2 -/-t2 +/-
200bp
Figure 5.8: Example of genotyping of single embryos prior to poly-A library
preparation
Single embryos were processed for DNA and RNA extraction. DNA was used for genotyping prior
to poly-A library preparation. Upon extraction, DNA was amplified for the t and t2 locus, as described
in Chapter 2, and subsequently digested with either SacI (t) or EcoRI (t2 and fragments separated
by gel electrophoresis in order to identify the mutations. The figure shows examples of 3 embryos
representative of each genotype. The TALEN-induced mutation masks the restriction site resulting in
a single band in the gel, while wild-type embryos present two bands as a result of the digestion by the
restriction enzyme and, finally, heterozygous embryos have the three bands.
Of the work described from here on, I only contributed to the discussion of results
and suggestions of further analyses. The libraries were prepared by Thomas Spruce and
computational analysis was done mostly by George Gentsch with contributions from
Nick Owens. Furthermore, the work described here forms part of a article submitted
for publication in Developmental Cell, currently under review.
The RNA-Seq poly-A(+) libraries consisted of the 6 conditions described above at
two developmental stages and biologial triplicates: a total of 36 libraries were made and
sequenced to produce paired-end reads that were aligned to Xenopus tropicalis gene
models. Reads were counted per gene model (except ribosomal and mitochondrial
RNA) and raw counts were used for differential expression analysis using DESeq2.
Furthermore, in order to identify genes differentially expressed with consistent fold
changes, both developmental stages were considered, meaning that a gene would have
to be differentially expressed (DE) at both time points to be considered.
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Figure 5.9: Morpholino-injected embryos show higher transcriptional vari-
ances than KO embryos
A) Principal component analysis (PCA) of the RNA-Seq data generated from biological triplicates
of each condition. The KO experiment comprises the control wild-type embryos (WT, yellow grade
with stroke around), heterozygous (Het., yellow with dashed stroke) and the homozygous mutants (KO,
yellow). The KD experiments includes uninjected embryos (Uninj., in blue), embryos injected with
a control morpholino (cMO, blue) and embryos injected with the 4 morpholinos targeting t and t2,
the morphants (MO, blue). Most of the variance between samples is explained by the developmental
stage (PC1 = 65%) and PC2 accounts for the differences seen between the conditions (PC2 = 14%).
B) Jitter plot showing the differences in the transcriptome (pairwise comparison with the appropriate
control) in percentage, of each condition. Genes with FDR 10% were coloured: navy blue <25%,
sky blue 25-67%, orange 150-400% and brown >400%. The piecharts represent the whole universe of
transcripts analysed, in grey are the unchanged gene, in orange the upregulated portion and in blue the
downregulated portion (based on a fold change ≥1.5 or FDR ≤10%).The percentage in each piechart
refers to the proportion of unchanged transcripts between the condition and the relative control.
Before the identification of DE genes, the principal component analysis (PCA),
shown in Figure 5.9A, indicated that most of the variance seen in the transcriptome of
the embryos was explained by the developmental stage (Fig.5.9A, PC1:65%). Principal
component 2, explained most of the remaining variance which was associated with the
condition. The PCA revealed that, at both stages, the control conditions, wild-type
(WT) and uninjected, clustered together (very similar transcriptionally), as well as
heterozygous (Het.) embryos (Fig.5.9A, yellow circles and triangles with dashed stroke
around). Interestingly, embryos injected with the control morpholino (cMO) did not
cluster as well with the other control conditions and the variance increased with time.
As expected, KO embryos were transcriptionally distinct from the control conditions
and these differences do not seem to increase over developmental time. However, em-
bryos injected with morpholinos against t and t2 had the most distinct transcriptome
and like cMO, the separation to the control conditions increased with time (Fig. 5.9A).
To better understand the consistent transcriptional differences between conditions,
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the transcript levels of annotated and expressed genes (genes with 7 or less fragments in
the control were disregarded) were analysed by pairwise comparison. As referred above,
for this analysis both developmental stages were considered and misregulated genes
were identified by a FDR≤10% and a fold change≥1.5. Figure 5.9B shows the results of
the pairwise comparison and reveals the same trend as the PCA. The transcriptome of
heterozygous and wild-type siblings were only 0.1% different, while KO embryos showed
3.5% of misregulated genes, with most being downregulated (Fig. 5.9B). Comparison
of the MO experiment conditions revealed that cMO-injected embryos have 1.6% of
its genes misregulated when compared to uninjected embryos. While KO embryos
displayed 96.5% of unchanged transcripts, KD (t and t2 MO-injected) embryos have
85.2%-86.5% when compared to uninjected and cMO, respectively. This means that
embryos injected with t and t2 MOs had a 4-fold increase in misregulated genes in
comparison to KO embryos (˜14% versus 3.5%, respectively).
In summary, KO and KD embryos were transcriptionally distinct from the corre-
spondent control embryos, however KD embryos showed a higher number of misreg-
ulated genes. Furthermore, embryos injected with a cMO also showed a significant
percentage of misregulated genes, unexpected for a control condition.
5.4.1 Activation of immune response genes in morpholino-injected
embryos
In order to understand which genes were causing the transcriptomic differences between
conditions, gene ontology (GO) analysis for terms associated with biological function
(BP) was used. First, the affected genes identified above where grouped in Venn dia-
grams, for up and down regulated genes. Five of the most populated categories were
analysed: (A) genes affected only by cMO, (B) genes affected by both the cMO and
the t/t2 MO, (C) genes affected only by t/t2 MO, (D) genes affected by both the t/t2
MO and in the KO and finally (E) genes affected only in KO embryos (Fig.5.10). The
Venn diagrams showed that most of the genes affected by the KO alone (E) and in the
KO and t/t2 MO (D) were downregulated and, more interestingly, that the number
of misregulated genes in MO alone (C) were almost five times the number of genes
affected in both KO and KD embryos (D). GO term analysis in each of these Venn
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fields was revealing on the nature of the genes affected in each condition. Genes down-
regulated in both KD and KO embryos (D) were highly enriched for terms associated
with muscle system process, cardiovasculogenesis and somitogenesis. These processes
are associated with mesoderm regulation and differentiation, the formation of somites
that will form muscle and in heart formation, known to be regulated by Brachyury.
Upregulated genes of the same group (D), showed enrichment for terms associated with
spinal cord development, which is also known to be a consequence of loss of Brachyury,
as neuromesodermal progenitors switch from a mesodermal to a neural fate under this
conditions (Gentsch et al., 2013). Hence, the genes misregulated in both KO and KD
embryos represented the regulatory core affected by the loss Brachyury and responsible
for the axial truncation phenotype observed in both conditions.
A B
Figure 5.10: Transcriptional differences between KO and KD embryos are
related to innate immune response
A) Venn diagrams of positive(orange) and negative (blue) transcript fold changes (≥1.5-fold and
FDR ≤10%). Main categories are represented by letter A-D, see text for more details. B) Repre-
sentation of the statistical significance (hypergeometric p-value) of enrichment for selected biological
processes among the indicated Venn fields.
The other group that showed significant association with GO terms were genes up-
regulated only in KD (B, 120 genes) and in both KD and cMO (C, 1058 genes) (Fig.
5.10B). In these groups there were genes associated with immune response, cytokine
production and NF-κB signalling pathways, such as Toll-like supressors, complement
components, cytokines, caspases and tumour suppressors. This overall immune re-
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sponse was a side effect of injecting control or t/t2 MO since these genes were only
misregulated in these two conditions. Furthermore, investigation of the binding of t
at tailbud stages, by ChiP-Seq (Gentsch et al., 2013), showed no binding events near
these genes, in contrast to genes affected in both morphants and mutant embryos (data
not shown).
The transcriptome comparison allowed the identification of the gene-regulatory core
affected by the loss of Brachyury by the overlap of genes affected in both KD and
KO embryos. This group of genes, although not extensive, was responsible for the
phenotype that makes morphants and mutants undistinguishable. The experiment also
indicated that the use of morpholinos caused a large misregulation of genes associated
with immune response. This observation was very pertinent, specially in that, since its
conception, morpholinos have never been described to cause such an immune response.
Although not shown here, the reduction of the morpholino dose, to concentrations that
still cause a phenotype, showed a reduction in the overexpression of genes associated
with the immune response (data not shown).
5.4.2 Off-target mis-splicing caused by morpholino
In the previous section I described that embryos injected with morpholinos showed
an increase in expression of genes associated with innate immune response, described
as a MO-side effect. However, when investigating the GO terms associated with genes
downregulated in KD alone (C) or KD and cMO (D) there was no significant enrichment
for a GO term. This indicated that this group of genes was not associated with any
biological function and its misregulation was not explained by the effect on any specific
pathway or cellular process. The ’randomness’ of genes downregulated in MO-injected
embryos led to investigate the off-target effects of MOs, such as mis-splicing, which in
turn can affect transcript stability. An initial hint of off-target hybridisation by MOs
resulted from ’BLASTing’ the cMO, t splice MO (MOsplice) and the t2 sequences;
the three morpholinos contained at least 8 consecutive bases that matched the most
frequently encountered canonical splice site in Xenopus (Fig. 5.11A).
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Figure 5.11: Morpholino-injected embryos have more events of mis-splicing
compared to control
A) Consensus sequence of of the most commonly found splice donour sequence in Xenopus embryos
at tailbud stage and the best alignment to cMO, t MOsplice and t2 MOsplice. B) Hierarchical heatmap
of differential splicing (alt, alternative; can, canonical, cr, cryptic) between t/t2 MO, cMO, t/t2 homo-
and heterozygotes. 758 and 153 blocked splice junctions were identified in t/t2 MO and cMO, respec-
tively. These mis-splicing events are positively correlated with decreased transcripts (RNA) and more
consecutive MO (10) base pairing (MO).
This observation strengthen the hypothesis that MO could hybridise to ’off-target’
mRNAs causing events of mis-splicing and consequently affect stability and expression
of transcripts. The hypothesis was tested by analysing the RNA-Seq data in search for
differential splicing in the different conditions. The software Leafcutter (Li, Knowles,
and Pritchard, 2016), an annotation-free method, that allows the identification of al-
ternative splicing events by focusing on intron excision events was used. The analysis
resulted in the identification of 758 and 153 intron clusters (blocked splice junctions)
that were differentially spliced in t/t2 and cMO morphant embryos, respectively (Fig.
5.11B). Figure 5.11B shows a heatmap of differential splicing and indicates that, for the
identified clusters, in embryos injected with MOs, canonical (can) splicing decreased
at the expense of alternative(alt) or cryptic (cr) splicing. Furthermore, the identi-
fied sites showed more consecutive base pairing with the corresponding injected MO
(cMO; 49:2 (nobs:nexp), Mann-Whitney U p<2.2e-16, t/t2 MOs; 92:26, p<7.8e-15).
Likewise, the blocked spliced junctions correlated positively with decreased transcript
levels (more than 1.5 fold change) compared to randomly selected active splice sites
(cMO; 19:1(nobs:nexp), cMO; 42:2, in both cases, Mann-Whitney U p<2.2e-16). The
number of alternative splicing events observed in embryos injected with t/t2 MOs is
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around 5 times more than the events detected in embryos injected with the cMO,
probably explained by the number of MO sequences injected; 4:1 (t/t2 MO: cMO).
Some of these mis-splicing events were validated by RT-qPCR using primers that
spanned an alternative/cryptic splice junction and for the gene dtymk, which showed
10-100 times increase of the spliced alternative while the whole transcript (measured
in exon1) expression level decreases (data not shown). Similar to the reduction of
immune response, mis-splicing decreased when reducing the MO dose to a level that
still produced a phenotype (data not shown), however, none of the side effects was
completely abrogated.
5.5 Summary
• I described how to successfully create and validate a Xenopus tropicalis t/t2 KO
embryo using TALENs.
• The morphological comparison of t/t2 MO-generated KD to TALEN-generated
KO tailbud embryos revealed that they were undistinguishable.
• Comparison of the whole poly(A) transcriptome of wild-type, KO, heterozygous
siblings and embryos injected with t/t2 MOs, cMO or uninjected revealed that
cMO embryos had significant transcript mis-regulation compared to other control
conditions, and similarly, t/t2 morphants had a bulk of mis-regulated genes not
shared with KO embryos.
• The transcriptome data also revealed a group of DE genes in both KO and KD
embryos as the core regulatory network responsible for the loss of Brachyury
phenotype, mostly associated with mesoderm regulation and differentiation.
• The majority of genes upregulated only in MO-injected embryos were associated
with immune response while downregulated genes were not associated with any
biological process.
• MO-injected embryos showed an increased level of cryptic or alternative splicing
and such events were associated with more than 10 consecutive base-pairing with
the corresponding MO sequence.
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• Two side effects were identified as a result of injecting MOs; immune response
and off-target mis-splicing, that could be mitigated but not abolished by reducing
the morpholino dose.
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Chapter 6
Discussion
During this project I have used tools of a modern embryologist to analyse early ver-
tebrate development through multi-’omics’ data integration, and genome editing. Al-
though developmental biology has embraced the use of in vitro stem-cell cultures, in
vivo studies are essential to understand biological processes in context. In the last
decade, highthroughput sequencing technologies have evolved at great speed which
allowed, at increasingly lower costs, to investigate many thousands of nuclei acid se-
quences at once, rather than single genomic loci or gene transcripts. The integration
of these big datasets has allowed the construction and understanding of gene regula-
tory networks involved in distinct developmental processes. In Chapter 3 and 4 I refer
to the use of RNA-Seq and ChIP-Seq, two sequencing applications, first to compare
the whole poly-(A) transcriptome of dorsalised and ventralised embryos, and second, to
investigate the in vivo cell type specific regulation at the chromatin level. Recent devel-
opments in the field of genome editing yielded molecular tools to sequence-specifically
introduce mutations. In Chapter 5, I refer to a collaboration project where we used en-
gineered nucleases to generate null mutants to compare their transcriptomes to that of
Brachyury morphants, revealing the implications of gene knockdown versus knockout.
My main projects are described in Chapter 3 and 4 which have in common the study
of cell type specific gene regulation during early development. Our animal model of
choice is the Xenopus embryo, which offers many advantages when studying early
development. The Xenopus embryo develops externally with simple culture require-
ments, relatively fast, and its size is ideal for manipulation and nucleic acid injection.
In the advent of modern developmental biology, Xenopus is particularly useful for its
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abundance in source material for high-throughput studies exploring the whole tran-
scriptome, proteome or genome. The genomes of the two Xenopus species, tropicalis
and laevis, have been sequenced in the last decade which has allowed, for example, the
generation of genomic maps of histone marks, transcriptional machinery proteins and
transcription factors for the first hours of development (Bogdanovic´ et al., 2016; Hon-
telez et al., 2015; Paranjpe et al., 2013; Heeringen et al., 2014; Gentsch et al., 2013).
Xenopus embryos are also ideal for single-cell transcriptome or proteome studies due
to their cell size, amenability for manual dissection, and their known cell fate (Onjiko,
Moody, and Nemes, 2015; De Domenico et al., 2015; Wu¨hr et al., 2014; Smits et al.,
2014; Flachsova, Sindelka, and Kubista, 2013). However, as the embryo develops, ma-
nipulation of single cells becomes less viable and, so far, there has not been single-cell
studies that span the developmental studies beyond the mid-blastula transition. Al-
though technologies such as Fluidigm for single-cell mRNA quantification have been
developed in recent years, these are not compatible with the cell size and the yolk
content of Xenopus embryos.
Thus, single-cell studies might not be feasible yet during certain stages in Xenopus
development. However, other technologies allow investigating cell type specific features,
based on the bulk analyses of cells (McClure and Southall, 2015). Some of them rely on
transgenic lines expressing a cell type specific promoter driving expression of fluorescent
nuclear proteins, such as isolation of nuclei tagged in specific cell types (INTACT) (Deal
and Henikoff, 2010a; Deal and Henikoff, 2010b) and batch isolation of tissue-specific for
chromatin immunoprecipitation (BiTS-ChIP) (Bonn et al., 2012a; Seyres et al., 2016).
The application of INTACT, yields a cell type specific analysis of chromatin and nuclear
RNA studies. This technique was first described in Arabidopsis thaliana (Deal and
Henikoff, 2010b) and has since then been applied to Drosophila melanogaster embryos
and a derivative of this concept to zebrafish embryos (Henry et al., 2012; Ma and
Weake, 2014; Steiner et al., 2012; Trinh et al., 2017). There is one published example
of INTACT applied to Xenopus laevis tailbud stage embryos to study the proteome of
cardiac and skeletal muscle cells (Amin et al., 2014). Commonly, nuclei are extracted
before selecting a specific cell type. This is particularly challenging with early stage
Xenopus embryos due to their high yolk content. Isolating nuclei from late blastula
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stage embryos has been achieved by running a sucrose gradient (Finkielstein, Lewellyn,
and Maller, 2001). However, there are no examples in the literature of successfully
isolating fluorescently labelled nuclei from early stage embryos, to be processed for
studying the transcriptome or chromatin.
I considered developing the tools described above, for Xenopus embryos, but rea-
soned that such an approach was too risky in producing timely results. The number
of cells needed for chromatin extraction was another limiting factor. Thus, I changed
strategy to study cell type specific regulation during early development by taking ad-
vantage of the easy manipulation of cell fate determination in early Xenopus embryos.
I have enriched the whole embryo for dorsal or ventral cells by dorsalisation or ven-
tralisation, which provided sufficient embryonic cell material to study cell type specific
gene regulatory networks.
In the next sections, I will discuss the results of Chapter 3 to 5.
6.1 Dorsal and ventral cells have a very distinct transcrip-
tome
I decided to use dorsalised and ventralised embryos as a proxy to study cell type specific
gene regulation in vivo across the dorso-ventral axis of gastrula stage embryos. Ultra-
violet (UV) irradiation shortly after fertilisation and treatment with lithium chloride
(LiCl) at 32-cell stage, are the most reported methods for high efficient ventralisation
and dorsalisation, respectively. At the start of this project neither LiCl- or UV-treated
embryos had been transcriptionally profiled and I reasoned this would be an useful
dataset, given the historical importance of the methods and the potential to identify
new genes involved in setting up the dorso-ventral axis. Furthermore, since I intended
to use these embryos for ChIP-Seq, these transcriptional profiles would complement
the analysis of the chromatin landscapes. The comparison revealed that dorsalised em-
bryos have more differentially expressed genes compared to ventralised embryos. My
goals were to report on these differences, evaluate whether these embryos really adopt
the transcriptomic signature of dorsal and ventral cells of the unperturbed embryo and
identify new genes differentially expressed along the dorso- ventral axis.
By the end of this project Ding et al. generated a RNA-Seq dataset from Xenopus
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laevis LiCl-treated embryos (Ding et al., 2017). Nevertheless, my comparison remains
relevant since I focus on comparing UV- and LiCl-treated embryos in order to identify
the genes that make dorsal and ventral cell different. In addition, whole transcriptome
datasets of dissected gastrula embryos have been released (Ding et al., 2016; Popov
et al., 2016; Blitz et al., 2017) which were useful to verify my experimental conditions.
This verification revealed that LiCl- and UV-treated embryos were truly enriched for
dorsal and ventral regions of the untreated embryo. Although the analysis of dissected
parts of the embryo might be better at averaging the expression of single cells in space
and time, it has the disadvantage of depending on visual cues, such as the emerging
dorsal blastopore, to identify these anatomical domains. In addition, the dissection
process could activate stress-responding pathways that introduce experimental arte-
facts. Furthermore, I have shown, that dorsalised and ventralised embryos not only
represent dorsal/ventral cells at a specific developmental time but also the cell type
progeny. For example, the over-representation of ectodermal markers in UV-treated
embryos. These markers are not ventrally enriched at gastrula stage, but ventral cells
are exposed to high levels of BMP and Wnt signalling and will become ectodermal.
In a way, these treated embryos resemble stem cell cultures in that an initial cue of
a signalling pathway, canonical Wnt in this case, alters the fate of the cells towards
dorsal or ventral. Although enriched for a cell type, similar to stem cell cultures under
differentiation, it represents an heterogeneous group of cells, but in an in vivo context.
One advantage of my experimental design over embryo dissections is that it leads to
the overexpression of genes that may be expressed at low levels and would not be identi-
fied otherwise. I observed this when analysing the expression pattern of non-annotated
and uncategorised genes whose transcript levels are normally very low during gastru-
lation (Fig. 3.11). Among these genes I chose to further study K00726, because of its
similarity to the Wnt enhancing protein Rnf220. In Chapter 3, I presented preliminary
results that indicate the gene does not have the same capacity of stabilising β-catenin
as Rnf220 (Ma et al., 2014), moreover, it might have the opposite effect. Further exper-
iments are required to test the function of K00726 in the same developmental context
and confirm the role of Rnf220 in stabilising β-catenin when injecting their mRNA in
ventral blastomers. Moreover, I could test the role of K00726 in activating or repressing
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Wnt signalling by performing a TOPflash assay in HEK293 cells. In order to under-
stand the functional differences between K00726 and RNF220, I could express variants
of the protein in which either the E3 ubiquitin ligase and/or the zinc-finger domains
are removed (Fig. 3.12) and see how Wnt activation is affected. Although I still do
not know how K00726 acts upstream of Wnt signalling I have strong evidence that it is
Wnt-activated. I have shown that β-catenin binds some cis-regulatory regions and that
the gene is induced in animal cap cells upon β-catenin mRNA injection. To further
corroborate its regulation, one could repeat the luciferase assays in the absence of any
β-catenin-associated TCF binding motifs. These experiments would substantiate an
action model by which Wnt signalling regulates K00726 in dorsal cells.
6.2 Cell type specific chromatin regulation in vivo
Transcriptome analysis of UV- and LiCl-treated embryos indicated that these embryos
accurately represent ventral and dorsal cells, respectively and thus they were appro-
priate to investigate cell type specific chromatin regulation. My approach avoided any
nuclei isolation followed by FACS sorting and lowered the number of embryos required
for chromatin profiling. Both UV and LiCl treatments allow for many embryos to be
manipulated at once and the whole embryo can subsequently be used for chromatin
extraction. The cell type specific chromatin landscape analysis included the profiling of
RNAPII, the active enhancer marker protein p300 and the T-box transcription factor
Brachyury.
Profiling of RNAPII allowed to corroborate whether the differences observed in the
transcriptome were reflected on the chromatin level. I showed that genes positively
differentially expressed have, comparatively, higher RNAPII occupancy within its gene
body. Furthermore, I was able to identify differentially transcribed genes in the two
cell types, that although the RNAPII levels might be heightened by the experimental
context, they should represent the differences seen in dorsal and ventral cells. Further
validation could have been achieved by RNAPII ChIP-qPCR on dorsal and ventral
dissected halves.
The profiling of p300 is used as a good indicator for enhancer activation in the
distinct cells (Heintzman et al., 2007; Visel et al., 2009). However, in my experiment
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I lacked biological replicates required to reliably identify cell type specific regulatory
regions, alternatively I compared regions within the same condition. Furthermore,
this study could have been complemented with ChIP-Seq for Groucho/transducin-like
enhancer of split (Gro/TLE) protein, a co-repressor shown to be a better predictor of
tissue-specific regulatory regions in early Xenopus development (Yasuoka et al., 2014).
Another aspect of cell type specific chromatin regulation was the recruitment of
sequence-specific transcription factors in different cell types. I chose Brachyury for
several reasons: (1) it is expressed in both cell types, (2) its binding profile had been
determined in Xenopus tropicalis at the developmental stage of interest (Gentsch et al.,
2013) and (3) the human ortholog had been shown to bind in a cell type-specific man-
ner in different mesodermal derivatives of human embryonic stem cells (hESCs) (Faial
et al., 2015). In Xenopus, Brachyury binds thousands of sites at gastrula stage but,
the majority at lower rather than higher levels indicating that these sites are unlikely
regulated by the TF (Gentsch et al., 2013). Knocking down Xbra and Xbra3, indicated
that only a very small subset of putative Brachyury targets were affected transcrip-
tionally (Gentsch et al., 2013). Gentsch et. al, also studied the binding profile of Xbra
in early tailbud embryos and the comparison of the two datasets revealed that at least
94% of the binding sites were maintained at later stages. These experiments revealed
that, in the whole embryo, Brachyury binds thousands of sites in a sequence-specific
manner (sites were enriched for the T-box motif), however, only a small proportion are
biologically relevant and, most of these binding events are maintained post gastrulation.
Brachyury binding profile is overall temporally unchanged when comparing gastrula
and tailbud embryos (Gentsch et al., 2013). Although I have identified a subset of ge-
nomic regions where Brachyury was differentially bound, the majority of the binding
events are similar in dorsalised and ventralised embryos. This indicates, that both tem-
porally and spatially, Brachyury binding during early Xenopus development is mostly
constant.
Different aspects can, independently or collectively, influence the differential bind-
ing of sequence-specific transcription factors, such as chromatin accessibility, histone
modifications and the presence or absence of co-factors (Biggin, 2011; Voss and Hager,
2014; Spitz and Furlong, 2012). I did not manage to generate reliable data for chro-
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matin accessibility or nucleosome positioning, but I did identify potential co-factors
based on the de novo motif analysis. I found differential enrichment for DNA motifs of
the Homeodomain and Forkhead family which suggest that TFs containing correspond-
ing DNA binding domains could act as co-factors required for Brachyury binding. It
has been shown that the Homeodomain protein Xom (Ventx 2.2), which is activated by
BMP signalling, mediates crosstalk between Wnt and BMP signalling by interacting
with LEF1/TCF, which is essential for ventral fate adoption (Gao et al., 2007). Fur-
thermore, Ventx2.1 has been shown to interact with Smad1 (Henningfeld et al., 2002)
which in turn interacts with Brachyury (Messenger et al., 2005). Both the Home-
odomain and the TCF motifs were enriched in ventralised embryos, suggesting that in
dorsal cells, in the absence of Ventx and zygotic Wnt, Brachyury was not capable of
binding these sites as efficiently. I could test this hypothesis by determining Brachyury
binding in embryos overexpressing, separately, dorso-ventral fate opposing homeobox
genes gsc and Ventx1/2 (Sander, Reversade, and Robertis, 2007), respectively, and
test the binding of Brachyury under these conditions.
The results described are complementary to those of Faial et al. in which human
embryonic stem cells had been differentiated into anterior mesendoderm and poste-
rior mesoderm by subjecting them to Activin-A (FlyA) or BMP (FlyB), respectively
(Faial et al., 2015). In both cell cultures BRACHYURY is expressed, but at lower
levels in FlyA . These culture conditions resemble our in vivo condition in that there
are higher levels of Nodal (Activin) signalling, in dorsalised and higher levels of BMP
in ventralised embryos. Furthermore, we also observed lower levels of Brachyury and
higher Eomes in dorsalised compared to ventralised embryos, similarly to FlyA. The
authors identified cell type specific genomic landscape for Brachyury binding in the
two cell types that correlated positively with gene expression. For example, in FlyA,
BRACHYURY occupies genomic regions near genes associated with anterior primitive
streak and endoderm, while in FlyB, binds regions near genes related to mid/posterior
primitive streak and its derivatives (Faial et al., 2015). The number of differentially
bound sites that I identified was smaller, and, although I find some examples of these
sites being associated with gene expression, I was not able to establish a similar correla-
tion. The 95 peaks preferentially bound in UV are near 82 genes and of these, 12/1125
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(1125 genes are overexpressed in LiCl) are downregulated and 15/489 (489 genes are
overexpressed in UV) are upregulated. The 373 peaks preferentially bound in LiCl are
near 349 genes, of which, 31/1125 are upregulated and 7/349 are downregulated. Al-
though there is some indication that DNA occupancy of Brachyury was stronger near
genes that are preferentially expressed in one condition over the other, this was not
significant.
On one hand, FlyA-treated cells differentiate into endoderm and many of the ge-
nomic sites that are preferentially bound by BRACHYURY in FlyA over FlyB are near
genes associated with endoderm. Furthermore, these sites are co-bound by SMAD2/3
and EOMES, both key regulators of endoderm, while BRACHYURY is not neces-
sary for the expression of endodermal markers. On the other hand, FlyB generates
cells expressing BRACHYURY-dependant mesodermal markers and, in these cells,
BRACHYURY sites are co-bound by EOMES and SMAD1. However, overexpression
of BRACHYURY leads to upregulation of both mesodermal and endodermal markers,
indicating its capacity in regulating both cell types (Faial et al., 2015).
In Xenopus, Brachyury is not involved in endoderm formation: in animal cap as-
says it is not capable of robustly inducing gsc nor Sox17, while VegT and Eomes can
induce both endodermal makers (Conlon et al., 2001). However, it has been shown
that the Drosphila ortholog of Brachyury promotes differentiation of endoderm, when
overexpressed in animal caps (Marcellini, 2006). The difference in Brachyury structure
between Drosophila and Xenopus reside in the N-terminal domain, which is essential
for the interaction with Smad1. Messenger et al. showed that an N-terminally trun-
cated Xbra is still capable of binding DNA but not Smad1, was capable of activating
endodermal genes, such as goosecoid (Messenger et al., 2005).
These observations suggest that the Brachyury-Smad1 interaction has allowed the
cell-type specific Brachyury-dependent gene regulation: in the presence of Smad1
Brachyury induces mesoderm and in the absence induces endoderm (Marcellini, 2006).
BRACHYURY and Xbra are different in that the former interacts with both SMAD2/3
and SMAD1, while the latter does only so with Smad1 (Messenger et al., 2005; Faial
et al., 2015). This suggests, that the capacity of BRACHYURY to bind SMAD2/3 has
improved its cell type specific capacity of either promoting expression of posterior or
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anterior mesendoderm markers. Since Xbra does not interact with Smad2/3, the same
cell-type specific regulation does not take place. In turn, I suggest that in dorsal cells,
with low Smad1 and high Smad2/3, VegT and Eomes take over in activating and regu-
lating endodermal genes. Although Eomes and Xbra have a similar expression pattern
during gastrulation (Gentsch et al., 2013) (Fig. 1.6), we have shown that the former
has higher expression in dorsalised and the later in ventralised embryos. It would be
interesting to test the binding profile of Eomes in dorsalised and ventralised embryos
and investigate the differences of gene targets. My hypothesis is that Eomes would
show a more cell type specific binding profile than Xbra does since dorsalised embryos
are enriched for mesendoderm cells, which are mostly regulated by Eomes.
Improvements in the ChIP-Seq and sequencing library preparation protocols have
allowed the investigation of chromatin landscape regulators from a small numbers of
cells (Gentsch and Smith, 2017; Gentsch, Patrushev, and Smith, 2015; Gentsch and
Smith, 2014). Given this, I would suggest a complementary experiment using Xenopus
animal cap cells and induce, with increasing levels of Activin, different mesodermal
types, and study the binding profile of T-box transcription factors in this context.
Higher levels of Activin generates mesodermal cells with dorso-anterior identity and
low Activin would lead to ventral and posterior identity, both expressing distinct levels
of Brachyury (Green and Smith, 1990; Green, New, and Smith, 1992; Green, Smith,
and Gerhart, 1994; Gurdon, Mitchell, and Mahony, 1995; Symes, Yorda´n, and Mercola,
1994; Gurdon et al., 1994; Wilson and Melton, 1994). This experiment would better
resemble the FlyA/FlyB comparison and could help dissect the differences in cell type
specific gene and chromatin regulation by Brachyury.
6.3 Off-target effects and immune response caused by mor-
pholinos
Antisense morpholino oligomers (MO) have been used for the past two decades by de-
velopmental biologist as an indispensable tool to study gene function. With the recent
emergence of genome editing tools, such as TALEN and CRISPR, morphant phenotypes
have been revisited. This led to the discovery, mainly in zebrafish, that phenotypes
previously associated with a morpholino knockdown, a morphant phenotype, did not
207
resemble the null mutant generated by CRISPR (or TALENs). This discrepancy could
be because mutations were not null or morpholinos were causing side effects. To this
end, we investigated the differences between embryos injected with a MO mix that
inhibit Brachyury expression and TALEN-generated Brachyury mutants and focused
on a whole poly-A transcriptome comparison, since, phenotypically, they are indistin-
guishable. We have found that while a regulatory core of Brachyury dependant genes is
affected similarly in morphants and mutants, there is a subset of genes that are only af-
fected in morphants. Furthermore, we observed that embryos injected with a standard
control morpholino also have this misregulation. Further investigation identified two
distinct side effects of the morpholino injection on the transcriptome: a cell-intrinsic
immune response and an increase of cryptic or alternative splicing associated with
regions partially complementary to the MO sequence.
These discoveries are relevant since morpholinos are widely used tools, and investi-
gators should be aware of its possible side effects. This is particularly true if analysing
later developmental stages with weak phenotypes. We advise that when studying gene
function by knockdown with morpholinos, dose optimisation is essential to mitigate
the side effects and the preferential use of translation- rather than splice-blocking mor-
pholinos, since the latter have a higher probability of binding to off-target splicing
junctions.
In this work we refer only to the side effects of Brachyury and control MOs, we
plan to analyse publicly available data of morphant transcriptomes to search for similar
side effects. Furthermore, we have plans to study each morpholino individually and its
effect in causing the same side effects as well as study the effect of culture temperature,
since it could affect MO hybridisation.
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Genes were selected based on the adjusted p-value from the DESeq2 analysis. The table includes
information derived from Xenbase (http://www.xenbase.org) (Karpinka et al., 2015) and the tem-
poral expression details were derived from Searchable Database of Xenopus tropicalis Gene
Expression Profiles (http://genomics.crick.ac.uk/apps/profiles/) (Collart et al., 2014; Owens et al.,
2016).
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Differential expression analysis of LiCl- and UV-treated embryos at gastrula stage (NF11.5)
Genes up-regulated in LiCl-treated embryos
Differential analysis using DESeq2
fc> 2, padj. <0.01
Gene baseMean log2FoldChange lfcSE stat pvalue padj
Xetrov72020486|Xetrov72020486|loc388630 641.423026 3.57642447 0.220930949 16.18797408 6.13E-59 1.15E-54
Xetrov72010022|Xetrov72010022|foxa4 5956.26946 1.61247093 0.133258953 12.10028218 1.05E-33 4.96E-30
Xetrov72030083|Xetrov72030083|mmp1 1410.07294 2.861498166 0.23616695 12.11642087 8.65E-34 4.96E-30
Xetrov72020478|Xetrov72020478|pm20d1 988.31045 2.774833745 0.243566411 11.39251397 4.56E-30 1.72E-26
Xetrov72033932|Xetrov72033932|fzd8 1440.88332 2.335087186 0.206532863 11.30612897 1.22E-29 3.29E-26
Xetrov72026575|Xetrov72026575|ppp1r3c.1 87.4201578 3.72992693 0.329796525 11.30978238 1.17E-29 3.29E-26
Xetrov72038527|Xetrov72038527|foxp2 100.577318 3.655346949 0.327388647 11.16516098 6.04E-29 1.26E-25
Xetrov72035990|Xetrov72035990|slc38a3 600.571736 2.101630869 0.196701093 10.68438837 1.20E-26 2.09E-23
Xetrov72005175|Xetrov72005175|srl 64.7584169 3.753328947 0.351716977 10.67144662 1.38E-26 2.17E-23
Xetrov72035278|Xetrov72035278 1632.69393 2.161124319 0.20972785 10.30442225 6.73E-25 9.05E-22
Xetrov72043560|Xetrov72043560 (K00726) 304.815714 3.776461936 0.367036389 10.28906683 7.89E-25 9.29E-22
Xetrov72014334|Xetrov72014334|pou4f1.2 76.035226 2.959439327 0.291450636 10.15417008 3.17E-24 2.60E-21
Xetrov72027551|Xetrov72027551|unnamed 1129.33058 2.407690305 0.237451592 10.13971008 3.68E-24 2.77E-21
Xetrov72026895|Xetrov72026895|unnamed 21.7486552 5.135245931 0.531410476 9.663426231 4.31E-22 2.80E-19
Xetrov72033588|Xetrov72033588|nedd9 600.291917 2.465059179 0.256255921 9.61952088 6.61E-22 4.15E-19
Xetrov72017783|Xetrov72017783|nog 478.797227 2.851782694 0.297430763 9.588055606 8.98E-22 5.45E-19
Xetrov72000768|Xetrov72000768|zic4 285.12217 2.5121135 0.26669608 9.419386683 4.54E-21 2.51E-18
Xetrov72016719|Xetrov72016719|cntnap1 169.452844 2.824716594 0.300148064 9.411077167 4.91E-21 2.57E-18
Xetrov72031314|Xetrov72031314|tspan7 197.268364 1.928856518 0.204926151 9.412446933 4.85E-21 2.57E-18
Xetrov72037173|Xetrov72037173 53.2129068 2.780640762 0.300910928 9.240743712 2.45E-20 1.12E-17
Xetrov72042969|Xetrov72042969 391.124768 2.094766616 0.228482513 9.168170433 4.81E-20 2.11E-17
Xetrov72017906|Xetrov72017906 49.679391 3.515090291 0.385844776 9.110115022 8.23E-20 3.37E-17
Xetrov72000221|Xetrov72000221 61.8204369 2.934841559 0.324015873 9.057709211 1.33E-19 5.23E-17
Xetrov72018683|Xetrov72018683 70.5610887 2.45208082 0.271828354 9.020695521 1.87E-19 7.18E-17
Xetrov72020695|Xetrov72020695|cpe 112.381395 2.477701753 0.276523237 8.960193648 3.24E-19 1.17E-16
Xetrov72021302|Xetrov72021302 48.6050449 4.332685893 0.488662073 8.866425548 7.55E-19 2.63E-16
Xetrov72032574|Xetrov72032574 108.202772 3.051889 0.345526309 8.832580676 1.02E-18 3.50E-16
Xetrov72002782|Xetrov72002782|pat 333.552463 1.888929198 0.214921074 8.788943616 1.51E-18 4.90E-16
Xetrov72021605|Xetrov72021605|fst 636.106348 3.545037588 0.409564009 8.65563749 4.90E-18 1.54E-15
Xetrov72000357|Xetrov72000357|chrd 3452.20507 3.326367304 0.386312628 8.61055804 7.27E-18 2.24E-15
Xetrov72026912|Xetrov72026912|sftpa 30.9970894 4.330721596 0.504608001 8.582348261 9.30E-18 2.82E-15
Xetrov72033032|Xetrov72033032 136.213555 2.633300436 0.309925456 8.49656067 1.95E-17 5.84E-15
Xetrov72021492|Xetrov72021492|foxd4l1.2 108.819124 3.465889199 0.409586591 8.46192057 2.63E-17 7.62E-15
Xetrov72003610|Xetrov72003610 71.883348 4.403552346 0.521523532 8.443631165 3.08E-17 8.78E-15
Xetrov72026864|Xetrov72026864|dkk1 1964.2233 2.451396192 0.291611285 8.406383136 4.23E-17 1.17E-14
Xetrov72013989|Xetrov72013989|dpf1 95.8225206 3.369221366 0.402554466 8.369603736 5.78E-17 1.56E-14
Xetrov72042269|Xetrov72042269 105.292894 2.524510136 0.303679828 8.313064954 9.33E-17 2.42E-14
Xetrov72024775|Xetrov72024775 25.6554835 4.588455136 0.552201093 8.309391622 9.62E-17 2.45E-14
Xetrov72030447|Xetrov72030447|il1r2 598.640418 3.208862033 0.389217187 8.244399629 1.66E-16 4.11E-14
Xetrov72014354|Xetrov72014354 552.717133 1.640801105 0.199075715 8.242095761 1.69E-16 4.14E-14
Xetrov72016834|Xetrov72016834|slc4a1 306.298524 2.807186934 0.343278103 8.177588119 2.90E-16 6.65E-14
Xetrov72006278|Xetrov72006278 2705.29004 2.517841089 0.312162256 8.065808866 7.28E-16 1.59E-13
Xetrov72009195|Xetrov72009195 362.732799 1.839246084 0.229264227 8.022385813 1.04E-15 2.25E-13
Xetrov72023130|Xetrov72023130 249.386979 2.778036006 0.34767869 7.990239501 1.35E-15 2.88E-13
Xetrov72020537|Xetrov72020537|unnamed 20.7707223 2.942927327 0.368429306 7.987766652 1.37E-15 2.91E-13
Xetrov72032369|Xetrov72032369 78.3303253 2.791043239 0.349886699 7.976991543 1.50E-15 3.14E-13
Xetrov72001973|Xetrov72001973 28.2639528 3.184238749 0.400255741 7.955510488 1.78E-15 3.61E-13
Xetrov72007519|Xetrov72007519 1580.83157 2.912458611 0.366539759 7.94581908 1.93E-15 3.87E-13
Xetrov72014053|Xetrov72014053|smoc1 161.029422 3.344590569 0.421777754 7.92974627 2.20E-15 4.35E-13
Xetrov72007533|Xetrov72007533 32.4474528 3.882858809 0.490613876 7.914286567 2.49E-15 4.88E-13
Xetrov72022463|Xetrov72022463 23.4537156 3.290877815 0.417448561 7.883313346 3.19E-15 6.13E-13
Xetrov72014980|Xetrov72014980|nkx2-8 55.6158214 3.169279717 0.402354243 7.876839316 3.36E-15 6.24E-13
Xetrov72004745|Xetrov72004745|fap 40.1574704 4.262599477 0.545789569 7.809968755 5.72E-15 9.98E-13
Xetrov72010166|Xetrov72010166|foxd3 751.891534 2.235472612 0.286342597 7.806985889 5.86E-15 1.01E-12
Xetrov72001653|Xetrov72001653|veph1 17.0381081 4.203636697 0.540526481 7.776930162 7.43E-15 1.26E-12
Xetrov72b000019|Xetrov72b000019|loc644100 10.3495156 4.462766825 0.574875405 7.763015752 8.29E-15 1.38E-12
Xetrov72011406|Xetrov72011406 27.0468143 4.300683009 0.554010526 7.762818231 8.31E-15 1.38E-12
Xetrov72020468|Xetrov72020468|mmp17 788.07947 2.108120772 0.272562654 7.734444696 1.04E-14 1.70E-12
Xetrov72005350|Xetrov72005350|cdk15 64.4012241 2.493475836 0.3229405 7.721161753 1.15E-14 1.86E-12
Xetrov72030361|Xetrov72030361|lhx1 2170.62922 1.921123201 0.250135928 7.68031691 1.59E-14 2.53E-12
Xetrov72013654|Xetrov72013654|unnamed 321.72706 3.367779592 0.439170653 7.668498724 1.74E-14 2.75E-12
Xetrov72019088|Xetrov72019088|slc12a3.2 6062.69761 1.477847129 0.193496408 7.63759464 2.21E-14 3.36E-12
Xetrov72010511|Xetrov72010511|frzb2 2403.84876 3.807537306 0.499309425 7.625606711 2.43E-14 3.63E-12
Xetrov72032712|Xetrov72032712|scn8a 123.48734 1.973712755 0.259414845 7.608326167 2.78E-14 4.09E-12
Xetrov72037692|Xetrov72037692|fbn1 109.402923 3.400639929 0.448281294 7.585950999 3.30E-14 4.75E-12
Xetrov72021109|Xetrov72021109|admp 4397.42161 2.852089404 0.37770419 7.551119317 4.32E-14 6.16E-12
Xetrov72000087|Xetrov72000087|lama4 143.525368 3.297307609 0.437608863 7.534828219 4.89E-14 6.87E-12
Xetrov72016923|Xetrov72016923|ppp1r9b 36.3983061 3.533130526 0.469615112 7.52346003 5.33E-14 7.44E-12
Xetrov72005652|Xetrov72005652 1669.04927 2.41204796 0.320720935 7.520706313 5.45E-14 7.49E-12
Xetrov72023862|Xetrov72023862|ntrk2 16.8060013 3.836041824 0.510416172 7.515517801 5.67E-14 7.74E-12
Appendix II
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Xetrov72028660|Xetrov72028660|lrp1 1286.60541 1.097356003 0.147237463 7.452967328 9.13E-14 1.21E-11
Xetrov72014322|Xetrov72014322 46.4195197 3.660744242 0.492504534 7.43291481 1.06E-13 1.39E-11
Xetrov72021397|Xetrov72021397|foxd4l1.1 3473.98249 1.84178813 0.247800742 7.432536784 1.07E-13 1.39E-11
Xetrov72022530|Xetrov72022530|tdgf1p2 278.894557 2.245111314 0.30233621 7.425876348 1.12E-13 1.45E-11
Xetrov72027037|Xetrov72027037|zc4h2 551.810408 2.200267109 0.296725942 7.415149123 1.21E-13 1.55E-11
Xetrov72033827|Xetrov72033827|cdh12 53.8983579 3.045957199 0.412172077 7.390013464 1.47E-13 1.82E-11
Xetrov72020291|Xetrov72020291|plbd2 456.028585 1.515875986 0.205105854 7.390700732 1.46E-13 1.82E-11
Xetrov72024253|Xetrov72024253|slc24a6 472.407663 1.34545408 0.182635761 7.366870917 1.75E-13 2.10E-11
Xetrov72024950|Xetrov72024950|usp28 639.020682 1.226036104 0.166640299 7.35738059 1.88E-13 2.22E-11
Xetrov72012417|Xetrov72012417|unnamed 857.468313 1.163098986 0.158210744 7.351580275 1.96E-13 2.31E-11
Xetrov72001239|Xetrov72001239|unnamed 14.8251512 3.859331036 0.525119451 7.349434546 1.99E-13 2.33E-11
Xetrov72000247|Xetrov72000247|fam184a 71.2677389 3.087403046 0.420778869 7.33735288 2.18E-13 2.53E-11
Xetrov72038648|Xetrov72038648|n4bp3 406.295228 1.62672629 0.221863125 7.332116538 2.27E-13 2.62E-11
Xetrov72009496|Xetrov72009496|slc29a2 1837.15644 1.176082177 0.160430588 7.33078519 2.29E-13 2.63E-11
Xetrov72018038|Xetrov72018038 555.203367 2.172074247 0.296433604 7.327354989 2.35E-13 2.68E-11
Xetrov72009360|Xetrov72009360|pdp2 52.2705078 3.536459216 0.484010329 7.306577986 2.74E-13 3.11E-11
Xetrov72010379|Xetrov72010379|akr1c1 88.4984187 4.021182397 0.553483487 7.265225598 3.72E-13 4.12E-11
Xetrov72037469|Xetrov72037469|ccdc77 1333.93229 2.675309275 0.36827337 7.264465732 3.75E-13 4.12E-11
Xetrov72009344|Xetrov72009344|znf565 48.8002259 2.679930141 0.369564775 7.251584356 4.12E-13 4.48E-11
Xetrov72007305|Xetrov72007305|acvr1 445.24808 1.142782707 0.157610561 7.25067345 4.15E-13 4.49E-11
Xetrov72038905|Xetrov72038905|pfkfb3 2201.06574 1.184957666 0.163537602 7.245781098 4.30E-13 4.63E-11
Xetrov72011327|Xetrov72011327 86.9549836 3.04160725 0.420009788 7.241753263 4.43E-13 4.74E-11
Xetrov72020194|Xetrov72020194|ndnf 192.424467 2.449071509 0.339359244 7.216752019 5.32E-13 5.63E-11
Xetrov72040518|Xetrov72040518 306.293095 2.630422201 0.365238786 7.201924616 5.94E-13 6.25E-11
Xetrov72020198|Xetrov72020198|frmd3 35.2692314 3.493329915 0.485131525 7.20078934 5.99E-13 6.26E-11
Xetrov72017851|Xetrov72017851|dkkx 179.591651 3.309234767 0.459794572 7.197202762 6.15E-13 6.40E-11
Xetrov72032672|Xetrov72032672|unnamed 15.9685699 3.617771743 0.503559347 7.184399937 6.75E-13 6.95E-11
Xetrov72034856|Xetrov72034856|sla 43.1015412 2.834837367 0.396820099 7.143885537 9.07E-13 9.19E-11
Xetrov72028840|Xetrov72028840|ptpru 337.156661 2.239553747 0.313548712 7.14260228 9.16E-13 9.22E-11
Xetrov72008861|Xetrov72008861|pcsk9 74.0990557 2.014114658 0.282266971 7.135495352 9.64E-13 9.63E-11
Xetrov72016999|Xetrov72016999|dhx58 83.5599549 2.873836072 0.402994749 7.131199802 9.95E-13 9.86E-11
Xetrov72026767|Xetrov72026767|hhex 1036.29611 2.629793847 0.369153043 7.123857976 1.05E-12 1.03E-10
Xetrov72042081|Xetrov72042081 190.253189 2.92934564 0.411752819 7.114330496 1.12E-12 1.10E-10
Xetrov72034880|Xetrov72034880|scgn 13.748937 3.797616132 0.533786041 7.11449128 1.12E-12 1.10E-10
Xetrov72031321|Xetrov72031321|gjb2 5454.23487 2.711715978 0.38121013 7.113441558 1.13E-12 1.10E-10
Xetrov72023107|Xetrov72023107 68.3774272 2.783217188 0.392413086 7.092569767 1.32E-12 1.26E-10
Xetrov72004111|Xetrov72004111 31.8247651 3.539818091 0.500553146 7.071812694 1.53E-12 1.45E-10
Xetrov72016524|Xetrov72016524 129.75793 2.07092726 0.293036203 7.06713792 1.58E-12 1.50E-10
Xetrov72006643|Xetrov72006643 171.912338 2.282161649 0.323098362 7.063364956 1.63E-12 1.52E-10
Xetrov72000023|Xetrov72000023|ush2a 86.1353566 2.223265147 0.314860738 7.061106325 1.65E-12 1.54E-10
Xetrov72042259|Xetrov72042259|hes7.1 266.652691 2.732497035 0.387521808 7.051208419 1.77E-12 1.64E-10
Xetrov72034822|Xetrov72034822|march11 37.4892545 3.166761696 0.449150018 7.05056567 1.78E-12 1.64E-10
Xetrov72039624|Xetrov72039624|epyc 26.6389025 2.652068018 0.37740155 7.027178394 2.11E-12 1.92E-10
Xetrov72013775|Xetrov72013775|pkdcc.1 840.97476 1.844506562 0.263206238 7.007837573 2.42E-12 2.16E-10
Xetrov72040358|Xetrov72040358 177.788542 2.618621723 0.37547972 6.974069666 3.08E-12 2.68E-10
Xetrov72003550|Xetrov72003550|npdc1.1 270.773162 1.256019258 0.180256119 6.967970143 3.22E-12 2.79E-10
Xetrov72002339|Xetrov72002339|kng1 807.871946 3.341370761 0.480893474 6.94825558 3.70E-12 3.18E-10
Xetrov72029992|Xetrov72029992|amhr2 41.6924201 2.923181134 0.420848155 6.945928351 3.76E-12 3.22E-10
Xetrov72000346|Xetrov72000346|gpr126 18.2792158 2.823021438 0.406568677 6.943529102 3.82E-12 3.26E-10
Xetrov72009273|Xetrov72009273|ces3 68.1856975 3.153092912 0.454425942 6.93862877 3.96E-12 3.34E-10
Xetrov72022000|Xetrov72022000|cfd 1735.81303 2.748610294 0.396427387 6.933452081 4.11E-12 3.45E-10
Xetrov72037991|Xetrov72037991|lrig3 10330.4583 1.744293333 0.251796374 6.927396543 4.29E-12 3.59E-10
Xetrov72000051|Xetrov72000051|hivep2 68.0483949 2.904800452 0.420429989 6.909118108 4.88E-12 4.06E-10
Xetrov72028857|Xetrov72028857|gli1.1 521.330224 2.868051257 0.415406514 6.904203864 5.05E-12 4.19E-10
Xetrov72006792|Xetrov72006792 46.2059033 2.397665767 0.34838095 6.882310203 5.89E-12 4.84E-10
Xetrov72016738|Xetrov72016738|grin2c 331.406375 1.711346802 0.249847507 6.84956525 7.41E-12 5.89E-10
Xetrov72006804|Xetrov72006804 24.8386081 3.109538011 0.456886398 6.805932555 1.00E-11 7.85E-10
Xetrov72042553|Xetrov72042553|mdga1 21.6317423 3.064404962 0.450355143 6.804418706 1.01E-11 7.90E-10
Xetrov72009386|Xetrov72009386|fmo2 49.4827174 3.763913787 0.555331024 6.777784103 1.22E-11 9.42E-10
Xetrov72025680|Xetrov72025680|bcl2l12 623.983332 1.159896637 0.171171598 6.776221364 1.23E-11 9.48E-10
Xetrov72038999|Xetrov72038999|il17ra 60.0748848 1.783061731 0.264192415 6.74910266 1.49E-11 1.13E-09
Xetrov72010533|Xetrov72010533|cebpa 16.9392375 2.705246029 0.403279688 6.708113765 1.97E-11 1.48E-09
Xetrov72038987|Xetrov72038987 721.359095 1.512469153 0.22548391 6.707658885 1.98E-11 1.48E-09
Xetrov72008248|Xetrov72008248|rasal2 522.33061 1.070773043 0.159723567 6.703913904 2.03E-11 1.50E-09
Xetrov72b000107|Xetrov72b000107|fam134b 52.5150577 2.096913535 0.313424965 6.690320702 2.23E-11 1.64E-09
Xetrov72009821|Xetrov72009821|fads1 165.206741 1.139676158 0.170513609 6.683784143 2.33E-11 1.71E-09
Xetrov72042967|Xetrov72042967 51.0426014 2.038162845 0.30530119 6.675908621 2.46E-11 1.79E-09
Xetrov72024866|Xetrov72024866 1218.0153 1.218005341 0.182986594 6.656254503 2.81E-11 2.02E-09
Xetrov72041348|Xetrov72041348|ces1 848.883529 1.655570416 0.249127476 6.645475012 3.02E-11 2.14E-09
Xetrov72017793|Xetrov72017793 7.92794489 3.584560945 0.539855677 6.639850416 3.14E-11 2.21E-09
Xetrov72018648|Xetrov72018648|tep1 31.2926198 2.799483892 0.422478021 6.62634209 3.44E-11 2.42E-09
Xetrov72041710|Xetrov72041710 24.327813 3.303177829 0.500358029 6.601628507 4.07E-11 2.83E-09
Xetrov72012470|Xetrov72012470 8.81429577 3.719143393 0.56461181 6.587080415 4.49E-11 3.11E-09
Xetrov72013833|Xetrov72013833|zic3 5123.11576 1.062058904 0.16130465 6.584180322 4.57E-11 3.16E-09
Xetrov72010596|Xetrov72010596|f3 82.9258306 2.84790698 0.43694151 6.517821986 7.13E-11 4.83E-09
Xetrov72043417|Xetrov72043417|sia1 89.4833114 3.321417557 0.510003937 6.512533168 7.39E-11 4.97E-09
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Xetrov72025882|Xetrov72025882|ddx25 848.25292 1.573329315 0.241619832 6.511590145 7.44E-11 4.98E-09
Xetrov72026786|Xetrov72026786|unnamed 4909.44468 1.508985207 0.2324073 6.492847727 8.42E-11 5.59E-09
Xetrov72007880|Xetrov72007880 24.4023002 3.007999309 0.464215301 6.47975045 9.19E-11 6.07E-09
Xetrov72042258|Xetrov72042258|per1 94.3124586 3.193757283 0.492948254 6.478889534 9.24E-11 6.08E-09
Xetrov72017405|Xetrov72017405|crtap 78.4356168 2.116812668 0.326804639 6.477303003 9.34E-11 6.13E-09
Xetrov72021204|Xetrov72021204|adh7 19.0290906 3.617300577 0.562435525 6.431493777 1.26E-10 8.04E-09
Xetrov72038083|Xetrov72038083|slc12a1 315.640421 2.800715244 0.435654041 6.428759939 1.29E-10 8.11E-09
Xetrov72029873|Xetrov72029873|b4galnt1 358.173319 2.07689573 0.323065906 6.428706007 1.29E-10 8.11E-09
Xetrov72008010|Xetrov72008010 580.318982 2.339831832 0.364115579 6.426069 1.31E-10 8.22E-09
Xetrov72024464|Xetrov72024464|cib3 8.4903905 3.581085339 0.559096784 6.405125982 1.50E-10 9.34E-09
Xetrov72014590|Xetrov72014590|gsc 1797.39966 3.156953015 0.493160961 6.401465783 1.54E-10 9.53E-09
Xetrov72030237|Xetrov72030237|tfap2e 143.624714 1.357461804 0.212117617 6.399571261 1.56E-10 9.62E-09
Xetrov72032656|Xetrov72032656|il1rapl1 6.17679681 3.251838669 0.508217433 6.398518547 1.57E-10 9.66E-09
Xetrov72037973|Xetrov72037973|pcdh12 19.3794457 2.543685624 0.398422525 6.384392101 1.72E-10 1.05E-08
Xetrov72030452|Xetrov72030452|ift57 459.942816 1.485996016 0.233303276 6.369374844 1.90E-10 1.16E-08
Xetrov72043015|Xetrov72043015 269.718721 2.257393807 0.354795644 6.36251838 1.98E-10 1.21E-08
Xetrov72040828|Xetrov72040828 246.498208 2.199710416 0.345878994 6.359768752 2.02E-10 1.22E-08
Xetrov72028195|Xetrov72028195 148.497571 2.646165486 0.416151208 6.358663479 2.04E-10 1.23E-08
Xetrov72002663|Xetrov72002663|bmp5 8.28193125 3.725441663 0.586721126 6.349595232 2.16E-10 1.29E-08
Xetrov72030239|Xetrov72030239|arl13b 99.1416357 1.410916197 0.223006859 6.32678387 2.50E-10 1.48E-08
Xetrov72009929|Xetrov72009929 3772.55431 1.725839526 0.274424108 6.288950129 3.20E-10 1.86E-08
Xetrov72041883|Xetrov72041883 70.4330676 2.358447075 0.375334943 6.283579818 3.31E-10 1.91E-08
Xetrov72032425|Xetrov72032425 21.0191029 2.587703665 0.411826731 6.283476687 3.31E-10 1.91E-08
Xetrov72038081|Xetrov72038081|anpep 859.729862 2.113346768 0.336598172 6.278544998 3.42E-10 1.96E-08
Xetrov72014618|Xetrov72014618|st6galnac4 459.815056 1.721960529 0.274474869 6.273654613 3.53E-10 2.01E-08
Xetrov72023462|Xetrov72023462|tdgf1p3 98.4724429 2.438551143 0.388970274 6.269248083 3.63E-10 2.06E-08
Xetrov72022088|Xetrov72022088|ngf 6.61253742 3.103480241 0.495314344 6.265678108 3.71E-10 2.11E-08
Xetrov72034574|Xetrov72034574|ccr2 9.13507969 3.672428364 0.586707829 6.2593819 3.87E-10 2.19E-08
Xetrov72043017|Xetrov72043017 18.4737167 2.113268946 0.338098358 6.250456107 4.09E-10 2.29E-08
Xetrov72041732|Xetrov72041732 54.3898645 3.238091525 0.518358775 6.246815301 4.19E-10 2.34E-08
Xetrov72030475|Xetrov72030475|slc35f2 1498.97223 1.024700194 0.164286719 6.237267385 4.45E-10 2.47E-08
Xetrov72036594|Xetrov72036594|gata4 3901.42723 1.22646839 0.196831458 6.231058814 4.63E-10 2.55E-08
Xetrov72034159|Xetrov72034159|darmin 9702.65989 1.588833506 0.255241765 6.2248179 4.82E-10 2.64E-08
Xetrov72002785|Xetrov72002785 38.7440049 2.348030667 0.379055707 6.194421086 5.85E-10 3.17E-08
Xetrov72017332|Xetrov72017332 153.545414 1.207612622 0.194967491 6.193917848 5.87E-10 3.17E-08
Xetrov72000644|Xetrov72000644 13.9028007 2.474400359 0.400586743 6.176940205 6.54E-10 3.50E-08
Xetrov72032793|Xetrov72032793|zbed1 489.133493 1.559144871 0.252829981 6.166772094 6.97E-10 3.70E-08
Xetrov72001076|Xetrov72001076|pkdcc.2 766.529183 2.064485721 0.335117546 6.160482337 7.25E-10 3.82E-08
Xetrov72037162|Xetrov72037162 28.4912426 3.018649719 0.491596328 6.140505014 8.23E-10 4.27E-08
Xetrov72042832|Xetrov72042832 172.562069 2.471132804 0.403880712 6.118471934 9.45E-10 4.86E-08
Xetrov72000486|Xetrov72000486|plg 25.2604054 2.907042798 0.475418575 6.114701758 9.67E-10 4.96E-08
Xetrov72019326|Xetrov72019326|c6.2 749.193482 2.616581149 0.43049495 6.078076295 1.22E-09 6.17E-08
Xetrov72006126|Xetrov72006126 50.2803604 1.991355222 0.327885941 6.073316887 1.25E-09 6.34E-08
Xetrov72000849|Xetrov72000849|slc3a1 1562.53291 1.839257055 0.30297017 6.070752966 1.27E-09 6.43E-08
Xetrov72020499|Xetrov72020499 81.9576373 2.491661326 0.410517042 6.069568544 1.28E-09 6.46E-08
Xetrov72002617|Xetrov72002617|txlnb 80.0943596 1.797542102 0.296342525 6.065758195 1.31E-09 6.58E-08
Xetrov72027003|Xetrov72027003|tmem150b 1992.61642 1.836888511 0.30281719 6.065998137 1.31E-09 6.58E-08
Xetrov72031241|Xetrov72031241|rab34 622.637967 1.460391388 0.241268395 6.052974263 1.42E-09 7.08E-08
Xetrov72029639|Xetrov72029639|pgm2l1 297.02007 2.066835371 0.34149726 6.052275126 1.43E-09 7.10E-08
Xetrov72030901|Xetrov72030901 20.6463634 2.287629322 0.378499455 6.043943502 1.50E-09 7.43E-08
Xetrov72031924|Xetrov72031924 1789.65121 2.145817084 0.355433967 6.03717507 1.57E-09 7.71E-08
Xetrov72008730|Xetrov72008730|cdh11 765.231966 2.436094647 0.404614683 6.020776677 1.74E-09 8.45E-08
Xetrov72014962|Xetrov72014962|chac1 240.647484 1.956524225 0.325106394 6.018104414 1.76E-09 8.54E-08
Xetrov72017675|Xetrov72017675|cd40 49.3123552 2.839093396 0.471942309 6.015763671 1.79E-09 8.65E-08
Xetrov72012345|Xetrov72012345 21.7052662 2.191377376 0.364691985 6.008844363 1.87E-09 9.00E-08
Xetrov72040709|Xetrov72040709 216.255516 2.724527465 0.453546959 6.007156283 1.89E-09 9.05E-08
Xetrov72008216|Xetrov72008216|pappa2 12.3729758 2.87227417 0.478905805 5.997576429 2.00E-09 9.55E-08
Xetrov72030939|Xetrov72030939|igsf3 847.648718 2.789471907 0.465359941 5.994224389 2.04E-09 9.70E-08
Xetrov72000300|Xetrov72000300|mecom 46.9294823 2.576142339 0.430880087 5.978791822 2.25E-09 1.06E-07
Xetrov72018587|Xetrov72018587|vcan 242.925608 1.606278078 0.269638748 5.957148555 2.57E-09 1.20E-07
Xetrov72035925|Xetrov72035925|ropn1l 54.8031745 2.392104841 0.402181915 5.947818014 2.72E-09 1.27E-07
Xetrov72028995|Xetrov72028995|bbx 60.497558 2.097007238 0.353263158 5.936105106 2.92E-09 1.35E-07
Xetrov72020356|Xetrov72020356|slco4c1 399.668691 2.33224432 0.393640243 5.924811701 3.13E-09 1.44E-07
Xetrov72010464|Xetrov72010464 23.7565025 3.158775932 0.533208315 5.924093534 3.14E-09 1.44E-07
Xetrov72041440|Xetrov72041440 4.64507192 3.443390395 0.58159003 5.92064894 3.21E-09 1.46E-07
Xetrov72018944|Xetrov72018944|dgkb 9.99599326 2.788587902 0.473095695 5.89434216 3.76E-09 1.70E-07
Xetrov72006322|Xetrov72006322 206.926452 2.598529101 0.441096177 5.891071465 3.84E-09 1.73E-07
Xetrov72041203|Xetrov72041203 115.590222 2.995196884 0.508602534 5.889071885 3.88E-09 1.75E-07
Xetrov72043461|Xetrov72043461 32.5191647 2.422035567 0.411549782 5.885158182 3.98E-09 1.78E-07
Xetrov72016275|Xetrov72016275|lgals9 47.0137804 3.0577544 0.519611778 5.884690317 3.99E-09 1.78E-07
Xetrov72026165|Xetrov72026165|nodal 276.584298 1.73195218 0.296249955 5.846252969 5.03E-09 2.22E-07
Xetrov72026826|Xetrov72026826|neurog3 97.6593725 2.528983817 0.432786388 5.843492054 5.11E-09 2.25E-07
Xetrov72014636|Xetrov72014636|six1 255.6886 2.217812454 0.37983325 5.838910773 5.25E-09 2.30E-07
Xetrov72020722|Xetrov72020722|bmp3 111.135853 2.005801716 0.344497148 5.822404423 5.80E-09 2.53E-07
Xetrov72004128|Xetrov72004128 19.2133035 3.280869556 0.563470593 5.822610085 5.79E-09 2.53E-07
Xetrov72024633|Xetrov72024633 5.59312298 3.402046519 0.584808845 5.817365025 5.98E-09 2.59E-07
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Xetrov72026317|Xetrov72026317|c17orf42 125.761964 1.178820169 0.202912439 5.809501737 6.27E-09 2.71E-07
Xetrov72012642|Xetrov72012642|fmn1 27.3232907 2.37883774 0.409852361 5.804133304 6.47E-09 2.78E-07
Xetrov72030483|Xetrov72030483|nck2 72.1469037 1.179120572 0.203132536 5.804685918 6.45E-09 2.78E-07
Xetrov72026086|Xetrov72026086|kcnj9 8.39752689 3.297908054 0.568711704 5.79891012 6.67E-09 2.86E-07
Xetrov72024727|Xetrov72024727|tecta.1 30.8133235 2.485436532 0.429240679 5.790309855 7.03E-09 2.99E-07
Xetrov72029971|Xetrov72029971|zic2 3891.90972 1.016963997 0.175644502 5.789899385 7.04E-09 2.99E-07
Xetrov72001095|Xetrov72001095|mycn 252.52484 1.113270334 0.193388425 5.756654433 8.58E-09 3.62E-07
Xetrov72030200|Xetrov72030200|znf205 181.533148 1.105264233 0.192280313 5.748192405 9.02E-09 3.79E-07
Xetrov72013259|Xetrov72013259|unnamed 6050.39148 1.849957654 0.32186646 5.747593758 9.05E-09 3.80E-07
Xetrov72025247|Xetrov72025247 29.3047897 2.530770545 0.440485161 5.745416128 9.17E-09 3.84E-07
Xetrov72009666|Xetrov72009666|cdh8 6.56300995 3.022583014 0.527220422 5.733053744 9.86E-09 4.09E-07
Xetrov72026667|Xetrov72026667 8.68410578 3.381671322 0.590432905 5.727443868 1.02E-08 4.21E-07
Xetrov72038683|Xetrov72038683|plat 99.3181239 3.064074371 0.535060522 5.726593989 1.02E-08 4.22E-07
Xetrov72009370|Xetrov72009370|fmo3 40.2439529 2.793255467 0.488269061 5.720730001 1.06E-08 4.34E-07
Xetrov72028461|Xetrov72028461|pex14 354.608375 1.36188369 0.238648871 5.706642084 1.15E-08 4.68E-07
Xetrov72014609|Xetrov72014609|crx 6389.28 1.966435848 0.344653724 5.705540701 1.16E-08 4.69E-07
Xetrov72001391|Xetrov72001391|agtr1 17.6354356 2.636590308 0.462284802 5.703389546 1.17E-08 4.73E-07
Xetrov72026491|Xetrov72026491|nkx2-3 36.1893034 2.346304862 0.411735932 5.698567161 1.21E-08 4.84E-07
Xetrov72024986|Xetrov72024986|ret 8.09283644 2.85355434 0.50082689 5.697685962 1.21E-08 4.85E-07
Xetrov72019277|Xetrov72019277|aqpep 13.0911412 2.938914971 0.516217307 5.693174043 1.25E-08 4.95E-07
Xetrov72034556|Xetrov72034556|shh 125.188605 2.92730824 0.515626294 5.677189617 1.37E-08 5.40E-07
Xetrov72006449|Xetrov72006449|LOC101732582 50.3434825 2.271008818 0.400124986 5.675748571 1.38E-08 5.43E-07
Xetrov72006076|Xetrov72006076 86.16561 2.102566068 0.372652227 5.642166916 1.68E-08 6.53E-07
Xetrov72023986|Xetrov72023986 6.53317005 2.75957911 0.489909262 5.632837182 1.77E-08 6.88E-07
Xetrov72000046|Xetrov72000046|utrn 37.8481749 1.387841649 0.246646811 5.626837997 1.84E-08 7.10E-07
Xetrov72002088|Xetrov72002088 36.6872001 2.579501378 0.459762336 5.610510425 2.02E-08 7.77E-07
Xetrov72040122|Xetrov72040122 1215.95942 2.275675773 0.406239124 5.601813411 2.12E-08 8.15E-07
Xetrov72014282|Xetrov72014282|dnase1 4.82273301 3.281172566 0.587239143 5.587455481 2.30E-08 8.82E-07
Xetrov72001996|Xetrov72001996|ripply2.1 406.561994 1.983092837 0.355149945 5.583818516 2.35E-08 8.95E-07
Xetrov72004182|Xetrov72004182|cacna1h 16.9202873 2.463738969 0.441270297 5.583287576 2.36E-08 8.96E-07
Xetrov72040807|Xetrov72040807 119.396936 1.995682168 0.357767596 5.578152389 2.43E-08 9.19E-07
Xetrov72013810|Xetrov72013810|tc2n 6.9079264 3.052548379 0.547365971 5.576796037 2.45E-08 9.25E-07
Xetrov72020827|Xetrov72020827|ifngr1 205.256557 1.18391841 0.21242328 5.573392938 2.50E-08 9.41E-07
Xetrov72034224|Xetrov72034224|adhfe1 116.522683 2.558785689 0.45927135 5.57140281 2.53E-08 9.48E-07
Xetrov72011678|Xetrov72011678 92.6758795 1.874229814 0.336486914 5.569993173 2.55E-08 9.54E-07
Xetrov72037148|Xetrov72037148|gmip 10.1248271 3.16711114 0.568778146 5.568271503 2.57E-08 9.61E-07
Xetrov72042029|Xetrov72042029 26.9490635 3.053572551 0.548468563 5.567452284 2.58E-08 9.64E-07
Xetrov72025838|Xetrov72025838|slc16a9 11.1818491 2.245945421 0.405033304 5.545088265 2.94E-08 1.09E-06
Xetrov72035977|Xetrov72035977 74.3871586 2.802721234 0.50556918 5.543694797 2.96E-08 1.10E-06
Xetrov72026572|Xetrov72026572|rassf4 55.4676267 2.324757911 0.419558688 5.540960001 3.01E-08 1.11E-06
Xetrov72003242|Xetrov72003242|hsd3b1 12.9040765 2.455987564 0.443615212 5.536301505 3.09E-08 1.14E-06
Xetrov72014511|Xetrov72014511|otx2 2185.72174 2.29355012 0.41535477 5.521906302 3.35E-08 1.23E-06
Xetrov72017121|Xetrov72017121|slc13a3 500.402898 1.861388292 0.337800984 5.510310457 3.58E-08 1.30E-06
Xetrov72029751|Xetrov72029751|slc43a2 127.978148 1.788057649 0.324638915 5.507835212 3.63E-08 1.31E-06
Xetrov72018271|Xetrov72018271 219.789057 1.053438717 0.191571994 5.498918173 3.82E-08 1.37E-06
Xetrov72033755|Xetrov72033755 31.5042533 2.459793857 0.447321997 5.498933376 3.82E-08 1.37E-06
Xetrov72027170|Xetrov72027170|fgf16 46.1475538 1.233296231 0.224266524 5.499243534 3.81E-08 1.37E-06
Xetrov72000127|Xetrov72000127|plekhg1 656.491554 1.633952881 0.297865769 5.48553427 4.12E-08 1.47E-06
Xetrov72042970|Xetrov72042970 51.2237501 1.907488858 0.347843204 5.483760601 4.16E-08 1.48E-06
Xetrov72034558|Xetrov72034558|gpr20 18.7814723 3.157396043 0.576233267 5.47937133 4.27E-08 1.52E-06
Xetrov72001394|Xetrov72001394|fam43a 333.264802 1.502676105 0.274373421 5.476755365 4.33E-08 1.53E-06
Xetrov72043407|Xetrov72043407|mogat2.1 6.11991041 3.257475417 0.595884592 5.466621324 4.59E-08 1.62E-06
Xetrov72039918|Xetrov72039918|myf6 7.90896553 3.108037762 0.569455957 5.457907193 4.82E-08 1.69E-06
Xetrov72002512|Xetrov72002512|tmem200a 3.67009774 3.152189449 0.57884619 5.445642561 5.16E-08 1.81E-06
Xetrov72039461|Xetrov72039461|ccr4 12.4920492 2.88109334 0.529101762 5.445253729 5.17E-08 1.81E-06
Xetrov72038497|Xetrov72038497|slc5a8 1176.4959 2.044616423 0.375781616 5.440969794 5.30E-08 1.85E-06
Xetrov72010279|Xetrov72010279|fut6 3.82592241 3.163263653 0.581788753 5.43713442 5.41E-08 1.88E-06
Xetrov72002854|Xetrov72002854 161.039805 2.102841287 0.386887295 5.435281322 5.47E-08 1.89E-06
Xetrov72013866|Xetrov72013866|ednrb2 21.6328953 1.514013852 0.279055245 5.425498631 5.78E-08 1.98E-06
Xetrov72043544|Xetrov72043544 157.371439 2.652451955 0.489818907 5.415168584 6.12E-08 2.07E-06
Xetrov72035518|Xetrov72035518|cmtm7 332.402395 1.17323532 0.216623354 5.416014934 6.09E-08 2.07E-06
Xetrov72021080|Xetrov72021080|fgfrl1 15.9813345 2.403710215 0.44416684 5.411728208 6.24E-08 2.11E-06
Xetrov72038488|Xetrov72038488|iqch 85.6602834 1.825768494 0.337922268 5.402924476 6.56E-08 2.20E-06
Xetrov72023270|Xetrov72023270 2.64104817 3.1684159 0.588408308 5.384723254 7.26E-08 2.41E-06
Xetrov72021263|Xetrov72021263|psat1 121.213133 1.719703836 0.319488173 5.38268388 7.34E-08 2.43E-06
Xetrov72021774|Xetrov72021774|pnp 53.2970261 2.473786991 0.459634179 5.382077972 7.36E-08 2.44E-06
Xetrov72026741|Xetrov72026741|unnamed 1566.37763 1.358648002 0.252595109 5.37875815 7.50E-08 2.48E-06
Xetrov72020580|Xetrov72020580|celf5 17.6250553 2.21480222 0.41201086 5.375591852 7.63E-08 2.52E-06
Xetrov72002857|Xetrov72002857 60.9027252 2.162549258 0.403539007 5.358959654 8.37E-08 2.73E-06
Xetrov72018552|Xetrov72018552 7.49399152 3.028301545 0.565470505 5.355366055 8.54E-08 2.78E-06
Xetrov72013050|Xetrov72013050|exoc3l2 73.4471401 1.938192977 0.362150134 5.351904621 8.70E-08 2.83E-06
Xetrov72003895|Xetrov72003895|dlg4 28.174036 3.058055654 0.571575595 5.350220824 8.78E-08 2.85E-06
Xetrov72002056|Xetrov72002056 16.410129 1.900510916 0.355819572 5.341220852 9.23E-08 2.99E-06
Xetrov72002106|Xetrov72002106 273.292416 1.145864884 0.214685377 5.337414697 9.43E-08 3.05E-06
Xetrov72001251|Xetrov72001251|fetub 57.9388723 2.6623001 0.498920254 5.336123515 9.50E-08 3.06E-06
Xetrov72009790|Xetrov72009790|chka 323.522063 1.376723718 0.258164689 5.332734394 9.67E-08 3.11E-06
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Xetrov72004164|Xetrov72004164|unc80 22.1141382 1.943384995 0.365114544 5.322672097 1.02E-07 3.27E-06
Xetrov72036759|Xetrov72036759 31.2608623 2.252450198 0.423370801 5.32027762 1.04E-07 3.30E-06
Xetrov72035966|Xetrov72035966 20.6900307 2.969331712 0.558445909 5.317133971 1.05E-07 3.35E-06
Xetrov72001465|Xetrov72001465|ostalpha 10.82163 2.06259585 0.387926079 5.316981663 1.06E-07 3.35E-06
Xetrov72032993|Xetrov72032993 24.694986 2.169974319 0.408229906 5.315569204 1.06E-07 3.37E-06
Xetrov72028498|Xetrov72028498 17.0522787 2.821179076 0.531007699 5.312877915 1.08E-07 3.42E-06
Xetrov72023742|Xetrov72023742|st3gal5 14.3027564 2.169240162 0.408851897 5.305686921 1.12E-07 3.53E-06
Xetrov72002841|Xetrov72002841 834.077361 1.563797818 0.294823676 5.304179905 1.13E-07 3.55E-06
Xetrov72016594|Xetrov72016594 17.323816 2.058116007 0.388800394 5.29350288 1.20E-07 3.75E-06
Xetrov72042510|Xetrov72042510 62.2054561 2.572679727 0.486344022 5.289835203 1.22E-07 3.82E-06
Xetrov72041037|Xetrov72041037|wdr93 16.1045662 2.035470816 0.384940143 5.287759289 1.24E-07 3.85E-06
Xetrov72015819|Xetrov72015819|loc402377 25.7300136 2.957824148 0.55941395 5.287362154 1.24E-07 3.86E-06
Xetrov72002758|Xetrov72002758|tube1 312.527674 1.432068598 0.271008177 5.28422652 1.26E-07 3.91E-06
Xetrov72021099|Xetrov72021099|pacsin1 80.7901054 1.427991839 0.270235313 5.284253282 1.26E-07 3.91E-06
Xetrov72016987|Xetrov72016987|tgm2 33.1095794 2.469843718 0.467799822 5.279702129 1.29E-07 4.00E-06
Xetrov72035832|Xetrov72035832 10.658158 2.950034622 0.558951646 5.277799329 1.31E-07 4.04E-06
Xetrov72033686|Xetrov72033686 79.2927454 1.100544263 0.209262872 5.259147288 1.45E-07 4.43E-06
Xetrov72038602|Xetrov72038602|plekho2 7.88655335 3.03294243 0.576747777 5.258698082 1.45E-07 4.44E-06
Xetrov72034914|Xetrov72034914|penk 12.2348467 2.714295265 0.516270085 5.257510257 1.46E-07 4.46E-06
Xetrov72026014|Xetrov72026014|crlf3 640.395223 1.23871203 0.235983108 5.249155512 1.53E-07 4.65E-06
Xetrov72007363|Xetrov72007363 10.2924932 3.130573508 0.596694227 5.246528899 1.55E-07 4.71E-06
Xetrov72035589|Xetrov72035589|slc6a3 7.54947004 3.114208968 0.594899937 5.234845012 1.65E-07 4.99E-06
Xetrov72030020|Xetrov72030020|erg 9.00736769 3.110402012 0.595354099 5.224457203 1.75E-07 5.26E-06
Xetrov72030823|Xetrov72030823 322.363442 1.736582819 0.332907024 5.216419887 1.82E-07 5.48E-06
Xetrov72027900|Xetrov72027900 22.0717116 2.375212206 0.456019279 5.208578483 1.90E-07 5.70E-06
Xetrov72029482|Xetrov72029482 62.4229921 1.534612107 0.294676017 5.20779439 1.91E-07 5.71E-06
Xetrov72043460|Xetrov72043460 90.0772767 2.03318738 0.390588537 5.205445593 1.94E-07 5.78E-06
Xetrov72021409|Xetrov72021409 88.2160026 1.797821681 0.345634475 5.201511456 1.98E-07 5.89E-06
Xetrov72017725|Xetrov72017725 138.30339 2.134407135 0.410741722 5.196470237 2.03E-07 6.02E-06
Xetrov72038020|Xetrov72038020|rasgrf1 13.2800685 2.619164119 0.504367395 5.19296875 2.07E-07 6.12E-06
Xetrov72031929|Xetrov72031929 2.85831283 3.081993884 0.593484254 5.193050804 2.07E-07 6.12E-06
Xetrov72019238|Xetrov72019238|nfasc 19.9508 2.180782086 0.420033242 5.191927371 2.08E-07 6.14E-06
Xetrov72038319|Xetrov72038319|plekhg7 248.123129 2.122788936 0.409832551 5.179649419 2.22E-07 6.53E-06
Xetrov72033604|Xetrov72033604|cdh6 15.1178872 2.399487964 0.463902172 5.172400797 2.31E-07 6.78E-06
Xetrov72032262|Xetrov72032262|myo16 7.54246637 2.955198761 0.572003838 5.166396735 2.39E-07 6.97E-06
Xetrov72028325|Xetrov72028325 2.66713087 3.059786335 0.593184096 5.158240683 2.49E-07 7.23E-06
Xetrov72022736|Xetrov72022736 10.6947747 3.061298716 0.594094514 5.152881642 2.57E-07 7.42E-06
Xetrov72008206|Xetrov72008206 73.5724578 1.998819988 0.388001136 5.151582828 2.58E-07 7.46E-06
Xetrov72036450|Xetrov72036450 216.267187 1.050783615 0.204207846 5.145657412 2.67E-07 7.69E-06
Xetrov72038390|Xetrov72038390|rhobtb2 42.1517442 1.900440714 0.37041845 5.130523913 2.89E-07 8.31E-06
Xetrov72042108|Xetrov72042108 5.50229005 2.954295707 0.576293893 5.126369965 2.95E-07 8.48E-06
Xetrov72035475|Xetrov72035475 44.7059752 2.497188945 0.487180346 5.125799854 2.96E-07 8.49E-06
Xetrov72023106|Xetrov72023106 9.29968224 2.090414137 0.409155277 5.109097336 3.24E-07 9.21E-06
Xetrov72034665|Xetrov72034665|ube2ql1 94.193338 1.216738798 0.238351176 5.104815582 3.31E-07 9.39E-06
Xetrov72041758|Xetrov72041758 61.8502354 2.264528456 0.444313138 5.096694793 3.46E-07 9.79E-06
Xetrov72008035|Xetrov72008035|slc39a4 6.54999056 3.012971071 0.591874764 5.090555058 3.57E-07 1.01E-05
Xetrov72038358|Xetrov72038358|abcd2 6.62521878 2.697504227 0.530207925 5.087634685 3.63E-07 1.02E-05
Xetrov72039736|Xetrov72039736|cd74 11.5994812 1.964924967 0.386232382 5.087416436 3.63E-07 1.02E-05
Xetrov72034033|Xetrov72034033|hdac9 83.1069189 2.017562038 0.39748102 5.07587013 3.86E-07 1.08E-05
Xetrov72007524|Xetrov72007524 14.345094 2.366160367 0.466555636 5.071550277 3.95E-07 1.10E-05
Xetrov72042107|Xetrov72042107 25.8082337 2.012934437 0.397176098 5.068115754 4.02E-07 1.12E-05
Xetrov72035399|Xetrov72035399|cck 3.79034987 3.011263585 0.595025928 5.060726677 4.18E-07 1.16E-05
Xetrov72031618|Xetrov72031618|kcne1 9.05969842 2.761221422 0.545996632 5.057213283 4.25E-07 1.18E-05
Xetrov72033662|Xetrov72033662|tgfbr2 62.0836568 1.721026584 0.340276538 5.0577292 4.24E-07 1.18E-05
PAC:20699956 50.7548235 2.506928452 0.497314384 5.040932926 4.63E-07 1.28E-05
Xetrov72002057|Xetrov72002057 48.8892223 1.306695442 0.259401067 5.037355689 4.72E-07 1.30E-05
Xetrov72013923|Xetrov72013923|nova1 56.3480245 2.851562201 0.566797265 5.031009103 4.88E-07 1.34E-05
Xetrov72033388|Xetrov72033388|nek10 42.5120733 1.995012655 0.396778032 5.028032037 4.96E-07 1.36E-05
Xetrov72032095|Xetrov72032095 3.11580042 2.928612426 0.582948255 5.023794826 5.07E-07 1.39E-05
Xetrov72020479|Xetrov72020479|gabra2 12.8984323 2.853075976 0.568175288 5.021471428 5.13E-07 1.41E-05
Xetrov72028979|Xetrov72028979|mcf2l 78.4607543 1.340206104 0.266956241 5.02032131 5.16E-07 1.41E-05
Xetrov72011581|Xetrov72011581|lrrc8c 310.069233 1.399431769 0.27924679 5.011451587 5.40E-07 1.47E-05
Xetrov72005441|Xetrov72005441|march4 4.37053556 2.889034015 0.577485754 5.002779715 5.65E-07 1.53E-05
Xetrov72041731|Xetrov72041731 6.3283106 2.762841637 0.552567406 5.00000834 5.73E-07 1.55E-05
Xetrov72013377|Xetrov72013377|numbl 795.235956 1.47115505 0.294293794 4.998933307 5.76E-07 1.56E-05
Xetrov72024086|Xetrov72024086 3.17486728 2.848790575 0.57057429 4.99284778 5.95E-07 1.61E-05
Xetrov72013979|Xetrov72013979|mamld1 9.33633553 2.88306708 0.577543898 4.991944492 5.98E-07 1.61E-05
Xetrov72028702|Xetrov72028702|c2cd3 222.075026 1.255825039 0.252106645 4.981324619 6.32E-07 1.69E-05
Xetrov72016194|Xetrov72016194 10.62754 2.241759081 0.449963656 4.982089226 6.29E-07 1.69E-05
Xetrov72020107|Xetrov72020107|tmem132b 28.6540916 2.616839127 0.525206829 4.982492574 6.28E-07 1.69E-05
Xetrov72037752|Xetrov72037752|mical3 245.197612 1.295958736 0.260624148 4.972519795 6.61E-07 1.76E-05
Xetrov72042087|Xetrov72042087|bai2 39.8408634 2.681836777 0.539422633 4.971680111 6.64E-07 1.77E-05
Xetrov72026735|Xetrov72026735|nkx6-2 310.231199 2.128491236 0.428335911 4.969210338 6.72E-07 1.79E-05
Xetrov72019393|Xetrov72019393|LOC100495742 314.659213 1.216103081 0.245053995 4.962592345 6.96E-07 1.84E-05
Xetrov72023152|Xetrov72023152|avd 129.408247 1.168214633 0.235643804 4.957544443 7.14E-07 1.88E-05
Xetrov72042977|Xetrov72042977 41.815315 2.186962313 0.441103855 4.957930625 7.12E-07 1.88E-05
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Xetrov72005969|Xetrov72005969 5.2714991 2.950373493 0.595847884 4.951554875 7.36E-07 1.93E-05
Xetrov72009217|Xetrov72009217|cdc14a 57.8945859 1.98895534 0.402154398 4.945750561 7.59E-07 1.98E-05
Xetrov72018695|Xetrov72018695|trpm6 91.1955953 1.604507995 0.325023127 4.93659639 7.95E-07 2.08E-05
Xetrov72015830|Xetrov72015830 59.0418895 2.157865697 0.437670272 4.93034559 8.21E-07 2.14E-05
Xetrov72008313|Xetrov72008313|adamts18 57.7907873 1.735445763 0.352080031 4.929122953 8.26E-07 2.15E-05
Xetrov72023173|Xetrov72023173 17.2840128 2.272952972 0.461127651 4.929118799 8.26E-07 2.15E-05
Xetrov72014803|Xetrov72014803 30.3869102 1.973984993 0.40072036 4.92609109 8.39E-07 2.18E-05
Xetrov72006084|Xetrov72006084|fev 7.30987464 2.933136487 0.596386065 4.918184142 8.74E-07 2.26E-05
Xetrov72041526|Xetrov72041526 7.47604204 2.796849346 0.568815636 4.916969872 8.79E-07 2.27E-05
Xetrov72021859|Xetrov72021859|dazl 810.754348 1.126846195 0.229277285 4.914774673 8.89E-07 2.28E-05
Xetrov72019099|Xetrov72019099|lifr 50.6389355 1.126922783 0.229257999 4.915522192 8.85E-07 2.28E-05
Xetrov72040572|Xetrov72040572|kcp 41.1896132 2.83207975 0.576800732 4.909979464 9.11E-07 2.32E-05
Xetrov72038392|Xetrov72038392|prkcq 3.03626255 2.799995461 0.571815502 4.896676381 9.75E-07 2.46E-05
Xetrov72034491|Xetrov72034491|tmeff1 248.535058 1.337848435 0.273924252 4.884008718 1.04E-06 2.62E-05
Xetrov72036219|Xetrov72036219|aqp4 4.9210607 2.659597095 0.544643862 4.883185661 1.04E-06 2.63E-05
Xetrov72040137|Xetrov72040137|kcnip1 40.74819 2.252011029 0.462182571 4.872557231 1.10E-06 2.76E-05
Xetrov72043101|Xetrov72043101|hsd3b7 37.8690327 2.641789266 0.542484674 4.869795209 1.12E-06 2.80E-05
Xetrov72035600|Xetrov72035600|znf527 5011.55683 1.076731501 0.221112535 4.869608595 1.12E-06 2.80E-05
Xetrov72003106|Xetrov72003106|rasal3 84.9902302 2.565489873 0.527297203 4.865358393 1.14E-06 2.85E-05
Xetrov72023442|Xetrov72023442 28.261162 2.12226959 0.43636587 4.863509586 1.15E-06 2.87E-05
Xetrov72023220|Xetrov72023220 39.6460559 1.296005811 0.266466537 4.863671915 1.15E-06 2.87E-05
Xetrov72035237|Xetrov72035237 9.20411278 2.747147339 0.565657775 4.856553666 1.19E-06 2.96E-05
Xetrov72042209|Xetrov72042209 39.8531369 1.833339224 0.377561957 4.855730799 1.20E-06 2.97E-05
Xetrov72007570|Xetrov72007570|gabra3 12.3883295 2.413151763 0.497074368 4.854709717 1.21E-06 2.98E-05
Xetrov72034689|Xetrov72034689|unnamed 2057.04488 1.676672064 0.345516896 4.852648544 1.22E-06 3.01E-05
Xetrov72004534|Xetrov72004534|grid2ip 42.5271541 1.946438571 0.401314846 4.850153417 1.23E-06 3.03E-05
Xetrov72036358|Xetrov72036358|klhl10 8.80162118 2.685546263 0.554138757 4.846342597 1.26E-06 3.08E-05
Xetrov72001014|Xetrov72001014|hrg 38.0888885 2.435843122 0.502976295 4.842858695 1.28E-06 3.13E-05
Xetrov72009368|Xetrov72009368 6.13789745 2.869860954 0.592855527 4.840742513 1.29E-06 3.16E-05
Xetrov72003911|Xetrov72003911 5.25467663 2.730997485 0.564417252 4.838614477 1.31E-06 3.19E-05
Xetrov72008182|Xetrov72008182 63.6467418 1.710583582 0.354531837 4.824908244 1.40E-06 3.41E-05
Xetrov72023223|Xetrov72023223 12.1593141 2.292060052 0.475582921 4.819475116 1.44E-06 3.50E-05
Xetrov72029758|Xetrov72029758 11.9146839 2.863312521 0.594452795 4.816719753 1.46E-06 3.54E-05
Xetrov72034161|Xetrov72034161|steap2 3.71442824 2.78151004 0.578006558 4.812246507 1.49E-06 3.62E-05
Xetrov72034496|Xetrov72034496|slc30a8 45.013217 2.489430427 0.517735403 4.808306351 1.52E-06 3.68E-05
Xetrov72010919|Xetrov72010919|rgs2 24.3062343 2.642182762 0.54966685 4.806880319 1.53E-06 3.69E-05
Xetrov72028506|Xetrov72028506 103.974665 1.992124313 0.415325511 4.796537316 1.61E-06 3.87E-05
Xetrov72009218|Xetrov72009218|rspry1 82.511054 1.109639029 0.231417752 4.794960718 1.63E-06 3.89E-05
Xetrov72012225|Xetrov72012225 352.644093 1.327526454 0.277382559 4.785904561 1.70E-06 4.06E-05
Xetrov72007904|Xetrov72007904|nlgn4x 6.57623175 2.809792068 0.58839172 4.775376628 1.79E-06 4.27E-05
Xetrov72024979|Xetrov72024979|mms19 616.152564 1.034526049 0.216779697 4.772246024 1.82E-06 4.32E-05
Xetrov72016513|Xetrov72016513 64.4683185 1.798578347 0.376876022 4.77233425 1.82E-06 4.32E-05
Xetrov72016946|Xetrov72016946|srms 5.08866763 2.820381872 0.591308279 4.769731746 1.84E-06 4.36E-05
Xetrov72001716|Xetrov72001716|cdc42ep3 48.7043625 2.005248015 0.421456817 4.757896739 1.96E-06 4.59E-05
Xetrov72011380|Xetrov72011380 53.8393176 1.214651548 0.255403226 4.755819126 1.98E-06 4.64E-05
Xetrov72028323|Xetrov72028323 58.0001996 1.965708424 0.414807888 4.738840515 2.15E-06 5.00E-05
Xetrov72010990|Xetrov72010990 8.23903446 2.229157407 0.470489283 4.737955763 2.16E-06 5.01E-05
Xetrov72005308|Xetrov72005308|unnamed 20.0905001 2.150701834 0.453987127 4.737363041 2.17E-06 5.02E-05
Xetrov72025791|Xetrov72025791 5281.04841 1.158466464 0.244680366 4.734611452 2.19E-06 5.08E-05
Xetrov72020466|Xetrov72020466|agxt2l1 12.0866638 1.779424766 0.376034346 4.732080423 2.22E-06 5.10E-05
Xetrov72028317|Xetrov72028317|htr3b 39.6698623 1.756190038 0.371120649 4.732126986 2.22E-06 5.10E-05
Xetrov72022766|Xetrov72022766|mef2bnb 89.8385016 1.240531479 0.262120093 4.732683642 2.22E-06 5.10E-05
Xetrov72010354|Xetrov72010354|gipc2 47.9237909 2.171195977 0.45878714 4.732469128 2.22E-06 5.10E-05
Xetrov72038048|Xetrov72038048|sh3tc2 8.05028119 2.33052468 0.492671546 4.730382135 2.24E-06 5.14E-05
Xetrov72029685|Xetrov72029685|sim2 10.9446437 1.935432132 0.40967822 4.724273924 2.31E-06 5.29E-05
Xetrov72020339|Xetrov72020339|prdm5 17.8258234 2.258679201 0.478251409 4.722786299 2.33E-06 5.32E-05
Xetrov72024277|Xetrov72024277 32.5806663 2.42255585 0.51315113 4.720940304 2.35E-06 5.37E-05
Xetrov72000070|Xetrov72000070|kif26b 147.030934 1.403954975 0.297667738 4.716517098 2.40E-06 5.47E-05
Xetrov72008518|Xetrov72008518|lrp3 67.9166697 1.03820692 0.220368391 4.711233393 2.46E-06 5.60E-05
Xetrov72008443|Xetrov72008443|adcy7 106.31542 1.528059772 0.324760168 4.705194554 2.54E-06 5.76E-05
Xetrov72001099|Xetrov72001099|zic1 2954.95603 1.231148187 0.261831009 4.702071744 2.58E-06 5.84E-05
Xetrov72026396|Xetrov72026396|b3galt6 284.802823 1.045123265 0.222459566 4.698036961 2.63E-06 5.94E-05
Xetrov72028416|Xetrov72028416|unnamed 342.769691 1.288419278 0.274310678 4.696934469 2.64E-06 5.96E-05
Xetrov72034208|Xetrov72034208|irx1 3353.47567 1.206901238 0.257061107 4.694997444 2.67E-06 6.01E-05
Xetrov72024793|Xetrov72024793|usp54 422.508553 1.255069796 0.267957712 4.683835325 2.82E-06 6.30E-05
Xetrov72005050|Xetrov72005050|nostrin 13.3868239 2.612080847 0.557804857 4.682786128 2.83E-06 6.32E-05
Xetrov72037879|Xetrov72037879|met 43.5684365 1.834597862 0.392004962 4.680037347 2.87E-06 6.39E-05
Xetrov72020186|Xetrov72020186|cdh24 4.87339454 2.682137239 0.573158393 4.679574216 2.87E-06 6.40E-05
Xetrov72016008|Xetrov72016008 48.3119635 1.980587804 0.423613746 4.675456885 2.93E-06 6.52E-05
Xetrov72023086|Xetrov72023086 22.6448062 1.421436186 0.304069466 4.674708728 2.94E-06 6.54E-05
Xetrov72015367|Xetrov72015367 8.10387297 2.605233046 0.557458038 4.673415518 2.96E-06 6.57E-05
Xetrov72036591|Xetrov72036591 13.2524594 2.356576589 0.504284037 4.673113591 2.97E-06 6.57E-05
Xetrov72032217|Xetrov72032217 20.5713981 2.064179054 0.441861341 4.671553864 2.99E-06 6.61E-05
Xetrov72037852|Xetrov72037852 9.02453384 2.516211425 0.538781639 4.670187774 3.01E-06 6.64E-05
Xetrov72007234|Xetrov72007234 11.4985677 2.262295908 0.484527108 4.669080159 3.03E-06 6.66E-05
Xetrov72035650|Xetrov72035650 9.75329728 2.063394611 0.442089234 4.66737132 3.05E-06 6.70E-05
217
Xetrov72043651|Xetrov72043651 6.06821365 2.625256641 0.562862456 4.664117516 3.10E-06 6.79E-05
Xetrov72014648|Xetrov72014648|fam181a 4.09167974 2.672992616 0.573575197 4.660230482 3.16E-06 6.90E-05
Xetrov72015602|Xetrov72015602 27.3085119 1.961817486 0.421697237 4.652194314 3.28E-06 7.15E-05
Xetrov72004150|Xetrov72004150|lrp2 291.257716 2.405033919 0.517179872 4.650285232 3.31E-06 7.21E-05
Xetrov72028961|Xetrov72028961|atp11a 11.0055734 2.084136981 0.448367794 4.648275382 3.35E-06 7.27E-05
Xetrov72040731|Xetrov72040731|osbpl8 125.912303 1.505468653 0.324242981 4.64302619 3.43E-06 7.44E-05
Xetrov72012285|Xetrov72012285 136.479174 1.879565123 0.404987776 4.641041619 3.47E-06 7.50E-05
Xetrov72004352|Xetrov72004352|sned1 72.8730011 2.077635393 0.448270967 4.634775723 3.57E-06 7.71E-05
Xetrov72003118|Xetrov72003118 83.878707 1.871364464 0.40377946 4.634620255 3.58E-06 7.71E-05
Xetrov72036022|Xetrov72036022 52.7701834 1.496368947 0.32325623 4.629049062 3.67E-06 7.91E-05
Xetrov72030134|Xetrov72030134|adc 3169.63955 1.710393587 0.369659386 4.626944833 3.71E-06 7.97E-05
Xetrov72019786|Xetrov72019786|gria2 5.17177367 2.386552139 0.516365588 4.621826467 3.80E-06 8.12E-05
Xetrov72001672|Xetrov72001672|nkx2-2 6.60227712 2.392497225 0.517847918 4.620076945 3.84E-06 8.17E-05
Xetrov72024903|Xetrov72024903|tnks2 495.280753 1.119819777 0.242709126 4.613834656 3.95E-06 8.41E-05
Xetrov72006911|Xetrov72006911 9.22531987 2.580151072 0.559377621 4.612538967 3.98E-06 8.46E-05
Xetrov72021782|Xetrov72021782|sfrp2 283.921713 1.278523213 0.277407366 4.608829368 4.05E-06 8.60E-05
Xetrov72015725|Xetrov72015725 6.98234302 2.397876449 0.520907211 4.603269834 4.16E-06 8.81E-05
Xetrov72020764|Xetrov72020764|dmrta1 7.43363702 2.501623686 0.543639807 4.601619773 4.19E-06 8.87E-05
Xetrov72036451|Xetrov72036451 40.2734736 1.791944038 0.390391758 4.590117492 4.43E-06 9.33E-05
Xetrov72025201|Xetrov72025201|tmprss4 155.083297 1.254373608 0.273874167 4.580109261 4.65E-06 9.77E-05
Xetrov72031785|Xetrov72031785 5.16045622 2.623411018 0.573295951 4.576015258 4.74E-06 9.95E-05
Xetrov72031081|Xetrov72031081|shox 4.76459684 2.600510523 0.569050174 4.569914287 4.88E-06 0.000101993
Xetrov72014818|Xetrov72014818|mettl11a 15.0365272 2.153113684 0.471208733 4.569341636 4.89E-06 0.000102159
Xetrov72000697|Xetrov72000697|capn10 107.967374 1.729187046 0.379017874 4.562283636 5.06E-06 0.000105188
Xetrov72020039|Xetrov72020039|zap70 6.39705644 2.315284592 0.508193432 4.555912071 5.22E-06 0.000107833
Xetrov72022753|Xetrov72022753 5.29794369 2.71684335 0.596552691 4.5542387 5.26E-06 0.000108502
Xetrov72014683|Xetrov72014683 475.631895 1.462804779 0.321537975 4.54939974 5.38E-06 0.000110738
Xetrov72029172|Xetrov72029172|tubgcp3 352.814364 2.10280755 0.462268362 4.548889174 5.39E-06 0.000110886
Xetrov72002033|Xetrov72002033|c1orf95 5.24113288 2.628428092 0.577963979 4.54773686 5.42E-06 0.000111373
Xetrov72002128|Xetrov72002128|ripply2.2 1883.22157 1.937347233 0.426422375 4.543258854 5.54E-06 0.000113395
Xetrov72024878|Xetrov72024878|igsf9b 9.91931824 2.158888364 0.475363878 4.54154904 5.58E-06 0.000114195
Xetrov72035614|Xetrov72035614|pkhd1l1 3.82200328 2.499022557 0.550973437 4.535649795 5.74E-06 0.000117225
Xetrov72042101|Xetrov72042101 13.1392512 2.479348011 0.54687909 4.533631027 5.80E-06 0.00011805
Xetrov72002377|Xetrov72002377 36.9706204 1.510353279 0.33316269 4.533380608 5.80E-06 0.000118063
Xetrov72029477|Xetrov72029477|slitrk1 11.3186199 2.413149901 0.532644782 4.530505101 5.88E-06 0.000119552
Xetrov72019558|Xetrov72019558 7.48447618 2.681572483 0.593455691 4.518572362 6.23E-06 0.000126218
Xetrov72008811|Xetrov72008811|pde3b 214.152063 1.009884393 0.223639853 4.515672773 6.31E-06 0.00012782
Xetrov72042387|Xetrov72042387 47.6967041 1.297834154 0.287535954 4.513641293 6.37E-06 0.000128774
Xetrov72034472|Xetrov72034472|serpinb5 24.4792166 1.877875638 0.416892063 4.504464837 6.65E-06 0.000134322
Xetrov72009224|Xetrov72009224|c8b 417.941694 2.240690127 0.497502489 4.503877225 6.67E-06 0.00013455
Xetrov72024798|Xetrov72024798|abca5 12.8644104 2.293684262 0.509296701 4.50363071 6.68E-06 0.000134562
Xetrov72011426|Xetrov72011426 34.5649751 2.287481941 0.50813489 4.501721857 6.74E-06 0.000135631
Xetrov72021412|Xetrov72021412|klhdc8a 14.4972779 1.766643459 0.392538943 4.50055591 6.78E-06 0.000136159
Xetrov72015771|Xetrov72015771 8.44166105 2.650189361 0.588872911 4.500443664 6.78E-06 0.000136159
Xetrov72003893|Xetrov72003893 6.20806692 2.649928713 0.589264037 4.497014151 6.89E-06 0.000138225
Xetrov72016819|Xetrov72016819|mllt6 246.529536 1.00888294 0.224385808 4.496197643 6.92E-06 0.000138609
Xetrov72036170|Xetrov72036170 62.057361 1.96399351 0.437221139 4.491991199 7.06E-06 0.000141076
Xetrov72036310|Xetrov72036310 10.4385493 2.643818924 0.589438407 4.485318388 7.28E-06 0.000145102
Xetrov72003088|Xetrov72003088|pnpla7 31.4016376 2.117216712 0.472480798 4.481064037 7.43E-06 0.000147318
Xetrov72011874|Xetrov72011874 111.865761 1.567683756 0.349836286 4.481192539 7.42E-06 0.000147318
Xetrov72018777|Xetrov72018777|nwd1 15.2965374 2.115114524 0.472081706 4.480399256 7.45E-06 0.00014755
Xetrov72019772|Xetrov72019772|gucy1a3 5.58110608 2.199742585 0.491099305 4.479221537 7.49E-06 0.000148055
Xetrov72012129|Xetrov72012129 44.7123678 2.4944912 0.557288815 4.476119263 7.60E-06 0.000149907
Xetrov72028146|Xetrov72028146 9.19147662 2.084108688 0.465756996 4.474669636 7.65E-06 0.000150612
Xetrov72015759|Xetrov72015759 154.502022 1.141995935 0.255286459 4.473390171 7.70E-06 0.000151317
Xetrov72035591|Xetrov72035591 177.56798 1.924638924 0.430281068 4.472980723 7.71E-06 0.000151333
Xetrov72007571|Xetrov72007571|gabra1 5.36968057 2.467192748 0.551890814 4.470436337 7.81E-06 0.000152985
Xetrov72034753|Xetrov72034753|obscn 17.0839204 2.457744182 0.550138795 4.467498392 7.91E-06 0.000154778
Xetrov72016631|Xetrov72016631|dnah9 197.51792 1.403502338 0.314218574 4.466643458 7.95E-06 0.000155237
Xetrov72014232|Xetrov72014232 20.1807518 1.878864647 0.421300036 4.459683092 8.21E-06 0.000159862
Xetrov72028701|Xetrov72028701|myo7a 5.3418545 2.445441148 0.548370587 4.459468111 8.22E-06 0.000159862
Xetrov72000396|Xetrov72000396 18.1694441 1.602244419 0.35951004 4.456744575 8.32E-06 0.000161572
Xetrov72000426|Xetrov72000426|pygm 8966.13688 1.083105697 0.243244351 4.452747583 8.48E-06 0.000164271
Xetrov72038769|Xetrov72038769|spam1 256.795531 2.29291582 0.515351516 4.449226885 8.62E-06 0.000166815
Xetrov72009828|Xetrov72009828|il5ra 3.45115763 2.375128481 0.533884098 4.44877173 8.64E-06 0.000166998
Xetrov72002526|Xetrov72002526 16.1904468 1.872580184 0.421302057 4.444744935 8.80E-06 0.000169807
Xetrov72003786|Xetrov72003786 27.0601861 1.727777618 0.389392947 4.437105579 9.12E-06 0.000175227
Xetrov72020694|Xetrov72020694|tbx1 420.251065 2.026379162 0.456831556 4.435725018 9.18E-06 0.000176174
Xetrov72004358|Xetrov72004358|pfas 194.419194 1.474721886 0.332490932 4.435374751 9.19E-06 0.000176281
Xetrov72031082|Xetrov72031082|tnfsf11 77.8646714 1.391829353 0.31391207 4.433819171 9.26E-06 0.000177377
Xetrov72001676|Xetrov72001676 83.2549203 1.617000466 0.364717217 4.433573164 9.27E-06 0.0001774
Xetrov72000863|Xetrov72000863|fyn 47.4702834 1.050920458 0.23719222 4.430670022 9.39E-06 0.000179622
Xetrov72041992|Xetrov72041992 6.92666459 2.230291882 0.503756798 4.427318679 9.54E-06 0.000182065
Xetrov72027695|Xetrov72027695|gramd1a 218.610787 1.23067014 0.278153724 4.424424455 9.67E-06 0.000183815
Xetrov72004413|Xetrov72004413|zeb2 1561.12758 1.217832634 0.275544861 4.419725454 9.88E-06 0.000187416
Xetrov72030214|Xetrov72030214 8.11459745 2.113235368 0.478132004 4.419773937 9.88E-06 0.000187416
218
Xetrov72026520|Xetrov72026520|gsg1l 6.68724661 2.559566914 0.579284201 4.418499434 9.94E-06 0.000188129
Xetrov72021265|Xetrov72021265|palm 635.261588 1.674801693 0.379355116 4.414865176 1.01E-05 0.000190742
Xetrov72005601|Xetrov72005601 35.1386787 1.415673903 0.321056564 4.409422088 1.04E-05 0.000195208
Xetrov72025566|Xetrov72025566|ptpn6 7.95214816 2.363919521 0.536321226 4.407656093 1.04E-05 0.000196218
Xetrov72018189|Xetrov72018189 13.1987016 1.757514636 0.398778607 4.407244038 1.05E-05 0.000196395
Xetrov72032584|Xetrov72032584 32.5373934 1.734245056 0.393580605 4.406327533 1.05E-05 0.000197032
Xetrov72016985|Xetrov72016985|epb42 2.05755183 2.6147381 0.593829104 4.403182804 1.07E-05 0.000199514
Xetrov72034450|Xetrov72034450 189.316897 1.873186368 0.425513715 4.402176244 1.07E-05 0.000200044
Xetrov72027264|Xetrov72027264|cd3e 7.57683593 2.386130251 0.542881775 4.39530366 1.11E-05 0.000205868
Xetrov72034882|Xetrov72034882|pqlc1.1 65.8958566 1.419074382 0.322900899 4.39476752 1.11E-05 0.000205969
Xetrov72024201|Xetrov72024201 55.081263 1.527254267 0.347970282 4.389036494 1.14E-05 0.000211056
Xetrov72011346|Xetrov72011346 7.17426511 2.072759026 0.472462394 4.387140758 1.15E-05 0.000212619
Xetrov72023839|Xetrov72023839 8.92755043 2.182306621 0.497496244 4.386579091 1.15E-05 0.000212825
Xetrov72036032|Xetrov72036032 17.3639625 2.042618036 0.465732294 4.385820058 1.16E-05 0.00021315
Xetrov72b000050|Xetrov72b000050 9.97817464 2.271889818 0.518168741 4.384459421 1.16E-05 0.000214067
Xetrov72042142|Xetrov72042142|cad 4325.91186 1.062736772 0.242428423 4.38371359 1.17E-05 0.000214592
Xetrov72009377|Xetrov72009377|rpe65 171.128437 1.570905983 0.358389957 4.383231041 1.17E-05 0.000214858
Xetrov72015346|Xetrov72015346|efcab11 70.5378819 1.412492253 0.322944443 4.373793335 1.22E-05 0.000223711
Xetrov72041585|Xetrov72041585|dgat1 44.3481594 1.210693562 0.27710996 4.369000527 1.25E-05 0.00022779
Xetrov72028673|Xetrov72028673|mxra5 13.8382227 2.001678191 0.45882551 4.362613125 1.29E-05 0.000234318
Xetrov72037920|Xetrov72037920|cyfip2 81.8481488 1.926810094 0.442588802 4.353499417 1.34E-05 0.000243572
Xetrov72009469|Xetrov72009469|slc7a6 203.820493 1.013074885 0.232766374 4.35232489 1.35E-05 0.000244409
Xetrov72039699|Xetrov72039699|sparc 189.206628 1.816322286 0.417359582 4.351936227 1.35E-05 0.000244607
Xetrov72031688|Xetrov72031688|rcan1 248.764563 1.897160143 0.436014456 4.351140465 1.35E-05 0.000245261
Xetrov72009557|Xetrov72009557|unnamed 45.7665349 1.358793837 0.313232175 4.337976571 1.44E-05 0.000259171
Xetrov72010441|Xetrov72010441|lrrn4cl 34.9453319 1.782816539 0.41224229 4.324681342 1.53E-05 0.000273734
Xetrov72040315|Xetrov72040315 6.14824749 2.276344373 0.526512812 4.323435863 1.54E-05 0.000274761
Xetrov72034251|Xetrov72034251|prkag1 16.8032989 1.964426737 0.454389771 4.323219541 1.54E-05 0.00027477
Xetrov72028785|Xetrov72028785|col4a2 43.0043846 1.631959674 0.377530828 4.322718977 1.54E-05 0.000275133
Xetrov72031578|Xetrov72031578|rab30 77.871819 1.092692143 0.252927089 4.320186298 1.56E-05 0.000277784
Xetrov72032963|Xetrov72032963 6.62336161 2.458184546 0.5697168 4.314748218 1.60E-05 0.00028337
Xetrov72014674|Xetrov72014674|prdm12 50.4037979 1.295187876 0.300533392 4.309630513 1.64E-05 0.000288919
Xetrov72042450|Xetrov72042450 14.8210186 2.034034204 0.472023606 4.309178987 1.64E-05 0.000289238
Xetrov72039634|Xetrov72039634|unnamed 47.2024049 2.228453312 0.517913114 4.302755137 1.69E-05 0.000296921
Xetrov72037656|Xetrov72037656 26.6395283 2.507981832 0.583032003 4.301619499 1.70E-05 0.000297613
Xetrov72027183|Xetrov72027183 7.84017573 2.567720613 0.596894387 4.301800568 1.69E-05 0.000297613
Xetrov72012002|Xetrov72012002 10.5490811 2.527585579 0.587640683 4.301243348 1.70E-05 0.000297841
Xetrov72025436|Xetrov72025436|slc23a2 56.6908731 1.617968561 0.376238711 4.300377693 1.71E-05 0.000298729
Xetrov72032985|Xetrov72032985 228.26687 1.212827424 0.28212269 4.298936119 1.72E-05 0.000300399
Xetrov72016635|Xetrov72016635|chd6 58.4996039 1.531778071 0.356426933 4.297593503 1.73E-05 0.000301943
Xetrov72033042|Xetrov72033042|lama1 882.310988 2.180090373 0.50769 4.294136924 1.75E-05 0.000306291
Xetrov72003103|Xetrov72003103 3.24670855 2.529148438 0.588994452 4.294010628 1.75E-05 0.000306291
Xetrov72033156|Xetrov72033156|ccdc165 19.7061407 1.860318013 0.4332717 4.293652259 1.76E-05 0.000306502
Xetrov72038018|Xetrov72038018|ppfia2 8.25412882 2.480906775 0.578416736 4.289133803 1.79E-05 0.000311937
Xetrov72033043|Xetrov72033043|lama3 4.06461001 2.46538697 0.574977106 4.287800232 1.80E-05 0.000313526
Xetrov72021174|Xetrov72021174|nfib 3.95879731 2.38882889 0.557351769 4.286034464 1.82E-05 0.000315736
Xetrov72018134|Xetrov72018134 3.52327841 2.395614631 0.559414636 4.28235959 1.85E-05 0.000320233
Xetrov72042247|Xetrov72042247 9.16599742 1.902510614 0.444408246 4.280997559 1.86E-05 0.000321782
Xetrov72012284|Xetrov72012284|aldh5a1 152.912018 1.519539662 0.354979112 4.280645283 1.86E-05 0.000321996
Xetrov72032860|Xetrov72032860 3.21257395 2.548090648 0.595569908 4.278407312 1.88E-05 0.000324952
Xetrov72007864|Xetrov72007864|pnliprp2 20.5168638 2.540799996 0.594550932 4.273477442 1.92E-05 0.000331616
Xetrov72042958|Xetrov72042958|arhgef10l 37.7800698 1.951072045 0.456638839 4.272680896 1.93E-05 0.000332499
Xetrov72016335|Xetrov72016335|sspo 5.67280374 2.343858833 0.548814797 4.270764651 1.95E-05 0.000335063
Xetrov72029767|Xetrov72029767|reps2 69.3716342 1.667129438 0.390683205 4.267215522 1.98E-05 0.000340125
Xetrov72036131|Xetrov72036131 49.1724818 2.007398753 0.470549627 4.266072351 1.99E-05 0.000341249
Xetrov72029144|Xetrov72029144|hip1 52.7001777 1.955327397 0.458858873 4.261282744 2.03E-05 0.000347697
Xetrov72014829|Xetrov72014829|lrrc57 96.5167766 1.011727831 0.237516835 4.259604721 2.05E-05 0.000349682
Xetrov72041445|Xetrov72041445 17.4715249 1.434111524 0.336806952 4.257962953 2.06E-05 0.00035194
Xetrov72002176|Xetrov72002176|otx1 2899.36577 1.42368357 0.334523466 4.255855615 2.08E-05 0.00035495
Xetrov72041578|Xetrov72041578 3.42486793 2.532565716 0.59514764 4.255357069 2.09E-05 0.000355421
Xetrov72007796|Xetrov72007796 34.7061551 1.14070258 0.268098998 4.25478121 2.09E-05 0.000356015
Xetrov72024990|Xetrov72024990|robo4 3.76873007 2.477287004 0.582437131 4.253312281 2.11E-05 0.000357713
Xetrov72035840|Xetrov72035840 9.69959069 1.80106054 0.424083199 4.246950935 2.17E-05 0.000367686
Xetrov72025171|Xetrov72025171|acap3 64.5215885 1.63956 0.386105165 4.24640784 2.17E-05 0.000368246
Xetrov72003636|Xetrov72003636 6.19998175 2.290546994 0.539905238 4.242498192 2.21E-05 0.000374049
Xetrov72002873|Xetrov72002873 17.2210608 1.364359209 0.321649302 4.241760205 2.22E-05 0.000374945
Xetrov72027962|Xetrov72027962 24.9095319 1.881142702 0.443790657 4.238806455 2.25E-05 0.000379571
Xetrov72005381|Xetrov72005381|pdk1 2309.14445 1.070604791 0.252995399 4.231716443 2.32E-05 0.000390687
Xetrov72004946|Xetrov72004946|ntn3 517.483899 1.578272081 0.373109436 4.230051368 2.34E-05 0.000392887
Xetrov72021577|Xetrov72021577 51.3265514 1.883971764 0.44587376 4.225347919 2.39E-05 0.000400469
Xetrov72038145|Xetrov72038145|hkdc1 361.40282 1.67691274 0.397415063 4.219550031 2.45E-05 0.000410542
Xetrov72002699|Xetrov72002699 20.4003656 1.785923431 0.423469234 4.217362891 2.47E-05 0.000413974
Xetrov72033420|Xetrov72033420|nrp1 55.3730002 1.511125115 0.358660558 4.213245868 2.52E-05 0.000420676
Xetrov72027320|Xetrov72027320 33.287345 1.717629108 0.407703561 4.212936245 2.52E-05 0.00042088
Xetrov72026175|Xetrov72026175 106.072317 1.835019734 0.435872606 4.209990969 2.55E-05 0.000426027
Xetrov72035427|Xetrov72035427|nrn1 7.80896846 2.339605965 0.555768827 4.209674691 2.56E-05 0.000426246
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Xetrov72022251|Xetrov72022251|spef1 60.056347 1.557781225 0.370223251 4.207680695 2.58E-05 0.000429576
Xetrov72027025|Xetrov72027025 5.61480777 2.50508128 0.595592234 4.206034154 2.60E-05 0.00043202
Xetrov72000021|Xetrov72000021|col12a1 4.12338037 2.49292046 0.592738668 4.205766546 2.60E-05 0.00043215
Xetrov72005226|Xetrov72005226 8.25624788 2.427500369 0.578457641 4.196504975 2.71E-05 0.000449406
Xetrov72029557|Xetrov72029557|tmprss2 30.0355722 1.629314812 0.388996099 4.188511962 2.81E-05 0.000463487
Xetrov72040644|Xetrov72040644|apbb3 139.130375 1.765467828 0.421647924 4.187066332 2.83E-05 0.000465632
Xetrov72040938|Xetrov72040938 1.75667285 2.484351171 0.59360825 4.18516955 2.85E-05 0.000469127
Xetrov72011374|Xetrov72011374 2.04568485 2.4678183 0.589729341 4.184662567 2.86E-05 0.000469354
Xetrov72036384|Xetrov72036384|unnamed 13.5331833 1.47489278 0.352853504 4.179901191 2.92E-05 0.00047765
Xetrov72018842|Xetrov72018842|rimbp2 54.453494 2.02774501 0.485610133 4.175664533 2.97E-05 0.000485357
Xetrov72028364|Xetrov72028364 12.3814264 1.903239188 0.456710028 4.16728136 3.08E-05 0.000500487
Xetrov72002425|Xetrov72002425 8.33634861 2.481176894 0.595470175 4.166752591 3.09E-05 0.000501217
Xetrov72003628|Xetrov72003628|adamtsl4 130.230778 2.234445885 0.536659513 4.16361926 3.13E-05 0.000507275
Xetrov72008594|Xetrov72008594|slc9a5 335.007131 1.9153346 0.460085718 4.162995124 3.14E-05 0.000508227
Xetrov72009533|Xetrov72009533|dab1 9.64533459 2.062308788 0.495533402 4.161795717 3.16E-05 0.000510466
Xetrov72001634|Xetrov72001634|fhl5 6.64913806 2.132067125 0.513590636 4.151296724 3.31E-05 0.000531268
Xetrov72004588|Xetrov72004588 16.667944 2.164974398 0.521691053 4.149916671 3.33E-05 0.000534026
Xetrov72000014|Xetrov72000014|dnah14 13.1646974 2.111537593 0.508843954 4.1496761 3.33E-05 0.000534132
Xetrov72023316|Xetrov72023316|npr2 5.83366016 2.475791951 0.596871938 4.147944966 3.35E-05 0.000536814
Xetrov72015742|Xetrov72015742 3.25789809 2.467096471 0.59476597 4.148012153 3.35E-05 0.000536814
Xetrov72030100|Xetrov72030100|asl 284.140783 1.25912965 0.303904012 4.143182057 3.43E-05 0.000545771
Xetrov72004330|Xetrov72004330|col5a2 39.9895746 1.985014997 0.480257715 4.133228755 3.58E-05 0.000567085
Xetrov72020488|Xetrov72020488|nfic 7.95037962 2.308740468 0.558658951 4.132647414 3.59E-05 0.000568043
Xetrov72019552|Xetrov72019552|vwa5a 81.5158456 1.641552245 0.397431329 4.130404735 3.62E-05 0.00057265
Xetrov72025770|Xetrov72025770 17.4564517 1.784157986 0.432055747 4.129462459 3.64E-05 0.00057452
Xetrov72006831|Xetrov72006831 1.93900551 2.454703075 0.594983195 4.125667912 3.70E-05 0.000582122
Xetrov72043007|Xetrov72043007 16.8651233 1.84736632 0.447915938 4.124359427 3.72E-05 0.000584952
Xetrov72038266|Xetrov72038266|gria1 4.2911146 2.459735708 0.596482885 4.123732246 3.73E-05 0.000586058
Xetrov72030753|Xetrov72030753|mdh2 310.361607 1.079676999 0.261878673 4.122813766 3.74E-05 0.00058791
Xetrov72037181|Xetrov72037181 4.97945504 2.404753777 0.583388431 4.122045709 3.76E-05 0.000588892
Xetrov72034005|Xetrov72034005|arhgap28 4.7115622 2.145133756 0.520454124 4.121657715 3.76E-05 0.000589394
Xetrov72012166|Xetrov72012166|ppp2r5b 22.3844849 1.761323832 0.42741071 4.120916465 3.77E-05 0.000590802
Xetrov72032834|Xetrov72032834|cdkl5 16.9418154 2.17570279 0.528168577 4.119334025 3.80E-05 0.000593394
Xetrov72028885|Xetrov72028885 26.4539781 1.462000687 0.354897365 4.119502792 3.80E-05 0.000593394
Xetrov72028141|Xetrov72028141 2.56061564 2.373424289 0.576513021 4.116861551 3.84E-05 0.000598305
Xetrov72026148|Xetrov72026148 6.74643625 2.378219609 0.577639589 4.117134032 3.84E-05 0.000598305
Xetrov72010736|Xetrov72010736|fam192a 809.944159 1.046898968 0.254367937 4.115687615 3.86E-05 0.000600366
Xetrov72039470|Xetrov72039470|ascl1 32.7275353 1.196097776 0.290722636 4.114223065 3.88E-05 0.000603691
Xetrov72014727|Xetrov72014727|gjb1 3089.17349 1.652483563 0.401766735 4.113042267 3.90E-05 0.000606288
Xetrov72024386|Xetrov72024386 3.36966374 2.431735949 0.591704217 4.109715429 3.96E-05 0.000614077
Xetrov72021641|Xetrov72021641|sh3gl2 43.379774 1.054303898 0.256953362 4.103094384 4.08E-05 0.000631405
Xetrov72023128|Xetrov72023128 6.65994497 1.900405462 0.463223535 4.102566728 4.09E-05 0.000632327
Xetrov72042373|Xetrov72042373 4.91005264 2.163949952 0.527561239 4.101798603 4.10E-05 0.000633389
Xetrov72001316|Xetrov72001316|nr2e1 10.0584448 1.964401043 0.479601651 4.095901336 4.21E-05 0.000648669
Xetrov72025800|Xetrov72025800|lrrtm3 6.09538418 2.108697147 0.515059906 4.094081333 4.24E-05 0.000652182
Xetrov72010924|Xetrov72010924|vegfb 30.1245705 1.829729477 0.447149061 4.091989984 4.28E-05 0.000656803
Xetrov72024109|Xetrov72024109 5.3538759 2.155719664 0.526828988 4.091877461 4.28E-05 0.000656803
Xetrov72020213|Xetrov72020213|eps8l3 37.220383 1.791908575 0.437964427 4.091447761 4.29E-05 0.000657485
Xetrov72035815|Xetrov72035815 38.196067 1.76160387 0.430738966 4.08972489 4.32E-05 0.000661311
Xetrov72033738|Xetrov72033738|eomes 3366.28921 1.153376551 0.2821632 4.087622163 4.36E-05 0.000666248
Xetrov72037703|Xetrov72037703|lrrk2 250.755482 1.349923088 0.330783985 4.080980788 4.48E-05 0.000683912
Xetrov72032309|Xetrov72032309 7.25614741 2.100259683 0.514712645 4.080450915 4.49E-05 0.000684918
Xetrov72041204|Xetrov72041204|alox12b 18.3443559 2.095903524 0.513993081 4.077688208 4.55E-05 0.000691985
Xetrov72023018|Xetrov72023018|otp 32.6922172 2.284603762 0.560576926 4.075450943 4.59E-05 0.000697545
Xetrov72008039|Xetrov72008039|hydin 267.769985 1.819440844 0.446564402 4.074307845 4.62E-05 0.000700415
Xetrov72019394|Xetrov72019394|pde5a 4.1543124 2.298084526 0.564073173 4.074089381 4.62E-05 0.000700509
Xetrov72029358|Xetrov72029358|naalad2 1548.55743 1.437448391 0.352953787 4.072624929 4.65E-05 0.000703231
Xetrov72000233|Xetrov72000233 2.65563971 2.420062518 0.594788155 4.068780618 4.73E-05 0.000714359
Xetrov72028507|Xetrov72028507 75.5909225 1.184686345 0.291335778 4.066394984 4.77E-05 0.000719974
Xetrov72029883|Xetrov72029883|pvrl3 93.215862 1.528409372 0.375965782 4.065288507 4.80E-05 0.000722242
Xetrov72006044|Xetrov72006044|cers6 15.5497744 1.95461861 0.480848095 4.064939903 4.80E-05 0.000722745
Xetrov72008361|Xetrov72008361|astn1 6.91293398 2.175574676 0.535335901 4.063943166 4.83E-05 0.000725261
Xetrov72013344|Xetrov72013344|cnga2 19.8382096 2.084530126 0.513293719 4.061086368 4.88E-05 0.000733024
Xetrov72015537|Xetrov72015537 5.80950417 2.207682272 0.544029135 4.058022133 4.95E-05 0.000741524
Xetrov72027983|Xetrov72027983 175.05295 1.643744802 0.405715102 4.051475511 5.09E-05 0.000760769
Xetrov72030010|Xetrov72030010|itgbl1 4.71767006 2.316242091 0.572096156 4.048693678 5.15E-05 0.000768647
Xetrov72028484|Xetrov72028484 8.44263873 2.327362053 0.575223301 4.046014913 5.21E-05 0.000775647
Xetrov72006010|Xetrov72006010 191.833276 1.420842836 0.351319218 4.044307182 5.25E-05 0.000780088
Xetrov72b000159|Xetrov72b000159|cnrip1 357.153403 1.208880653 0.299057357 4.042303677 5.29E-05 0.000785546
Xetrov72015793|Xetrov72015793|ccdc85c 34.53357 1.773525056 0.438735873 4.042352509 5.29E-05 0.000785546
Xetrov72008036|Xetrov72008036|hmcn1 7.53172529 1.880608374 0.465637669 4.038780583 5.37E-05 0.000794849
Xetrov72032984|Xetrov72032984 174.364582 1.718203163 0.425443095 4.038620403 5.38E-05 0.000794849
Xetrov72029137|Xetrov72029137|gtf2ird1 359.786425 1.137285633 0.282252448 4.029320711 5.59E-05 0.000825659
Xetrov72026490|Xetrov72026490|hoga1 9.49314329 1.894968206 0.470612009 4.02660402 5.66E-05 0.000834467
Xetrov72034364|Xetrov72034364|abhd3 51.2052506 1.329300353 0.330141443 4.026457082 5.66E-05 0.000834467
Xetrov72003110|Xetrov72003110 14.7621565 1.685588252 0.418711654 4.025654017 5.68E-05 0.000836011
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Xetrov72008038|Xetrov72008038 4.26343838 2.214203801 0.550203432 4.024336585 5.71E-05 0.000840049
Xetrov72032338|Xetrov72032338|sdc3 95.6886225 1.824581468 0.453529854 4.023068056 5.74E-05 0.000843579
Xetrov72037494|Xetrov72037494 6.34967027 2.140228646 0.532000525 4.022982208 5.75E-05 0.000843579
Xetrov72029536|Xetrov72029536|mid1 91.8190222 1.356892812 0.337554025 4.019779678 5.83E-05 0.000854462
Xetrov72b000110|Xetrov72b000110|steap1 1.71133582 2.382071928 0.592787788 4.01842274 5.86E-05 0.00085806
Xetrov72036845|Xetrov72036845 7.28714104 1.844513344 0.459179722 4.01697474 5.90E-05 0.000862677
Xetrov72024167|Xetrov72024167 59.7627791 1.318980228 0.328401721 4.016362108 5.91E-05 0.00086425
Xetrov72032492|Xetrov72032492 4.95520326 2.359029948 0.58775665 4.013616774 5.98E-05 0.000873013
Xetrov72028450|Xetrov72028450|cyp26c1 66.148314 1.875120105 0.467355304 4.012193913 6.02E-05 0.000877613
Xetrov72032421|Xetrov72032421 10.1298234 1.929496113 0.481117496 4.010446785 6.06E-05 0.000883448
Xetrov72023886|Xetrov72023886 43.449823 1.528282605 0.381257187 4.008534549 6.11E-05 0.000889942
Xetrov72038147|Xetrov72038147|pdzrn4 21.8798987 1.826904593 0.456282617 4.003888218 6.23E-05 0.000906211
Xetrov72032980|Xetrov72032980 14.8564875 2.32925474 0.581952473 4.002482762 6.27E-05 0.000910909
Xetrov72036907|Xetrov72036907 8.68578578 2.32926341 0.58226268 4.000365285 6.32E-05 0.00091839
Xetrov72018824|Xetrov72018824 629.780947 1.723006554 0.43089329 3.998685046 6.37E-05 0.000924221
Xetrov72025178|Xetrov72025178|wdfy4 34.8685148 1.70473545 0.426605788 3.996043882 6.44E-05 0.000932758
Xetrov72003615|Xetrov72003615 3.47800443 2.36691234 0.592758091 3.993049401 6.52E-05 0.000941397
Xetrov72018749|Xetrov72018749|nav1 116.913484 1.609135309 0.40336034 3.989324557 6.63E-05 0.000955274
Xetrov72008524|Xetrov72008524|ccdc66 299.628276 1.03790484 0.260248218 3.988134278 6.66E-05 0.000958174
Xetrov72025101|Xetrov72025101|pkd2l1 10.1957706 2.164727409 0.542779349 3.988227286 6.66E-05 0.000958174
Xetrov72036964|Xetrov72036964 99.1478271 1.485931853 0.372933507 3.984441802 6.76E-05 0.00097023
Xetrov72041022|Xetrov72041022|socs2 10.1338117 2.017070316 0.506657993 3.981127989 6.86E-05 0.00098087
Xetrov72002923|Xetrov72002923|fndc4 3.10387135 2.371183619 0.595562531 3.981418401 6.85E-05 0.00098087
Xetrov72025137|Xetrov72025137|cdhr1 22.9082579 1.823820697 0.458266242 3.979827732 6.90E-05 0.000984812
Xetrov72010848|Xetrov72010848 20.7822986 1.698357522 0.426788377 3.979390289 6.91E-05 0.000985821
Xetrov72018971|Xetrov72018971|arhgef40 67.0879428 1.285138046 0.323090075 3.977646309 6.96E-05 0.000991433
Xetrov72016001|Xetrov72016001 3.96829165 2.307489583 0.580135608 3.977500352 6.96E-05 0.000991433
Xetrov72023368|Xetrov72023368 2.09176102 2.364420055 0.594540293 3.976887826 6.98E-05 0.000992489
Xetrov72011781|Xetrov72011781 5.5113838 1.990173436 0.500765888 3.974259198 7.06E-05 0.000999868
Xetrov72010720|Xetrov72010720 12.1609546 2.060869272 0.518541356 3.974358548 7.06E-05 0.000999868
Xetrov72027131|Xetrov72027131 472.833607 1.798703915 0.452591933 3.974228849 7.06E-05 0.000999868
Xetrov72036485|Xetrov72036485 4.99211321 2.244664464 0.564966633 3.973092096 7.09E-05 0.001003412
Xetrov72032611|Xetrov72032611 5.56733916 1.919254265 0.483704111 3.967827068 7.25E-05 0.001022491
Xetrov72022850|Xetrov72022850|unnamed 251.642879 1.027208018 0.258864658 3.968127697 7.24E-05 0.001022491
Xetrov72012429|Xetrov72012429|kiaa1409 12.0094215 1.938061957 0.488442914 3.967837188 7.25E-05 0.001022491
Xetrov72034884|Xetrov72034884|rbms3 4.38844279 2.236065796 0.563880098 3.965498702 7.32E-05 0.001030981
Xetrov72009242|Xetrov72009242|ces2 104.644677 1.491507472 0.376291079 3.963706707 7.38E-05 0.001037204
Xetrov72039500|Xetrov72039500|fchsd1 17.4522859 1.445123435 0.364622332 3.963343185 7.39E-05 0.001038011
Xetrov72017222|Xetrov72017222|b4galnt2 38.3298073 1.53585321 0.387728432 3.961157042 7.46E-05 0.001046002
Xetrov72011938|Xetrov72011938 3.30640652 2.306752136 0.582829506 3.957850647 7.56E-05 0.001057434
Xetrov72022502|Xetrov72022502|cer1 467.494117 1.289314886 0.327053691 3.942211695 8.07E-05 0.001122168
Xetrov72b000160|Xetrov72b000160|fam36a 37.4387887 1.391679862 0.353041546 3.941971921 8.08E-05 0.001122462
Xetrov72003349|Xetrov72003349 17.2069941 1.55911991 0.395968006 3.937489613 8.23E-05 0.001140914
Xetrov72010051|Xetrov72010051|slc7a10 6.67833514 1.902561476 0.483512575 3.934874864 8.32E-05 0.001149372
Xetrov72042548|Xetrov72042548 19.8014017 1.840816033 0.467931082 3.933946912 8.36E-05 0.001152131
Xetrov72012775|Xetrov72012775 14.6498015 2.150647485 0.546748811 3.933520184 8.37E-05 0.001153335
Xetrov72005686|Xetrov72005686|foxb1 956.968809 1.475425346 0.375112378 3.933288881 8.38E-05 0.001153602
Xetrov72013161|Xetrov72013161|atpbd4 82.8001014 1.019213972 0.259441694 3.928489503 8.55E-05 0.001173433
Xetrov72009807|Xetrov72009807|ak5 2.90580316 2.33611457 0.59475667 3.927849303 8.57E-05 0.001174848
Xetrov72026897|Xetrov72026897|etv2 364.839263 1.457628886 0.371147983 3.927352307 8.59E-05 0.001176421
Xetrov72011067|Xetrov72011067|cyba 17.3321767 1.723996285 0.43899709 3.927124635 8.60E-05 0.001176679
Xetrov72042752|Xetrov72042752 9.60957484 2.119464128 0.540074104 3.924395028 8.69E-05 0.001189236
Xetrov72033015|Xetrov72033015 4.02425721 2.336454346 0.595590406 3.922921394 8.75E-05 0.001195668
Xetrov72020803|Xetrov72020803|adra2c 15.0527086 2.067697578 0.527764003 3.917845033 8.93E-05 0.001216979
Xetrov72016688|Xetrov72016688 67.9813443 1.982452769 0.506012856 3.917791309 8.94E-05 0.001216979
Xetrov72014908|Xetrov72014908|unnamed 2.50035759 2.330801989 0.594954741 3.917612263 8.94E-05 0.001217003
Xetrov72023361|Xetrov72023361 11.1382591 1.763266463 0.450543148 3.913646161 9.09E-05 0.001234501
Xetrov72041205|Xetrov72041205|art1 9.52341682 2.297809638 0.587680611 3.909963331 9.23E-05 0.001252571
Xetrov72016354|Xetrov72016354|adamtsl2 25.0576018 2.136474341 0.54654621 3.909046121 9.27E-05 0.001256431
Xetrov72000783|Xetrov72000783|esr1 3.25794755 2.181291803 0.558420271 3.90618306 9.38E-05 0.001270489
Xetrov72037170|Xetrov72037170|nxnl1 3.54001677 2.26044753 0.578753904 3.905714528 9.39E-05 0.001272038
Xetrov72004216|Xetrov72004216|scn3a 13.7342265 1.969313808 0.504644657 3.90237721 9.53E-05 0.001287578
Xetrov72008021|Xetrov72008021 83.0205588 1.162256123 0.297842085 3.902256196 9.53E-05 0.001287578
Xetrov72042273|Xetrov72042273 37.9629447 1.350729855 0.346315581 3.900286124 9.61E-05 0.001296032
Xetrov72018967|Xetrov72018967|fam13a 290.539904 1.007057987 0.25820994 3.900151899 9.61E-05 0.001296032
Xetrov72015078|Xetrov72015078|grem1 2.71407503 2.297842189 0.589509188 3.897890374 9.70E-05 0.001305389
Xetrov72021815|Xetrov72021815|cyb5r1 4.14948926 2.245989478 0.57626352 3.897504181 9.72E-05 0.001306538
Xetrov72018886|Xetrov72018886|cntnap4 4.21874108 2.127708954 0.546058378 3.896486236 9.76E-05 0.001311104
Xetrov72030241|Xetrov72030241|manea 67.5185467 1.559727583 0.400789318 3.891639603 9.96E-05 0.001334722
Xetrov72014847|Xetrov72014847 146.196 1.49781529 0.38509228 3.889497063 0.00010045 0.001345602
Xetrov72006361|Xetrov72006361 29.693353 1.53710904 0.395227589 3.889174445 0.00010059 0.001346422
Xetrov72040479|Xetrov72040479 29.8383817 1.545460994 0.397752539 3.885483668 0.00010213 0.001363181
Xetrov72033715|Xetrov72033715|dtna 149.986354 1.16854759 0.301371791 3.877428554 0.00010557 0.001403131
Xetrov72042725|Xetrov72042725|dhcr7 3113.09883 1.323261259 0.341570746 3.874047398 0.00010704 0.001418747
Xetrov72028426|Xetrov72028426 2.27906284 2.287429816 0.590540442 3.873451594 0.00010731 0.001421222
Xetrov72016201|Xetrov72016201|nova2 191.689309 1.656095503 0.427585857 3.873129746 0.00010745 0.001422101
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Xetrov72041582|Xetrov72041582|cyp11b2 5.5708846 2.004140857 0.51768558 3.871347657 0.00010824 0.001430529
Xetrov72036442|Xetrov72036442|or56a1 11.1362129 1.796845375 0.464692891 3.866737387 0.0001103 0.001455789
Xetrov72023942|Xetrov72023942 5.9317113 2.283946377 0.590907029 3.865153508 0.00011102 0.001461173
Xetrov72024794|Xetrov72024794 28.9970398 1.745445575 0.451678382 3.86435491 0.00011138 0.001464938
Xetrov72035666|Xetrov72035666 38.3347521 1.693937792 0.438441385 3.863544481 0.00011175 0.001468783
Xetrov72000289|Xetrov72000289|fam83b 51.1708854 1.551347658 0.401707879 3.86188009 0.00011252 0.001476767
Xetrov72007647|Xetrov72007647|slc38a5 83.3609064 1.212748395 0.314153909 3.860363851 0.00011322 0.001484926
Xetrov72012830|Xetrov72012830|col27a1 38.929186 1.855117624 0.481843758 3.850039757 0.0001181 0.00153716
Xetrov72015574|Xetrov72015574 4.66643567 2.2873207 0.594256038 3.849049152 0.00011858 0.001542323
Xetrov72008372|Xetrov72008372 12.0258256 2.118056428 0.550675279 3.846289288 0.00011992 0.001554423
Xetrov72041261|Xetrov72041261 171.268608 1.611892702 0.419070125 3.846355548 0.00011989 0.001554423
Xetrov72000646|Xetrov72000646 30.2969275 2.075231432 0.539984948 3.84312829 0.00012148 0.001572424
Xetrov72010854|Xetrov72010854|lrrc19 7.47428583 2.171075157 0.564984839 3.842714009 0.00012168 0.001574
Xetrov72029601|Xetrov72029601|zc3h12a 17.3590872 1.789221082 0.465663376 3.842305785 0.00012188 0.001575539
Xetrov72016957|Xetrov72016957|gga3 122.340578 1.124737898 0.292741225 3.842089195 0.00012199 0.001575849
Xetrov72007765|Xetrov72007765 177.653059 1.418172972 0.369433126 3.838781292 0.00012365 0.001593948
Xetrov72000977|Xetrov72000977|vit 1.50085968 2.265525521 0.590489553 3.83669027 0.0001247 0.001605437
Xetrov72026363|Xetrov72026363|wnt4 55.1561173 1.498379127 0.39059239 3.836170815 0.00012497 0.001607406
Xetrov72039496|Xetrov72039496|glt8d2 4.78511717 2.198113581 0.574472148 3.826318805 0.00013007 0.001664273
Xetrov72011066|Xetrov72011066|rgs16 438.294382 1.085321851 0.283686807 3.825774844 0.00013036 0.001666821
Xetrov72006912|Xetrov72006912|ciita 1.59348809 2.27564666 0.594893685 3.825299743 0.00013061 0.001668905
Xetrov72027970|Xetrov72027970 28.3881578 1.888206933 0.493721258 3.824439197 0.00013107 0.00167361
Xetrov72013786|Xetrov72013786|ism2 434.432871 1.511235883 0.395588978 3.82021736 0.00013333 0.001700213
Xetrov72017290|Xetrov72017290|tom1l1 132.653363 1.80499567 0.472623383 3.819099385 0.00013394 0.001705627
Xetrov72039444|Xetrov72039444|tmem173 3.50958571 2.210357905 0.578881819 3.818323241 0.00013436 0.00170869
Xetrov72036336|Xetrov72036336|fam189b 9.84438647 1.809756637 0.474137166 3.816947431 0.00013511 0.001715925
Xetrov72022849|Xetrov72022849 5.00450427 2.136407707 0.559704626 3.817027066 0.00013507 0.001715925
Xetrov72032840|Xetrov72032840|abcc4 12.5022048 1.368891388 0.359006996 3.812993626 0.00013729 0.001742445
Xetrov72006609|Xetrov72006609 34.1923769 1.288916721 0.338246043 3.810589203 0.00013864 0.001755931
Xetrov72012507|Xetrov72012507|kif26a 667.609111 1.495616513 0.392527934 3.810216762 0.00013885 0.001757397
Xetrov72007805|Xetrov72007805 1.61417302 2.224171221 0.584287726 3.806636905 0.00014087 0.001781822
Xetrov72009497|Xetrov72009497|p4htm 5.1279247 2.097817752 0.551597344 3.8031687 0.00014286 0.00180333
Xetrov72037759|Xetrov72037759|dock4 27.8294148 1.450410252 0.381461346 3.802246985 0.00014339 0.001807631
Xetrov72016033|Xetrov72016033 14.6488854 2.034876513 0.53526542 3.801621472 0.00014375 0.00181099
Xetrov72024928|Xetrov72024928|ncam1 150.210131 1.899196373 0.499962958 3.798674165 0.00014547 0.001831433
Xetrov72000121|Xetrov72000121|ltbp1 5.59463312 2.046284045 0.53912749 3.795547591 0.00014732 0.001853431
Xetrov72027693|Xetrov72027693|cacng7 4.09958115 2.263338933 0.596357118 3.795274449 0.00014748 0.001854234
Xetrov72001970|Xetrov72001970 129.733707 1.114896495 0.294058242 3.791413868 0.00014979 0.001877036
Xetrov72004692|Xetrov72004692|adam23 7.57405124 2.02407351 0.534028379 3.790198406 0.00015053 0.001882487
Xetrov72003731|Xetrov72003731 7.77933032 1.820599956 0.480399596 3.789761631 0.00015079 0.001883849
Xetrov72018755|Xetrov72018755|spef2 79.9478422 1.231107991 0.324857254 3.789689089 0.00015084 0.001883849
Xetrov72033525|Xetrov72033525|cdh17 3.06388092 2.241326022 0.591614544 3.788490402 0.00015157 0.001889202
Xetrov72011589|Xetrov72011589 31.9538 2.192592129 0.578941407 3.787243581 0.00015233 0.001897448
Xetrov72032356|Xetrov72032356|unnamed 6.5986048 2.034614577 0.538465183 3.778544354 0.00015775 0.00196107
Xetrov72019923|Xetrov72019923|slc28a3 51.7374301 1.182196461 0.312991139 3.777092424 0.00015867 0.001968635
Xetrov72004766|Xetrov72004766|loc388210 42.8879642 1.870515628 0.495417791 3.77563273 0.0001596 0.001978897
Xetrov72033012|Xetrov72033012 134.474456 1.174836783 0.311276851 3.774250411 0.00016049 0.001986302
Xetrov72023242|Xetrov72023242 6.893192 2.128402735 0.563933345 3.774209762 0.00016052 0.001986302
Xetrov72002721|Xetrov72002721 6.80707235 2.253538597 0.597119301 3.774017341 0.00016064 0.001986531
Xetrov72043496|Xetrov72043496 35.4504627 1.249733444 0.331169436 3.773698019 0.00016085 0.001987593
Xetrov72016913|Xetrov72016913|aoc3 5.84511509 1.889329439 0.500676039 3.773556733 0.00016094 0.001987593
Xetrov72016567|Xetrov72016567 47.0052831 1.161694869 0.308000395 3.771731753 0.00016212 0.001998462
Xetrov72010923|Xetrov72010923|igf2 1823.64958 1.845325777 0.489254879 3.771706442 0.00016214 0.001998462
Xetrov72023501|Xetrov72023501|sh2d4a 75.0660736 1.179250134 0.312674171 3.771498395 0.00016227 0.001998821
Xetrov72023474|Xetrov72023474|fam190a 6.39659442 1.844522731 0.48924204 3.770164014 0.00016314 0.002008225
Xetrov72040897|Xetrov72040897 13.8292661 1.66932993 0.442813658 3.769824844 0.00016336 0.002009643
Xetrov72015512|Xetrov72015512 18.1530278 1.234473358 0.32748732 3.769530246 0.00016356 0.002010703
Xetrov72042561|Xetrov72042561|gpr33 2.31300587 2.179701505 0.578315391 3.769053255 0.00016387 0.002013235
Xetrov72003077|Xetrov72003077 7.34713496 1.88613512 0.500671033 3.767214387 0.00016508 0.002024155
Xetrov72035700|Xetrov72035700 24.5045376 1.695591973 0.450188498 3.766404474 0.00016562 0.002029408
Xetrov72002499|Xetrov72002499 6.00910801 2.103510014 0.55864066 3.765408004 0.00016628 0.002036195
Xetrov72015494|Xetrov72015494 2.90600213 2.212073571 0.58774076 3.763689231 0.00016743 0.002047585
Xetrov72015791|Xetrov72015791 10.8162717 2.042318104 0.543212052 3.759706906 0.00017011 0.002078987
Xetrov72014934|Xetrov72014934|clec4e 104.14967 1.039044804 0.276374139 3.759558718 0.00017021 0.002078987
Xetrov72032279|Xetrov72032279 52.0059625 1.420151119 0.377938419 3.757625705 0.00017153 0.002090779
Xetrov72005662|Xetrov72005662 3.42113905 2.237740757 0.596381923 3.752194137 0.00017529 0.002131362
Xetrov72013772|Xetrov72013772|olfm1 22.3699707 1.536399044 0.409520625 3.751701253 0.00017564 0.00213418
Xetrov72042674|Xetrov72042674|unnamed 3.38851513 2.209167146 0.589328513 3.748617444 0.00017781 0.002153641
Xetrov72033178|Xetrov72033178 47.4218543 1.703132817 0.454330276 3.748666791 0.00017778 0.002153641
Xetrov72025466|Xetrov72025466 23.010839 1.211851112 0.323350159 3.747798095 0.00017839 0.002157911
Xetrov72032117|Xetrov72032117|unnamed 26.3374102 1.734618614 0.463520444 3.74226992 0.00018237 0.002200302
Xetrov72003335|Xetrov72003335 2091.50294 1.300055318 0.347575501 3.740353722 0.00018376 0.002214308
Xetrov72023913|Xetrov72023913 23.7460838 1.429987528 0.382359859 3.739899718 0.00018409 0.002216893
Xetrov72005026|Xetrov72005026|grk7 15.5037266 1.576587595 0.421586044 3.73965794 0.00018427 0.002217608
Xetrov72028322|Xetrov72028322 4.13140532 1.876108416 0.501989831 3.737343466 0.00018598 0.002235258
Xetrov72005701|Xetrov72005701|frzb 4282.48347 1.360177865 0.363964723 3.737114562 0.00018614 0.002235866
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Xetrov72042660|Xetrov72042660 2.59847594 2.209054623 0.591293346 3.735970709 0.00018699 0.002241767
Xetrov72015353|Xetrov72015353 10.5961351 1.653726598 0.44268172 3.73570112 0.00018719 0.002242742
Xetrov72036573|Xetrov72036573|unnamed 10.0123193 2.173492028 0.581906885 3.735119969 0.00018763 0.002246499
Xetrov72039583|Xetrov72039583 5.37540642 2.022991585 0.541665356 3.734762735 0.00018789 0.002248261
Xetrov72030419|Xetrov72030419 5.13328091 2.086198859 0.55877421 3.733527461 0.00018882 0.002255023
Xetrov72038616|Xetrov72038616|klhl25 26.3084801 1.111894867 0.298057326 3.730473201 0.00019112 0.002279647
Xetrov72017809|Xetrov72017809 10.4392159 2.106079048 0.56463613 3.729975706 0.0001915 0.002282707
Xetrov72030660|Xetrov72030660|wnt11 38.4135411 1.968313713 0.527999904 3.727867562 0.00019311 0.002300426
Xetrov72002391|Xetrov72002391 3.23721758 2.160047389 0.579556062 3.727072376 0.00019372 0.002306235
Xetrov72000478|Xetrov72000478 9.65708884 2.080666084 0.558558396 3.725064557 0.00019527 0.0023232
Xetrov72027073|Xetrov72027073|c1orf158 15.8749967 2.094700994 0.562405355 3.724539558 0.00019567 0.00232657
Xetrov72006867|Xetrov72006867 7.0960384 1.983644949 0.532695663 3.723786554 0.00019626 0.002332052
Xetrov72040813|Xetrov72040813 9.62863663 2.158626383 0.58019297 3.72053178 0.0001988 0.002356368
Xetrov72023353|Xetrov72023353 5.27371681 1.982885273 0.532939943 3.720654266 0.00019871 0.002356368
Xetrov72031862|Xetrov72031862 76.3070575 1.687810301 0.453611797 3.72082541 0.00019857 0.002356368
Xetrov72011379|Xetrov72011379 9.63950609 2.186535211 0.588002636 3.718580627 0.00020035 0.002371656
Xetrov72003988|Xetrov72003988|or1e1 6.62530578 1.971915076 0.530283035 3.718608638 0.00020032 0.002371656
Xetrov72003227|Xetrov72003227 10.4210825 1.773280598 0.477008389 3.717504007 0.0002012 0.0023773
Xetrov72016517|Xetrov72016517 89.170619 1.569430551 0.422145867 3.717744682 0.00020101 0.0023773
Xetrov72035718|Xetrov72035718 23.3862366 1.89329315 0.509494826 3.716020366 0.00020239 0.002389796
Xetrov72012582|Xetrov72012582|pappa 21.2053001 1.670184822 0.449547267 3.715259653 0.000203 0.002392497
Xetrov72007089|Xetrov72007089 18.7951361 1.943707904 0.523160538 3.715318269 0.00020295 0.002392497
Xetrov72035830|Xetrov72035830|lrrc3b 4.54162458 2.121855514 0.57107865 3.715522394 0.00020278 0.002392497
Xetrov72018594|Xetrov72018594|svep1 23.3882577 1.578981604 0.42507605 3.714586144 0.00020354 0.002395879
Xetrov72005984|Xetrov72005984|stat4 4.61773871 2.146145172 0.578397216 3.710503981 0.00020685 0.002427263
Xetrov72002351|Xetrov72002351 7.33644926 1.938305136 0.523039242 3.705850309 0.00021068 0.002469196
Xetrov72019320|Xetrov72019320|rai14 101.905388 1.068836053 0.288503399 3.704760699 0.00021159 0.002476752
Xetrov72010797|Xetrov72010797 13.4551358 1.8520673 0.500153893 3.702994868 0.00021307 0.002492513
Xetrov72009819|Xetrov72009819|fezf2 72.0708857 2.020757667 0.545836402 3.702130636 0.0002138 0.002497917
Xetrov72032283|Xetrov72032283 53.8814644 1.115467029 0.301729807 3.696906981 0.00021824 0.002548279
Xetrov72027254|Xetrov72027254 24.9911227 2.01227061 0.544523411 3.695471246 0.00021948 0.002561136
Xetrov72038883|Xetrov72038883|gabrg2 8.96678393 1.851105197 0.501706446 3.689618126 0.00022459 0.002614305
Xetrov72041363|Xetrov72041363 4.13679982 2.165630916 0.587204958 3.688032408 0.000226 0.002626093
Xetrov72028594|Xetrov72028594 13.9086833 2.142670601 0.581665867 3.683679448 0.00022989 0.002667759
Xetrov72017513|Xetrov72017513|crhr1.2 9.41640268 2.196224358 0.596399443 3.68247218 0.00023098 0.002677129
Xetrov72021266|Xetrov72021266|shd 6.65835063 2.087865664 0.567324165 3.680198716 0.00023305 0.00269945
Xetrov72016311|Xetrov72016311 1.63814579 2.18887509 0.594955321 3.679057926 0.0002341 0.002708222
Xetrov72007212|Xetrov72007212 2.89647894 2.186311724 0.59439567 3.678209371 0.00023488 0.002713482
Xetrov72041925|Xetrov72041925 14.1352959 1.768084222 0.480706741 3.678093256 0.00023498 0.002713482
Xetrov72029927|Xetrov72029927|c1orf114 17149.5322 1.107853423 0.301275147 3.677214778 0.00023579 0.002721173
Xetrov72026780|Xetrov72026780|spib 33.3816005 2.011782604 0.547780687 3.672605935 0.00024009 0.002763965
Xetrov72043192|Xetrov72043192|sycp2 50.5297544 1.318881627 0.359200357 3.671715807 0.00024093 0.002771917
Xetrov72007520|Xetrov72007520 5.38959622 1.772447912 0.483000548 3.669660252 0.00024287 0.002792595
Xetrov72003710|Xetrov72003710 2.47559577 2.187137922 0.596036778 3.669468067 0.00024306 0.00279299
Xetrov72036045|Xetrov72036045 8.42154021 1.500828826 0.410052283 3.66009138 0.00025213 0.002883138
Xetrov72012201|Xetrov72012201 3.99174178 2.164199473 0.591939795 3.656114169 0.00025607 0.002924665
Xetrov72015754|Xetrov72015754|snapc4 94.2110404 1.14095221 0.312566348 3.650272075 0.00026196 0.002984758
Xetrov72034157|Xetrov72034157|kcng2 6.91569655 2.001118415 0.548587383 3.647766017 0.00026453 0.003011533
Xetrov72004938|Xetrov72004938|nr4a2 26.454268 1.572007525 0.431096099 3.646536188 0.0002658 0.003021158
Xetrov72001637|Xetrov72001637|plscr2 8.40311342 2.061730341 0.565706346 3.644523976 0.00026789 0.003041222
Xetrov72016816|Xetrov72016816|unnamed 12.0354735 1.818474274 0.499054301 3.643840502 0.0002686 0.003046416
Xetrov72007857|Xetrov72007857 36.9362315 1.53890484 0.422338038 3.643775129 0.00026867 0.003046416
Xetrov72043649|Xetrov72043649 14.6459866 2.092282304 0.574962839 3.63898701 0.00027371 0.003098055
Xetrov72003432|Xetrov72003432|slc34a3 8.66231928 1.831295256 0.503243553 3.638984034 0.00027372 0.003098055
Xetrov72021248|Xetrov72021248 55.8762814 1.890856066 0.519600937 3.639054381 0.00027364 0.003098055
Xetrov72028238|Xetrov72028238 6.67033201 1.753319251 0.482414797 3.634464079 0.00027856 0.003141546
Xetrov72035767|Xetrov72035767 29.7819446 1.934922715 0.532380129 3.634475838 0.00027855 0.003141546
Xetrov72018291|Xetrov72018291 26.036369 2.128073765 0.586561445 3.628049169 0.00028557 0.003212928
Xetrov72021812|Xetrov72021812 17.6819583 1.506147647 0.415163563 3.627841608 0.0002858 0.003213592
Xetrov72011539|Xetrov72011539 26.5441506 1.48344064 0.408944275 3.627488468 0.00028619 0.003216069
Xetrov72032090|Xetrov72032090 4.3605848 2.143995498 0.591127586 3.626958968 0.00028678 0.003218828
Xetrov72005126|Xetrov72005126|tgfb1i1 9.02449105 2.163824024 0.596798624 3.625718858 0.00028816 0.003232389
Xetrov72004919|Xetrov72004919 17.4715701 1.65803324 0.457640486 3.623003845 0.0002912 0.003260695
Xetrov72011650|Xetrov72011650 3.15234166 2.157827498 0.595584457 3.623041991 0.00029116 0.003260695
Xetrov72020282|Xetrov72020282|katnal2 327.066626 1.013535762 0.28005159 3.619103766 0.00029563 0.00330668
Xetrov72005653|Xetrov72005653|prss29 74.1322447 1.252324739 0.346034602 3.61907373 0.00029566 0.00330668
Xetrov72043518|Xetrov72043518 35.5598107 1.170437653 0.323461736 3.618473289 0.00029635 0.003308466
Xetrov72012876|Xetrov72012876|c5 174.121849 1.650048628 0.456406797 3.615302485 0.0003 0.003335387
Xetrov72042318|Xetrov72042318 2.20151162 2.152157058 0.595279482 3.615372479 0.00029992 0.003335387
Xetrov72043082|Xetrov72043082 48.0727371 1.34364919 0.371718595 3.614694575 0.0003007 0.003341251
Xetrov72019649|Xetrov72019649 57.03913 1.461611782 0.404588836 3.612585543 0.00030316 0.003364583
Xetrov72023652|Xetrov72023652 178.730191 1.222858485 0.338676084 3.610702213 0.00030537 0.003387115
Xetrov72014227|Xetrov72014227|fhl1 11.8370842 1.847761162 0.511809576 3.610251249 0.0003059 0.003391013
Xetrov72042755|Xetrov72042755 4.71471021 1.861475698 0.515663858 3.609862646 0.00030636 0.003394099
Xetrov72039058|Xetrov72039058|rgma 445.965656 1.069050627 0.296212934 3.609061262 0.00030731 0.003402599
Xetrov72010206|Xetrov72010206|dmbx1 275.103053 1.447960191 0.402041906 3.601515587 0.00031637 0.003488562
223
Xetrov72037788|Xetrov72037788|lamb1 3379.97709 1.585054231 0.440153643 3.601138507 0.00031683 0.003491583
Xetrov72035294|Xetrov72035294 16.7865885 1.707707712 0.474398479 3.599732691 0.00031854 0.003506409
Xetrov72008802|Xetrov72008802|gpr56 88.7056446 1.48378837 0.412213379 3.599563835 0.00031875 0.003506638
Xetrov72020704|Xetrov72020704|cd34 9.52862543 1.722066106 0.478735512 3.597113781 0.00032177 0.00353157
Xetrov72017770|Xetrov72017770|tmem98 13.7396629 1.339918198 0.372718249 3.594989516 0.00032441 0.003556366
Xetrov72040836|Xetrov72040836|dgki 6.14404538 1.963998506 0.546849218 3.591480869 0.0003288 0.003601007
Xetrov72040814|Xetrov72040814|rergl 8.57746038 1.756318968 0.489029526 3.591437478 0.00032886 0.003601007
Xetrov72001349|Xetrov72001349|hao1 909.02975 1.406287595 0.39161117 3.591030344 0.00032937 0.003604542
Xetrov72006623|Xetrov72006623 7.33738702 1.673621687 0.466121092 3.590529835 0.00033001 0.003609374
Xetrov72010358|Xetrov72010358|dbx1 22.2669519 1.540243239 0.429285815 3.587920182 0.00033333 0.003639343
Xetrov72007359|Xetrov72007359 7.11811499 2.099261223 0.585086707 3.58794893 0.00033329 0.003639343
Xetrov72031305|Xetrov72031305|msra.2 122.018692 1.137946678 0.317293997 3.586410995 0.00033526 0.003656222
Xetrov72030212|Xetrov72030212|gabra5 1.5440101 2.128587533 0.593768375 3.584878588 0.00033724 0.003673612
Xetrov72022200|Xetrov72022200|yjefn3 4.08136258 1.905287521 0.531480116 3.584870751 0.00033725 0.003673612
Xetrov72042385|Xetrov72042385 6.7837798 1.874790463 0.523336089 3.582383293 0.00034047 0.003702357
Xetrov72036532|Xetrov72036532 45.3379898 1.647753437 0.460312344 3.579642081 0.00034407 0.003739251
Xetrov72025601|Xetrov72025601|gpr162 1.92235366 2.130423978 0.595345972 3.57846375 0.00034562 0.003749896
Xetrov72010843|Xetrov72010843 40.5362435 1.365302634 0.382012287 3.573975706 0.0003516 0.003807712
Xetrov72022803|Xetrov72022803 28.8930599 1.837605052 0.514579202 3.571083019 0.00035551 0.003839244
Xetrov72037269|Xetrov72037269 17.9788066 1.380124967 0.386612827 3.569785764 0.00035727 0.003856095
Xetrov72042007|Xetrov72042007 1.25455373 2.066274766 0.579172345 3.56763368 0.00036022 0.003881222
Xetrov72022052|Xetrov72022052 10.4204023 2.018469006 0.566036747 3.565968138 0.00036252 0.003903725
Xetrov72037687|Xetrov72037687|reln 13.0947344 1.494990603 0.419284889 3.565572337 0.00036306 0.003907388
Xetrov72001924|Xetrov72001924|tcf21 2.78099365 2.107019454 0.591050012 3.564875071 0.00036403 0.003913318
Xetrov72042534|Xetrov72042534 1.57865152 2.121076942 0.595052698 3.564519496 0.00036452 0.003914158
Xetrov72019555|Xetrov72019555|c19orf26 86.827271 1.124971395 0.315745254 3.562908334 0.00036677 0.003933783
Xetrov72021850|Xetrov72021850|tmem119 24.3299125 1.918373838 0.538722275 3.56096996 0.00036949 0.003956182
Xetrov72008118|Xetrov72008118 26.0159766 1.181532972 0.331847394 3.560470848 0.00037019 0.003961458
Xetrov72018307|Xetrov72018307|a2ml1 111.761715 1.757067753 0.493563996 3.559959333 0.00037091 0.003966928
Xetrov72043464|Xetrov72043464 2.63621996 2.080271367 0.585136984 3.555186948 0.00037771 0.004032765
Xetrov72038274|Xetrov72038274|unc5a 23.8247692 1.558488554 0.438356132 3.555302272 0.00037755 0.004032765
Xetrov72036504|Xetrov72036504|hcn4 7.21711985 2.004664726 0.563938466 3.554757913 0.00037833 0.004037063
Xetrov72023714|Xetrov72023714 17.2226455 1.631886939 0.459260492 3.553292668 0.00038044 0.004057319
Xetrov72033979|Xetrov72033979|map3k3 14.7495552 1.721941528 0.484785867 3.551963135 0.00038237 0.004073262
Xetrov72011226|Xetrov72011226|mgp 2.74572973 2.08861237 0.588603258 3.548421357 0.00038755 0.004121442
Xetrov72028791|Xetrov72028791|lmo7 804.475206 1.156852494 0.326190241 3.54655765 0.0003903 0.004146022
Xetrov72024981|Xetrov72024981|slc27a3 21.4036925 1.592053161 0.449007356 3.545717325 0.00039155 0.004155631
Xetrov72043514|Xetrov72043514 59.1393788 1.369554772 0.386263326 3.545650541 0.00039165 0.004155631
Xetrov72023543|Xetrov72023543 16.0768827 1.334478504 0.376452375 3.544880023 0.00039279 0.004165451
Xetrov72019781|Xetrov72019781|pde8b 54.4103648 1.512708909 0.426886205 3.543588179 0.00039472 0.004181204
Xetrov72016015|Xetrov72016015 5.26549963 2.061083542 0.581623536 3.543672867 0.0003946 0.004181204
Xetrov72035440|Xetrov72035440 11.790862 1.736473329 0.49029388 3.541698969 0.00039756 0.004208895
Xetrov72012094|Xetrov72012094 4.34332414 2.095007676 0.591648055 3.540969431 0.00039866 0.004218179
Xetrov72018820|Xetrov72018820|prr14l 459.143016 1.100285992 0.310820802 3.539936786 0.00040022 0.00423234
Xetrov72030129|Xetrov72030129|fuca1 197.233041 1.146178929 0.323944252 3.538198081 0.00040287 0.00425553
Xetrov72002992|Xetrov72002992 3.56047605 2.038377003 0.576749337 3.534251145 0.00040893 0.00431717
Xetrov72032248|Xetrov72032248 10.1710525 1.453855446 0.411396445 3.533952382 0.0004094 0.004319631
Xetrov72001455|Xetrov72001455|unnamed 155.648497 2.091870324 0.59246072 3.530816903 0.00041428 0.00435895
Xetrov72042893|Xetrov72042893|xa-1 4.91823449 2.064164962 0.584949866 3.528789529 0.00041747 0.004388779
Xetrov72042579|Xetrov72042579 2.11566127 2.082681216 0.590704878 3.525755911 0.00042228 0.004433192
Xetrov72000816|Xetrov72000816|bai3 8.22217628 1.477860532 0.419301964 3.52457336 0.00042417 0.004449572
Xetrov72020387|Xetrov72020387|slc41a1 26.1844534 1.2734801 0.361323864 3.524483785 0.00042431 0.004449572
Xetrov72033171|Xetrov72033171|myom1 30.3106796 1.814656687 0.515042457 3.523314751 0.00042619 0.004465982
Xetrov72038357|Xetrov72038357|slc6a15 36.8874333 1.566485781 0.444837358 3.521479821 0.00042915 0.004485307
Xetrov72020536|Xetrov72020536|gtpbp3 23.7323239 1.274720535 0.362068109 3.52066504 0.00043047 0.004496615
Xetrov72019451|Xetrov72019451|eef2.2 51.4470784 1.154690884 0.328203943 3.518211492 0.00043447 0.004528352
Xetrov72006857|Xetrov72006857 8.1168182 1.653631313 0.470150678 3.5172369 0.00043606 0.004539987
Xetrov72032426|Xetrov72032426 1.17089759 2.061677874 0.586659089 3.51426904 0.00044097 0.004580541
Xetrov72037177|Xetrov72037177 5.3318415 1.892349595 0.539379134 3.508384874 0.00045084 0.004667978
Xetrov72027941|Xetrov72027941 76.1237717 1.150425442 0.328131578 3.505988206 0.00045492 0.004705039
Xetrov72040922|Xetrov72040922|nodal3.2 7.80284636 2.035840623 0.580712458 3.505763645 0.0004553 0.004706426
Xetrov72041983|Xetrov72041983 7.89523107 1.913359777 0.545833473 3.505391061 0.00045594 0.00470785
Xetrov72002551|Xetrov72002551 1.90320727 2.088681267 0.595824095 3.505533401 0.00045569 0.00470785
Xetrov72029538|Xetrov72029538|sh2b2 80.2008304 1.028851878 0.293574717 3.504565678 0.00045735 0.004717295
Xetrov72005651|Xetrov72005651 3.66252854 2.088251428 0.596594349 3.500286971 0.00046476 0.004784749
Xetrov72005138|Xetrov72005138|chrna7 5.34814364 1.828157243 0.52268695 3.497614096 0.00046944 0.004818218
Xetrov72010901|Xetrov72010901|crp.3 2.31327247 2.063469418 0.590458324 3.494691046 0.00047461 0.004865988
Xetrov72005402|Xetrov72005402 28.4032273 1.900328248 0.54412067 3.492475753 0.00047857 0.004895869
Xetrov72018158|Xetrov72018158 3.29393891 2.06950311 0.592893092 3.49051648 0.00048209 0.004923885
Xetrov72020787|Xetrov72020787|fam113a 94.000657 1.314200473 0.376575599 3.489871563 0.00048325 0.004933107
Xetrov72003967|Xetrov72003967 31.9435523 1.748175877 0.501978055 3.482574309 0.00049662 0.005061305
Xetrov72005546|Xetrov72005546 6.65886614 1.974110399 0.567060929 3.481302091 0.00049898 0.00507991
Xetrov72019920|Xetrov72019920|map9 94.9365213 1.294488731 0.371868177 3.481041972 0.00049947 0.005082019
Xetrov72020069|Xetrov72020069|ggt1 1276.28534 1.503938449 0.432323707 3.478732312 0.00050379 0.005120567
Xetrov72029169|Xetrov72029169|scube1 42.7215698 1.44857541 0.416506587 3.477917169 0.00050533 0.005127861
Xetrov72023170|Xetrov72023170 22.4586143 1.398817858 0.402424285 3.475977741 0.000509 0.005162306
224
Xetrov72037272|Xetrov72037272|znf268 48.2082194 1.087039449 0.312882813 3.474270254 0.00051225 0.00519133
Xetrov72004046|Xetrov72004046 4.10380282 2.074171776 0.597023972 3.474185078 0.00051241 0.00519133
Xetrov72023539|Xetrov72023539 4.07745759 1.856670537 0.534493686 3.473699664 0.00051334 0.005197934
Xetrov72000969|Xetrov72000969 6335.2487 1.288150881 0.371115303 3.47102604 0.00051847 0.005238699
Xetrov72020283|Xetrov72020283|hcn1 2.27020935 2.068355228 0.595888199 3.471045796 0.00051844 0.005238699
Xetrov72022817|Xetrov72022817 23.9665543 1.300479385 0.374648406 3.47119957 0.00051814 0.005238699
Xetrov72034843|Xetrov72034843|ca8 6.76470923 1.705685931 0.491617441 3.469539094 0.00052135 0.005261772
Xetrov72022984|Xetrov72022984|cmtm5 40.9409603 1.141385547 0.328985131 3.469413778 0.0005216 0.005261772
Xetrov72006686|Xetrov72006686 15.0257933 1.354248893 0.390566842 3.467393403 0.00052553 0.005295812
Xetrov72029308|Xetrov72029308|dscam 37.3162646 1.278049023 0.368845897 3.464994548 0.00053024 0.005331864
Xetrov72009475|Xetrov72009475 7.71743316 1.758097862 0.507652692 3.463190268 0.00053381 0.005362022
Xetrov72012973|Xetrov72012973 9.81524967 1.953887967 0.564281884 3.462609774 0.00053496 0.005370738
Xetrov72002364|Xetrov72002364 1.94700768 2.061499782 0.595704399 3.460608625 0.00053896 0.005402178
Xetrov72025376|Xetrov72025376|dixdc1 3.8897844 2.020361536 0.584405896 3.457120385 0.00054598 0.005460969
Xetrov72033705|Xetrov72033705 37.2896902 1.472283953 0.426033503 3.45579383 0.00054868 0.005482091
Xetrov72019580|Xetrov72019580|tgm1 7.63565316 1.917861422 0.555143727 3.454711505 0.00055088 0.005501225
Xetrov72025940|Xetrov72025940 29.0711918 1.361037747 0.394248745 3.452231024 0.00055597 0.005546169
Xetrov72000862|Xetrov72000862|epha7 35.5346532 1.960385912 0.568097844 3.450789215 0.00055895 0.005572929
Xetrov72030702|Xetrov72030702|myo18a 60.575416 1.022539493 0.296479195 3.448941814 0.00056279 0.005608227
Xetrov72010500|Xetrov72010500|ctsw 6.84968367 1.529608322 0.444152934 3.443877558 0.00057344 0.005708288
Xetrov72032509|Xetrov72032509|rabl3 7.32283811 1.68832474 0.490588019 3.441430841 0.00057865 0.005757119
Xetrov72037719|Xetrov72037719|ptprz1 4.86035922 2.053821258 0.596869023 3.440991537 0.00057959 0.005763429
Xetrov72035318|Xetrov72035318 392.055689 1.259103091 0.36597235 3.440432293 0.00058079 0.005772305
Xetrov72023342|Xetrov72023342 17.1469172 1.20143678 0.349261266 3.439937078 0.00058185 0.005779827
Xetrov72000622|Xetrov72000622|nlgn1 3.23747109 1.855550283 0.539963107 3.436439007 0.00058942 0.005848811
Xetrov72034569|Xetrov72034569|sfrp4 6.22144392 1.828853198 0.532494398 3.434502228 0.00059364 0.005884566
Xetrov72035066|Xetrov72035066 18.818798 1.826786328 0.532098703 3.433171925 0.00059656 0.005907298
Xetrov72016328|Xetrov72016328 1.34245337 2.041548753 0.594780141 3.432442698 0.00059817 0.005920094
Xetrov72038674|Xetrov72038674|unnamed 660.379216 1.139464645 0.332210478 3.429947944 0.0006037 0.00596226
Xetrov72021276|Xetrov72021276 20.5851 1.382464662 0.403161385 3.429060206 0.00060568 0.005978661
Xetrov72037337|Xetrov72037337|creb3l3 1.89228862 2.021493325 0.589616856 3.428486321 0.00060696 0.005988177
Xetrov72028729|Xetrov72028729|myh15 3.59437516 1.961133603 0.572117523 3.427850963 0.00060838 0.005996252
Xetrov72016633|Xetrov72016633|lama5 2678.82782 1.417935367 0.413653179 3.427836263 0.00060841 0.005996252
Xetrov72011948|Xetrov72011948 3.304951 2.045320356 0.596846369 3.426879112 0.00061056 0.00601428
Xetrov72024967|Xetrov72024967|prdm16 10.0367299 1.909137126 0.558145156 3.420502903 0.00062506 0.006126951
Xetrov72008928|Xetrov72008928|rhpn2 980.552941 1.091247239 0.319028426 3.420532937 0.00062499 0.006126951
Xetrov72008516|Xetrov72008516 140.14877 1.502640318 0.439762824 3.416933481 0.00063331 0.006199435
Xetrov72025562|Xetrov72025562 92.764131 1.097805632 0.321332623 3.416415123 0.00063451 0.00620158
Xetrov72003350|Xetrov72003350 1206.43131 1.542165459 0.451382404 3.416538716 0.00063423 0.00620158
Xetrov72025631|Xetrov72025631|rnf207 8.11188676 1.718819647 0.50320826 3.415722247 0.00063613 0.006214155
Xetrov72039229|Xetrov72039229|prkar2b 108.19672 1.409386437 0.412674957 3.415245857 0.00063725 0.006221807
Xetrov72018436|Xetrov72018436 1.65684057 2.032739575 0.595448185 3.413797581 0.00064064 0.006251732
Xetrov72010118|Xetrov72010118|unnamed 14.6493596 1.304761545 0.383016171 3.406544273 0.00065791 0.006403646
Xetrov72025209|Xetrov72025209|myos 173.587662 1.730160786 0.508148511 3.404832935 0.00066205 0.006437255
Xetrov72020380|Xetrov72020380|slc7a8 1345.95906 1.268552306 0.372928031 3.401600846 0.00066992 0.006503789
Xetrov72004414|Xetrov72004414|srebf1 16.7755561 1.056600474 0.310737199 3.400302503 0.00067311 0.006531385
Xetrov72039144|Xetrov72039144|plin1 1.95724196 2.011459389 0.591743356 3.399209079 0.00067581 0.006550804
Xetrov72033544|Xetrov72033544 15.2378107 1.24649893 0.366939535 3.397014522 0.00068125 0.006596776
Xetrov72012132|Xetrov72012132 6.93461759 1.725255558 0.508064804 3.395739172 0.00068444 0.006613985
Xetrov72013088|Xetrov72013088|lrfn1 11.9186179 1.752639049 0.516227837 3.395088222 0.00068607 0.006626331
Xetrov72025686|Xetrov72025686|slc43a1 1202.69896 1.038293936 0.30596119 3.393547844 0.00068994 0.006653475
Xetrov72007997|Xetrov72007997|tulp1 65.9966516 1.608237409 0.473905116 3.393585249 0.00068984 0.006653475
Xetrov72027211|Xetrov72027211|cyhr1 14.2704009 1.366286837 0.402696481 3.392845233 0.00069171 0.006660333
Xetrov72017912|Xetrov72017912 54.3618901 1.410879179 0.415824859 3.39296497 0.00069141 0.006660333
Xetrov72011441|Xetrov72011441 10.13663 1.98823886 0.586114864 3.392234152 0.00069325 0.006671015
Xetrov72023587|Xetrov72023587 1.83092183 1.974849202 0.582224048 3.391905932 0.00069408 0.006672972
Xetrov72028042|Xetrov72028042 13.6610506 1.390253997 0.409971375 3.391100167 0.00069613 0.006689208
Xetrov72015532|Xetrov72015532 7.05013826 1.788882632 0.527627192 3.39042919 0.00069783 0.006698768
Xetrov72023364|Xetrov72023364 8.39355574 1.728119915 0.50974191 3.390186057 0.00069845 0.006701297
Xetrov72042978|Xetrov72042978 21.600422 1.543790103 0.455604229 3.388445505 0.0007029 0.006740539
Xetrov72029976|Xetrov72029976|bivm 7.35832812 1.899395093 0.560770371 3.387117419 0.00070631 0.006767507
Xetrov72014630|Xetrov72014630 145.515278 1.228632618 0.362773375 3.386777264 0.00070719 0.006771314
Xetrov72029075|Xetrov72029075|fam160a2 23.8009787 1.336426492 0.394832586 3.384792793 0.00071232 0.006806614
Xetrov72009427|Xetrov72009427|unnamed 806.864858 1.11359623 0.329077556 3.383993256 0.0007144 0.006823004
Xetrov72028453|Xetrov72028453 4.28291149 1.954661135 0.577946824 3.382077819 0.0007194 0.006860321
Xetrov72035329|Xetrov72035329 18.4603847 1.664371918 0.492596154 3.378775708 0.00072809 0.006929216
Xetrov72021699|Xetrov72021699|sgtb 22.1325249 1.57785931 0.467558953 3.374674572 0.00073903 0.007015573
Xetrov72042393|Xetrov72042393|adamts12 2.51282143 2.000427108 0.592869153 3.374146047 0.00074045 0.007025516
Xetrov72009009|Xetrov72009009|mmp2 6.70985289 2.010713827 0.596207721 3.372505511 0.00074488 0.007063508
Xetrov72020929|Xetrov72020929|msr1 5.22076044 1.9908067 0.590415565 3.371873671 0.00074659 0.007069818
Xetrov72031875|Xetrov72031875 50.1357236 1.083811423 0.321428271 3.371860915 0.00074662 0.007069818
Xetrov72036061|Xetrov72036061 4.06485751 1.963458426 0.58272098 3.369465825 0.00075314 0.007124382
Xetrov72024130|Xetrov72024130 32.2427307 2.011704969 0.597492289 3.366913692 0.00076015 0.007187031
Xetrov72035341|Xetrov72035341 182.375094 1.086163656 0.322734101 3.365506318 0.00076403 0.00721655
Xetrov72013908|Xetrov72013908|foxa1 1755.70488 1.032093805 0.306828507 3.363748088 0.00076892 0.007251768
Xetrov72042847|Xetrov72042847 6.18895869 1.855981884 0.551742547 3.363854926 0.00076862 0.007251768
225
Xetrov72002457|Xetrov72002457 15.5952072 1.79851561 0.535369235 3.359392906 0.00078114 0.007349706
Xetrov72005007|Xetrov72005007|fzd5 11.758146 1.441077254 0.428996055 3.359185327 0.00078173 0.00735049
Xetrov72007631|Xetrov72007631 2.0203395 2.002399226 0.596249082 3.358326721 0.00078416 0.007368246
Xetrov72000005|Xetrov72000005|syne1 56.772047 1.608919539 0.479120595 3.358068 0.00078489 0.007368246
Xetrov72014827|Xetrov72014827|prrt1 36.4077287 1.462268923 0.43546033 3.357984238 0.00078513 0.007368246
Xetrov72031546|Xetrov72031546 2.98662745 1.996330537 0.59481808 3.356203523 0.0007902 0.007411704
Xetrov72034592|Xetrov72034592 22.3976763 1.321552663 0.394214304 3.352371156 0.00080123 0.007496412
Xetrov72036486|Xetrov72036486 1.65636352 1.930230199 0.576073486 3.350666616 0.00080617 0.007538958
Xetrov72032931|Xetrov72032931 19.0257819 1.199280745 0.357943691 3.350473199 0.00080674 0.007540481
Xetrov72026457|Xetrov72026457 5.96574253 1.685266175 0.503374684 3.347935898 0.00081416 0.007591543
Xetrov72000796|Xetrov72000796|tbx18 9.45458223 1.560354021 0.466126893 3.347487659 0.00081548 0.007599544
Xetrov72029060|Xetrov72029060|tubgcp5 176.185142 1.087991884 0.32505662 3.347084228 0.00081666 0.007603089
Xetrov72003609|Xetrov72003609 5.02386865 1.992066632 0.595299899 3.346324494 0.00081891 0.007620186
Xetrov72002900|Xetrov72002900 6.57811492 1.650583824 0.493450578 3.34498306 0.00082288 0.007642034
Xetrov72015471|Xetrov72015471 35.0830549 1.440473136 0.430696116 3.344523164 0.00082424 0.007650943
Xetrov72030122|Xetrov72030122 6.23373515 1.935486968 0.579365439 3.340701458 0.00083567 0.007734159
Xetrov72024020|Xetrov72024020|cers4 9.91358622 1.604778997 0.480519712 3.339673604 0.00083877 0.007757895
Xetrov72035897|Xetrov72035897 2.51209971 1.971947495 0.590753367 3.338021593 0.00084377 0.007793821
Xetrov72034126|Xetrov72034126|entpd3 21.0882232 1.381945933 0.414097092 3.337250993 0.00084612 0.007811632
Xetrov72032428|Xetrov72032428 381.393375 1.327049933 0.398050962 3.333869424 0.00085647 0.007899475
Xetrov72026993|Xetrov72026993 2.52783108 1.862762164 0.559277103 3.330660516 0.0008664 0.007983275
Xetrov72037598|Xetrov72037598 5.12453097 1.790357073 0.537718567 3.329542966 0.00086989 0.008007547
Xetrov72001128|Xetrov72001128|foxa2 568.067649 1.313677051 0.394548818 3.329567826 0.00086981 0.008007547
Xetrov72031998|Xetrov72031998 34.0986314 1.321693339 0.397094209 3.32841252 0.00087342 0.008036186
Xetrov72042518|Xetrov72042518 13.0323416 1.986527002 0.596995449 3.327541282 0.00087616 0.008057421
Xetrov72002742|Xetrov72002742 3.98643514 1.86946175 0.561911498 3.326968319 0.00087796 0.008066129
Xetrov72029602|Xetrov72029602|kcnq4 185.688791 1.288612105 0.387730309 3.323475295 0.00088903 0.008151677
Xetrov72004624|Xetrov72004624|c2orf67 36.2689194 1.362037161 0.410423924 3.318610544 0.00090467 0.008267085
Xetrov72023944|Xetrov72023944 3.66260423 1.979420043 0.596655778 3.317524303 0.00090819 0.008295273
Xetrov72028470|Xetrov72028470|gcgr 1.92710162 1.960083373 0.591217052 3.315336332 0.00091533 0.008340257
Xetrov72014309|Xetrov72014309|nkx2-1 4.36024793 1.684639734 0.508117913 3.31545039 0.00091496 0.008340257
Xetrov72021097|Xetrov72021097 10.563703 1.654289763 0.499018727 3.315085533 0.00091615 0.008343707
Xetrov72043386|Xetrov72043386 8.56262115 1.96766359 0.593865413 3.313315687 0.00092197 0.008388577
Xetrov72010125|Xetrov72010125 1.66413311 1.972812258 0.595503997 3.312844698 0.00092352 0.008394605
Xetrov72038380|Xetrov72038380|sema3e 1.90136938 1.970465941 0.595127047 3.311000482 0.00092963 0.008441977
Xetrov72032818|Xetrov72032818 2.19971668 1.959283443 0.591896008 3.310181886 0.00093235 0.008458549
Xetrov72035785|Xetrov72035785|reck 258.177879 1.265683464 0.38239748 3.309863502 0.00093342 0.008464099
Xetrov72035107|Xetrov72035107 3.26055208 1.855874362 0.560813433 3.309254472 0.00093545 0.008478452
Xetrov72000020|Xetrov72000020 12.5059686 1.466621396 0.443677942 3.305599078 0.00094774 0.008573323
Xetrov72042272|Xetrov72042272 7.6315603 1.663379936 0.504047416 3.300046551 0.00096669 0.008719636
Xetrov72023380|Xetrov72023380 1.32634391 1.873887991 0.567918898 3.299569706 0.00096833 0.008726105
Xetrov72028613|Xetrov72028613 6.23982487 1.71318131 0.519243896 3.299376892 0.000969 0.008727926
Xetrov72013709|Xetrov72013709|pip5kl1 13.9662704 1.636788494 0.496750092 3.294993842 0.00098424 0.008848279
Xetrov72033704|Xetrov72033704 12.2840324 1.354266868 0.411066651 3.294518939 0.0009859 0.008857065
Xetrov72009106|Xetrov72009106|itfg1 27.0079521 1.402144663 0.425608534 3.294446775 0.00098616 0.008857065
Xetrov72006127|Xetrov72006127|socs1 83.3246115 1.582441751 0.480359462 3.294286628 0.00098672 0.008857889
Xetrov72032937|Xetrov72032937 151.065698 1.211171128 0.367781068 3.293185085 0.00099059 0.008884199
Xetrov72036307|Xetrov72036307 12.9283193 1.394131959 0.423412611 3.292608492 0.00099263 0.008898199
Xetrov72020628|Xetrov72020628|palm2 6.64842458 1.418906189 0.431166805 3.29085211 0.00099884 0.008936926
Xetrov72028600|Xetrov72028600|dnhd1 20.3630303 1.077705047 0.327930793 3.286379537 0.00101484 0.009065141
Xetrov72037493|Xetrov72037493 4.44979658 1.876604281 0.571243432 3.285121853 0.00101938 0.009094768
Xetrov72018326|Xetrov72018326 9.9230832 1.628383224 0.495860885 3.283951754 0.00102362 0.009128287
Xetrov72033075|Xetrov72033075|tg 4.55469435 1.897595864 0.577906048 3.283571562 0.00102501 0.009136283
Xetrov72035000|Xetrov72035000|ptpla 4.76117894 1.946799723 0.593479044 3.280317549 0.0010369 0.009232799
Xetrov72013406|Xetrov72013406|traf3 16.8371322 1.161670175 0.354161846 3.280054548 0.00103787 0.009233466
Xetrov72012270|Xetrov72012270 52.2619959 1.6972348 0.517566395 3.279260046 0.0010408 0.009255131
Xetrov72004671|Xetrov72004671|iqca1 35.3259976 1.801111872 0.549345006 3.278653401 0.00104304 0.009257564
Xetrov72017962|Xetrov72017962 5.68565811 1.541936052 0.470341022 3.278336311 0.00104421 0.009263605
Xetrov72011535|Xetrov72011535|sec16b 7.71112168 1.813853466 0.553620793 3.27634635 0.0010516 0.009311586
Xetrov72028803|Xetrov72028803|col2a1 15.4965087 1.763614669 0.539512385 3.268904883 0.00107965 0.009515232
Xetrov72043583|Xetrov72043583 1491.38255 1.275441026 0.391071778 3.261398799 0.00110864 0.009752511
Xetrov72036309|Xetrov72036309 1.2835722 1.844504154 0.565993571 3.25887828 0.00111854 0.0098258
Xetrov72016245|Xetrov72016245|ldlrad2 26.3769445 1.524977561 0.468260909 3.25668347 0.00112722 0.00988825
Xetrov72010077|Xetrov72010077|b3galt2 2.422932 1.939547458 0.59594283 3.254586447 0.00113558 0.009952274
Xetrov72029839|Xetrov72029839 4.40882476 1.768683318 0.543593706 3.25368616 0.00113918 0.009975769
Xetrov72041670|Xetrov72041670 21.6247265 1.480622963 0.455064891 3.253652376 0.00113932 0.009975769
Xetrov72032470|Xetrov72032470|cnga4 34.8534574 1.573886674 0.483765997 3.25340492 0.00114031 0.009979821
226
Differential expression analysis of LiCl- and UV-treated embryos at gastrula stage (NF11.5)
Genes up-regulated in UV-treated embryos
Differential analysis using DESeq2
fc> 2, padj. <0.01
Gene baseMean log2FoldChangelfcSE stat pvalue padj
Xetrov72013731|Xetrov72013731|olfm4 1445.53534 -3.1107165 0.23676178 -13.138592 1.98E-39 1.86E-35
Xetrov72034206|Xetrov72034206|tfap2a 14475.0918 -2.4889449 0.22245881 -11.18834 4.65E-29 1.09E-25
Xetrov72039428|Xetrov72039428|wnt8a 5500.65442 -3.1396011 0.29388338 -10.683153 1.22E-26 2.09E-23
Xetrov72032930|Xetrov72032930 166.283654 -3.5389594 0.34256531 -10.330758 5.12E-25 7.41E-22
Xetrov72037431|Xetrov72037431|ndel1 210.016842 -1.4796726 0.14371296 -10.296028 7.34E-25 9.22E-22
Xetrov72030238|Xetrov72030238|klf5 1981.79676 -2.4080827 0.23490405 -10.251346 1.17E-24 1.29E-21
Xetrov72022004|Xetrov72022004 1692.69288 -3.6539613 0.35757026 -10.218862 1.63E-24 1.71E-21
Xetrov72043094|Xetrov72043094|slc17a9 317.04323 -2.0603023 0.20240998 -10.178857 2.46E-24 2.44E-21
Xetrov72027348|Xetrov72027348|LOC100495414 1105.89507 -2.1896213 0.21534818 -10.167819 2.76E-24 2.48E-21
Xetrov72040301|Xetrov72040301|atp6v1f 208.070725 -2.2361076 0.2199199 -10.167827 2.76E-24 2.48E-21
Xetrov72018049|Xetrov72018049 80.6316919 -2.1781402 0.21438326 -10.160029 2.99E-24 2.56E-21
Xetrov72013980|Xetrov72013980|bmp4 4801.06584 -1.2535448 0.12358037 -10.143558 3.54E-24 2.77E-21
Xetrov72017149|Xetrov72017149|fam83d 318.271262 -1.9447315 0.1922632 -10.114944 4.74E-24 3.44E-21
Xetrov72026085|Xetrov72026085|styk1 397.5499 -3.1868102 0.32296884 -9.8672375 5.77E-23 4.03E-20
Xetrov72017350|Xetrov72017350|tfap2c 19634.2945 -2.4195528 0.24599296 -9.8358621 7.89E-23 5.31E-20
Xetrov72001125|Xetrov72001125|t 10361.1977 -1.1203717 0.11691952 -9.5824177 9.48E-22 5.58E-19
Xetrov72029880|Xetrov72029880|krt5.7 14133.0588 -3.2338795 0.3430034 -9.4281266 4.17E-21 2.38E-18
Xetrov72003648|Xetrov72003648|gabpb2 2929.21674 -1.4630621 0.15592068 -9.3833738 6.39E-21 3.25E-18
Xetrov72006138|Xetrov72006138|hes6.1 5062.74555 -2.0035823 0.21578798 -9.2849576 1.62E-20 8.02E-18
Xetrov72034773|Xetrov72034773|dlx5 4175.75298 -3.2005009 0.34550658 -9.2632128 1.98E-20 9.58E-18
Xetrov72020617|Xetrov72020617|ptger4 642.783034 -2.5016414 0.2701446 -9.260379 2.04E-20 9.59E-18
Xetrov72010111|Xetrov72010111|fen1 624.693668 -1.09404 0.11920899 -9.1774955 4.41E-20 1.98E-17
Xetrov72030413|Xetrov72030413|lims1 275.963244 -1.4949254 0.16381315 -9.1257964 7.12E-20 3.05E-17
Xetrov72021606|Xetrov72021606|pnhd 4067.34007 -1.1933357 0.13098126 -9.1107364 8.18E-20 3.37E-17
Xetrov72013649|Xetrov72013649|flvcr2 296.000436 -1.4553308 0.1603956 -9.0733835 1.15E-19 4.62E-17
Xetrov72001392|Xetrov72001392|vash2 50.94414 -3.0953339 0.34369609 -9.0060201 2.14E-19 8.05E-17
Xetrov72021834|Xetrov72021834|gas1 1522.48967 -1.4220697 0.15831478 -8.9825454 2.65E-19 9.77E-17
Xetrov72010328|Xetrov72010328|sertad4 46.8974603 -2.7077767 0.30342787 -8.9239552 4.50E-19 1.60E-16
Xetrov72026742|Xetrov72026742|tmem45b 442.137592 -2.2791776 0.25854747 -8.8153157 1.19E-18 4.01E-16
Xetrov72034152|Xetrov72034152|evx1 715.148804 -3.6292978 0.4127731 -8.7924766 1.46E-18 4.83E-16
Xetrov72021366|Xetrov72021366|slc35d2 207.866371 -2.4646737 0.28109301 -8.7681786 1.82E-18 5.80E-16
Xetrov72000818|Xetrov72000818|sptlc3 244.043796 -2.8285836 0.33421849 -8.4632768 2.60E-17 7.62E-15
Xetrov72034934|Xetrov72034934|bambi 10747.8423 -2.089403 0.24821802 -8.4176123 3.84E-17 1.08E-14
Xetrov72016951|Xetrov72016951|krt12 5289.6775 -2.848162 0.33980538 -8.3817449 5.21E-17 1.42E-14
Xetrov72003469|Xetrov72003469|bspry 935.410782 -3.7295315 0.44835851 -8.3181904 8.93E-17 2.37E-14
Xetrov72029688|Xetrov72029688|grhl3 10042.85 -2.2713323 0.27325222 -8.3122189 9.39E-17 2.42E-14
Xetrov72002596|Xetrov72002596 24.118979 -4.3187106 0.52189559 -8.2750471 1.28E-16 3.22E-14
Xetrov72014027|Xetrov72014027|rnf128 446.025617 -1.33401 0.16246123 -8.2112514 2.19E-16 5.29E-14
Xetrov72018107|Xetrov72018107|krt 27308.9286 -3.0530329 0.37191133 -8.2090344 2.23E-16 5.32E-14
Xetrov72021147|Xetrov72021147|smad7 601.228621 -2.1147325 0.25806392 -8.1946075 2.51E-16 5.87E-14
Xetrov72000684|Xetrov72000684|grhl1 797.986212 -2.8792759 0.35138555 -8.1940645 2.53E-16 5.87E-14
Xetrov72039865|Xetrov72039865|msx2 1215.026 -3.1354959 0.38420999 -8.1608911 3.33E-16 7.55E-14
Xetrov72014892|Xetrov72014892|vgll1 118.404477 -3.3110689 0.40649476 -8.1454159 3.78E-16 8.47E-14
Xetrov72006474|Xetrov72006474|ap1s3 360.873847 -2.433596 0.30154749 -8.0703575 7.01E-16 1.55E-13
Xetrov72007776|Xetrov72007776 455.410174 -2.3450351 0.29436176 -7.9665072 1.63E-15 3.38E-13
Xetrov72029606|Xetrov72029606|elf1 775.491221 -2.7961167 0.35106462 -7.9646783 1.66E-15 3.39E-13
Xetrov72020426|Xetrov72020426|ugt3a2 2898.80478 -3.1970663 0.40435349 -7.9066123 2.64E-15 5.14E-13
Xetrov72018069|Xetrov72018069|syngr2 38.0497923 -2.5969331 0.32952265 -7.8808941 3.25E-15 6.13E-13
Xetrov72032929|Xetrov72032929 42.4620483 -3.5340749 0.44844139 -7.8807956 3.25E-15 6.13E-13
Xetrov72016136|Xetrov72016136|lonrf3 40.6879124 -2.2881028 0.29051759 -7.8759528 3.38E-15 6.24E-13
Xetrov72020138|Xetrov72020138|fzd10 2576.83921 -2.4773296 0.31460397 -7.8744383 3.42E-15 6.26E-13
Xetrov72010707|Xetrov72010707|mob2.1 807.214381 -1.1650844 0.14836742 -7.8526972 4.07E-15 7.37E-13
Xetrov72008577|Xetrov72008577|aldh1l1 1160.44215 -2.8583889 0.36408019 -7.8509871 4.13E-15 7.40E-13
Xetrov72034292|Xetrov72034292|fam83a 26.4668582 -2.9940369 0.38250989 -7.8273451 4.98E-15 8.85E-13
Xetrov72039646|Xetrov72039646|c5orf15 647.127872 -2.0419136 0.26096044 -7.8246094 5.09E-15 8.96E-13
Xetrov72000591|Xetrov72000591|dll1 3540.39719 -1.3686321 0.17594793 -7.7786198 7.33E-15 1.26E-12
Xetrov72034061|Xetrov72034061|sp8 547.091631 -1.9309363 0.24935708 -7.7436595 9.66E-15 1.60E-12
Xetrov72043369|Xetrov72043369 134.572151 -2.2848291 0.2957921 -7.7244424 1.12E-14 1.82E-12
Xetrov72009488|Xetrov72009488|slc7a5 1795.90189 -2.1061969 0.27497196 -7.6596787 1.86E-14 2.93E-12
Xetrov72036251|Xetrov72036251 176.594703 -2.3497206 0.30685391 -7.6574569 1.90E-14 2.95E-12
Xetrov72021417|Xetrov72021417|xbp1 13119.5848 -1.618897 0.21156784 -7.6519047 1.98E-14 3.06E-12
Xetrov72041369|Xetrov72041369 23.9388601 -2.5417954 0.33271419 -7.6395761 2.18E-14 3.34E-12
Xetrov72038483|Xetrov72038483|rasef 560.788449 -1.7064663 0.22358568 -7.6322701 2.31E-14 3.48E-12
Xetrov72010727|Xetrov72010727|cd82 175.6034 -1.6725877 0.21980952 -7.6092596 2.76E-14 4.09E-12
Xetrov72027391|Xetrov72027391|hes3.3 324.888452 -3.4519873 0.45412824 -7.6013491 2.93E-14 4.28E-12
Appendix III
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Xetrov72033670|Xetrov72033670|fzd6 522.400716 -3.053496 0.40475499 -7.5440602 4.56E-14 6.45E-12
Xetrov72041367|Xetrov72041367|unnamed 204.405448 -3.606461 0.47950304 -7.5212473 5.43E-14 7.49E-12
Xetrov72005915|Xetrov72005915|unnamed 160.897511 -1.7541779 0.23377926 -7.5035654 6.21E-14 8.42E-12
Xetrov72027542|Xetrov72027542|cnfn.1 3712.98222 -1.2289995 0.16440327 -7.4755175 7.69E-14 1.03E-11
Xetrov72003454|Xetrov72003454|unnamed 199.183502 -3.1124158 0.41660041 -7.4709858 7.96E-14 1.06E-11
Xetrov72039732|Xetrov72039732|mespb 1651.86566 -2.123736 0.28633949 -7.4168463 1.20E-13 1.54E-11
Xetrov72038189|Xetrov72038189 1716.45899 -3.0220111 0.40843109 -7.399072 1.37E-13 1.72E-11
Xetrov72034083|Xetrov72034083|cndp1 171.735434 -3.1024213 0.41926855 -7.3996042 1.37E-13 1.72E-11
Xetrov72003455|Xetrov72003455 223.747378 -3.4850678 0.47163378 -7.3893515 1.48E-13 1.82E-11
Xetrov72014283|Xetrov72014283|unnamed 756.398586 -2.1769298 0.29476546 -7.3852948 1.52E-13 1.86E-11
Xetrov72025856|Xetrov72025856|trim29 1131.02178 -2.8602406 0.38766966 -7.3780357 1.61E-13 1.94E-11
Xetrov72009180|Xetrov72009180|faah.2 212.561958 -3.6669277 0.49791329 -7.3645909 1.78E-13 2.12E-11
Xetrov72035022|Xetrov72035022|unnamed 2278.86944 -3.1548437 0.43234327 -7.2970807 2.94E-13 3.32E-11
Xetrov72036159|Xetrov72036159|esrp1 587.1712 -2.2167969 0.3041811 -7.2877534 3.15E-13 3.53E-11
Xetrov72011430|Xetrov72011430|gadd45a 6763.86808 -1.1925523 0.16396255 -7.2733212 3.51E-13 3.91E-11
Xetrov72033063|Xetrov72033063|dsp 3575.60746 -2.8539889 0.39302067 -7.2616763 3.82E-13 4.19E-11
Xetrov72b000175|Xetrov72b000175|c8orf4 178.459729 -2.1865025 0.30233158 -7.2321339 4.75E-13 5.06E-11
Xetrov72032954|Xetrov72032954|unnamed 72.7170569 -1.792399 0.24915475 -7.1939189 6.30E-13 6.52E-11
Xetrov72010954|Xetrov72010954|h1fx 2978.06641 -1.353398 0.18903737 -7.1594202 8.10E-13 8.29E-11
Xetrov72006199|Xetrov72006199|ag1 5233.95287 -3.2404107 0.45414287 -7.1352232 9.66E-13 9.63E-11
Xetrov72025654|Xetrov72025654|neurl 134.365784 -2.1358917 0.30034683 -7.1114176 1.15E-12 1.11E-10
Xetrov72031247|Xetrov72031247|upk1b 9451.28319 -1.3573633 0.19149082 -7.0883992 1.36E-12 1.30E-10
Xetrov72028867|Xetrov72028867|erbb3 260.308001 -2.5835833 0.3656615 -7.0655055 1.60E-12 1.51E-10
Xetrov72011194|Xetrov72011194 94.3039814 -2.3114174 0.32765583 -7.0544065 1.73E-12 1.61E-10
Xetrov72014430|Xetrov72014430|degs3 484.364315 -2.79221 0.39697062 -7.0337949 2.01E-12 1.84E-10
Xetrov72015022|Xetrov72015022|unnamed 241.328565 -2.80811 0.39975727 -7.0245376 2.15E-12 1.94E-10
Xetrov72021940|Xetrov72021940|msx1 1692.37805 -3.3429197 0.47616186 -7.0205532 2.21E-12 1.99E-10
Xetrov72012878|Xetrov72012878|actn1 1442.22368 -1.2209777 0.17399363 -7.0173702 2.26E-12 2.03E-10
Xetrov72036954|Xetrov72036954|vtcn1 232.517754 -3.1767416 0.45370532 -7.0017727 2.53E-12 2.25E-10
Xetrov72038705|Xetrov72038705|slc22a4 1819.08757 -2.371902 0.33891788 -6.9984565 2.59E-12 2.29E-10
Xetrov72000605|Xetrov72000605|dvl3 1128.17809 -1.6623634 0.23785868 -6.9888703 2.77E-12 2.44E-10
Xetrov72012759|Xetrov72012759 449.654175 -2.6927138 0.38587062 -6.9782815 2.99E-12 2.62E-10
Xetrov72029432|Xetrov72029432|ripk4 229.295315 -1.1852523 0.17034717 -6.9578633 3.45E-12 2.98E-10
Xetrov72011734|Xetrov72011734|gata2 14240.8925 -2.0077099 0.28931684 -6.939485 3.94E-12 3.34E-10
Xetrov72029399|Xetrov72029399 164.699097 -3.1112604 0.45196937 -6.8837861 5.83E-12 4.81E-10
Xetrov72002242|Xetrov72002242|tp63 75.407778 -3.6036993 0.52376924 -6.8803188 5.97E-12 4.89E-10
Xetrov72000894|Xetrov72000894|angel2 191.825874 -1.2403275 0.1803505 -6.8773165 6.10E-12 4.97E-10
Xetrov72041412|Xetrov72041412|stard10 1514.45727 -1.9213656 0.27957729 -6.8723951 6.31E-12 5.13E-10
Xetrov72002073|Xetrov72002073|sh3bgrl2 190.363222 -1.2947888 0.18856108 -6.8666811 6.57E-12 5.31E-10
Xetrov72006498|Xetrov72006498 462.798599 -2.7074862 0.39444009 -6.8641253 6.69E-12 5.38E-10
Xetrov72016218|Xetrov72016218|znf534 308.893102 -3.4961195 0.50978903 -6.8579733 6.98E-12 5.60E-10
Xetrov72037027|Xetrov72037027 300.906225 -2.8708911 0.42043903 -6.8283173 8.59E-12 6.77E-10
Xetrov72b000276|Xetrov72b000276|upk3a 4046.74409 -1.028424 0.15088675 -6.8158666 9.37E-12 7.35E-10
Xetrov72006242|Xetrov72006242|msgn1 1268.24626 -3.1936036 0.47278421 -6.7548863 1.43E-11 1.09E-09
Xetrov72015207|Xetrov72015207|unnamed 483.110584 -1.5142652 0.2246911 -6.7393199 1.59E-11 1.20E-09
Xetrov72009072|Xetrov72009072 15803.1008 -1.805583 0.26795851 -6.738293 1.60E-11 1.21E-09
Xetrov72017868|Xetrov72017868|arf1 286.884487 -1.1624839 0.17335324 -6.7058675 2.00E-11 1.49E-09
Xetrov72034932|Xetrov72034932|dlx6 179.687575 -3.1513088 0.47190549 -6.6778389 2.42E-11 1.78E-09
Xetrov72037025|Xetrov72037025|ap1m2 149.664273 -2.6170444 0.39218563 -6.6729737 2.51E-11 1.82E-09
Xetrov72013920|Xetrov72013920 1509.18836 -2.9887093 0.44810474 -6.6696667 2.56E-11 1.86E-09
Xetrov72036953|Xetrov72036953|loc100130701 51.9491319 -2.4047845 0.36119785 -6.6578041 2.78E-11 2.01E-09
Xetrov72019767|Xetrov72019767|tbx3 647.230384 -2.9175032 0.43843819 -6.6543091 2.85E-11 2.03E-09
Xetrov72031403|Xetrov72031403|ndfip2 954.774459 -1.0744679 0.16147687 -6.6540053 2.85E-11 2.03E-09
Xetrov72014952|Xetrov72014952|ttc9b 34.5123348 -2.5299846 0.38055907 -6.6480734 2.97E-11 2.11E-09
Xetrov72005483|Xetrov72005483|sp5 1134.91573 -2.7925804 0.42294736 -6.6026667 4.04E-11 2.83E-09
Xetrov72009247|Xetrov72009247 198.73164 -1.460257 0.22119648 -6.6016286 4.07E-11 2.83E-09
Xetrov72009945|Xetrov72009945|klf17 6557.17254 -1.5191463 0.23184045 -6.5525507 5.66E-11 3.89E-09
PAC:20701767 53.9282227 -3.0863204 0.47151246 -6.5455755 5.93E-11 4.06E-09
Xetrov72031806|Xetrov72031806|mid1ip1 69.5389603 -2.2149619 0.33889841 -6.5357695 6.33E-11 4.32E-09
Xetrov72021223|Xetrov72021223|elovl7 2474.84002 -1.8966731 0.29034719 -6.5324315 6.47E-11 4.40E-09
Xetrov72011200|Xetrov72011200|rnf11 223.896711 -1.0150156 0.15574005 -6.51737 7.16E-11 4.83E-09
Xetrov72043357|Xetrov72043357|pvrl4 105.362368 -2.6733211 0.41096855 -6.5049288 7.77E-11 5.19E-09
Xetrov72017993|Xetrov72017993|fam100b 555.495523 -1.0720334 0.16498245 -6.4978631 8.15E-11 5.42E-09
Xetrov72004308|Xetrov72004308|dip2a 356.147562 -2.2121846 0.34165716 -6.4748668 9.49E-11 6.18E-09
Xetrov72033062|Xetrov72033062|nbeal2 108.865713 -2.4496379 0.37867115 -6.4690377 9.86E-11 6.41E-09
Xetrov72020853|Xetrov72020853|gcnt4 75.8631412 -2.676359 0.41375196 -6.4685107 9.90E-11 6.41E-09
Xetrov72017857|Xetrov72017857|dlx3 83.3390419 -3.0898672 0.47823244 -6.4610155 1.04E-10 6.71E-09
Xetrov72041776|Xetrov72041776|b4galt3 3040.04794 -1.3664548 0.21181305 -6.4512302 1.11E-10 7.13E-09
Xetrov72031776|Xetrov72031776|dynlt3 29.7356669 -3.4630326 0.5382906 -6.4333886 1.25E-10 7.97E-09
Xetrov72005022|Xetrov72005022 744.614948 -2.25216 0.35024647 -6.4302148 1.27E-10 8.08E-09
Xetrov72023029|Xetrov72023029 40.2418167 -2.1322371 0.33222457 -6.4180595 1.38E-10 8.64E-09
228
Xetrov72005788|Xetrov72005788|hoxd1 3622.56635 -2.1260038 0.33136405 -6.4159157 1.40E-10 8.73E-09
Xetrov72003647|Xetrov72003647|vsig8 279.597059 -3.3671361 0.52688236 -6.3906791 1.65E-10 1.01E-08
Xetrov72031271|Xetrov72031271|tspo 1323.84684 -1.6313268 0.25681779 -6.3520789 2.12E-10 1.28E-08
Xetrov72011760|Xetrov72011760|elovl1 116.061457 -2.091626 0.32941347 -6.3495461 2.16E-10 1.29E-08
Xetrov72008444|Xetrov72008444|rabgap1l 2341.74485 -1.3930242 0.21953294 -6.3453995 2.22E-10 1.32E-08
Xetrov72007505|Xetrov72007505 24.0102656 -2.7169473 0.42823044 -6.3445917 2.23E-10 1.33E-08
Xetrov72029876|Xetrov72029876|mfsd2a 246.389014 -1.5769436 0.24868865 -6.3410354 2.28E-10 1.35E-08
Xetrov72026724|Xetrov72026724|ventx3.2 1047.36615 -2.0642172 0.32754128 -6.3021589 2.94E-10 1.72E-08
Xetrov72000561|Xetrov72000561|myb 1359.23394 -2.6235624 0.41669388 -6.2961386 3.05E-10 1.78E-08
Xetrov72023338|Xetrov72023338|rbm47 295.508042 -1.5326687 0.24390053 -6.283991 3.30E-10 1.91E-08
Xetrov72017537|Xetrov72017537|fam83c 553.879579 -1.872636 0.29820395 -6.2797157 3.39E-10 1.95E-08
Xetrov72025347|Xetrov72025347|xarp 2501.24069 -1.5266759 0.24399632 -6.2569626 3.93E-10 2.21E-08
Xetrov72036708|Xetrov72036708|unnamed 72.5778983 -2.6371931 0.42183798 -6.2516729 4.06E-10 2.28E-08
Xetrov72032154|Xetrov72032154|rhbdl2 87.9962528 -1.9019006 0.30470002 -6.2418789 4.32E-10 2.41E-08
Xetrov72038749|Xetrov72038749|znf703 6842.65123 -1.8625557 0.29885574 -6.2322902 4.60E-10 2.54E-08
Xetrov72036727|Xetrov72036727|unnamed 1334.32182 -2.5931818 0.41633191 -6.2286407 4.70E-10 2.58E-08
Xetrov72026530|Xetrov72026530|anxa4 2380.39643 -1.6167343 0.26000418 -6.218109 5.03E-10 2.75E-08
Xetrov72024531|Xetrov72024531 17.2860794 -3.4319739 0.55310053 -6.2049731 5.47E-10 2.98E-08
Xetrov72027642|Xetrov72027642|LOC733709 385.09188 -2.0742309 0.33514762 -6.1890067 6.05E-10 3.26E-08
Xetrov72026749|Xetrov72026749|ventx1.1 7802.72117 -1.866222 0.30158913 -6.1879618 6.09E-10 3.27E-08
Xetrov72021382|Xetrov72021382|ccno 1106.27724 -2.501505 0.40501996 -6.1762511 6.56E-10 3.50E-08
Xetrov72033689|Xetrov72033689|unnamed 323.470471 -2.1203345 0.34344436 -6.173735 6.67E-10 3.55E-08
Xetrov72029799|Xetrov72029799|sh3d21 301.554601 -2.3676077 0.38422723 -6.1619985 7.18E-10 3.79E-08
Xetrov72003017|Xetrov72003017 162.526732 -1.4018239 0.22798986 -6.1486241 7.82E-10 4.10E-08
Xetrov72010031|Xetrov72010031 362.934617 -2.8191443 0.4585413 -6.1480706 7.84E-10 4.10E-08
Xetrov72029975|Xetrov72029975|bace2 680.594595 -1.098649 0.1788634 -6.1423914 8.13E-10 4.24E-08
Xetrov72026836|Xetrov72026836|ventx1.2 5063.6638 -1.6957189 0.27608843 -6.1419411 8.15E-10 4.24E-08
Xetrov72021876|Xetrov72021876|cldn23 31.9825228 -2.2548324 0.36741062 -6.1370911 8.40E-10 4.35E-08
Xetrov72028704|Xetrov72028704|crybg3 60.7736817 -2.3947301 0.39042879 -6.1335899 8.59E-10 4.43E-08
Xetrov72034304|Xetrov72034304|myc 1597.61551 -1.531999 0.25081721 -6.10803 1.01E-09 5.15E-08
Xetrov72018136|Xetrov72018136|osbpl2 97.2584757 -2.6745814 0.44136082 -6.0598524 1.36E-09 6.81E-08
Xetrov72014664|Xetrov72014664|cdx4 4798.26388 -2.0435662 0.3379107 -6.0476518 1.47E-09 7.28E-08
Xetrov72016646|Xetrov72016646|evpl 1317.98276 -2.6030131 0.43087987 -6.0411573 1.53E-09 7.54E-08
Xetrov72035138|Xetrov72035138|tspan13 344.074001 -2.0214616 0.33501203 -6.033997 1.60E-09 7.85E-08
Xetrov72030272|Xetrov72030272|sp7 195.766034 -2.5008835 0.41465563 -6.0312301 1.63E-09 7.96E-08
Xetrov72020269|Xetrov72020269|ptbp1 4682.3276 -1.1101441 0.18424772 -6.0252798 1.69E-09 8.24E-08
Xetrov72039848|Xetrov72039848|cdx1 2828.90051 -2.2761917 0.37815248 -6.0192432 1.75E-09 8.51E-08
Xetrov72002394|Xetrov72002394|id2 640.944636 -1.973364 0.32843422 -6.0083994 1.87E-09 9.00E-08
Xetrov72021249|Xetrov72021249 99.140883 -1.5385089 0.25633578 -6.0019279 1.95E-09 9.32E-08
Xetrov72021419|Xetrov72021419|ogfod2 1305.84958 -1.4197782 0.23675114 -5.9969226 2.01E-09 9.56E-08
Xetrov72021167|Xetrov72021167|foxi4.1 239.692589 -2.7460185 0.45856673 -5.9882637 2.12E-09 1.00E-07
Xetrov72002567|Xetrov72002567 9.31425622 -3.0938057 0.51684855 -5.9859038 2.15E-09 1.02E-07
Xetrov72025690|Xetrov72025690|znf503 216.455962 -1.6081583 0.26913367 -5.9753144 2.30E-09 1.08E-07
Xetrov72008785|Xetrov72008785 87.7877483 -1.1164125 0.18771415 -5.9474076 2.72E-09 1.27E-07
Xetrov72003657|Xetrov72003657|anxa9 56.7191723 -3.1918578 0.53798496 -5.9329871 2.97E-09 1.38E-07
Xetrov72038568|Xetrov72038568|retsat 324.750713 -1.7292735 0.29151352 -5.9320525 2.99E-09 1.38E-07
Xetrov72010211|Xetrov72010211 14.6376242 -2.757002 0.46490262 -5.9302785 3.02E-09 1.39E-07
Xetrov72027495|Xetrov72027495 52.1821452 -1.7715069 0.29908484 -5.9230916 3.16E-09 1.44E-07
Xetrov72032967|Xetrov72032967 51.1963065 -1.5223734 0.25742629 -5.9138225 3.34E-09 1.52E-07
Xetrov72017053|Xetrov72017053|c20orf151 379.394529 -2.1589957 0.36657908 -5.889577 3.87E-09 1.74E-07
Xetrov72017394|Xetrov72017394|bmp7.1 826.298605 -2.4441722 0.41605268 -5.8746701 4.24E-09 1.89E-07
Xetrov72010329|Xetrov72010329|pim1 3681.20981 -1.1684239 0.19921643 -5.865098 4.49E-09 1.99E-07
Xetrov72029142|Xetrov72029142|sytl2 1224.13678 -2.0682868 0.35282672 -5.862047 4.57E-09 2.02E-07
Xetrov72032891|Xetrov72032891|dscr6 187.293487 -2.9237593 0.50066807 -5.839716 5.23E-09 2.30E-07
Xetrov72041997|Xetrov72041997 12421.0984 -1.4653767 0.25187504 -5.8178718 5.96E-09 2.59E-07
Xetrov72016257|Xetrov72016257|rgl3 618.361454 -2.376732 0.41018207 -5.7943342 6.86E-09 2.93E-07
Xetrov72013268|Xetrov72013268|dlc 4463.34658 -1.7310685 0.29943382 -5.7811389 7.42E-09 3.14E-07
Xetrov72042539|Xetrov72042539|lmo4.2 3328.98562 -2.0358501 0.35219558 -5.7804534 7.45E-09 3.15E-07
Xetrov72005156|Xetrov72005156|slc19a2 71.9357196 -2.6864223 0.4683176 -5.7363258 9.68E-09 4.04E-07
Xetrov72021228|Xetrov72021228|klf2 1162.9176 -1.1691863 0.20386578 -5.7350789 9.75E-09 4.06E-07
Xetrov72028183|Xetrov72028183 34.5028563 -2.1460606 0.37452479 -5.7300896 1.00E-08 4.15E-07
Xetrov72038446|Xetrov72038446|atp6v0a4 24.7761356 -3.2788959 0.57268494 -5.7254795 1.03E-08 4.24E-07
Xetrov72035015|Xetrov72035015|cthrc1 24.19456 -3.0855 0.53958603 -5.7182725 1.08E-08 4.40E-07
Xetrov72002680|Xetrov72002680 560.900171 -1.561608 0.27361995 -5.7072153 1.15E-08 4.68E-07
Xetrov72028175|Xetrov72028175|tectb 27.7279234 -2.4074927 0.42187681 -5.7066249 1.15E-08 4.68E-07
Xetrov72016928|Xetrov72016928|jup 3031.19647 -1.0819342 0.18962079 -5.7057781 1.16E-08 4.69E-07
Xetrov72029463|Xetrov72029463|tm9sf2 1152.37742 -1.5380833 0.26959894 -5.705079 1.16E-08 4.69E-07
Xetrov72027234|Xetrov72027234|hes5.1 215.72737 -2.5755863 0.4520264 -5.697867 1.21E-08 4.85E-07
Xetrov72039422|Xetrov72039422|wnt5b 1345.73866 -1.0666168 0.18734778 -5.6932451 1.25E-08 4.95E-07
Xetrov72000620|Xetrov72000620 108.299434 -2.9436676 0.5176991 -5.6860589 1.30E-08 5.15E-07
Xetrov72014474|Xetrov72014474|zfp36 276.227774 -2.3324342 0.41085113 -5.6770786 1.37E-08 5.40E-07
229
Xetrov72031077|Xetrov72031077|slc25a30 3860.12429 -1.3362725 0.235387 -5.6769171 1.37E-08 5.40E-07
Xetrov72028678|Xetrov72028678|aim1l 97.682044 -2.7190548 0.47980818 -5.6669622 1.45E-08 5.70E-07
Xetrov72010880|Xetrov72010880 843.279295 -1.8748128 0.33316728 -5.6272418 1.83E-08 7.10E-07
Xetrov72030993|Xetrov72030993 21.7070474 -2.8455088 0.50904147 -5.5899351 2.27E-08 8.71E-07
Xetrov72005893|Xetrov72005893 52.9689003 -2.8810241 0.51578059 -5.5857552 2.33E-08 8.87E-07
Xetrov72022102|Xetrov72022102 479.413203 -1.5542199 0.27844895 -5.581705 2.38E-08 9.03E-07
Xetrov72006787|Xetrov72006787 456.908534 -1.8947061 0.34126667 -5.5519812 2.82E-08 1.05E-06
Xetrov72035942|Xetrov72035942|twsg1 167.924763 -1.2944807 0.23355404 -5.542532 2.98E-08 1.10E-06
Xetrov72039030|Xetrov72039030|gata3 1178.16661 -2.5836925 0.46755849 -5.5259236 3.28E-08 1.21E-06
Xetrov72021451|Xetrov72021451|klf3 136.065514 -2.3524105 0.42600214 -5.5220627 3.35E-08 1.23E-06
Xetrov72031167|Xetrov72031167 764.089034 -1.63956 0.29709917 -5.5185612 3.42E-08 1.25E-06
Xetrov72010729|Xetrov72010729|kctd15 1204.73229 -1.2578606 0.22838482 -5.5076365 3.64E-08 1.31E-06
Xetrov72033622|Xetrov72033622|zbtb10 11421.9059 -1.0048466 0.18247729 -5.5066939 3.66E-08 1.32E-06
Xetrov72042851|Xetrov72042851|unnamed 175.434489 -2.8942712 0.52615446 -5.5008014 3.78E-08 1.36E-06
Xetrov72031544|Xetrov72031544|cldn4 8415.9859 -1.1474506 0.20903858 -5.4891811 4.04E-08 1.44E-06
Xetrov72006253|Xetrov72006253|unnamed 300.899204 -2.6665157 0.48677244 -5.4779512 4.30E-08 1.53E-06
Xetrov72040869|Xetrov72040869|helb 30.6831641 -2.0701785 0.37793736 -5.4775702 4.31E-08 1.53E-06
Xetrov72017806|Xetrov72017806|tk1 2798.8855 -1.0867337 0.19889812 -5.4637706 4.66E-08 1.64E-06
Xetrov72042741|Xetrov72042741 7.81840827 -2.6762192 0.49024936 -5.4588939 4.79E-08 1.68E-06
Xetrov72034895|Xetrov72034895|unnamed 176.86995 -2.6388157 0.48512438 -5.4394621 5.34E-08 1.86E-06
Xetrov72038929|Xetrov72038929 33.6745849 -2.6600893 0.48948553 -5.4344596 5.50E-08 1.90E-06
Xetrov72005090|Xetrov72005090|unnamed 155.751752 -1.9556505 0.36010199 -5.430824 5.61E-08 1.93E-06
Xetrov72017671|Xetrov72017671|cant1 766.858075 -1.1725585 0.21595681 -5.4295973 5.65E-08 1.93E-06
Xetrov72039344|Xetrov72039344|dusp6 1907.67554 -1.0871335 0.20060136 -5.4193724 5.98E-08 2.04E-06
Xetrov72038814|Xetrov72038814|tcp11l2 700.845304 -1.1296622 0.20860061 -5.4154309 6.11E-08 2.07E-06
Xetrov72008551|Xetrov72008551|cdh1 1023.60938 -1.7082479 0.31603955 -5.4051713 6.47E-08 2.17E-06
Xetrov72006428|Xetrov72006428|emp2 321.923144 -2.3713852 0.43984981 -5.3913521 6.99E-08 2.34E-06
Xetrov72040736|Xetrov72040736|kitlg 138.875958 -1.9872946 0.36897267 -5.3860211 7.20E-08 2.40E-06
Xetrov72007936|Xetrov72007936 1119.6209 -1.3364894 0.24824852 -5.3836751 7.30E-08 2.42E-06
Xetrov72037995|Xetrov72037995|wdr72 15.2106339 -2.8994632 0.53979585 -5.3714071 7.81E-08 2.57E-06
Xetrov72017393|Xetrov72017393|krt16 7.568057 -2.8381392 0.52844673 -5.3707196 7.84E-08 2.58E-06
Xetrov72039319|Xetrov72039319|inpp5a.2 43.0435233 -1.8421695 0.34334756 -5.36532 8.08E-08 2.65E-06
Xetrov72026559|Xetrov72026559|c1galt1c1 326.08285 -1.5562369 0.29031992 -5.3604206 8.30E-08 2.71E-06
Xetrov72005248|Xetrov72005248|unnamed 253.087191 -2.8238366 0.52781583 -5.3500415 8.79E-08 2.85E-06
Xetrov72034931|Xetrov72034931|psmg2 193.521007 -1.0477782 0.19639118 -5.3351592 9.55E-08 3.07E-06
Xetrov72019117|Xetrov72019117|tdrd7 1200.8732 -1.2551826 0.23556825 -5.3283184 9.91E-08 3.18E-06
Xetrov72004255|Xetrov72004255|ppl 1000.49575 -1.7490747 0.32928926 -5.3116666 1.09E-07 3.43E-06
Xetrov72004826|Xetrov72004826|cd2ap 129.69019 -1.4601462 0.27501097 -5.3094106 1.10E-07 3.47E-06
Xetrov72018443|Xetrov72018443|mfsd6l 145.776927 -1.3835293 0.26065337 -5.307928 1.11E-07 3.49E-06
Xetrov72011709|Xetrov72011709 78.8313671 -1.2289832 0.23289171 -5.2770585 1.31E-07 4.05E-06
Xetrov72014957|Xetrov72014957|neurog2 349.616433 -1.7419917 0.33042478 -5.2719767 1.35E-07 4.15E-06
Xetrov72b000232|Xetrov72b000232|atp6v1g3 16.6226673 -2.7246145 0.51757562 -5.2641863 1.41E-07 4.32E-06
Xetrov72036480|Xetrov72036480|prss8 682.247558 -1.5176125 0.28899243 -5.2513918 1.51E-07 4.60E-06
Xetrov72038246|Xetrov72038246|fes 118.453892 -1.4356032 0.27421398 -5.2353392 1.65E-07 4.99E-06
Xetrov72012797|Xetrov72012797 137.85826 -1.9652911 0.37646369 -5.2204001 1.79E-07 5.37E-06
Xetrov72038789|Xetrov72038789 1751.37009 -1.5582389 0.30198151 -5.1600474 2.47E-07 7.19E-06
Xetrov72005256|Xetrov72005256|tuba3e 1634.80287 -2.5629331 0.49669228 -5.1600019 2.47E-07 7.19E-06
Xetrov72026860|Xetrov72026860|unnamed 38.8372702 -2.3232235 0.45028717 -5.1594264 2.48E-07 7.20E-06
Xetrov72000636|Xetrov72000636|tab2 159.336781 -1.0289133 0.1996684 -5.1531105 2.56E-07 7.42E-06
Xetrov72028104|Xetrov72028104|cdknx 783.009872 -1.9243668 0.37550113 -5.1247963 2.98E-07 8.51E-06
Xetrov72021245|Xetrov72021245|lef1 432.975112 -1.2915931 0.25262037 -5.1127831 3.17E-07 9.05E-06
Xetrov72043445|Xetrov72043445 98.6653508 -1.9021716 0.37680626 -5.0481422 4.46E-07 1.24E-05
Xetrov72033177|Xetrov72033177|mst1r 2756.44992 -1.2761562 0.25280713 -5.0479438 4.47E-07 1.24E-05
Xetrov72007537|Xetrov72007537 15.5405702 -2.4355813 0.48671593 -5.0041125 5.61E-07 1.53E-05
Xetrov72031288|Xetrov72031288|cdx2 3771.5127 -1.9375897 0.38724678 -5.0035012 5.63E-07 1.53E-05
Xetrov72028213|Xetrov72028213 104.54194 -1.4386516 0.28837968 -4.9887414 6.08E-07 1.64E-05
Xetrov72023161|Xetrov72023161|cetn1 725.512991 -1.8840065 0.37879667 -4.9736618 6.57E-07 1.76E-05
Xetrov72000867|Xetrov72000867|slc33a1 365.710525 -1.4606795 0.29383522 -4.971084 6.66E-07 1.77E-05
Xetrov72036422|Xetrov72036422 55.7067852 -1.5543404 0.31428028 -4.9457139 7.59E-07 1.98E-05
Xetrov72002931|Xetrov72002931 16.7426685 -2.4039655 0.48865786 -4.9195269 8.68E-07 2.24E-05
Xetrov72039789|Xetrov72039789|szl 1568.5382 -1.9880929 0.40447603 -4.9152305 8.87E-07 2.28E-05
Xetrov72023840|Xetrov72023840|acsl1 460.521297 -1.0866016 0.22115609 -4.9132791 8.96E-07 2.30E-05
Xetrov72038071|Xetrov72038071|kiaa1324l 1847.86491 -1.979406 0.40293762 -4.9124377 9.00E-07 2.30E-05
Xetrov72024265|Xetrov72024265 197.803025 -2.0300074 0.4135434 -4.9088134 9.16E-07 2.34E-05
Xetrov72006150|Xetrov72006150|arl6ip1 199.768913 -1.2656408 0.25788921 -4.9076918 9.22E-07 2.35E-05
Xetrov72031615|Xetrov72031615|upk3b 3420.5296 -1.0695134 0.21811171 -4.903512 9.41E-07 2.39E-05
Xetrov72019175|Xetrov72019175|rnf31 224.877723 -1.2839663 0.26186828 -4.9030997 9.43E-07 2.39E-05
Xetrov72006165|Xetrov72006165|pdgfa 1085.90219 -1.4000484 0.28682471 -4.8811988 1.05E-06 2.65E-05
Xetrov72005942|Xetrov72005942|slc9a3r2 20.4819578 -2.4148484 0.49649401 -4.8638017 1.15E-06 2.87E-05
Xetrov72026612|Xetrov72026612|hmx3 61.9124328 -2.4664482 0.5084446 -4.8509675 1.23E-06 3.03E-05
Xetrov72043331|Xetrov72043331 7785.68887 -1.2431438 0.25630834 -4.8501887 1.23E-06 3.03E-05
230
Xetrov72036736|Xetrov72036736 15.8141961 -2.6867891 0.55439423 -4.8463512 1.26E-06 3.08E-05
Xetrov72009545|Xetrov72009545|spata1 83.5038516 -1.9120951 0.39499142 -4.8408523 1.29E-06 3.16E-05
Xetrov72026423|Xetrov72026423|gnb3 3036.42989 -1.590959 0.32974339 -4.8248399 1.40E-06 3.41E-05
Xetrov72016429|Xetrov72016429 699.510248 -1.5515739 0.32251685 -4.8108305 1.50E-06 3.63E-05
Xetrov72039534|Xetrov72039534|cdc123 109.804596 -1.4184287 0.29502971 -4.8077486 1.53E-06 3.68E-05
Xetrov72005612|Xetrov72005612|gbx2.2 646.040627 -2.4207419 0.50589494 -4.7850684 1.71E-06 4.07E-05
Xetrov72016406|Xetrov72016406|rab25 214.280943 -2.7098978 0.56800898 -4.7708714 1.83E-06 4.35E-05
Xetrov72015217|Xetrov72015217 349.592898 -1.6319106 0.34233728 -4.7669671 1.87E-06 4.41E-05
Xetrov72033128|Xetrov72033128|rreb1 4266.5078 -1.0631651 0.22320323 -4.7632156 1.91E-06 4.49E-05
Xetrov72025906|Xetrov72025906|atp6v1b1 33.921292 -2.4296498 0.51126793 -4.7522046 2.01E-06 4.71E-05
Xetrov72028370|Xetrov72028370 1259.92922 -1.6672597 0.35101782 -4.7497864 2.04E-06 4.76E-05
Xetrov72017250|Xetrov72017250|foxj1 1130.67482 -1.8067723 0.38087264 -4.7437702 2.10E-06 4.89E-05
Xetrov72001031|Xetrov72001031 561.666083 -1.4904048 0.31422612 -4.7430963 2.10E-06 4.90E-05
Xetrov72027641|Xetrov72027641 45.2165046 -1.2772465 0.27063969 -4.7193615 2.37E-06 5.40E-05
Xetrov72b000199|Xetrov72b000199|efna4 42.6330504 -1.1938068 0.25329003 -4.7132011 2.44E-06 5.55E-05
Xetrov72006270|Xetrov72006270 1870.19027 -1.0731827 0.22833463 -4.7000434 2.60E-06 5.89E-05
Xetrov72028552|Xetrov72028552 49.9454728 -1.6807835 0.35793162 -4.6958229 2.66E-06 5.99E-05
Xetrov72041631|Xetrov72041631|shroom4 903.136572 -1.4068206 0.2997871 -4.6927324 2.70E-06 6.07E-05
Xetrov72042825|Xetrov72042825 6.82186979 -2.7166531 0.57953377 -4.6876528 2.76E-06 6.19E-05
Xetrov72010384|Xetrov72010384 6.4498804 -2.5849738 0.55142518 -4.6878052 2.76E-06 6.19E-05
Xetrov72026036|Xetrov72026036|tead4 1268.38776 -1.0513598 0.22513958 -4.6698131 3.01E-06 6.65E-05
Xetrov72020681|Xetrov72020681|mknk2 2593.33121 -1.0380466 0.22249221 -4.6655414 3.08E-06 6.75E-05
Xetrov72013461|Xetrov72013461|sptlc2 438.502643 -1.5315214 0.32840026 -4.6635815 3.11E-06 6.80E-05
Xetrov72022451|Xetrov72022451|mad2l1 103.497695 -1.034233 0.22206627 -4.657317 3.20E-06 6.98E-05
Xetrov72027411|Xetrov72027411|hes9.1 176.889961 -1.8374491 0.39537913 -4.6473094 3.36E-06 7.30E-05
Xetrov72043598|Xetrov72043598 395.097802 -1.9550702 0.42161217 -4.6371294 3.53E-06 7.64E-05
Xetrov72000077|Xetrov72000077|greb1 250.353747 -2.2314511 0.48230904 -4.6266001 3.72E-06 7.97E-05
Xetrov72034068|Xetrov72034068 6634.52398 -1.3416418 0.29005587 -4.6254599 3.74E-06 8.01E-05
Xetrov72005843|Xetrov72005843|dlx2 79.9755241 -1.6124449 0.34866099 -4.6246782 3.75E-06 8.03E-05
Xetrov72037468|Xetrov72037468 8.88137403 -2.4190942 0.52626158 -4.5967524 4.29E-06 9.06E-05
Xetrov72043595|Xetrov72043595|eppk1 884.493993 -1.8969756 0.41273262 -4.5961367 4.30E-06 9.08E-05
Xetrov72023052|Xetrov72023052 10.9964405 -2.6199429 0.57093154 -4.5888915 4.46E-06 9.38E-05
Xetrov72017709|Xetrov72017709|lasp1 64.8561646 -1.0323195 0.22579846 -4.5718624 4.83E-06 0.00010125
Xetrov72007013|Xetrov72007013 13.5777856 -1.8329294 0.40163643 -4.5636533 5.03E-06 0.00010474
Xetrov72024698|Xetrov72024698|myo9a 139.461105 -1.1185098 0.24537483 -4.5583723 5.16E-06 0.00010681
Xetrov72003116|Xetrov72003116 77.4429748 -1.2039982 0.26437381 -4.5541507 5.26E-06 0.0001085
Xetrov72042623|Xetrov72042623|capns1 122.679957 -1.7009959 0.37503478 -4.5355682 5.74E-06 0.00011723
Xetrov72025509|Xetrov72025509|acsbg1 16.9462866 -2.1650949 0.47755001 -4.5337552 5.79E-06 0.00011805
Xetrov72040463|Xetrov72040463 87.5933594 -1.1091533 0.24711627 -4.4883863 7.18E-06 0.00014333
Xetrov72036399|Xetrov72036399 115.298378 -1.3668821 0.30478385 -4.4847589 7.30E-06 0.00014523
Xetrov72027607|Xetrov72027607|hes8 447.26319 -2.2933761 0.51199059 -4.4793325 7.49E-06 0.00014805
Xetrov72042371|Xetrov72042371 44.9403679 -1.2416792 0.27791259 -4.4678768 7.90E-06 0.00015467
Xetrov72001947|Xetrov72001947|hspc159 1198.63801 -1.6315286 0.36585589 -4.4594844 8.22E-06 0.00015986
Xetrov72005615|Xetrov72005615|gbx2.1 426.468384 -2.2201405 0.4996048 -4.4437933 8.84E-06 0.00017039
Xetrov72010075|Xetrov72010075 85.9920756 -1.0632147 0.23941385 -4.4409074 8.96E-06 0.00017251
Xetrov72002865|Xetrov72002865|unnamed 16.7907911 -2.052775 0.46447736 -4.4195373 9.89E-06 0.00018742
Xetrov72016298|Xetrov72016298 107.137786 -1.3706212 0.31043929 -4.4151021 1.01E-05 0.00019072
Xetrov72037160|Xetrov72037160|dnajb1 121.926485 -1.8268954 0.41436559 -4.4088974 1.04E-05 0.00019529
Xetrov72029943|Xetrov72029943|krt8 6825.7542 -1.2494493 0.28480699 -4.3870036 1.15E-05 0.00021262
Xetrov72007047|Xetrov72007047 91.3633853 -2.5398989 0.57919545 -4.385219 1.16E-05 0.00021353
Xetrov72017754|Xetrov72017754|hoxb4 74.3499476 -2.2843102 0.52175713 -4.3781102 1.20E-05 0.00021975
Xetrov72026284|Xetrov72026284 19.882441 -1.8907947 0.43192464 -4.3776031 1.20E-05 0.00022005
Xetrov72027308|Xetrov72027308|upk2 4718.48612 -1.1907971 0.27235201 -4.372272 1.23E-05 0.00022484
Xetrov72035506|Xetrov72035506|c7orf44 38.8721624 -1.0586733 0.2422793 -4.3696399 1.24E-05 0.00022734
Xetrov72043196|Xetrov72043196|cdh26 589.183119 -1.3906694 0.31922489 -4.3563941 1.32E-05 0.00024084
Xetrov72010982|Xetrov72010982|tmed10 325.354775 -1.6165907 0.37167547 -4.3494683 1.36E-05 0.0002469
Xetrov72020305|Xetrov72020305|slc45a3 18.2583329 -2.4197232 0.55663404 -4.3470629 1.38E-05 0.00024938
Xetrov72014526|Xetrov72014526|tmem164 942.390786 -1.1764737 0.27102946 -4.3407594 1.42E-05 0.00025616
Xetrov72005251|Xetrov72005251|tuba1a 1469.78343 -2.4154973 0.55720765 -4.3350038 1.46E-05 0.00026195
Xetrov72032084|Xetrov72032084 145.455725 -1.688873 0.38982564 -4.3323806 1.48E-05 0.00026484
Xetrov72017911|Xetrov72017911 8.17692568 -2.2989833 0.53204109 -4.3210635 1.55E-05 0.00027694
Xetrov72043395|Xetrov72043395 563.512013 -1.7989672 0.41656588 -4.318566 1.57E-05 0.0002793
Xetrov72026516|Xetrov72026516|oaf 379.504929 -1.0464644 0.24247113 -4.3158308 1.59E-05 0.00028225
Xetrov72025964|Xetrov72025964|wrap73 224.275432 -2.1602445 0.50119258 -4.3102084 1.63E-05 0.00028844
Xetrov72012057|Xetrov72012057 12.3186131 -1.8378066 0.42693619 -4.3046401 1.67E-05 0.00029496
Xetrov72034353|Xetrov72034353|unnamed 177.783181 -1.4411398 0.33500746 -4.301814 1.69E-05 0.00029761
Xetrov72016659|Xetrov72016659|fer1l4 292.444191 -1.5866804 0.37041618 -4.2835073 1.84E-05 0.00031905
Xetrov72007370|Xetrov72007370|sdc1 64.3159034 -1.2339456 0.28923355 -4.2662604 1.99E-05 0.00034125
Xetrov72021202|Xetrov72021202 1136.07589 -2.5250156 0.59249954 -4.2616331 2.03E-05 0.00034747
Xetrov72020505|Xetrov72020505|foxn4 562.80467 -2.0476678 0.4806057 -4.2605983 2.04E-05 0.00034845
Xetrov72042742|Xetrov72042742|zbtb7b 18.9326554 -2.0878991 0.49075488 -4.2544643 2.10E-05 0.0003562
231
Xetrov72040867|Xetrov72040867|mesp2 3.86725544 -2.4759933 0.58360758 -4.2425653 2.21E-05 0.00037405
Xetrov72004891|Xetrov72004891|map3k2 174.653619 -1.1465914 0.27059836 -4.2372444 2.26E-05 0.00038188
Xetrov72014783|Xetrov72014783|gch1 502.753809 -2.2088918 0.52203102 -4.231342 2.32E-05 0.00039099
Xetrov72019728|Xetrov72019728|gas2l1 358.491435 -1.032794 0.24489629 -4.217271 2.47E-05 0.00041397
Xetrov72042612|Xetrov72042612|foxh1 1947.6299 -1.0964964 0.26134471 -4.1955945 2.72E-05 0.00045082
Xetrov72017277|Xetrov72017277|unnamed 24.6635422 -1.9736666 0.47240605 -4.1779028 2.94E-05 0.00048142
Xetrov72017287|Xetrov72017287|ubp1 209.193968 -2.4197583 0.57949205 -4.1756541 2.97E-05 0.00048536
Xetrov72016724|Xetrov72016724|erbb2 639.050035 -1.4464019 0.34655875 -4.1736125 3.00E-05 0.0004893
Xetrov72017684|Xetrov72017684|afmid 10.1086506 -2.1907648 0.52545042 -4.1693083 3.06E-05 0.00049734
Xetrov72042628|Xetrov72042628 43.6067684 -1.9030956 0.45665031 -4.1675119 3.08E-05 0.00050041
Xetrov72028521|Xetrov72028521|unnamed 282.917822 -1.1508118 0.27625557 -4.1657505 3.10E-05 0.00050299
Xetrov72027644|Xetrov72027644|c15orf17 23.2636728 -1.6168599 0.38903431 -4.1560855 3.24E-05 0.00052249
Xetrov72009964|Xetrov72009964|elavl4 33.9431522 -1.864905 0.44945701 -4.14924 3.34E-05 0.00053469
Xetrov72035937|Xetrov72035937|unnamed 54.5802764 -1.8208167 0.43923006 -4.1454737 3.39E-05 0.00054126
Xetrov72013484|Xetrov72013484|syt16 81.4137359 -1.9488809 0.47026965 -4.1441774 3.41E-05 0.00054387
Xetrov72034338|Xetrov72034338|fam69c 30.9733092 -2.1059529 0.5096816 -4.1318991 3.60E-05 0.00056942
Xetrov72024328|Xetrov72024328|emx1.2 15.5950809 -2.067338 0.50083302 -4.127799 3.66E-05 0.00057792
Xetrov72017932|Xetrov72017932|eif1 4577.7467 -1.1651649 0.28282671 -4.1197131 3.79E-05 0.00059339
Xetrov72035701|Xetrov72035701 15.163566 -2.2575128 0.54833853 -4.1170056 3.84E-05 0.00059831
Xetrov72035876|Xetrov72035876|unnamed 172.682997 -1.7525895 0.4262245 -4.1118929 3.92E-05 0.00060881
Xetrov72036556|Xetrov72036556|fzd3 673.843662 -1.2020959 0.29305889 -4.1018921 4.10E-05 0.00063339
Xetrov72018129|Xetrov72018129|slc25a19 97.9760989 -1.4326051 0.34933875 -4.1009053 4.12E-05 0.00063532
Xetrov72005689|Xetrov72005689 6.29568802 -2.1547605 0.52675295 -4.0906472 4.30E-05 0.00065922
Xetrov72002283|Xetrov72002283 6.30548862 -2.3346075 0.57097555 -4.0888046 4.34E-05 0.0006634
Xetrov72b000086|Xetrov72b000086 303.411154 -1.4267789 0.34937813 -4.083767 4.43E-05 0.00067631
Xetrov72026791|Xetrov72026791|elovl3 12.0095004 -2.1049331 0.51640065 -4.0761627 4.58E-05 0.00069598
Xetrov72006613|Xetrov72006613|unnamed 83.1662673 -2.4072741 0.59247166 -4.0631042 4.84E-05 0.00072729
Xetrov72001200|Xetrov72001200|fam82a1 37.08796 -1.0022405 0.24796032 -4.0419392 5.30E-05 0.00078615
Xetrov72012075|Xetrov72012075 52.3289613 -1.4476216 0.35826602 -4.0406332 5.33E-05 0.00078992
Xetrov72021445|Xetrov72021445|gmpr2 48.5965897 -1.6266349 0.40303079 -4.0360065 5.44E-05 0.00080312
Xetrov72005926|Xetrov72005926|hagh 44.6461708 -1.0634242 0.26414152 -4.025964 5.67E-05 0.00083556
Xetrov72000541|Xetrov72000541|capn13 528.523884 -1.6611476 0.41572556 -3.9957792 6.45E-05 0.00093276
Xetrov72036576|Xetrov72036576|unnamed 82.7448221 -2.3470132 0.58833942 -3.9892162 6.63E-05 0.00095527
Xetrov72001957|Xetrov72001957|fam177b 17.5386253 -1.3252624 0.33240098 -3.9869388 6.69E-05 0.00096228
Xetrov72004305|Xetrov72004305|col18a1 3859.48501 -1.2641107 0.3176306 -3.9798139 6.90E-05 0.00098481
Xetrov72029630|Xetrov72029630 642.962226 -1.1096351 0.27901793 -3.9769312 6.98E-05 0.00099249
Xetrov72019280|Xetrov72019280|kit 1481.28459 -1.6983079 0.42726886 -3.9747992 7.04E-05 0.00099976
Xetrov72008632|Xetrov72008632|kifc3 757.587246 -1.0126647 0.25477169 -3.9747929 7.04E-05 0.00099976
Xetrov72033472|Xetrov72033472|vill 100.811312 -2.3055969 0.58033828 -3.97285 7.10E-05 0.00100341
Xetrov72026535|Xetrov72026535|slc25a16 322.635297 -1.0976154 0.27712376 -3.960741 7.47E-05 0.00104627
Xetrov72016351|Xetrov72016351 2.32444472 -2.3289348 0.5887556 -3.9556903 7.63E-05 0.00106624
Xetrov72020061|Xetrov72020061|epb41l4a 75.4212235 -1.3653144 0.34675942 -3.9373535 8.24E-05 0.00114091
Xetrov72040856|Xetrov72040856 11.3265538 -1.7610462 0.44751529 -3.9351643 8.31E-05 0.00114912
Xetrov72020429|Xetrov72020429|lpcat4 298.585928 -1.4802601 0.37622536 -3.9345037 8.34E-05 0.00115031
Xetrov72027545|Xetrov72027545 6.12144164 -2.3211894 0.59053256 -3.9306712 8.47E-05 0.00116368
Xetrov72027174|Xetrov72027174|c1orf93 224.218089 -1.002099 0.25721811 -3.8959117 9.78E-05 0.00131328
Xetrov72038242|Xetrov72038242|cnnm3 278.499404 -1.1052488 0.28431919 -3.8873519 0.00010134 0.00135465
Xetrov72036687|Xetrov72036687|cyp2a13 161.424582 -1.4891161 0.38402265 -3.8776778 0.00010546 0.00140268
Xetrov72030691|Xetrov72030691|p2ry2 760.048438 -1.0707481 0.27628642 -3.8755001 0.00010641 0.00141329
Xetrov72039181|Xetrov72039181|epb49 8.74171971 -1.6984689 0.43929168 -3.8663808 0.00011046 0.00145588
Xetrov72010708|Xetrov72010708|pmm2 2772.06359 -1.1639381 0.3010307 -3.8665095 0.0001104 0.00145588
Xetrov72011932|Xetrov72011932|slc22a20 5.45603346 -2.2039297 0.57054721 -3.862835 0.00011208 0.00147203
Xetrov72023912|Xetrov72023912|s1pr3 11.3255105 -1.8873279 0.48965707 -3.8543872 0.00011602 0.00151429
Xetrov72042153|Xetrov72042153 48.5512363 -1.6182291 0.41992352 -3.8536282 0.00011638 0.00151794
Xetrov72010968|Xetrov72010968|tnni2 35.6289407 -1.3222659 0.34317772 -3.8530063 0.00011668 0.00152075
Xetrov72020621|Xetrov72020621|mmp11 41.5404928 -2.0206473 0.52542849 -3.8457131 0.0001202 0.00155701
Xetrov72007986|Xetrov72007986 107.705314 -1.1165919 0.29072374 -3.8407319 0.00012267 0.00158242
Xetrov72010303|Xetrov72010303 29.6649213 -2.1369973 0.55808231 -3.8291794 0.00012857 0.00164841
Xetrov72016215|Xetrov72016215|lgals3 1188.57297 -1.0589802 0.27675443 -3.8264252 0.00013002 0.00166427
Xetrov72018434|Xetrov72018434 21.1979893 -1.7294804 0.45288968 -3.8187675 0.00013412 0.00170677
Xetrov72027085|Xetrov72027085|scn3b 10.2055255 -2.0260263 0.53166956 -3.8106871 0.00013858 0.00175593
Xetrov72038842|Xetrov72038842|atp6v1b2 499.097398 -1.1287513 0.29745029 -3.794756 0.00014779 0.00185687
Xetrov72018725|Xetrov72018725|myo5b 829.480741 -1.3800207 0.3638855 -3.7924587 0.00014916 0.00187164
Xetrov72037045|Xetrov72037045 27.2137305 -1.3241925 0.34929866 -3.7910037 0.00015004 0.00187889
Xetrov72017187|Xetrov72017187|cpne1 753.194339 -1.0103776 0.26668155 -3.7887045 0.00015143 0.00188882
Xetrov72006244|Xetrov72006244|unnamed 12.831364 -1.7278149 0.45691705 -3.7814629 0.00015591 0.0019395
Xetrov72005792|Xetrov72005792|hoxd13 10.3969025 -1.9516237 0.5174106 -3.7719052 0.00016201 0.00199846
Xetrov72035352|Xetrov72035352|frat1 7.86336347 -1.6240353 0.43148374 -3.7638389 0.00016732 0.00204759
Xetrov72003666|Xetrov72003666|golph3l 953.780306 -1.1128105 0.29603738 -3.7590203 0.00017058 0.00208212
Xetrov72027478|Xetrov72027478|esr10 113.670398 -1.3933419 0.37161709 -3.7494021 0.00017726 0.00215106
Xetrov72005493|Xetrov72005493|foxj1.2 233.427702 -2.1918007 0.58468883 -3.7486618 0.00017778 0.00215364
232
Xetrov72017641|Xetrov72017641|hoxb1 25.2544748 -2.1501451 0.574244 -3.7443058 0.00018089 0.00218394
Xetrov72b000108|Xetrov72b000108|agr2 262.488026 -1.8154699 0.48756286 -3.7235607 0.00019643 0.00233267
Xetrov72019210|Xetrov72019210|kiaa1324 468.704476 -1.7045764 0.45965899 -3.70835 0.00020861 0.00244648
Xetrov72008965|Xetrov72008965|irak2 22.6940515 -1.725796 0.46579015 -3.7050934 0.00021131 0.00247504
Xetrov72026079|Xetrov72026079|sgms1 1696.50786 -1.2651899 0.34171921 -3.7024256 0.00021355 0.00249656
Xetrov72032066|Xetrov72032066 13876.0566 -1.0096035 0.27482035 -3.6736854 0.00023908 0.00275529
Xetrov72028093|Xetrov72028093|unnamed 31.1674755 -1.9706475 0.53777793 -3.6644261 0.00024789 0.00284338
Xetrov72037807|Xetrov72037807|cep152 1036.29006 -1.1708904 0.31960191 -3.6635903 0.0002487 0.00285094
Xetrov72014018|Xetrov72014018|nr6a1 4404.28454 -1.3989929 0.38221945 -3.6601823 0.00025204 0.00288314
Xetrov72018222|Xetrov72018222 32.3736698 -1.0278242 0.28136428 -3.6530018 0.00025919 0.00295856
Xetrov72024689|Xetrov72024689 181.689262 -2.1655799 0.59314824 -3.6509927 0.00026123 0.0029782
Xetrov72012134|Xetrov72012134 18.1897118 -1.3506193 0.3712957 -3.6375839 0.00027521 0.00311205
Xetrov72025319|Xetrov72025319|gbp1 17.1009511 -1.1806493 0.32472896 -3.6357991 0.00027712 0.00313094
Xetrov72017884|Xetrov72017884|myl9 61.5035713 -1.0869997 0.29904692 -3.6348802 0.00027811 0.00314024
Xetrov72003655|Xetrov72003655|creb3l4 208.004514 -2.1680891 0.59676204 -3.6330882 0.00028005 0.00315646
Xetrov72017538|Xetrov72017538 386.046581 -1.3695071 0.37704864 -3.6321763 0.00028104 0.00316575
Xetrov72013135|Xetrov72013135|hsp90aa1.2 10.4892096 -1.9358006 0.53367578 -3.6272972 0.0002864 0.00321653
Xetrov72026858|Xetrov72026858|unnamed 5.2737444 -2.1424065 0.59433482 -3.604713 0.0003125 0.00345196
Xetrov72042530|Xetrov72042530 34.5134593 -2.0553817 0.57127828 -3.5978642 0.00032084 0.00352345
Xetrov72031134|Xetrov72031134|phox2a 87.0717936 -1.0142916 0.28206234 -3.5959837 0.00032317 0.00354487
Xetrov72010856|Xetrov72010856|fam3a 977.258726 -1.3615958 0.38052858 -3.5781697 0.00034601 0.00375172
Xetrov72038238|Xetrov72038238|fam13b 173.819992 -1.0003036 0.27992701 -3.5734446 0.00035232 0.00381132
Xetrov72018433|Xetrov72018433 6810.38546 -1.3313888 0.37308944 -3.5685512 0.00035896 0.00387078
Xetrov72017707|Xetrov72017707|hoxb5 11.1957687 -2.0693524 0.58149828 -3.5586561 0.00037276 0.0039844
Xetrov72013752|Xetrov72013752|znf329 108.32329 -1.4751373 0.41803786 -3.528717 0.00041758 0.00438878
Xetrov72006674|Xetrov72006674|chpf 270.260241 -1.2042932 0.34136847 -3.5278396 0.00041897 0.00440089
Xetrov72042984|Xetrov72042984|fblim1 61.2975022 -1.5971725 0.45345673 -3.5222158 0.00042796 0.00447962
Xetrov72001104|Xetrov72001104|pdia6 1343.60554 -1.0277666 0.2924658 -3.5141428 0.00044118 0.00458054
Xetrov72036913|Xetrov72036913|hs3st3a1 171.318817 -1.3048033 0.37139915 -3.5132103 0.00044273 0.00459411
Xetrov72021872|Xetrov72021872|slc25a22 205.098072 -1.3860706 0.39455847 -3.5129662 0.00044313 0.00459581
Xetrov72020174|Xetrov72020174|slain2 336.832377 -1.068072 0.30445506 -3.5081433 0.00045125 0.00466965
Xetrov72023443|Xetrov72023443|camk1g 11.6850162 -1.5059436 0.42965669 -3.5049927 0.00045662 0.00471232
Xetrov72012756|Xetrov72012756|iqsec2 54.30814 -1.2741915 0.36449358 -3.4957858 0.00047267 0.00484871
Xetrov72020878|Xetrov72020878|gcnt1 78.2504035 -1.0866101 0.31111835 -3.4925942 0.00047835 0.00489587
Xetrov72011491|Xetrov72011491 208.695902 -1.2246581 0.35078483 -3.4911946 0.00048087 0.00491674
Xetrov72016080|Xetrov72016080 363.765167 -1.2762017 0.36559029 -3.4907976 0.00048158 0.00492137
Xetrov72041478|Xetrov72041478|tfcp2l1 376.735999 -1.4410543 0.41520538 -3.4707025 0.0005191 0.0052422
Xetrov72037659|Xetrov72037659|trpv6 12.6914415 -1.9364281 0.55897214 -3.4642659 0.00053168 0.00534348
Xetrov72031953|Xetrov72031953 265.656367 -1.2883383 0.37220121 -3.4614028 0.00053737 0.005392
Xetrov72027323|Xetrov72027323|hes3.1 2036.14364 -1.1187134 0.32324012 -3.4609362 0.0005383 0.00539848
Xetrov72042859|Xetrov72042859|unnamed 208.733484 -2.0240884 0.58913013 -3.4357238 0.00059097 0.00586118
Xetrov72032691|Xetrov72032691 276.329224 -1.4557188 0.42389478 -3.4341512 0.00059441 0.00588909
Xetrov72039904|Xetrov72039904|unnamed 454.022225 -1.9031162 0.55616751 -3.42184 0.00062199 0.00610769
Xetrov72040162|Xetrov72040162|sap30l 19.8960648 -1.2124256 0.35480111 -3.417198 0.00063269 0.00619663
Xetrov72012187|Xetrov72012187|adap1 900.607733 -1.0064217 0.29505571 -3.4109549 0.00064736 0.00630712
Xetrov72035057|Xetrov72035057|chmp4c 76.4368893 -1.4331027 0.42115552 -3.4027874 0.00066702 0.00647895
Xetrov72033573|Xetrov72033573|casd1 150.849574 -1.7828627 0.52665027 -3.3852877 0.00071104 0.0067978
Xetrov72014019|Xetrov72014019|chst4 283.318665 -1.1206416 0.33120284 -3.3835507 0.00071555 0.00683055
Xetrov72034324|Xetrov72034324 46.2911855 -1.818535 0.53759745 -3.3827076 0.00071775 0.00684808
Xetrov72036962|Xetrov72036962 3.13809594 -2.0132289 0.59564238 -3.379929 0.00072505 0.00691068
Xetrov72013642|Xetrov72013642 40.3956593 -1.2958385 0.38379133 -3.3764143 0.00073437 0.00697487
Xetrov72038928|Xetrov72038928|slc18a2 47.5807158 -2.0009918 0.59334639 -3.3723839 0.00074521 0.00706351
Xetrov72021587|Xetrov72021587 12.760488 -1.9459992 0.57819999 -3.3656161 0.00076373 0.00721655
Xetrov72007774|Xetrov72007774 14.8044 -1.20412 0.35827533 -3.3608788 0.00077695 0.00732019
Xetrov72029860|Xetrov72029860|cyp4f22 60.485332 -1.8445189 0.55063652 -3.349794 0.00080872 0.00755524
Xetrov72020407|Xetrov72020407|kcna1 28.014804 -1.2498167 0.37339643 -3.3471576 0.00081645 0.00760309
Xetrov72036590|Xetrov72036590|tdh 24.9568319 -1.4045906 0.41984795 -3.3454745 0.00082142 0.00763604
Xetrov72034683|Xetrov72034683|hoxa1 431.75623 -1.5219162 0.45639799 -3.3346251 0.00085414 0.0078819
Xetrov72022127|Xetrov72022127 9.275179 -1.5786567 0.47501998 -3.3233479 0.00088944 0.00815168
Xetrov72026902|Xetrov72026902|hmx2 38.355637 -1.9817074 0.59704227 -3.3192079 0.00090273 0.00825342
Xetrov72010158|Xetrov72010158|fa2h 91.9575414 -1.7914712 0.54033635 -3.3154741 0.00091488 0.00834026
Xetrov72002030|Xetrov72002030 24.177272 -1.7248241 0.52046672 -3.3139951 0.00091973 0.00837227
Xetrov72036278|Xetrov72036278|axin2 22.6735237 -1.5558808 0.46974842 -3.3121576 0.00092579 0.00841119
Xetrov72010040|Xetrov72010040|syt8 594.513727 -1.451108 0.43983162 -3.2992353 0.00096949 0.00872815
Xetrov72016788|Xetrov72016788|arhgap27 338.190491 -1.1321988 0.34453099 -3.2862031 0.00101548 0.00906514
Xetrov72016332|Xetrov72016332|rab3d 78.8445567 -1.6747285 0.51110003 -3.2767137 0.00105023 0.00930823
Xetrov72010152|Xetrov72010152|foxf1 100.037452 -1.7740458 0.54192852 -3.273579 0.00106195 0.00939001
Xetrov72018611|Xetrov72018611|dmxl1 164.018939 -1.0698204 0.32707889 -3.2708329 0.00107231 0.00946138
Xetrov72022781|Xetrov72022781|ypel1 12.4225859 -1.5009288 0.46064903 -3.2582914 0.00112085 0.00983697
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